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Transition metal-catalyzed reactions are rapidly being developed for the synthesis complex natural and non-
natural products. Among these, palladium-catalyzed reactions are both attractive and reliable. However, a
formidable challenge at the forefront of organic chemistry is the control of selectivity to enable the selective
formation of diverse structural motifs from readily available substrate classes. Herein, progress toward
broadening the scope of palladium-catalyzed C–C bond-forming reactions is demonstrated, with a particular
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readily available 2-B(pin)-substituted allylic acetates, benzoates, and carbonates. Depending on the choice of
reagents, catalysts and reaction conditions, 2-B(pin)-substituted allylic acetates and derivatives can be steered
into one of three reaction manifolds: allylic substitution, Suzuki-Miyaura cross-coupling, or elimination to
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reactivity of allylic carbonates approaching that of aryl bromides. Additionally, we also probe the
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C–2 substituents in 1,2,3-trisubstituted η3-allylpalladium intermediates provide stronger preference for
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based system via a deprotonative cross-coupling process. Under conditions where the azaarylmethyl amines
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ABSTRACT	
	
PART	I:	CHEMOSELECTIVE	PALLADIUM	CATALYZED	REACTIONS	OF	BIFUNCTIONAL	2-B(PIN)-SUBSTITUTED	
ALLYLIC	ACETATE	DERIVATIVES	
PART	II:	PALLADIUM	CATALYZED	DEPROTONATIVE	ARYLATION	OF	AZAARYLMETHYL	AMINES	AND	ETHERS	
	
Byeong-Seon	Kim	
Professor	Patrick	J.	Walsh	
	
	 Transition	 metal-catalyzed	 reactions	 are	 rapidly	 being	 developed	 for	 the	 synthesis	 complex	
natural	 and	non-natural	 products.	 	Among	 these,	palladium-catalyzed	 reactions	 are	both	attractive	 and	
reliable.		However,	a	formidable	challenge	at	the	forefront	of	organic	chemistry	is	the	control	of	selectivity	
to	 enable	 the	 selective	 formation	 of	 diverse	 structural	 motifs	 from	 readily	 available	 substrate	 classes.		
Herein,	 progress	 toward	 broadening	 the	 scope	 of	 palladium-catalyzed	 C–C	 bond-forming	 reactions	 is	
demonstrated,	with	a	particular	focus	on	controlling	reactivity,	regioselectivity,	and	chemoselectivity.		
	 Chapters	1	and	2	describe	detailed	studies	of	chemoselectivity	with	palladium-based	phosphine	
catalysts	and	readily	available	2-B(pin)-substituted	allylic	acetates,	benzoates,	and	carbonates.		Depending	
on	 the	 choice	 of	 reagents,	 catalysts	 and	 reaction	 conditions,	 2-B(pin)-substituted	 allylic	 acetates	 and	
derivatives	can	be	steered	into	one	of	three	reaction	manifolds:	allylic	substitution,	Suzuki-Miyaura	cross-
coupling,	or	elimination	to	form	allenes,	all	with	excellent	chemoselectivity.		Detailed	study	of	this	system	
indicates	the	relative	order	of	reactivity	toward	Pd(0)	is	Ar–I	>	Ar–Br	>	allylic	carbonate	>	allylic	benzoate	>	
allylic	acetate,	with	the	reactivity	of	allylic	carbonates	approaching	that	of	aryl	bromides.		Additionally,	we	
also	probe	the	regioselectivity	with	1,2,3-trisubstituted	allylic	substrates	in	Tsuji-Trost	allylic	substitution	
iv	
reactions.	 	 Bulkier	 C–2	 substituents	 in	 1,2,3-trisubstituted	 η3-allylpalladium	 intermediates	 provide	
stronger	preference	for	nucleophilic	attack	at	anti-oriented	benzylic	termini.	
	 Chapters	3	and	4	describe	a	direct	C–H	functionalization	approach	to	produce	skeletally	diverse	
aryl(pyridyl)methyl	 core	 structures.	 	 The	 novel	 arylation	 step	 is	 catalyzed	 by	 a	 Pd(OAc)2/NIXANTPHOS-
based	 system	 via	 a	 deprotonative	 cross-coupling	 process.	 	 Under	 conditions	 where	 the	 azaarylmethyl	
amines	 or	 ethers’	 benzylic	 C–H	 is	 reversibly	 deprotonated,	 a	 Pd(OAc)2/NIXANTPHOS-based	 catalyst	
couples	 the	resulting	carbanions	with	various	aryl	halides	 to	provide	new	C–C	bonds.	 	The	efficient	and	
operationally	simple	protocols	enable	generation	of	either	arylation	products	or	tandem	arylation/[1,2]-
Wittig	rearrangement	products	with	remarkable	selectivity	and	good	to	excellent	yields.		Choice	of	base,	
solvent,	 and	 reaction	 temperature	 play	 a	 pivotal	 role	 in	 tuning	 the	 reactivity	 of	 intermediates	 and	
controlling	the	relative	rates	of	competing	processes.		These	practical	methods	will	be	applicable	for	the	
synthesis	of	a	broad	array	of	pyridyl-containing	amines,	ethers	and	alcohols.	
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1	
CHAPTER	1	
Breaking	Conjugation:	Unusual	Regioselectivity	with	2-Substituted	Allylic	Substrates	in	the	
Tsuji-Trost	Reaction	
Adapted	with	permission	from	Chem.	Sci.	2014,	5,	1241–1250	Copyright	2014	Royal	Society	of	
Chemistry.	
	
1.1. Introduction	
	 Transition	metal-catalyzed	 allylic	 substitution	 reactions	 are	 among	 the	most	 powerful	
synthetic	 methods	 in	 organic	 chemistry.1,2	 	 In	 particular,	 the	 palladium-catalyzed	 Tsuji-Trost	
reaction	has	become	an	efficient	method	to	construct	carbon–carbon	and	carbon–heteroatom	
bonds.1b,1c,2b,3		One	of	the	most	interesting	and	challenging	aspects	of	allylic	substitutions	is	the	
control	 of	 regioselectivity.1a,1b,4	 	 The	 regioselectivity	 of	 the	 palladium-catalyzed	 allylic	
substitution	 reaction	depends	on	 several	 parameters1a,4b,4c	 including:	 the	nature	of	 the	 ligand,	
solvent,	counter	anion,	leaving	group,	nucleophile,	base,	allyl	fragment,	and	additives.2f,3a,5	
	 The	 mechanism	 of	 the	 Pd-catalyzed	 allylic	 substitution	 has	 been	 well	 investigated.		
Initial	 coordination	 of	 the	 allylic	 substrate	 at	 the	 double	 bond	 is	 followed	 by	 attack	 of	
palladium(0)	 on	 the	 C–O	 s*-orbital	 of	 the	 leaving	 group,	 generating	 a	 cationic	 (η3-allyl)PdLn	
intermediate.		Stabilized	anionic	nucleophiles	directly	attack	the	η3-allyl	terminus.6		The	overall	
process	occurs	with	a	net	retention	of	configuration	(via	a	double	inversion	pathway).1b,1c,7		For	
unsymmetrical	(η3-allyl)Pd	intermediates,	attack	can	occur	at	either	of	the	termini,	giving	rise	to	
regioselectivity	issues.	 	Another	complicating	factor	of	η3-allyls	bearing	terminal	substituents	is	
the	possibility	of	syn-anti	isomerization,	as	shown	in	the	center	of	Scheme	1.8		This	isomerization	 
2	
Scheme	1.1	 The	Dynamic	Manifold	of	Intermediates	in	Pd-Assisted	Allylic	Alkylation.	
	
	
can	be	fast,	with	all	of	the	isomeric	substrates	feeding	into	the	(η3-allyl)Pd	manifold	and	giving	
rise	to	the	same	product	distribution	(Scheme	1.1).9	 	
	 However,	if	the	isomerization	is	slow	relative	to	nucleophilic	attack,10	or	in	the	presence	
of	 chiral11	 or	 electronically	 differentiated12	 ligands,	 the	 reaction	 can	 show	 strong	 memory	
effects.		Under	conditions	of	slow	isomerization,	nucleophilic	attack	has	a	strong	preference	for	
reaction	 at	 anti-oriented	 termini.13	 	 In	 the	 absence	 of	memory	 effects,	 the	 regioselectivity	 is	
largely	dependent	on	the	steric	and	electronic	nature	of	the	terminal	η3-allyl	substituents.4b,4c		In	
general,	 nucleophilic	 attack	will	 occur	 at	 the	 allylic	 terminus	with	 the	 highest	 partial	 positive	
charge.14	 	 Conjugated	 products	 are	 frequently	 preferred,	 in	 particular	 with	 strongly	 electron	
withdrawing	 groups.1b,3a,15	 	 It	 is	 possible	 to	 influence	 the	 regioselectivity	 to	 some	 extent	 by	
R1 R3
OAc
R2
R1
R3OAc
R2
R3R1
OAc
R2
R3
R1 OAc
R2
R1
R3
R2
Pd
L L
R1 R3
R2
Pd
L L
R1
R3
R2
Pd
L L
R1 R3
Nu
R2
R1
R3Nu
R2
R3R1
Nu
R2
R3
R1 Nu
R2
syn anti
syn syn
anti syn
3	
controlling	 the	 steric	 bulk	 of	 the	 ligands.13,16	 	 In	 these	 cases,	 the	 preferred	 regio-	 and	 stereo-
selectivity	can	be	understood	in	terms	of	distortion	of	the	(η3-allyl)Pd	intermediate.16-17			
	 Previous	 mechanistic	 investigations	 have	 mostly	 focused	 on	 substrates	 giving	 rise	 to	
mono-	or	1,3-disubstituted	 (η3-allyl)Pd	 intermediates.1b,18	 	 In	general,	1-aryl-3-alkyl-substituted	
(η3-allyl)Pd	complexes	have	a	strong	preference	for	nucleophilic	attack	at	the	alkyl-substituted	
terminus,	 yielding	 conjugated	 products.16-17,19	 	 This	 preference	 can	 be	 further	 increased	 by	
utilization	 of	 ligands	 to	 force	 the	 alkyl	 substituent	 into	 the	 more	 reactive	 anti-configuration	
(Scheme	1.1).	13,16-17	
	 Our	 interest	 in	 trisubstituted	 (η3-allyl)Pd	 intermediates	 grew	 out	 of	 methods	 we	
developed	for	the	synthesis	of	2-B(pin)-substituted	allylic	acetates	and	related	compounds.20,21		
At	 the	outset	 of	 our	 studies,	we	demonstrated	2-B(pin)-substituted	 allylic	 acetates	 undergoes	
the	Tsuji-Trost	allylic	substitution	reaction	successfully.21		In	the	meantime,	a	few	methods	with	
boron-substituted	 allyls	 have	 been	 reported	 in	 allylic	 substitution	 reactions	 (Scheme	 1.2).21,22		
Before	our	preliminary	 results	 (Scheme	1.2D),21	however,	no	prior	examples	of	allylic	acetates	
containing	 a	 boron	 at	 the	 2-position	 were	 employed	 in	 transition	 metal-catalyzed	 allylic	
substitution	 reactions,	 although	 some	 examples	 of	 3-boron	 substituted	 analogs	 had	 been	
generated	or	proposed	as	intermediates.22	
	 As	 inferred	 by	 Scheme	 1.2D,21	 2-B(pin)-substituted	 allylic	 acetates	 are	 expected	 to	
generate	 (η3-1-aryl-2-boryl-3-alkyl-allyl)palladium	 intermediates.	 	 Contrary	 to	 aliphatic	
substitutions,16	 however,	 nucleophilic	 attack	 occurred	 at	 the	 benzylic	 position	 with	 very	 high	
selectivity	(Scheme	1.2D).		In	general,	products	derived	from	benzylic	attack	of	(η3-1-aryl-3-alkyl-	
allyl)palladium	 intermediates	 are	 the	 minor	 isomer.16-17,19a-d	 	 Herein,	 we	 have	 undertaken	 an	
experimental	 and	 computational	 investigation	 of	 cationic	 (η3-1-phenyl-2-B(pin)-3-alkyl-	
4	
allyl)Pd(PPh3)2	and	related	intermediates.		We	present	a	systematic	substrate-selectivity	study	to	
elucidate	 the	 origin	 of	 the	 unusual	 selectivity	 in	 allylic	 substitutions	 with	 cationic	 (η3-1,2,3-
trisubstituted	allyl)palladium	intermediates.	
	
Scheme	1.2.	 Metal	Catalyzed	Allylic	Substitution	of	Borylated	Allylic	Acetates	and	Carbonates	
	
	
1.2. Results	and	Discussion	
	 A	fundamental	unanswered	question	in	the	Tsuji-Trost	allylic	substitution	reaction	with	
1,2,3-trisubstituted	 allylic	 acetates	 is:	 What	 is	 the	 impact	 of	 the	 2-substituent	 on	 the	
regioselectivity	 of	 nucleophilic	 attack?	 	 This	 question	 emerged	 as	 we	 explored	 palladium-
catalyzed	 allylic	 substitution	 of	 2-B(pin)-substituted	 allylic	 acetates,	 and	 inspired	 us	 to	
investigate	this	topic.	
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Table	 1.1	 Palladium-Catalyzed	 Allylic	 Substitution	 Reaction	 with	 2-B(pin)-Substituted	 Allylic	
Acetatesa	
	
1.2.1. Reactions	of	2-B(pin)-Substituted	Allylic	Acetates	with	Palladium	Catalysts. 
	 We	 recently	 communicated21	 the	 palladium-catalyzed	 allylic	 substitution	 reaction	
employing	 2-B(pin)-substituted	 allylic	 acetates	 (1.1,	 Table	 1.1).	 	 In	 our	 initial	 study,	 we	 were	
surprised	to	find	that	the	2-B(pin)	group	plays	a	decisive	role	in	determining	the	regioselectivity	
of	 nucleophilic	 attack.	 	 For	 example,	 2-B(pin)-substituted	 allylic	 acetate	 1.1a	 underwent	
substitution	 with	 sodium	 dimethyl	 malonate	 to	 furnish	 2-B(pin)-substituted	 allylic	 alkylation	
product	1.2a	with	excellent	regioselectivity	(>90:10)	in	79%	yield	(Table	1.1,	entry	1).		Analogous	
R1
OAc
B(pin)
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a See the experimental sextion for details. b Yield of purified and isolated products. c Ratios 
were determined by 1H NMR spectroscopy of unpurified reaction mixtures. d Reference 21.  
e Bis(trimethylsilyl)acetamide, CH2(CO2Me)2 and catalytic KOAc were used instead of 
NaCH(CO2Me)2.
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reactions	with	electron	withdrawing	or	donating	substituents	on	the	aryl	groups	(1.1b	and	1.1c)	
provided	 the	 benzylic	 substitution	 products	 (1.2b	 and	 1.2c)	 with	 excellent	 regioselectivity	
(>95:5)	 in	 92	 and	 80%	 yield,	 respectively	 (entries	 2	 and	 3).	 	 It	 is	 noteworthy	 that	 isomeric	 2-
B(pin)-substituted	 allylic	 acetates	 1.1a	 and	 1.1d	 underwent	 substitution	 to	 afford	 the	 same	
product,	 1.2a,	 with	 nearly	 identical	 regioselectivities	 (entries	 1	 vs.	 4).	 	 This	 result	 clearly	
demonstrates	 the	 absence	 of	 regiochemical	memory	 effects.10	 	 Allylic	 acetate	1.1d,	 however,	
afforded	 a	 diminished	 yield	 of	 the	 substitution	 product	 (51%,	 entry	 4)	 relative	 to	 1.1a	 (79%	
yield).		Primary	and	secondary	amines	also	participated	in	the	allylic	substitution	reaction	to	give	
similar	 regioselectivities	 (>90:10)	 by	 nucleophilic	 attack	 at	 the	 benzylic	 position.21	 	 We	 were	
concerned	 that	 the	 3-n-butyl	 substituent	 might	 adopt	 a	 conformation	 180°	 opposite	 the	
palladium	center	and	hinder	nucleophilic	attack	at	 the	3-position	 (Figure	1.1).	 	To	 remove	any	
potential	conformational	 issues	caused	by	the	3-n-butyl	substituent,	2-B(pin)-substituted	allylic	
acetate	 1.1e,	 with	 a	 smaller	 3-methyl	 substituent	 in	 place	 of	 the	 n-butyl	 group	 of	 1.1a,	 was	
prepared	 (see	 Supporting	 Information	 for	 details).	 	 Interestingly,	 1.1e	 also	 provided	 benzylic	
substitution,	 affording	 1.2e	 with	 excellent	 regioselectivity	 (>95:5)	 in	 70%	 yield	 (entry	 5).	 	 As	
outlined	 in	 Table	 1,	 the	 1-aryl-2-B(pin)-3-alkyl	 η3-allyls	 showed	 a	 strong	 preference	 for	
nucleophilic	attack	at	the	benzylic	site,	in	contrast	to	the	observed	regioselectivity	in	Tsuji-Trost	
allylic	 substitution	 reactions	 with	 1-aryl-substituted	 η3-allyl	 intermediates.19a-c,19e	 	 The	 unique	
regioselectivity	 of	 2-B(pin)-substituted	 allylic	 acetates	 makes	 them	 potentially	 valuable	 in	
synthesis.		The	factors	that	control	the	regioselectivity	with	2-B(pin)-substituted	allylic	acetates,	
however,	are	unclear.		This	is	the	subject	of	the	following	section.	
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Figure	1.1.	Interference	between	alkyl	group	and	incoming	nucleophile.	
	
 
1.2.2. Computational	Analysis	
	 Many	different	computational	methods	have	been	used	to	 investigate	the	reactivity	of	
(η3-allyl)Pd	complexes.23	 	 In	 these	calculations	 it	 is	 found	 that	 the	 transition	 state	 is	unusually	
sensitive	to	the	nature	of	the	solvent	employed.24		To	minimize	such	solvent	related	issues,	we	
employ	 a	 neutral	 model	 nucleophile	 (ammonia)	 reacting	 with	 a	 cationic	 (η3-allyl)Pd(PPh3)2	
complex	to	yield	a	cationic	allyl	ammonium	product	coordinated	to	a	neutral	Pd0(PPh3)2	moiety.		
This	 procedure	 maintains	 the	 overall	 charge,	 minimizing	 computational	 artifacts	 arising	 from	
imperfect	 solvation	of	 complexes	with	different	 charges.12	 	All	 calculations	were	performed	 in	
Jaguar25	 with	 B3LYP-D3,	 which	 uses	 the	 dispersion-correction	 of	 Grimme	 and	 co-workers26	
together	 with	 the	 classical	 B3LYP	 functional.27	 	 We	 utilized	 the	 LACVP*	 basis	 set28	 and	 PBF	
solvation29	with	default	parameters	for	THF.	
	 We	 located	 the	 approximate	 “transition	 states”	 by	 scanning	 the	 forming	 C–N	 bond	
distance	while	 relaxing	 all	 other	 coordinates	 in	 the	 presence	 of	 the	 continuum	 solvent.	 	 This	
technique	 has	 been	 successful	 for	 very	 similar	 systems,30	 and	 is	 expected	 to	 yield	 final	
transitions	 state	energies	within	 a	 few	kJ	mol-1	 of	 the	expected	 fully	 converged	 values.31	 	 The	
final	 structures	 were	 also	 subjected	 to	 traditional	 transition	 state	 searching,	 but	 numerical	
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component	 in	 solvated	 Jaguar	calculations	makes	 the	energy	 surface	discontinuous	with	 small	
bumps	that	tend	to	impact	negatively	the	transition	search	algorithm.		The	energy	profile	is	also	
unusually	flat,	with	changes	of	only	a	few	kJ	mol-1	over	a	0.2–0.3	Å	span	in	reaction	coordinate	
(here	taken	as	the	forming	C–N	bond	distance).		Thus,	the	transition	state	search	results	differed	
depending	 on	 the	 starting	 point,	 by	 up	 to	 4	 kJ	 mol-1.	 	 Furthermore,	 the	 final	 frequency	
calculation	 always	 yielded	 2–3	 additional	 imaginary	 frequencies,	 with	wavenumbers	 up	 to	 31	
cm-1.		However,	the	reaction	coordinate	was	always	well	defined,	with	imaginary	frequencies	in	
the	 range	 106–207	 cm-1,	 and	 on	 visualization,	 this	 vector	 always	 corresponded	well	 with	 the	
expected	attack	of	the	nucleophile	on	an	allyl	terminus.		Qualitatively,	the	results	from	the	full	
TS	searches	and	the	scans	were	the	same,	and	numerically,	the	final	energies	were	within	a	few	
kJ	mol-1	 from	each	other.	 	Due	 to	 the	uncertainty	 in	 the	 former,	 the	energies	 reported	herein	
come	from	the	scan	approach.	
	 All	 transition	states	were	fully	validated	by	QRC	calculations.32	 	For	the	scans,	the	QRC	
was	 implemented	 by	 minimizing	 the	 end	 points	 on	 the	 scan	 and	 verifying	 that	 they	
corresponded	 to	pre-reactive	 complex	and	an	allyl	 ammonium	complex,	 respectively.	 	 For	 the	
results	 from	 the	 TS	 searches,	 the	 starting	 points	 for	 the	 minimizations	 were	 constructed	 by	
distortion	along	the	Cartesian	eigenvector	corresponding	to	the	reaction	coordinate,	scaled	by	
0.3.	
	 It	 has	 been	 previously	 demonstrated	 that	 the	 regioselectivity	 in	 Pd-catalyzed	 allylic	
substitution	 can	 be	 rationalized	 by	 considering	 the	 geometry	 of	 the	 intermediate	 η3-allyl	
palladium	 complex,16	 and	 in	 particular	 the	 steric	 constraints	 along	 the	 path	 of	 the	 incoming	
nucleophile.17		This	rationale	has	been	successfully	applied	to	both	mono-	and	1,3-disubstituted	
η3-allyl	complexes,	the	latter	including	a	highly	relevant	cationic	(η3-1-phenyl-3-methyl-allyl)PdL2	
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intermediate.17	 	 Steric	 interactions	between	 the	 ligand	and	allyl	moieties	 caused	a	 rotation	of	
the	allyl	toward	a	product-like	conformation.		Such	a	rotation	could	selectively	elongate	one	Pd–
C	 bond,	 thereby	 increasing	 its	 reactivity.	 	 Both	 of	 these	 factors	 are	 known	 to	 influence	 the	
regioselectivity	of	the	nucleophilic	attack.17		We	are	unaware,	however,	of	previously	considered	
cases	 in	 which	 the	 regioselective	 benzylic	 attack	 dominates.	 	 We	 therefore	 calculated	 the	
structures	of	 intermediates	 for	a	 few	model	systems	to	rationalize	 the	observed	behavior.	 	To	
avoid	 extensive	 conformational	 searching,	 we	 performed	 the	 computational	 study	 on	 the	
smallest	relevant	system,	cationic	(η3-1-Ph-2-B(pin)-3-Me-allyl)Pd(PPh3)2.			
	 We	first	considered	three	possible	 intermediates	(Figures	1.2	and	1.3).	 	 In	the	absence	
of	 ligand-allyl	 interactions,	 the	 dominant	 structure-determining	 factor	 in	(η3-allyl)Pd	
complexes	is	 the	repulsion	 between	 the	 substituent	 and	Pd.		Due	 to	 the	 tilt	 of	the	 η3-allyl	
moiety,	 an	anti-substituent	is	 much	 closer	 to	 Pd	 than	 a	syn-substituent,	 as	 can	 be	 seen	 in	
representative	X-ray	structures	with	both	syn	and	anti	aryl	moieties.33		Measuring	the	distances	
from	Pd	to	the	aryl	substituent	ipso-carbons,	the	anti-aryls	are	closer	to	Pd	by	ca.	0.3	Å,	and	are	
clearly	 within	 the	 repulsive	 region.		 For	 this	 reason,	 unencumbered	 complexes	 almost	
exclusively	 prefer	 the	 less	 encumbered	syn	 configuration.	 	 However,	 the	 preference	 can	 be	
shifted	by	ligands	that	protrude	into	the	η3-allyl	coordination	plane.		For	example,	2,9-dicyano-
1,10-phenanthroline,	which	 selectively	 interferes	with	 syn-methyl	 groups	 in	 crotyl	 complexes,	
shifts	 the	 preference	 to	 anti.13	 	 The	 last	 important	 interaction	 is	 the	 repulsion	 between	 a	 2-
substituent	 and	 a	 syn-substituent.	 	 There	 are	 X-ray	 structures	 showing	 the	anti	 preference	 of	
alkyl	groups	in	such	complexes.13		For	aryl	groups,	the	preference	for	the	syn	isomer	is	stronger;	
the	 syn-aryl	 is	much	more	 in	 the	 allyl	 plane,	 and	 therefore	 better	 conjugated	 to	 the	η3-allyl.		
Phenyl	groups	in	the	anti	position	also	suffer	from	a	severe	1,3-allylic	strain	with	the	hydrogen	in	
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the	opposing	position,	causing	the	aryl	to	rotate	and	further	reduce	conjugation.		Thus,	anti-allyl	
groups	are	virtually	only	observed	in	(η3-1,1-diphenyl	allyls),	where	one	of	the	phenyls	must	be	
anti.	 	 It	 is	 from	 such	 structures	 we	 can	 see	 the	 interactions	 in	 the	 X-ray	 (mostly	 1,1,3-
triphenyl).34	 	 Togni	 has	 suggested	 that	 a	 phenyl	 that	 can	 adopt	 the	 syn	 or	 anti	 position,	 but	
prefers	 anti	 when	 a	 very	 hindered	 ligand	 is	 employed.34	 	 Moreover,	 Faller	 and	 co-workers	
generalized	that	steric	factors	of	substitutions	on	allyl	moieties	can	change	the	ratio	of	syn	and	
anti	 isomers	 in	 cationic	 (η3-1,2-disubstituted	 allyl)Pd	 and	 (η3-1,2,3-trisubstituted	 allyl)Pd	
intermediates.35		Their	studies	demonstrate	that	bulky	substitution	on	C-2	can	force	generation	
of	 the	anti-allylpalladium	 intermediate.	 	Additionally,	 the	anti	 isomer	of	 the	 (η3-1-B(pin)-2-Ph-
allyl)	palladium		complex	was	isolated	by	Yoshida	and	co-workers.36		Therefore,	1-syn-3-anti	INT-
1.3	(Figure	1.2)	 is	considered	the	most	stable	intermediate,	whereas	1-anti-3-syn	INT-1.2	is	less	
stable	than	1-syn-3-syn	INT-1.1.	
	 Next,	we	performed	the	calculation	of	transition	states.	 	The	initial	results	using	the	1-
syn-3-syn	INT-1.1	indicated	attack	distal	to	the	C-1-aryl	group	to	be	favored	through	TS-1.2	by	4	
kJ	mol-1	over	attack	at	the	benzylic	position	through	TS-1.1	(Figures	1.2	and	1.3).		We,	therefore,	
broadened	our	calculation	to	include	attack	on	1-anti-3-syn	INT-1.2	and	1-syn-3-anti	INT-1.3	via	
TS-1.3	 reaction.	 	 It	 is	 known	 that	 (η3-allyl)Pd	 intermediates	 can	 rapidly	 equilibrate	 before	 the	
addition	 of	 nucleophile.9	 	 This	 is	 important	 in	 most	 enantioselective	 allylic	 substitution		
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Figure	 1.2.	 Four	 possible	 reaction	 paths	 for	 nucleophilic	 addition	 of	 ammonia	 to	 1-phenyl-2-
B(pin)-3-alkyl	substituted	η3-allyls.	
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Figure	 1.3.	 Calculated	 energy	 diagram	 for	 allylic	 substitution	 leading	 to	 benzylic	 and	 aliphatic	
substitution	products.	Values	in	parentheses	are	the	energies	relative	to	1-syn,	3-anti	INT-1.3.	
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reactions.5,37	 	 If	the	rate	of	isomerization	among	INT-1.1,	INT-1.2,	and	INT-1.3	 is	fast,	the	more	
reactive	 INT-1.2	 will	 predominantly	 lead	 to	 TS-1.3	 instead	 of	 TS-1.4	 to	 afford	 the	 benzylic	
substitution	product	1.2.	 	Despite	the	higher	energy	of	1-anti-3-syn	 INT-1.2,	attack	at	the	anti-
position	of	1-anti-3-syn	INT-1.2	was	found	to	be	favored,	with	a	free	energy	of	activation	of	only	
47	kJ	mol-1	relative	to	1-syn-3-anti	INT-1.3	and	leading	to	the	observed	major	product.		The	next	
lowest	path	was	 attack	 at	 the	anti-configured	position	of	 1-syn-3-anti	 INT-1.3	 through	TS-1.4,	
leading	to	the	minor	product.		This	pathway	is	only	6	kJ	mol-1	higher	in	energy	than	TS-1.3.		It	is	
well	established	that	anti-complexes	are	more	reactive	than	syn-complexes	toward	nucleophilic	
attack.10d,13		One	reason	for	this	is	that,	in	general,	the	syn-	substituent	is	pushed	away	from	the	
metal,	into	the	path	of	the	nucleophile.		This	ground	state	affect	is	more	severe	in	the	presence	
of	a	2-substituent	and	raises	the	energy	of	attack	at	the	syn-substituted	carbon,	as	reflected	in	
Figure	1.3.			
	 In	 transition	 states	 TS-1.1	 and	 TS-1.3	 (Figures	 2	 and	 3),	 the	 distances	 between	 the	
ammonia	nucleophile	and	Carbon-1	 is	2.72	Å	 in	TS-1.1	vs.	2.87	Å	 in	TS-1.3.	 	For	 the	small	NH3	
nucleophile,	 there	 is	 little	 repulsive	 interaction,	 however,	 larger	 nucleophiles	 will	 encounter	
more	severe	steric	interactions	in	the	TS.		A	more	important	effect	arises	upon	elongation	of	the	
Pd–C	 bond	 in	 the	 TS.	 	 This	 elongation	 alleviates	 the	 repulsion	 between	 Pd	 and	 an	 anti-
substituent.	 	 In	contrast,	 the	rehybridization	on	nucleophilic	attack	pushes	 the	syn	 substituent	
down	 into	 the	 ligand,	 resulting	 in	 destabilization.	 	 Furthermore,	 the	 conjugation	 penalty	 that	
was	 found	 for	1-anti-3-syn	 INT-1.2	 is	much	 less	 severe	 in	TS-1.3,	because	most	of	 the	penalty	
has	 already	been	paid	 in	 formation	of	 the	anti-isomer	 (the	aryl	 ring	 is	 rotated	away	 from	 the	
plane	of	the	allyl	to	avoid	clashing	with	the	anti-hydrogen	at	C-3).		These	combined	effects	lead	
to	a	drastic	lowering	of	barriers	to	attack	at	anti-positions	(TS-1.3	and	1.	1.4)	compared	to	syn-
14	
positions	 (TS-1.1	 and	 1.2),	 such	 that	 the	 energy	 for	 the	 anti-addition	 TS	 is	 lower	 despite	 the	
preceding	 intermediate	 being	 high	 in	 energy	 (Curtin-Hammett	 principle).	 	 The	 calculated	 6	 kJ	
mol-1	difference	is	similar	to	the	observed	>20:1	regioselectivity,	which	would	correspond	to	ca.	
8	kJ	mol-1	difference	in	allylic	alkylation	reaction	(Table	1.1)	with	a	malonate	nucleophile.		It	is	in	
even	better	agreement	with	the	~10:1	regioselectivity	that	corresponds	to	ca.	6	kJ	mol-1	in	allylic	
amination	reaction	(Scheme	1.3).	
	
Scheme	 1.3.	 Palladium-catalyzed	 Allylic	 Amination	 Reaction	 with	 2-B(pin)-Substituted	 Allylic		
Acetates21	
	
	
	 It	 is	also	 important	that	allylic	substitution	products	with	the	 	 (Z)-olefin	geometry	have	
not	been	detected	 in	any	of	experiments	outlined	here.	 	 This	 clearly	 shows	 that	 any	anti,syn-
complexes	 are	 attacked	exclusively	 at	 the	anti-	position,	 and	 also	 that	anti,anti-complexes	do	
not	play	a	role	in	this	chemistry,	in	good	agreement	with	earlier	studies.10d,13,16-17			
	
1.2.3. Factors	 Controlling	 Regioselectivity	 with	 2-Alkyl-Substituted	 Allylic	 Acetates	
and	Carbonates.			
	 To	determine	the	generality	of	the	conclusions	drawn	from	the	unusual	regioselectivity	
with	2-B(pin)-substituted	allylic	acetates,	we	prepared	a	series	of	1,3-di-	and	1,2,3-trisubstituted	
allylic	 acetates	 and	 carbonates.	 	 The	 stereodefined	 di-	 or	 trisubstituted	 allylic	 acetates	 and	
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carbonates	synthesized	for	this	study	include	the	parent	derivatives,	bearing	a	2-hydrogen	(1.1f	
and	 1.1g),	 and	 the	 2-methyl	 (1.1h	 and	 1.1m),	 2-n-butyl	 (1.1i),	 and	 2-cyclohexyl	 (1.1j–l)	
derivatives	 (Chart	 1.1).	 	 The	 synthesis	 of	 these	 compounds	 is	 described	 in	 the	 experimental	
section.	
	
Chart	1.1.		Substrates	for	probing	the	impact	of	the	2-substituent	on	the	allylic	substitution	
	
	
	 We	conducted	 the	allylic	 substitution	 reactions	with	 the	 substrates	 in	Chart	1.1	under	
the	condition	in	Table	1.		The	results	of	this	study	are	presented	in	Table	1.2.		When	subjected	to	
catalyst	generated	from	10	mol	%	Pd(OAc)2/20	mol	%	PPh3	with	3	equiv	of	NaCH(CO2Me)2	at	40	
°C	the	parent	allylic	acetate	1.1f	(G	=	H)	cleanly	underwent	allylic	substitution	with	nucleophilic	
attack	distal	to	the	aryl	group	with	high	regioselectivity	(10:90)	in	85%	yield	(Table	1.2,	entry	1).		
As	 a	 control	 experiment,	 we	 employed	 the	 isomeric	 allylic	 acetate	 1.1g,	 which	 resulted	 in	
formation	of	the	same	allylic	substitution	product	1.3f	with	very	similar	regioselectivity	(9:91)	in	
95%	yield	(entry	2),	confirming	the	absence	of	memory	effects	in	this	system.		These	results	can	
be	contrasted	with	 the	2-B(pin)-substituted	allylic	acetates	1.1a–e,	which	underwent	attack	at	
the	 benzylic	 position	 with	 high	 regioselectivity	 (>90:10,	 Table	 1).	 	 Additionally,	 a	 catalyst	
precursor	from	[Pd(allyl)Cl]2/4PPh3	resulted	in	formation	of	the	same	allylic	substitution	product	
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Table	1.2.	Probing	Regioselectivity	with	2-Alkyl	Substituted	Allylic	Acetatesa	
	
	
1.3f	with	slightly	diminished	regioselectivity	(17:83)	in	87%	yield	(entry	3).		The	same	reaction	at	
25	°C	provided	similar	regioselectivity	16:84	in	87%	yield	(entry	4).	 	Unfortunately,	no	reaction	
occurred	with	 sodium	 dimethyl	malonate	 and	 2-methyl-substituted	 allylic	 acetate	 1.1h	 under	
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the	 identical	 condition	 using	 Pd(OAc)2	 as	 a	 catalyst	 precursor,	 highlighting	 the	 impact	 on	
reactivity	of	 an	 alkyl	 group	at	 the	2-position	 (Table	1.2,	 entry	5).	 	 In	 the	presence	of	 catalytic		
[Pd(allyl)Cl]2/4PPh3	 and	 3	 equiv	 of	 NaCH(CO2Me)2	 in	 THF	 at	 40	 °C,	 however,	 the	 2-methyl	
substrate	1.1h	 provided	 the	 allylic	 substitution	 product	with	 regioselectivity	 of	 63:37	 favoring	
benzylic	attack	and	forming	predominantly	regioisomer	1.2h		(entry	6).		While	the	Pd-catalyzed	
allylic	 substitution	with	 stabilized	 carbon	nucleophiles	 is	 usually	 irreversible	 and	under	 kinetic	
control,	dialkyl	malonates	can	act	as	 leaving	groups	at	higher	temperature	and	longer	reaction	
times,	 and	 product	 formation	 can	 be	 under	 thermodynamic	 control.38	 	 To	 investigate	 this	
possibility,	 reaction	 of	 1.1h	 at	 40	 and	 70	 °C	 with	 longer	 reaction	 times	 did	 not	 result	 in	
significant	changes	in	the	regioselectivities	(entries	7	and	8).		Furthermore,	control	experiments	
showed	 that	 the	 reaction	of	 the	mixture	of	1.2h	 and	1.3h	 (63:37)	 in	 the	presence	of	 catalytic	
[Pd(allyl)Cl]2/4PPh3	and	3	equiv	of	NaCH(CO2Bn)2	in	THF	at	40	°C	or	70	°C	led	to	the	same	ratio	of	
1.2h	 and	 1.3h	 without	 any	 detectable	 amount	 of	 corresponding	 substitution	 products	 from	
NaCH(CO2Bn)2.39	 	 The	 larger	 2-n-butyl	 substituted	 allylic	 acetate	 1.1i	 resulted	 in	 increased	
benzylic	attack	with	a	regioselectivity	of	81:19	of	1.2i:1.3i	(entries	9	and	10).		After	observing	a	
switch	 in	 regioselectivity	 upon	 changing	 the	 size	 of	 the	 substituent	 at	 the	 2-position,	 we	
employed	 the	 larger	 2-cyclohexyl	 group	 to	 further	 explore	 this	 trend	 further.	 	 Substrate	 1.1j	
underwent	 reaction	with	NaCH(CO2Me)2	and	catalyst	generated	 from	[Pd(allyl)Cl]2	or	Pd(OAc)2	
to	 afford	 predominantly	 product	 1.2j	 via	 benzylic	 attack	 with	 regioselectivities	 of	 84:16	 and	
86:14,	respectively	(entries	11–13).		It	is	noteworthy	that	benzylic	acetate	1.1j	 is	more	reactive	
with	 the	 Pd(OAc)2-based	 catalyst	 than	 aliphatic	 acetate	 1.1h,	 which	 did	 not	 react	 with	 this	
catalyst	 (as	 noted	 earlier).	 To	 investigate	 the	 impact	 of	 allylic	 acetate	 geometry	 on	 product	
distribution	we	inverted	the	geometry	of	the	allylic	acetate	substrate	from	the	(E)-alkene	to	the	
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(Z)-alkene.		Unfortunately,	(Z)-trisubstituted	allylic	acetate	1.1k	exhibited	no	reaction	under	the	
same	condition	(entry	14).	 	Apparently,	 the	sterically	more	hindered	(Z)-alkene	does	not	allow	
the	 formation	 of	 allylpalladium	 intermediate.	 	 It	 is	 known	 that	 allylic	 carbonates	 are	 more	
reactive	than	their	acetate	counterparts	by	about	2	orders	of	magnitude.40		Using	more	reactive	
allylic	 carbonate	1.1l	 led	 to	 only	 5%	 isolated	 yield	 of	 the	 allylic	 substitution	product	1.2j	with	
83:17	 regioselectivity	 (entry	 15).	 	 Thus,	 regardless	 of	 (E)-	 or	 (Z)-geometry	 of	 the	 starting	
materials,	 the	 benzylic	 substitution	products	with	 (E)-configuration	were	observed	 (entries	 12	
and	 15).	 	 The	 close	 regiochemical	 agreement	 from	 both	 (E)-	 and	 (Z)-substrates	 strongly	
supported	 a	 rapid	 isomerization	 of	 sterically	 hindered	 1,2,3-trisubstitued	 allylpalladium	
intermediates	before	 the	nucleophilic	 addition	 step.	 	 It	 is	noteworthy	 that	 the	 smaller	3-ethyl	
substituted	allylic	acetate	1.1m	provided	allylic	substitution	products	with	a	53:47	ratio	(entries	
16	and	17).	 	The	investigation	of	the	impact	of	size	at	the	C-2	position	revealed	a	tendency	for	
the	benzylic	substitution	product	with	increasing	size	of	the	C-2	substituent.	
	 Steric	effects	in	organic	chemistry	can	be	quantified	by	a	range	of	methods,	from	simple	
A-values	of	substituents	 to	explicit	modeling.	 	For	 the	Tsuji-Trost	 reaction,	steric	 influences	on	
the	activation	barrier	have	been	modeled	using	explicit	probes.17	More	recently,	Sigman	and	co-
workers41	demonstrated	that	selectivities	in	the	Tsuji-Trost	reaction	can	be	reproduced	using	a		
linear	 correlation	 with	 Charton	 steric	 parameters.42	 	 We	 therefore	 attempted	 a	 correlation	
between	 the	 Charton	 value	 of	 the	 2-substituents	 and	 the	 logarithm	 of	 the	 observed	
regioselectivity,	 as	 shown	 in	 Table	 1.3.	 	 Consideration	 of	 this	 steric	 parameter	 quantitatively	
revealed	 its	strong	 linear	 free	energy	relationship	 in	Figure	1.4	(slope	Ψ	=	1.70	and	R2	=	0.97),	
supporting	our	contention	that	the	effect	we	observed	 is	due	to	a	steric	effect.	 	Our	modeling	
studies	indicate	that	the	repulsion	with	the	2-substituents	has	a	strong	influence	on	the	relative	
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importance	 of	 anti-	 and	 syn-configured	 (η3-allyl)palladium	 intermediates,	 and	 thus	 on	 the	
regioselectivity.	
	
Table	1.3.		Quantitative	Analysis	of	Regioselectivity	versus	Charton	Parameter	of	C-2	Substituent	
 
 
Figure	1.4.	Plot	of	the	logarithm	of	the	ratio	of	regioisomers	versus	Charton	steric	parameters	of	
the	C-2	substituents	in	the	Pd-catalyzed	allylic	substitution	reactions.		
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1.2.4. Palladium-Catalyzed	 1,4-Elimination	 Reaction	 of	 1,2,3-Trisubstituted	 Allylic	
Acetates.	
	 The	 palladium-catalyzed	 elimination	 reaction	 of	 allylic	 acetates	 is	 a	 useful	method	 to	
form	 1,3-dienes.43	 	 Palladium(0)	 mediated	 ionization	 of	 allylic	 acetates	 1.1	 forms	 η3-
allylpalladium(II)	intermediates	1.5	(Scheme	1.3).		Allylpalladium(II)	regenerates	palladium(0)	via	
anti-	 or	 syn-	 elimination	 to	 furnish	 1,3-dienes	 1.4.44	 	 Consistent	 with	 this	 proposed	 reaction	
pathway,	 we	 observed	 varying	 amounts	 of	 elimination	 byproducts	 (1H	 NMR)	 in	 unpurified	
reaction	mixtures	with	2-n-butyl	allylic	acetate	1.1i	and	2-cyclohexyl	allylic	acetates	1.1j	 (Table	
1.2,	entries	9–13).		Under	the	same	condition,	the	smaller	2-methyl	allylic	acetate	1.1h	did	not	
produce	elimination	byproducts	(1H	NMR).			
	 Inspired	 by	 these	 observations,	 allylic	 acetates	 1.1i	 and	 1.1j	 were	 reexamined	 in	 the	
allylic	 substitution	 reaction	 and	 1,3-dienes	 were	 isolated	 at	 40	 °C	 in	 17	 and	 22%	 yield,	
respectively	 (Table	 1.4,	 entries	 1	 and	 3).	 	 The	 ratios	 of	 dienes	 were	 determined	 by	 1H	 NMR	
spectroscopy	 of	 unpurified	 reaction	 mixtures,	 and	 the	 stereochemistry	 of	 the	 dienes	 was	
confirmed	by	 comparison	 to	 similar	 known	 compounds.	 	 In	 the	 reactions	 above,	 the	 ratios	 of	
(Z,E)	 and	 (E,E)	 isomers	 were	 24:76	 for	 1.4i	 and	 85:15	 for	 1.4j.	 	 At	 70	 °C	 little	 change	 in	 the	
regioselectivity	of	allylic	substitution	products	or	the	ratio	of	(Z,E)	to	(E,E)	elimination	products	
were	observed.		However,	at	70	°C,	1,3-dienes	1.4	were	the	major	products.		At	70	°C,	2-n-butyl	
allylic	acetate	1.1i	provided	the	allylic	substitution	product	in	20%	isolated	yield	with	the	same	
regioselectivity	 (81:19).	 	 The	 1,4-elimination	 product	 was	 isolated	 in	 67%	 yield	with	 a	 similar	
diene	ratio	 to	the	reaction	at	40	°C	[(Z,E)-1.4i	 :	 (E,E)-1.4i	=	27	 :	73,	Table	1.4,	entry	2].	 	The	2-
cyclohexyl	 allylic	 acetate	1.1j	 resulted	 in	 formation	of	15%	of	allylic	 substitution	products	and	
70%	yield	of	1,4-elimination	product	also	with	a	similar	ratio	of	isomers	[(Z,E)-1.4j	 :	(E,E)-1.4j	=		
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86:14,	Table	1.4,	entry	4].		It	is	noteworthy	that	only	two	geometric	isomers	of	1,3-dienes	were	
observed	among	four	possible	isomers.	
	 Very	importantly,	the	observation	of	1,2-(Z)-configured	diene	indicates	the	presence	of	
a	 1-anti-η3-allyl	 complex	 as	 a	 reactive	 intermediate.44h	 	 Irrespective	 of	 the	 mechanism	 of	
elimination	(E2	or	β-hydride	elimination),	the	(Z,E)-product	can	arise	from	an	intermediate	with	
the	 phenyl	 substituent	 in	 the	 anti-position	 of	 the	 (η3-allyl)Pd	 intermediate.	 	 This	 observation	
lends	further	support	to	our	interpretation	that	anti-configured	intermediates	are	important	in	
the	nucleophilic	attack.		The	newly	formed	double	bond	in	the	3,4-position	can	be	formed	from	
either	 intermediate,	 with	 a	 configuration	 controlled	 by	 the	 preferred	 orientation	 of	 the	 3,4	
single	bond	in	the	intermediate.45		Allylic	strain	would	thus	favor	the	3,4-(E)-configuration	of	the	
diene	products,	in	full	agreement	with	our	observations.	
	
Scheme	1.3.	Plausible	Mechanism	of	Allylic	Acetates	to	Form	1,3-Dienes	
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Table	1.4.	Palladium-Catalyzed	1,4-Elimination	of	Allylic	Acetates	1.1i	and	1.1j	
	
	
	
1.3. Summary	and	Outlook	
	 We	have	investigated	the	unusual	regioselectivity	of	the	palladium-catalyzed	Tsuji-Trost	
allylic	substitution	reaction	with	1,2,3-trisubstituted	allylic	substrates.		With	1,3-unsymmetrically	
substituted	 2-B(pin)-allylic	 acetates,	 the	 boryl	 group	 plays	 a	 pivotal	 role	 in	 determining	 the	
regioselectivity	 of	 the	 allylic	 substitution	 reaction.	 	 The	 unsymmetrical	 2-B(pin)-substituted	
allylic	acetates	show	preference	for	nucleophilic	attack	at	the	benzylic	site,	which	is	opposite	to	
the	 expected	 regioselectivity	 in	 Tsuji-Trost	 allylic	 substitution	 reactions	with	 (η3-1-aryl-3-alkyl-
allyl)Pd	intermediates.		A	computational	study	of	the	mechanism	responsible	for	regioselectivity	
with	cationic	(η3-1-Ph-2-B(pin)-3-Me-allyl)Pd(PPh3)2	indicates	that	the	unusual	regioselectivity	is	
controlled	 by	 the	 relative	 reactivity	 of	 the	 syn-	 and	 anti-oriented	 allylic	 termini.	 	 Through	
systematic	studies	 involving	variation	of	the	size	of	the	C-2	substituent,	we	demonstrated	that	
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the	 bulkier	 the	 group	 at	 the	 2-position	 of	 1-aryl-2,3-disubstituted	 η3-allyl	 intermediates,	 the	
greater	 propensity	 for	 nucleophilic	 attack	 at	 the	 benzylic	 position.	 	 The	 use	 of	 Charton	 steric	
parameters	 led	 to	 a	 strong	 correlation	 between	 the	 size	 of	 the	 C-2	 substituent	 and	 the	
regioselectivity	 of	 nucleophilic	 attack	 at	 the	 corresponding	 η3-allyls.	 	 Based	 on	 the	 working	
models	garnered	from	computational	and	experimental	studies,	we	attribute	this	selectivity	to	
the	 repulsion	between	 the	1-	and	2-substituents,	 forcing	 the	1-aryl	group	 into	a	 reactive	anti-
position	through	rapid	syn-anti	isomerization.	
	 Finally,	palladium-catalyzed	1,4-elimination	reactions	of	allylic	acetates	also	support	the	
presence	 of	 the	 anti-oriented	 allylpalladium	 intermediates.	 	 These	 results	 contribute	 to	 our	
fundamental	understanding	of	regioselectivity	in	Tsuji-Trost	allylic	substitution	reactions	and	will	
be	useful	in	their	predictive	power	in	the	application	of	this	chemistry	to	synthesis.	
	
1.4. Experimental	Section	
General	Methods.		All	reactions	were	performed	under	a	nitrogen	atmosphere	with	oven-dried	
glassware.	 	 All	manipulations	 involving	 dicyclohexylborane,	 dimethylzinc	 and	 diethylzinc	were	
carried	out	under	an	inert	atmosphere	in	a	Vacuum	Atmospheres	drybox	with	an	attached	MO-
40	Dritrain	or	by	using	standard	Schlenk	or	vacuum	line	techniques.	 	Chemicals	were	obtained	
from	 Aldrich,	 Acros,	 or	 GFS	 Chemicals	 unless	 otherwise	 specified.	 	 Solvents	 were	 purchased	
from	 Fischer	 Scientific.	 	 Toluene	 was	 dried	 through	 an	 activated	 alumina	 column,	 and	 then	
thoroughly	 degassed	 prior	 to	 use.	 	 Tetrahydrofuran	 was	 distilled	 from	 sodium	 and	
benzophenone	 under	 N2.	 	 B(pin)-substituted	 alkynes	 were	 prepared	 by	 literature	 methods.46		
Dimethylzinc	and	diethylzinc	solutions	(2.0	M	in	toluene)	were	prepared	and	stored	in	a	Vacuum	
Atmospheres	drybox.		NMR	spectra	were	obtained	on	Brüker	300,	360,	400	or	500	MHz	Fourier	
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transform	 spectrometers	 at	 the	University	 of	 Pennsylvania	NMR	 facility.	 	 1H	 and	 13C{1H}	NMR	
spectra	were	referenced	to	residual	solvent.		11B{1H}	NMR	spectra	were	referenced	to	BF3·OEt2.	
The	infrared	spectra	were	obtained	using	a	Perkin-Elmer	1600	series	spectrometer.		HRMS	data	
was	obtained	on	a	Waters	LC-TOF	mass	spectrometer	(model	LCT-XE	Premier)	using	electrospray	
ionization	in	positive	or	negative	mode,	depending	on	analyte.	Thin-layer	chromatography	was	
performed	on	Whatman	precoated	silica	gel	60	F-254	plates	and	visualized	by	ultraviolet	light	or	
by	staining	with	ceric	ammonium	molybdate	or	phosphomolybdic	acid	solutions	or	with	iodine.		
Silica	gel	(Silicaflash,	P60,	40-63	μm,	Silicycle)	was	used	for	air-flashed	chromatography.	Analysis	
of	 regioisomeric	 ratios	 was	 performed	 by	 analysis	 of	 1H	 NMR	 spectra	 of	 unpurified	 reaction	
products.	 	The	vinyl	boronate	ester	 is	susceptible	to	oxidation	of	the	B–C	bond	on	silica	under	
air,	 and	 hence	 a	 rapid	 purification	 is	 necessary	 to	 minimize	 oxidation	 to	 the	 corresponding	
ketone.	
	
Caution.	Dialkylzinc	reagents	are	pyrophoric.	Care	must	be	used	when	handling	them.	
	
Preparation	of	2-Substituted	Allylic	Substrates	
General	Procedure	A:	Synthesis	of	B(pin)-Substituted	Allylic	Acetates.	To	a	suspension	of	HBCy2	
(770	mg,	4.32	mmol)	 in	toluene	(4.0	mL)	equipped	with	a	stir	bar	under	N2	was	added	alkyne-
4,4,5,5-tetramethyl-[1,3,2]-dioxaborolane	(4.32	mmol),	and	the	reaction	mixture	was	stirred	at	
rt	for	30	min,	after	which	it	was	homogeneous.	The	reaction	vessel	was	cooled	to	–78	°C	in	a	dry	
ice	 bath,	 treated	 with	 Me2Zn	 (2.16	 mL,	 2.0	 M	 in	 toluene,	 4.32	 mmol),	 and	 stirred	 at	 that	
temperature	for	30	min.	The	solution	was	then	warmed	to	–20	°C	by	placing	the	flask	in	a	–20	°C	
cold	bath,	and	aldehyde	(3.60	mmol)	was	added.	The	reaction	mixture	was	stirred	at	–20	°C	until	
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TLC	 showed	 complete	 consumption	 of	 the	 aldehyde	 (usually	 12	 h).	 When	 the	 reaction	 was	
complete,	the	reaction	mixture	was	warmed	to	0	°C	in	an	ice	bath,	and	distilled	acetic	anhydride	
(1.1	g,	1.02	mL,	10.8	mmol)	was	slowly	added.	The	reaction	mixture	was	stirred	at	0	°C	until	TLC	
showed	complete	consumption	of	the	intermediate	allylic	alkoxide	(usually	4–6	h).	The	reaction	
mixture	was	then	diluted	with	EtOAc	(10	mL)	and	quenched	with	saturated	NH4Cl	(15	mL)	at	0	
°C.	The	organic	layer	was	separated	and	the	aqueous	solution	was	extracted	with	EtOAc	(3	x	25	
mL).	 The	 combined	 organic	 solution	 was	 dried	 over	 MgSO4,	 filtered,	 and	 the	 solvent	 was	
removed	under	reduced	pressure	to	yield	a	colorless	oil.	The	crude	product	was	purified	by	flash	
column	 chromatography	on	 silica	 gel	 (hexanes:EtOAc	 =	 97:3)	 to	 afford	 the	 allylic	 acetate	 as	 a	
colorless	oil.	Importantly,	the	2-B(pin)	allylic	acetate	product	is	susceptible	to	oxidation	of	the	B–
C	bond	on	silica	under	air,	and	hence	a	rapid	purification	is	necessary	to	minimize	oxidation	to	
the	ketone.	The	allylic	acetates	are	stored	under	N2	at	0	°C	to	preserve	their	purity.		
	
	
2-B(pin)	substituted	allylic	acetates	1.1a–d	were	prepared	by	General	Procedure	A	according	to	
our	previous	communication.21	
	
	(E)-1-Phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-2-en-1-yl	
acetate	 (1.1e).	The	product	was	prepared	by	General	Procedure	A	using	4,4,5,5-tetramethyl-2-
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(prop-1-yn-1-yl)-1,3,2-dioxaborolane	(717	mg,	4.32	mmol),	benzaldehyde	(382	mg,	366	uL,	3.60	
mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	
(hexanes:EtOAc	 =	 97:3)	 to	 afford	 the	 allylic	 acetate	 as	 a	 colorless	 oil	 (799	mg,	 70%	 yield).	 1H	
NMR	(300	MHz,	CDCl3)	δ	7.35		–	7.22	(m,	5H),	6.42	(s,	1H),	6.21	(q,	J	=	6.9	Hz,	1H),	2.01	(s,	3H),	
1.93	(d,	J	=	6.9	Hz,	3H),	1.19	(s,	6H),	1.16	(s,	6H);	 13C{1H}	NMR	(75	MHz,	CDCl3)	δ	170.1,	141.1,	
140.3,	128.3,	127.9,	127.7,	83.4,	78.0,	24.9,	24.8,	21.5,	17.3	(the	quaternary	vinyl	C	bearing	the	
boron	 group	 is	 not	 observed);	 11B	NMR	 (CDCl3,	 128	MHz)	 δ	 29.8;	 IR	 (neat)	 2979,	 2933,	 1740,	
1641,	 1407,	 1372,	 1312,	 1267,	 1234,	 1144	 cm-1;	 HRMS	 m/z	 339.1750	 [(M+Na)+;	 calcd	 for	
C18H25BO4Na:	339.1744].	
		
	
Allylic	acetates	1.1f–h	were	prepared	according	to	our	previous	communication.21	
	
	(E)-2-Butyl-1-phenylhept-2-en-1-yl	 acetate	 (1.1i).	 To	 a	 suspension	 of	 HBCy2	
(107	mg,	0.6	mmol)	in	toluene	(1.0	mL)	equipped	with	a	stir	bar	under	N2	was	
added	5-decyne	 (0.11	mL,	0.6	mmol)	 at	0	 °C	 in	an	 ice	bath,	 and	 the	 reaction	
mixture	was	stirred	at	rt	for	30	min,	after	which	it	was	homogeneous.	The	reaction	vessel	was	
cooled	to	–78	°C	in	a	dry	ice	bath,	treated	with	Et2Zn	(0.45	mL,	2.0	M	in	toluene,	0.9	mmol),	and	
stirred	at	this	temperature	for	30	min.	The	solution	was	then	warmed	to	–10	°C	by	placing	the	
n-Bu
OAc
H
Ph Ph
OAc
H
n-Bu Ph
Me
n-Bu
OAc
Ph
n-Bu
n-Bu
OAc
Ph
Me
Et
OAc
Ph
Cy
n-Bu
OAc
Ph
OAc
Cy
n-Bu
1.1f 1.1g 1.1h
1.1m
1.1i
1.1j 1.1k 1.1l
BocO
Ph
Cy
n-Bu
Ph
n-Bu
n-Bu
OAc
1.1i
27	
flask	in	a	–10	°C	cold	bath,	and	(−)-MIB	(23.9	mg,	0.1	mmol)	was	added	under	positive	pressure	
of	nitrogen.	The	solution	was	stirred	for	5	min,	and	benzaldehyde	(51	uL,	0.5	mmol)	was	added.	
The	reaction	mixture	was	stirred	at	–10	°C	for	12	h	until	TLC	showed	complete	consumption	of	
the	aldehyde.	The	reaction	mixture	was	then	warmed	to	0	°C	in	an	ice	bath,	and	distilled	acetic	
anhydride	(142	uL,	1.5	mmol)	was	slowly	added.	The	reaction	mixture	was	stirred	at	0	°C	for	3	h	
until	 TLC	 showed	 complete	 consumption	 of	 the	 intermediate	 allylic	 alkoxide.	 The	 reaction	
mixture	was	then	diluted	with	EtOAc	(5	mL)	and	quenched	with	saturated	NH4Cl	(5	mL)	at	0	°C.	
The	organic	 layer	was	 separated,	 and	 the	 aqueous	 solution	was	 extracted	with	 EtOAc	 (3	 x	 10	
mL).	The	combined	organic	solution	was	washed	with	brine	(10	mL),	dried	over	MgSO4,	filtered,	
and	the	solvent	was	removed	under	reduced	pressure	to	yield	a	colorless	oil.	The	crude	product	
was	purified	by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	97:3)	to	afford	the	
allylic	acetate	as	a	colorless	oil	(109	mg,	76%	yield).	1H	NMR	(300	MHz,	CDCl3)	δ	7.34	–	7.24	(m,	
5H),	6.22	(s,	1H),	6.52	(t,	J	=	7.5	Hz,	1H),	2.11	(s,	3H),	2.10	–	2.02	(m,	2H),	2.01	–	1.94	(m,	1H),	
1.92	–	1.81	(m,	1H),	1.44	–	1.18	(m,	8H),	0.91	(t,	J	=	7.0	Hz,	3H),	0.85	(t,	J	=	7.0	Hz,	3H);	13C{1H}	
NMR	 (75	MHz,	CDCl3)	δ	170.1,	139.6,	137.7,	129.2,	128.4,	127.9,	127.3,	79.1,	32.1,	31.5,	27.9,	
27.6,	23.1,	22.7,	21.6,	14.2,	14.1;	IR	(neat)	2957,	2931,	2872,	2861,	1743,	1466,	1456,	1369,	1233	
cm-1;	HRMS	m/z	311.1985	[(M+Na)+;	calcd	for	C19H28O2Na:	311.1987].		
	
Preparation	of	allylic	acetate	1.1j	
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1) t-BuLi (2 equiv), THF
2) PhCHO (1 equiv)
Ac2O (3 equiv)
DMAP(0.2 equiv)
CH2Cl2, rt, 2h
1.1j, 87% yield1.1j-ol,  78% yield
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		(E)-2-Cyclohexyl-1-phenylhept-2-en-1-ol	 (1.1j-ol).	 To	 an	 oven-dried	 Schlenk	
flask	 equipped	with	 a	 stir	 bar	 under	 N2	 was	 added	 (E)-(1-Bromohex-1-en-1-
yl)cyclohexane47	(245	mg,	1.0	mmol)	and	THF	(2	mL).	The	reaction	vessel	was	cooled	to	–78	°C	in	
a	dry	 ice	bath	and	 stirred	 for	5	min.	 t-BuLi	 (1.2	mL,	2.0	mmol,	1.7	M	 in	pentanes)	was	 slowly	
added	over	5	min,	causing	the	solution	to	become	light	yellow	in	color.	The	reaction	mixture	was	
stirred	at	–78	°C	for	20	min,	and	the	reaction	vessel	was	transferred	to	0	°C	in	an	ice	bath.	The	
reaction	mixture	was	stirred	at	0	°C	for	10	min.	The	reaction	vessel	was	again	cooled	to	–78	°C	
by	placing	the	flask	in	a	dry	ice	bath.		The	reaction	vessel	was	stirred	at	–78	°C	for	5	min,	before	
benzaldehyde	 (102	 uL,	 1.0	 mmol)	 was	 added	 slowly	 and	 the	 reaction	 mixture	 was	 slowly	
warmed	to	rt	over	2	h.	The	reaction	mixture	was	diluted	with	EtOAc	(5	mL)	and	quenched	with	
saturated	 NH4Cl	 (10	 mL).	 The	 organic	 layer	 was	 separated	 and	 the	 aqueous	 solution	 was	
extracted	with	EtOAc	(3	x	10	mL).	The	combined	organic	 layer	was	washed	with	brine	 (10mL),	
dried	 over	MgSO4,	 filtered,	 and	 the	 solvent	 was	 removed	 under	 reduced	 pressure	 to	 yield	 a	
colorless	 oil.	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	
(hexanes:EtOAc	=	97:3)	to	afford	the	allylic	alcohol	as	a	colorless	oil	(231	mg,	78%	yield).	1H	NMR	
(500	MHz,	CDCl3)	δ	7.37	–	7.21	(m,	5H),	5.48	(t,	J	=	7.5	Hz,	1H),	5.21	(s,	1H),	2.30	(tt,	J	=	12.0	Hz,	
3.5	Hz,	1H),	2.13	(dt,	J	=	7.5	Hz,	6.8	Hz,	1H),	1.76	–	1.58	(m,	4H),	1.48	(dq,	J	=	12.5	Hz,	3.5	Hz,	1H),	
1.40		–	1.30	(m,	8H),	0.91	(t,	J	=	7.0	Hz,	3H);	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	146.0,	143.6,	128.3,	
128.2,	127.3,	127.0,	75.9,	39.7,	32.4,	32.1	(two	overlapping	resonances),	27.7,	27.3,	27.2,	26.4,	
22.7,	14.2;	 IR	 (neat)	3369,	2928,	2852,	1493,	1449,	1379,	1239,	1188,	1172,	1014	cm-1;	HRMS	
m/z	295.2028	[(M+Na)+;	calcd	for	C19H28ONa:	295.2038].	
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	(E)-2-Cyclohexyl-1-phenylhept-2-en-1-yl	 acetate	 (1.1j).	 To	 a	 20	mL	 glass	 vial	
equipped	 with	 a	 stir	 bar	 was	 added	 (E)-2-cyclohexyl-1-phenylhept-2-en-1-ol	
(136	mg,	0.5	mmol)	and	CH2Cl2	(1	mL).	DMAP	(12.2	mg,	0.1	mmol)	was	added	
to	the	solution	and	the	reaction	mixture	was	stirred	at	rt	for	5	min.	To	the	reaction	mixture	was	
added	 acetic	 anhydride	 (142	 uL,	 1.5	 mmol)	 and	 the	 vial	 was	 sealed	 with	 a	 screw	 cap.	 The	
reaction	mixture	was	stirred	at	rt	 for	2	h.	The	reaction	mixture	was	diluted	with	CH2Cl2	 (5	mL)	
and	quenched	with	DI	water	(10	mL).	The	organic	layer	was	separated	and	the	aqueous	solution	
was	 extracted	 with	 CH2Cl2	 (2	 x	 10	 mL).	 The	 combined	 organic	 layer	 was	 dried	 over	 MgSO4,	
filtered,	and	the	solvent	was	removed	under	reduced	pressure	to	yield	a	colorless	oil.	The	crude	
product	was	purified	by	 flash	 column	 chromatography	on	 silica	 gel	 (hexanes:EtOAc	=	 98:2)	 to	
afford	the	allylic	acetate	as	a	colorless	oil	(130	mg,	87%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	7.33	–	
7.21	(m,	5H),	6.29	(s,	1H),	5.41	(t,	J	=	7.0	Hz,	1H),	2.34	(tt,	J	=	12.0	Hz,	3.5	Hz,	1H),	2.13	(dt,	J	=	7.0	
Hz,	7.0	Hz,	2H),	2.08	(s,	3H),	1.77		–	1.69	(m,	1H),	1.68	–	1.53	(m,	3H),	1.44	(dq,	J	=	12.5	Hz,	3.5	
Hz,	 1H),	 1.38	 –	 1.04	 (m,	 9H),	 0.90	 (t,	 J	 =	 7.0	Hz,	 3H);	 13C{1H}	NMR	 (125	MHz,	 CDCl3)	 δ	 170.1,	
141.8,	140.0,	129.7,	128.3,	127.8,	127.7,		76.8,	40.0,	32.3,	32.0,	31.7,	27.6,	27.2	(two	overlapping	
resonances),	 26.3,	 22.7,	 21.7,	 14.3;	 IR	 (neat)	 2928,	 2953,	 1741,	 1449,	 1369,	 1232,	 1077	 cm-1;	
HRMS	m/z	337.2140	[(M+Na)+;	calcd	for	C21H30O2Na:	337.2144].	
	
Preparation	of	allylic	acetate	1.1k.	
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	(Z)-2-Cyclohexyl-1-phenylhept-2-en-1-yl	 acetate	 (1.1k).	 To	 a	 20	 mL	 glass	 vial	
equipped	 with	 a	 stir	 bar	 was	 added	 (Z)-2-cyclohexyl-1-phenylhept-2-en-1-ol48	
(120	mg,	0.38	mmol)	and	CH2Cl2	(1	mL).	DMAP	(9.8	mg,	0.08	mmol)	was	added	to	
the	solution	and	the	reaction	mixture	was	stirred	at	 rt	 for	5	min.	To	the	reaction	mixture	was	
added	 acetic	 anhydride	 (108	 uL,	 1.14	 mmol)	 and	 the	 vial	 was	 sealed	 with	 a	 screw	 cap.	 The	
reaction	mixture	was	stirred	at	rt	 for	2	h.	The	reaction	mixture	was	diluted	with	CH2Cl2	 (5	mL)	
and	quenched	with	DI	water	(10	mL).	The	organic	layer	was	separated	and	the	aqueous	solution	
was	 extracted	 with	 CH2Cl2	 (2	 x	 10	 mL).	 The	 combined	 organic	 layer	 was	 dried	 over	 MgSO4,	
filtered,	and	the	solvent	was	removed	under	reduced	pressure	to	yield	a	colorless	oil.	The	crude	
product	was	purified	by	 flash	 column	 chromatography	on	 silica	 gel	 (hexanes:EtOAc	=	 98:2)	 to	
afford	the	allylic	acetate	as	a	colorless	oil	(126	mg,	91%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	7.34	–	
7.22	(m,	5H),	6.77	(s,	1H),	5.47	(t,	J	=	7.5	Hz	1H),	2.33		–	2.20	(m,	2H),	2.15	(s,	3H),	1.88	(tt,	J	=	
11.5	Hz,	3.0	Hz,	1H),	1.73	–	1.65	(m	2H),	1.63	–	1.55	(m,	2H),	1.42	–	1.00	(m,	10H),	0.90	(t,	J	=	7.0	
Hz,	3H);	 13C{1H}	NMR	(125	MHz,	CDCl3)	δ	170.2,	142.4,	139.7,	129.4,	128.4,	127.4,	126.2,	74.0,	
40.1,	35.2,	34.5,	32.4,	28.0,	27.3,	27.2,	26.5,	22.7,	21.5,	14.3;	HRMS	m/z	255.2117	 [(M–OAc)+;	
calcd	for	C19H27:	255.2113].	
	
Preparation	of	allylic	carbonate	1.1l.	
		
	(Z)-tert-Butyl	 (2-cyclohexyl-1-phenylhept-2-en-1-yl)	 carbonate	 (1.1l).	 To	 a	
flame-dried	round-bottomed	flask	equipped	with	a	stir	bar	under	N2	was	added	
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(Z)-2-cyclohexyl-1-phenylhept-2-en-1-ol48	 (150	mg,	 0.55	mmol)	 and	 THF	 (2	mL).	 	 The	 solution	
was	cooled	to	–78	°C	in	a	dry	ice	bath	and	a	2.5	M	solution	of	n-BuLi	in	hexanes	(0.24	mL,	0.61	
mmol)	was	added	dropwise.	The	solution	was	then	stirred	at	–78	°C	for	10	min	and	the	reaction	
vessel	was	placed	into	a	0	°C	ice	bath	and	stirred	at	0	°C	for	5	min.		N-BOC-Imidazole	(185	mg,	
1.1	mmol)	 in	 THF	 (2	mL)	was	 added	 to	 the	 reaction	 vessel	 at	 0	 °C.	 The	 reaction	mixture	was	
allowed	to	warm	to	rt	and	stirred	for	2	h.	The	reaction	mixture	was	diluted	with	EtOAc	(5	mL)	
and	quenched	with	DI	water	(10	mL).	The	organic	layer	was	separated	and	the	aqueous	solution	
was	extracted	with	EtOAc	(3	x	10	mL).	The	combined	organic	 layer	was	washed	with	brine	(10	
mL),	dried	over	MgSO4,	filtered,	and	the	solvent	was	removed	under	reduced	pressure	to	yield	a	
colorless	 oil.	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	
(hexanes:EtOAc	=	98:2)	to	afford	the	allylic	carbonate	as	a	colorless	oil	(205	mg,	71%	yield).	1H	
NMR	(500	MHz,	CDCl3)	δ	7.33	–	7.29	(m,	4H),	7.27	–	7.22	(m,	1H),	6.54	(s,	1H),	5.49	(t,	J	=	7.0	Hz,	
1H),	2.35	–	2.21	(m,	2H),	1.90	(tt,	J	=	11.5	Hz,	3.0	Hz,	1H),	1.75	–	1.65	(m,	2H),	1.63	–	1.53	(m,	
2H),	1.49	(s,	9H),	1.43	–	1.01	(m,	10H),	0.91	(t,	J	=	7.0	Hz,	3H);	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	
153.3,	142.5,	139.5,	129.5,	128.3,	127.4,	126.2,	82.0,	76.7,	39.6,	35.0,	34.6,	32.4,	28.1,	27.9,	27.2	
(two	overlapping	 resonances),	 26.5,	 22.6,	 14.3;	 IR	 (neat)	 2956,	 2927,	 2853,	 1742,	 1496,	 1449,	
1393,	1369,	1279,	1254,	1163,	1086,	cm-1;	HRMS	m/z	359.2567	[(M+Na)+;	calcd	for	C24H36O3Na:	
359.2562].	
	
Preparation	of	allylic	acetate	1.1m.	
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	(E)-2-Methyl-1-phenylpent-2-en-1-yl	 acetate	 (1.1m).	 To	 a	 20	 mL	 glass	 vial	
equipped	with	 a	 stir	 bar	was	 added	 (E)-2-methyl-1-phenylpent-2-en-1-ol49	 (550	
mg,	3.12	mmol)	and	CH2Cl2	(6	mL).	DMAP	(38	mg,	0.31	mmol)	and	Et3N	(1.3	mL,	
9.36	mmol)	were	added	to	the	solution	and	the	vial	was	sealed	with	a	screw	cap.	The	reaction	
mixture	was	stirred	at	 rt	 for	5	min.	To	 the	 reaction	mixture	was	added	acetic	anhydride	 (0.88	
mL,	9.36	mmol)	and	the	resulting	solution	was	stirred	at	rt	for	30	min.	The	reaction	mixture	was	
then	 diluted	with	 CH2Cl2	 (5	mL)	 and	 quenched	with	 DI	 water	 (10	mL).	 The	 organic	 layer	 was	
separated	 and	 the	 aqueous	 solution	 was	 extracted	 with	 CH2Cl2	 (2	 x	 20	 mL).	 The	 combined	
organic	 layer	 was	 dried	 over	 MgSO4,	 filtered,	 and	 the	 solvent	 was	 removed	 under	 reduced	
pressure	 to	 yield	 a	 colorless	 oil.	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	 (hexanes:EtOAc	=	97:3)	to	afford	the	allylic	acetate	as	a	colorless	
oil	(126	mg,	91%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	7.35	–	7.24	(m,	5H),	6.18	(s,	1H),	5.59	(t,	J	=	
7.5	Hz,	1H),	2.13	(s,	3H),	2.06	(dq,	 J	=	7.5	Hz,	7.0	Hz,	2H),	1.51	(s,	3H),	0.99	(t,	 J	=	7.5	Hz,	3H);	
13C{1H}	NMR	(125	MHz,	CDCl3)	δ	170.2,	139.4,	132.6,	130.7,	128.4,	127.8,	126.8,	80.2,	21.5,	21.2,	
14.1,	 12.6;	 IR	 (neat)	 2965,	 2934,	 2874,	 1742,	 1495,	 1454,	 1370,	 1235,	 1021	 cm-1;	 HRMS	m/z	
241.1205	[(M+Na)+;	calcd	for	C14H18O2Na:	241.1204].	
	
Palladium	Catalyzed	Allylic	Substitution	of	Allylic	Acetates	
General	Procedure	B21:	Palladium	Catalyzed	Allylic	Substitution	of	2-B(pin)-Substituted	Allylic	
Acetates	with	NaCH(CO2Me)2.		
To	a	Schlenk	flask	equipped	with	a	stir	bar	was	added	[Pd(allyl)Cl]2	(1.8	mg,	0.005	mmol,	5	mol	
%)	and	PPh3	(5.3	mg,	0.02	mmol,	20	mol	%)	in	0.5	mL	of	dry	and	degassed	THF	at	rt	under	N2	and	
the	 solution	 stirred	 at	 rt	 for	 30	min.	 To	 this	 catalyst	 solution	was	 added	 2-B(pin)-substituted	
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allylic	acetate	(0.10	mmol)	and	the	reaction	mixture	stirred	for	an	additional	30	–	45	min.	 In	a	
separate	5	mL	round	bottomed	flask	equipped	with	a	stir	bar	and	condenser	was	added	sodium	
hydride	 (7.9	mg,	 0.33	mmol)	 in	 2.0	mL	 of	 dry	 and	 degassed	 THF	 under	 N2,	 and	 the	 reaction	
mixture	cooled	 to	0	 °C	 in	an	 ice	bath.	To	 this	white	 suspension	was	added	dropwise	dimethyl	
malonate	(35	µL,	39.6	mg,	0.3	mmol)	at	0	°C,	which	was	accompanied	by	rapid	evolution	of	H2.	
The	reaction	soon	became	clear,	after	which	 it	was	heated	to	 reflux	under	N2	 for	15	min.	The	
dimethyl	malonate	 sodium	 solution	 (3	 equiv)	was	 cooled	 to	 rt,	 and	 then	 cannulated	 into	 the	
Schlenk	 flask	 containing	 the	catalyst	and	2-B(pin)-substituted	allylic	acetate	 solution	at	 rt.	 The	
reaction	mixture	was	warmed	to	40	°C	and	stirred	until	TLC	showed	complete	consumption	of	
the	2-B(pin)	substituted	allylic	acetate.	The	reaction	mixture	was	then	cooled	to	rt,	diluted	with	
EtOAc	(4	mL)	and	quenched	with	saturated	NH4Cl	(4	mL).	The	organic	layer	was	separated	and	
the	aqueous	solution	was	extracted	with	EtOAc	(3	x	5	mL).	The	combined	organic	solution	was	
dried	over	MgSO4,	filtered	through	celite	and	the	solvent	was	removed	under	reduced	pressure	
to	yield	a	pale	red	oil.	The	crude	product	was	dissolved	 in	CDCl3	and	the	ratio	of	regioisomers	
was	determined	by	1H	NMR	spectroscopy	of	unpurified	reaction	mixtures.	CDCl3	was	removed	
under	reduced	pressure	and	the	crude	product	was	purified	by	flash	column	chromatography	on	
silica	gel.	The	vinyl	boronate	ester	is	susceptible	to	oxidation	of	the	B–C	bond	on	silica	under	air,	
and	hence	a	rapid	purification	is	necessary	to	minimize	oxidation	to	the	corresponding	ketone.		
	
General	Procedure	C21:	Palladium	Catalyzed	Allylic	Substitution	of	2-B(pin)-Substituted	Allylic	
Acetates	with	BSA,	CH2(CO2Me)2	and	catalytic	KOAc.	To	a	Schlenk	flask	equipped	with	a	stir	bar	
was	added	Pd(OAc)2	(2.2	mg,	0.01	mmol,	10	mol	%)	and	PPh3	(5.3	mg,	0.02	mmol,	20	mol	%)	in	
1.0	mL	of	dry	and	degassed	THF	at	rt	under	N2	and	the	solution	stirred	at	rt	for	30	min.	To	this	
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catalyst	 solution	 was	 added	 2-B(pin)-substituted	 allylic	 acetate	 (0.10	mmol)	 and	 the	 reaction	
mixture	stirred	for	an	additional	15	min,	after	which	N,O-bis(trimethylsilyl)acetamide	(BSA)	(73	
µL,	 61.0	mg,	 0.30	mmol,	 3	 equiv)	 and	dimethylmalonate	 (34	µL,	 39.6	mg,	 0.3	mmol,	 3	 equiv)	
were	 added	at	 rt	 followed	by	 catalytic	 KOAc.	 The	 reaction	mixture	was	warmed	 to	40	 °C	 and	
stirred	 until	 TLC	 showed	 complete	 consumption	 of	 the	 2-B(pin)	 substituted	 allylic	 acetate,	
typically	10	–	12	h.	The	reaction	mixture	was	then	cooled	to	rt,	diluted	with	EtOAc	(4	mL)	and	
filtered	through	a	plug	of	silica	and	the	solvent	was	removed	under	reduced	pressure.	The	crude	
product	 was	 dissolved	 in	 CDCl3	 and	 the	 ratio	 of	 regioisomers	 was	 determined	 by	 1H	 NMR	
spectroscopy	of	unpurified	reaction	mixtures.	CDCl3	was	removed	under	reduced	pressure	and	
the	crude	product	was	purified	by	flash	column	chromatography	on	silica	gel.		
	
Preparation	of	Pd/2	equiv	PPh3	stock	solution	(0.143	M	of	Pd)	in	THF.	
To	an	oven-dried	microwave	vial	equipped	with	a	stir	bar	was	charged	with	[Pd(allyl)Cl]2	(9.1	mg,	
0.025	mmol)	or	Pd(OAc)2	(11.2	mg,	0.05	mmol)	and	PPh3	(26.2	mg,	0.10	mmol)	and	the	vial	was	
capped,	and	then	the	vial	was	purged	with	N2.	To	the	vial	was	added	3.5	mL	of	dry	and	degassed	
THF	and	the	stock	solution	was	stirred	at	rt	for	30	min	before	use.	
	
Preparation	of	NaCH(CO2Me)2	stock	solution	(0.1M)	in	THF.		
To	 an	 oven-dried	microwave	 vial	 equipped	with	 a	 stir	 bar	was	 charged	with	NaH	 (48	mg,	 2.0	
mmol)	and	the	vial	was	capped,	and	then	the	vial	was	purged	with	N2.	To	the	vial	was	added	dry	
and	degassed	THF	(1.77	mL)	at	rt	and	the	reaction	mixture	cooled	to	0	°C	in	an	ice	bath.	To	this	
white	 suspension	was	 added	 dropwise	 dimethyl	malonate	 (229	uL,	 264	mg,	 2.0	mmol).	 Upon	
addition	of	the	dimethyl	malonate,	rapid	evolution	of	a	gas,	presumably	H2,	was	observed.	Once	
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the	H2	evolution	ceased,	the	resulting	solution	was	heated	to	reflux	for	1	min.	The	stock	solution	
was	cooled	and	stirred	at	rt	for	10	min	before	use.	
	
General	 Procedure	 D:	Palladium	 Catalyzed	 Allylic	 Substitution	 of	 2-B(pin)-Substituted	 Allylic	
Acetates	 or	 2-Substituted	 Allylic	 Acetates	 with	 NaCH(CO2Me)2.	 To	 an	 oven-dried	microwave	
vial	equipped	with	a	stir	bar	was	charged	with	the	allylic	acetate	1.1e	(63.2	mg,	0.20	mmol)	and	
the	 vial	 was	 capped	 and	 purged	 with	 N2.	 	 To	 the	 vial	 was	 added	 a	 stock	 solution	 of	
[Pd(allyl)Cl]2/2	equiv	PPh3	in	0.143	M	THF	(1.4	mL,	10	mol%	Pd	and	20	mol	%	PPh3)	by	a	syringe	
and	 the	 reaction	 mixture	 was	 stirred	 at	 rt	 for	 30	 min,	 after	 which	 a	 stock	 solution	 of	
NaCH(CO2Me)2	 in	0.1	M	THF	(0.6	mL,	0.6	mmol)	was	added	by	a	syringe	at	rt.	 	The	sealed	vial	
was	warmed	 to	40	 °C	 and	 stirred	until	 TLC	 taken	under	positive	pressure	of	 nitrogen	 showed	
complete	consumption	of	allylic	acetate,	 typically	0.5	–	24	h.	 	Note	 that	aliquots	 for	TLC	were	
taken	under	positive	pressure	of	nitrogen.		The	reaction	mixture	was	cooled	to	rt,	diluted	with	
EtOAc	(2	mL)	and	then	quenched	with	three	drops	of	water.		The	solution	was	filtered	through	a	
plug	 of	MgSO4	 and	 celite.	 	 The	 pad	 was	 rinsed	 with	 additional	 ethyl	 acetate	 (5	 mL)	 and	 the	
solvent	 was	 removed	 under	 reduced	 pressure	 to	 yield	 a	 pale	 red	 or	 yellow	 oil.	 The	 crude	
product	was	 dissolved	 in	 CDCl3	 and	 the	 ratio	 of	 regioisomers	 and	 the	 ratio	 of	 1,4-elimination	
products	were	determined	by	1H	NMR	spectroscopy	of	unpurified	reaction	mixtures.	CDCl3	was	
removed	 under	 reduced	 pressure	 and	 the	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	(hexanes:EtOAc	=	95:5)	to	afford	the	mixture	of	dimethyl	malonate	
substituted	 products	 and	 the	mixture	 of	 1,4-elimination	 products.	 The	 vinyl	 boronate	 ester	 is	
susceptible	 to	oxidation	of	 the	B–C	bond	on	 silica	under	 air,	 and	hence	 a	 rapid	purification	 is	
necessary	to	minimize	oxidation	to	the	corresponding	ketone.	
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Dimethyl	 (E)-2-(1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hept-2-en-1-yl)malonate	(1.2a).	The	compound	was	prepared	by	General	
Procedure	 B	 using	 1.1a	 and	 the	 result	 was	 reported	 in	 our	 previous	
communication	(>90:10,	76%	yield).21		
The	tile	compound	can	also	be	prepared	by	General	Procedure	B	using	1.1d	and	the	result	was	
reported	in	our	previous	communication	(>90:10,	51%	yield).21	
	
Dimethyl	 (E)-2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(4-
(trifluoromethyl)phenyl)hept-2-en-1-yl)malonate	 (1.2b).	 The	
compound	 was	 prepared	 by	 General	 Procedure	 C	 using	 1.1b	 and	 the	
result	was	reported	in	our	previous	communication	(>95:5,	92%	yield).21		
	
Dimethyl	 (E)-2-(1-(4-methoxyphenyl)-2-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)hept-2-en-1-yl)malonate	(1.2c).	The	compound	was	
prepared	 by	 General	 Procedure	 C	 using	 1.1c	 and	 the	 result	 was	
reported	in	our	previous	communication	(>95:5,	80%	yield).21		
	
	Dimethyl	 (E)-2-(1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)but-2-en-1-yl)malonate	 (1.2e).	 	 The	 product	 was	 prepared	 by	 General	
Procedure	D	using	(E)-1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)but-2-en-1-yl	 acetate	1.1e	 (63.2	mg,	0.2	mmol),	 a	0.143	M	 [Pd(allyl)Cl]2/2PPh3	 from	a	 stock	
solution	 (1.4	mL),	and	0.1	M	NaCH(CO2Me)2	stock	solution	 (0.6	mL).	The	reaction	mixture	was	
CH(CO2Me)2
B(pin)
n-Bu
1.2a
CH(CO2Me)2
B(pin)
n-Bu
F3C
1.2b
CH(CO2Me)2
B(pin)
n-Bu
MeO
1.2c
CH(CO2Me)2
B(pin)
Me
1.2e
37	
stirred	at	40	°C	for	3	h.	The	regioisomer	1.2e	 (benzylic	substitution	product)	was	confirmed	by	
1H	NMR	spectra	of	unpurified	reaction	products.	The	crude	product	was	purified	by	flash	column	
chromatography	on	 silica	 gel	 (hexanes:EtOAc	 =	 95:5)	 to	 afford	dimethyl	malonate	 substituted	
vinyl	boronate	ester	as	an	oil	(54.4	mg,	70%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	7.27	–	7.23	(m,	
2H),	7.22	–	7.17	(m,	2H),	7.14	–	7.09	(m,	1H),	6.32	(q,	J	=	7.0	Hz,	1H),	4.44	(d,	J	=	12.0	Hz,	1H),	
4.20	(d,	J	=	12.0	Hz,	1H),	3.69	(s,	3H),	3.48	(s,	3H),	1.88	(d,	J	=	7.0	Hz,	3H),	1.16	(s,	6H),	1.14	(s,	
6H);	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	169.1,	169.0,	142.4,	141.8,	128.4,	128.2,	126.5,	83.2,	55.9,	
53.0,	 52.4	 (two	 overlapping	 resonances),	 25.0,	 24.9,	 17.5	 (the	 quaternary	 vinyl	 C	 bearing	 the	
boron	 group	 is	 not	 observed);	 11B	NMR	 (CDCl3,	 125	MHz)	 δ	 29.2;	 IR	 (neat)	 2979,	 2953,	 1761,	
1740,	1625,	1496,	1434,	1408,	1373,	1310,	1267,	1194,	1140,	1027	cm-1;	HRMS	m/z	411.1967	
[(M+Na)+;	calcd	for	C21H29BO6Na:	411.1955].		
	
Dimethyl	 (E)-2-(1-phenylhept-2-en-1-yl)malonate	 (1.2f,	
minor)	 and	 Dimethyl	 (E)-2-(1-phenylhept-1-en-3-
yl)malonate	 (1.3f,	major).	 The	 reaction	was	performed	
following	General	 Procedure	D	with	1.1g	 (23.2	mg,	 0.1	mmol)	 in	 the	 presence	 of	 5	mol	%	 of	
[Pd(allyl)Cl]2	 and	20	mol%	of	PPh3	of	 the	 stock	 solution	 	 and	3	equiv	of	NaCH(CO2Me)2	from	a	
stock	solution.	The	reaction	mixture	was	stirred	at	40	°C	 for	30	min.	The	ratio	of	 regioisomers	
was	1.2f:1.3f	=	13:87	determined	by	1H	NMR	spectra	of	unpurified	reaction	products.	The	crude	
product	was	purified	by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	90:10)	to	
afford	 the	mixture	of	dimethyl	malonate	substituted	products	as	a	colorless	oil	 (26.5	mg,	87%	
yield).	The	NMR	spectral	data	match	the	previously	published	data.21	
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The	 title	 compound	 can	 also	 be	made	 by	 General	 Procedure	 D	with	1.1g	 at	 rt	 for	 30	min	 to	
afford	the	mixture	of	products	1.2f	and	1.3f	(16:84,	25.3	mg,	83%	yield).	
The	 title	compound	can	also	be	made	by	General	Procedure	B	using	1.1f	 in	 the	presence	of	5	
mol	%	of	Pd(OAc)2	and	10	mol	%	of	PPh3	at	40	°C	 for	12	h	and	the	result	was	reported	 in	our	
previous	communication	(1.2f:1.3f=10:90,	85%	yield).21		
The	title	compound	can	also	be	made	by	General	Procedure	B	using	1.1g	 in	 the	presence	of	5	
mol	%	of	Pd(OAc)2	and	10	mol	%	of	PPh3.	(1.2f:1.3f=9:91,	95%	yield).	21	
	
Dimethyl	 (E)-2-(2-methyl-1-phenylhept-2-en-1-
yl)malonate	(1.2h,	major)	and	dimethyl	(E)-2-(2-methyl-
1-phenylhept-1-en-3-yl)malonate	 (1.3h,	 minor).	 The	
reaction	was	 performed	 following	General	 Procedure	D	with	1.1h	 (24.6	mg,	 0.1	mmol)	 in	 the	
presence	of	5	mol	%	of	[Pd(allyl)Cl]2	and	20	mol	%	of	PPh3	of	the	stock	solution		and	3	equiv	of	
NaCH(CO2Me)2	from	a	stock	solution.	The	reaction	mixture	was	stirred	at	40	°C	for	3	h.	The	ratio	
of	 regioisomers	was	1.2h:1.3h	 =	 63:37	 determined	 by	 1H	NMR	 spectra	 of	 unpurified	 reaction	
products.	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	
(hexanes:EtOAc	 =	 95:5)	 to	 afford	 the	mixture	of	 dimethyl	malonate	 substituted	products	 as	 a	
colorless	oil	(28.0	mg,	88%	yield)	and	characterized	as	the	mixture	of	regioisomers.	The	reaction	
of	1.1h	provided	the	mixture	of	1.2h	and	1.3h	(79%,	63:37)	at	40	°C	for	24	h,	and	1.2h	and	1.3h	
(65%,	 64:36)	 at	 70	 °C	 for	 24	 h.	 Dimethyl	 (E)-2-(2-methyl-1-phenylhept-2-en-1-yl)malonate	
(1.2h).	1H	NMR	(500	MHz,	CDCl3)	δ	7.35	–	7.10	(m,	5H),	5.42	(t,	J	=	7.5	Hz,	1H),	4.09	(d,	J	=	12.5	
Hz,	1H),	4.03	(d,	J	=	12.5	Hz,	1H),	3.72	(s,	3H),	3.47	(s,	3H),	2.02	–	1.93	(dt,	J	=	7.5	Hz,	7.0	Hz,	2H),	
1.48	(s,	3H),	1.39	–	1.15	(m,	4H)	0.89	(t,	J	=	7.5	Hz,	3H);	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	168.7,	
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168.5,	 140.1,	 134.8,	 128.5,	 128.1,	 127.1,	 126.6,	 55.8,	 53.9,	 52.7,	 52.6,	 32.0,	 27.8,	 22.5,	 15.1,	
14.2;	 Dimethyl	 (E)-2-(2-methyl-1-phenylhept-1-en-3-yl)malonate	 (1.3h).	 1H	 NMR	 (500	 MHz,	
CDCl3)	δ	7.34	–	7.28	(m,	2H),	7.22	–	7.16	(m,	3H),	6.39	(s,	1H),	3.77	(s,	3H),	3.64	(s,	3H),	3.54	(d,	J	
=	11.0	Hz,	1H),	2.97	(ddd,	J	=	11.0	Hz,	8.5	Hz,	6.5	Hz,	1H),	1.77	(s,	3H),	1.52	–	1.42	(m,	2H),	1.40	–	
1.15	(m,	4H),	0.88	(t,	J	=	7.0	Hz,	3H);	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	169.1,	168.8,	138.0,	136.7,	
129.5,	129.1,	128.3,	126.5,	56.7,	52.73,	52.61,	49.8,	30.4,	29.5,	22.7,	14.2,	13.9;	(1.2h+1.3h)	 IR	
(neat)	 2954,	 2929,	 2858,	 1762,	 1740,	 1600,	 1494,	 1453,	 1434,	 1316,	 1265,	 1243,	 1160,	 1143,	
1130cm-1;	(1.2h+1.3h)	HRMS	m/z	341.1730	[(M+Na)+;	calcd	for	C19H26O4Na:	341.1729].	
	
	
Dimethyl	 (E)-2-(2-butyl-1-phenylhept-2-en-1-yl)malonate	 (1.2i,	 major	 of	 1.2i+1.3i),	 dimethyl	
(E)-2-(6-benzylidenedecan-5-yl)malonate	 (1.3i,	 minor	 of	 1.2i+1.3i),	 ((1Z,3E)-2-butylhepta-1,3-
dien-1-yl)benzene	((1Z,3E)-1.4i,	minor	of	1.4i)	and	((1E,3E)-2-butylhepta-1,3-dien-1-yl)benzene	
((1E,3E)-	1.4i,	major	of	1.4i).	
The	reaction	was	performed	following	General	Procedure	D	with	1.1i	(28.8	mg,	0.1	mmol)	in	the	
presence	of	5	mol	%	of	[Pd(allyl)Cl]2	and	20	mol%	of	PPh3	of	the	stock	solution		and	3	equiv	of	
NaCH(CO2Me)2	stock	 solution.	 The	 reaction	mixture	was	 stirred	 at	 40	 °C	 for	 8	 h.	 The	 ratio	 of	
isomers	 was	 1.2i:1.3i	 =	 81:19	 and	 (1Z,3E)-1.4i:(1E,3E)-1.4i	 =	 24:76	 determined	 by	 1H	 NMR	
spectra	 of	 unpurified	 reaction	 products.	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	(hexanes:EtOAc	=	95:5)	to	afford	the	mixture	of	dimethyl	malonate	
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substituted	products	as	a	colorless	oil	 (27.0	mg,	75%	yield)	and	the	mixture	of	1,4-elimination	
products	as	a	colorless	oil	(4.3	mg,	15%	yield).	
The	title	compound	can	also	be	made	at	70	°C	for	8	h	to	afford	the	mixture	of	products	1.2i:1.3i	
(81:19,	7.2	mg,	20%	yield)	and	(1Z,3E)-1.4i:(1E,3E)-1.4i	(27:73,	15.3	mg,	67%	yield).			
	
	Dimethyl	 (E)-2-(2-butyl-1-phenylhept-2-en-1-
yl)malonate	(1.2i).	1H	NMR	(500	MHz,	CDCl3)	δ	7.35	–	
7.15	(m,	5H),	4.04	(d,	JAB	=	12.0	Hz,	1H),	5.36	(t,	J	=		7.5	
Hz,	1H),	4.02	(d,	JAB	=	12.0	Hz,	1H),	3.71	(s,	3H),	3.41	(s,	3H),	2.12	–	2.04	(m,	1H),	2.06	–	1.98	(m,	
2H),	 1.67	–	 1.58	 (m,	 1H)	 1.55	–	 1.10	 (m,	 8H),	 0.90	 (t,	 J	 =	 7.0	Hz,	 3H),	 0.83	 (t,	 J	 =	 7.0	Hz,	 3H);	
13C{1H}	NMR	(125	MHz,	CDCl3)	δ	168.7,	168.5	140.2,	139.6,	128.6,	128.4,	127.2,	125.2,	57.0,	52.6,	
52.5,	51.2,	32.2,	30.7,	30.6,	27.7,	23.0,	22.5,	14.2,	14.1;	Dimethyl	 (E)-2-(6-benzylidenedecan-5-
yl)malonate	 (1.3i).	 1H	NMR	 (500	MHz,	CDCl3)	δ	7.35	–	7.15	 (m,	5H),	6.31	 (s,	1H),	3.76	 (s,	3H),	
3.66	(s,	3H),	3.63	(d,	J	=	10.5	Hz,	1H),	2.98	(ddd,	J	=	10.5	Hz,	9.0	Hz,	4.5	Hz,	1H),	2.24	–	2.12	(m,	
2H),	1.57	–	1.10	 (m,	10H),	0.94	–	0.80	 (m,	6H);	 13C{1H}	NMR	 (125	MHz,	CDCl3)	δ	169.3,	168.9,	
142.3,	138.2,	128.7,	128.3,	128.2,	126.5,	57.0,	52.7,	52.6,	49.9,	31.7,	31.0,	30.7,	29.3,	23.4,	22.9,	
14.2,	 14.0;	 (1.2i+1.3i)	 IR	 (neat)	 2955,	 2931,	 2860,	 1763,	 1741,	 1600,	 1494,	 1454,	 1434,	 1378,	
1315,	1274,	1245,	1193,	1159,	1141,	1030	cm-1;	(1.2i+1.3i)	HRMS	m/z	383.2202	[M+Na)+;	calcd	
for	C22H32O4Na:	383.2198].	
	
((1Z,3E)-2-Butylhepta-1,3-dien-1-yl)benzene	 	 ((1Z,3E)-
1.4i).	 	 1H	 NMR	 (500	MHz,	 CDCl3)	 δ	 7.35	 –	 7.29	 (m,	 2H),	
7.27	–	7.23	(m,	2H),	7.22	–	7.17	(m,	1H),	6.47	(d,	J	=	16.0	
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Hz,	1H),	6.32	(s,	1H),	5.86	(dt,	J	=	16.0	Hz,	7.0	Hz,	1H),	2.34	(t,	J	=		7.5	Hz,	2H),	2.09	(dt,	J	=		7.5	Hz,	
7.0	Hz,	 2H),	 1.58	–	 1.34	 (m,	 6H),	 0.96	–	 0.87	 (m,	 6H);	 13C{1H}	NMR	 (125	MHz,	 CDCl3)	 δ	 139.4,	
138.4,	132.4,	128.9,	128.2,	127.8,	126.9,	126.3,	35.6,	34.7,	31.5,	23.0,	22.9,	14.3,	14.0;	((1E,3E)-
2-Butylhepta-1,3-dien-1-yl)benzene	 ((1E,3E)-1.4i.	 	 1H	NMR	(500	MHz,	CDCl3)	δ	7.35	–	7.29	(m,	
2H),	7.27	–	7.23	(m,	2H),	7.22	–	7.17	(m,	1H),	6.37	(s,	1H),	6.11	(d,	J	=	15.5	Hz,	1H),	5.79	(dt,	J	=	
15.5	Hz,	7.0	Hz,	1H),	2.45	–2.38	(m,	2H),	2.14	(dt,	J	=	7.5	Hz,	7.0	Hz,	2H),	1.58	–	1.34	(m,	6H),	0.94	
(t,	J	=	7.5	Hz,	3H),	0.92	(t,	J	=	7.5	Hz,	3H);	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	141.2,	138.4,	134.4,	
130.2,	 129.6,	 128.9,	 128.4,	 126.5,	 35.4,	 31.7,	 27.6,	 23.3,	 23.0,	 14.2,	 14.0;	 (1Z,3E)-1.4i	 and	
(1Z,3E)-1.4i	 IR	 (neat)	2958,	2931,	2861,	1739,	1636,	1372,	1306,	1240,	1145	 cm-1;	 (1Z,3E)-1.4i	
and	(1Z,3E)-1.4i	HRMS-CI	m/z	228.1884	[(M)+;	calcd	for	C17H24:	228.1878].	
	
	
Dimethyl	 (E)-2-(2-cyclohexyl-1-phenylhept-2-en-1-yl)malonate	 (1.2j,	 major	 of	 1.2j+1.3j),	
dimethyl	 (E)-2-(2-cyclohexyl-1-phenylhept-1-en-3-yl)malonate	 (1.3j,	 minor),	 (1Z,3E)-2-
cyclohexylhepta-1,3-dien-1-yl)benzene	 ((1Z,3E)-1.4j,	 major	 of	 1.4j)	 and	 (1E,3E)-2-
cyclohexylhepta-1,3-dien-1-yl)benzene	((1E,3E)-1.4j,	minor	of	1.4j)		
The	reaction	was	performed	following	General	Procedure	D	with	1.1j	(31.4	mg,	0.1	mmol)	in	the	
presence	of	5	mol	%	of	[Pd(allyl)Cl]2	and	20	mol%	of	PPh3	of	the	stock	solution		and	3	equiv	of	
NaCH(CO2Me)2	stock	 solution.	 The	 reaction	mixture	was	 stirred	at	40	 °C	 for	24	h.	 The	 ratio	of	
regioisomers	was	1.2j:1.3j	=	84:16	and	(1Z,3E)-1.4j:(1E,3E)-1.4j	=	85:15	determined	by	1H	NMR	
spectra	 of	 unpurified	 reaction	 products.	 The	 crude	 product	 was	 purified	 by	 flash	 column	
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chromatography	on	silica	gel	(hexanes:EtOAc	=	95:5)	to	afford	the	mixture	of	dimethyl	malonate	
substituted	products	as	a	colorless	oil	 (23.6	mg,	61%	yield)	and	the	mixture	of	1,4-elimination	
products	as	a	colorless	oil	(5.6	mg,	22%	yield).	
The	title	compound	can	also	be	made	in	the	presence	of	10	mol	%	of	Pd(OAc)2	instead	of	5	mol	
%	of	[Pd(allyl)Cl]2	at	40	°C	for	24	h	to	afford	the	mixture	of	products	1.2j	and	1.3j	 (86:14,	26.3	
mg,	68%	yield).	
The	title	compound	can	also	be	made	at	70	°C	 to	afford	the	mixture	of	products	1.2j	and	1.3j	
(5.8	mg,	15%	yield)	and	1,4-elimination	products	((1Z,3E)-1.4j	:	(1E,3E)-1.4j	(86:14,	17.8	mg,	70%	
yield).		
Allylic	 acetate	 1.1k	 (31.4	 mg,	 0.1	 mmol)	 did	 not	 afford	 allylic	 substitution	 products	 in	 the	
presence	of	5	mol	%	of	[Pd(allyl)Cl]2	and	20	mol%	of	PPh3	of	the	stock	solution		and	3	equiv	of	
NaCH(CO2Me)2	stock	solution		The	reaction	mixture	was	stirred	at	40	°C	for	24	h.	
The	title	compound	can	also	be	made	from	1.1l	instead	of	1.1j	at	40	°C	to	afford	the	mixture	of	
products	1.2j	and	1.3j	(83:17,	1.9	mg,	5%	yield).		
	
	Dimethyl	 (E)-2-(2-cyclohexyl-1-phenylhept-2-en-1-
yl)malonate	(1.2j).	1H	NMR	(500	MHz,	CDCl3)	δ	7.35	–	
7.06	 (m	5H),	5.36	 (t,	 J	=	6.0	Hz,	1H),	4.18	 (d,	 J	=	12.5	
Hz,	1H),	3.92	(d,	J	=	12.5	Hz,	1H),	3.69	(s,	3H),	3.41	(s,	3H),	2.36	(tt,	J	=	12.0	Hz,	3.5	Hz,	1H),	2.15	–	
2.05	(m,	2H),	1.80	–	1.10	(m,	14H),	0.92	(t,	J	=	7.0	Hz,	1H);	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	168.9,	
168.4,	 143.3,	 141.0,	 128.9,	 128.3,	 127.0,	 125.7,	 58.8,	 52.6,	 52.5,	 48.0,	 41.7,	 32.5,	 31.8,	 31.6,	
27.4,	 27.2,	 27.0,	 26.3,	 22.6,	 14.3;	 Dimethyl	 (E)-2-(2-cyclohexyl-1-phenylhept-1-en-3-
yl)malonate	(1.3j).	While	the	resonances	in	the	1H	spectrum	for	the	major	regioisomer	overlap	
CH(CO2Me)2
Cy
n-BuPh
Cy
n-BuPh
CH(CO2Me)2
1.2j 1.3j
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with	most	of	 those	 for	 the	minor	regioisomer,	some	of	 the	resolved	resonances	 for	 the	minor	
regioisomer	are	1H	NMR	(500	MHz,	CDCl3)	δ	7.35	–	7.06	(m	5H),	6.28	(s,	1H),	3.10	(dt,	J	=	8.0	Hz,	
4.5	Hz,	1H),	2.67	(tt,	J	=	12.0	Hz,	3.0	Hz,	1H);	1.2j	+	1.3j	IR	(neat)	2928,	2853,	1763,	1743,	1494,	
1450,	1434,	1277,	1246,	1194,	1139,	1030	cm-1;	1.2j	+	1.3j	HRMS	m/z	409.2375	[(M+Na)+;	calcd	
for	C24H34O4Na:	409.2355].	
	
	(1Z,3E)-2-Cyclohexylhepta-1,3-dien-1-yl)benzene	
((1Z,3E)-1.4j):	1H	NMR	(500	MHz,	CDCl3)	δ	7.33	–	7.28	(m,	
2H),	7.27	–	7.23	(m,	2H),	7.21	–	7.16	(m,	1H),	6.42	(d,	J	=	
15.5	Hz,	1H),	6.30	(s,	1H),	5.72	(dt,	J	=	15.5	Hz,	7.0	Hz,	1H),	2.38	(tt,	J	=	11.5	Hz,	3.0	Hz,	1H),	2.12–	
2.05	(m,	2H),	1.93	–	1.86	(m,	2H),	1.86	–	1.78	(m,	2H),	1.70	–	1.15	(m,	8H),	0.90	(t,	J	=	7.0	Hz,	3H)	
;	 13C{1H}	NMR	 (125	MHz,	CDCl3)	δ	144.6,	138.7,	131.1,	129.7,	128.1,	128.0,	126.2,	124.4,	41.3,	
35.6,	 33.6	 (two	 overlapping	 resonances),	 27.4	 (two	 overlapping	 resonances),	 26.8,	 22.9,	 14.0;	
(1E,3E)-2-Cyclohexylhepta-1,3-dien-1-yl)benzene	((1E,3E)-1.4j):	1H	NMR	(500	MHz,	CDCl3)	δ	7.4		
–	7.15	(m,	5H),	6.49	(s,	1H),	5.94	(dt,	J	=	15.5	Hz,	7.0	Hz,	1H)	2.74	(tt,	J	=	12.0	Hz,	3.5	Hz,	1H),	2.16	
–	2.05	(m,	2H),	1.78	–	1.70	(m,	2H),	1.70	–	1.11	(m,	10H),	0.94	(t,	J	=	7.0	Hz,	3H);	13C{1H}	NMR	
(125	MHz,	CDCl3)	δ	146.2,	138.6,	131.6,	130.4,	129.1,	128.3,	126.3,	123.9,	39.4,	35.5,	33.6,	31.9,	
27.4,	 26.6,	 26.4,	 22.9,	 14.0.	 (1Z,3E)-1.4j+(1E,3E)-1.4j	 IR	 (neat)	 3022,	 2956,	 2927,	 2853,	 1599,	
1493,	1448,	1378,	1073,	962	cm-1;	(1Z,3E)-1.4j+(1E,3E)-1.4j	HRMS-CI	m/z	254.2012	[(M)+;	calcd	
for	C19H26:	254.2035].			
	
Dimethyl	 (E)-2-(2-methyl-1-phenylpent-2-en-1-
yl)malonate	 (1.2m,	 major)	 and	 dimethyl	 (E)-2-(2-
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methyl-1-phenylpent-1-en-3-yl)malonate	(1.3m,	minor):	The	reaction	was	performed	following	
General	Procedure	D	with	1m	(21.8	mg,	0.1	mmol)	in	the	presence	of	10	mol	%	of	Pd(OAc)2	and	
20	mol%	of	PPh3	of	the	stock	solution		and	3	equiv	of	NaCH(CO2Me)2	stock	solution.	The	reaction	
mixture	 was	 stirred	 at	 40	 °C	 for	 4	 h.	 The	 ratio	 of	 regioisomers	 was	 1.2m:1.3m	 =	 53:47	
determined	by	1H	NMR	spectra	of	unpurified	reaction	products.	The	crude	product	was	purified	
by	 flash	column	chromatography	on	silica	gel	 (hexanes:EtOAc	=	95:5)	 to	afford	 the	mixture	of	
dimethyl	 malonate	 substituted	 products	 (1.2m+1.3m)	 as	 a	 colorless	 oil	 (26.1	mg,	 90%	 yield).	
Dimethyl	(E)-2-(2-methyl-1-phenylpent-2-en-1-yl)malonate	(1.2m).	1H	NMR	(500	MHz,	CDCl3)	δ	
7.33	–	7.17	(m,	5H),	5.43	(t,	J	=	7.0	Hz,	1H),	4.11	(d,	JAB	=	12.5	Hz,	1H),	4.00	(d,	JAB	=	12.5	Hz,	1H),	
3.71	 (s,	3H),	3.47	 (s,	3H),	2.00	 (dt,	J	=	7.5	Hz,	7.0	Hz,	2H),	1.48	 (s,	3H),	0.94	 (t,	J	=	7.5	Hz,	3H);	
13C{1H}	 NMR	 (125	MHz,	 CDCl3)	 δ	 168.7,	 168.5,	 140.1,	 134.4,	 128.5,	 128.2,	 128.1,	 127.1,	 55.8,	
54.0,	 52.5	 (two	 overlapping	 resonances),	 21.4,	 14.8,	 14.3;	 Dimethyl	 (E)-2-(2-methyl-1-
phenylpent-1-en-3-yl)malonate	(1.3m).	1H	NMR	(500	MHz,	CDCl3)	δ	7.34	–	7.28	(m,	2H),	7.23	–	
7.13	(m,	3H),	6.39	(s,	1H),	3.76	(s,	3H),	3.64	(s,	3H),	3.55	(d,	J	=	11.0	Hz,	1H),	2.88	(ddd,	J	=	11.0,	
11.0,	3.5	Hz,	1H),	1.77	(s,	3H),	1.60	–	1.51	(m,	1H),	1.50	–	1.39	(m,	1H),	0.88	(t,	J	=	7.5	Hz,	3H);	
13C{1H}	 NMR	 (125	MHz,	 CDCl3)	 δ	 169.1,	 168.7,	 138.0,	 136.4,	 129.7,	 129.1,	 128.3,	 126.5,	 56.6,	
52.74,	52.61,	51.5,	23.9,	14.0,	11.9;	1.2m+1.3m	 IR	 (neat)	3027,	2958,	2934,	2874,	1760,	1739,	
1600,	1494,	1453,	1435,	1319,	1261,	1241,	1193,	1161,	1144,	1031	cm-1;	1.2m+1.3m	HRMS	m/z	
291.1595	[(M+H)+;	calcd	for	C17H23O4:	291.1596].	
The	title	compound	can	also	be	made	in	the	presence	of	5	mol	%	of	Pd(OAc)2	instead	of	5	mol	%	
of	[Pd(allyl)Cl]2	at	40	°C	for	24	h	to	afford	the	mixture	of	products	1.2m	and	1.3m	 (53:47,	13.4	
mg,	56%	yield).	
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Computational	Studies:	Performed	by	Prof.	Peo-Ola	Norrby.	
	 All	 structures	 have	 been	 optimized	 in	 solvent	 using	 Jaguar	 v.	 7.950	 at	 the	 B3LYP-
D3/lacvp*	 level.	 	 B3LYP-D3	 uses	 the	 hybrid	 B3LYP	 functional51	 augmented	 with	 dispersion	
corrections	 developed	 by	 Grimme	 and	 coworkers,26	 as	 implemented	 in	 Jaguar.50	 	 The	 lacvp*	
basis	 set	 combines	 6-31G*	 for	 light	 elements	 with	 the	 Hay-Wadt	 ECP	 and	 basis	 set	 for	 Pd.28	
Continuum	solvation	used	the	PBF	model29	with	parameters	for	THF.		
	 Conformational	 preferences	 were	 checked	 for	 the	 η3-(1-phenyl-3-ethyl-allyl)Pd(PPh3)2	
moiety,	with	different	2-substituents	(H,	Me,	or	B(pin)).	 	 In	this	famework,	the	ethyl	group	has	
two	low	energy	conformations	(open	or	closed,	only	the	former	allowing	nucleophilic	attack	at	
the	3-position).	
	 The	effect	of	the	2-BPin-substituent	on	nucleophilic	attack	was	tested	with	the	smaller	
η3-(1-phenyl-3-methyl-allyl)Pd(PPh3)2	moiety,	using	NH3	as	a	model	nucleophile.	 	 The	effect	of	
continuum	solvation	on	this	transition	state	is	significant.		Previous	experience	with	very	similar	
systems	have	shown	that	the	barrier	is	very	soft,	with	only	a	few	kJ/mol	variation	over	a	range	of	
more	than	0.2	Å	 in	the	forming	C–N	bond.	 	The	 low	curvature	makes	transition	state	searches	
unreliable,	 especially	 with	 continuum	 solvent,	 but	 on	 the	 other	 hand,	 relaxed	 scans	
(constraining	 forming	C–N	bond,	 2.0-2.5	Å	 in	 steps	of	 0.1	Å,	 full	 optimization	of	 all	 remaining	
coordinates)	 gives	 reproducible	 structures	 with	 no	 hysteresis.	 	 For	 all	 calculated	 scans,	 the	
highest	energy	was	found	for	a	C–N	distance	of	2.2	Å;	these	are	the	structures	reported	herein.		
See	the	Appendix	A	for	raw	data	and	details.	
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CHAPTER	2	
Palladium-Catalyzed	Chemoselective	Allylic	Substitution,	Suzuki-Miyaura	Cross-Coupling,	and	
Allene	Formation	of	Bifunctional	2-B(pin)-Substituted	Allylic	Acetate	Derivatives	
Adapted	with	permission	from	Chem.	Eur.	J.	2014,	20,	11726–11739	Copyright	2014	John	Wiley	
&	Sons.	
	
2.1. Introduction	
	 One	of	 the	most	 significant	 impediments	 to	 the	efficient	 synthesis	of	 complex	natural	
and	non-natural	products	 is	 the	 low	 level	of	chemoselectivity	exhibited	by	many	reagents	and	
catalysts.1	 	 To	 compensate	 for	 poor	 chemoselectivity,	 synthetic	 organic	 chemists	 have	 been	
forced	 to	design	and	 implement	elaborate	protecting	group	 strategies	 in	 their	 construction	of	
complex	natural	products.2	
	 Although	considerable	effort	has	been	devoted	to	understanding	chemoselectivity	with	
classical	 reagents,	 fewer	 studies	 have	 focused	 on	 chemoselectivity	 with	 transition	 metal	
catalysts.	 	 Given	 the	 increasing	 importance	 of	 transition	metal-catalyzed	 reactions	 in	 organic	
synthesis,3	we	 set	 out	 to	 optimize	 and	 control	 catalyst	 chemoselectivity	 in	 some	 of	 the	most	
synthetically	 valuable	 transition	 metal-catalyzed	 reactions,	 the	 Tsuji-Trost	 allylic	 substitution4	
and	 the	 Suzuki-Miyaura	 cross-coupling	 reactions.5	 	 Palladium	 phosphine	 complexes	 catalyze	
both	 reactions	 even	 though	 the	 mechanistic	 pathways	 are	 distinct	 (Figure	 2.1).	 	 Allylic	
substitutions	 begin	 with	 coordination	 of	 the	 substrate	 to	 palladium(0)	 to	 form	 a	 π-complex	
(Figure	 2.1,	 right-hand	 cycle).	 	 Backside	 attack	 by	 the	 palladium	 on	 the	 carbon	 bearing	 the	
leaving	 group	 in	 an	 oxidative	 ionization	 generates	 a	 π-allylpalladium	 complex.	 	 External	
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nucleophilic	 addition	 to	 the	 π-allylpalladium	 complex	 followed	 by	 liberation	 of	 the	 product	
regenerates	 the	 palladium(0).	 	 In	 contrast,	 in	 the	 Suzuki-Miyaura	 cross-coupling	 palladium(0)	
undergoes	 oxidative	 addition	 with	 an	 aryl	 halide	 to	 form	 the	 palladium(II)	 aryl	 halide	
intermediate	 (Figure	2.1,	 left-hand	cycle).6	 	Transmetallation	with	boronic	acid	derivatives	and	
bases	 provides	 the	 second	 Pd–C	 bond.7	 	 Reductive	 elimination	 forms	 the	 C–C	 bond	 of	 the	
product	 and	 regenerates	 palladium(0).	 	More	broadly	 speaking,	 the	palladium	does	not	 come	
into	 contact	with	 the	 leaving	 group	 or	 nucleophile	 in	 the	 allylic	 substitution,8	whereas	 in	 the	
Suzuki-Miyaura	 cross-couplings,	 palladium	directly	 interacts	with	 both	 coupling	 partners.	 	 The	
common	denominator	in	these	reactions	is	the	ability	of	the	same	palladium	catalyst	to	promote	
both	processes.	
	 With	this	backdrop,	we	asked	a	fundamental	question:	Could	the	chemoselectivity	of	a	
palladium-phosphine-based	 catalyst	 toward	 an	 allylic	 acetate,	 an	 aryl	 halide,	 and	 a	 vinyl	
boronate	ester	be	controlled	by	careful	choice	of	reagents	and	conditions?		This	report	answers	
this	question	and	introduces	a	third	orthogonal	reaction	pathway	of	2-B(pin)-substituted	allylic	
acetates	 that	 generates	 allenes	 with	 excellent	 chemoselectivity.	 	 Based	 on	 the	 highly	
chemoselective	 reactions	 developed	herein,	 2-B(pin)-substituted	 allylic	 acetate	 derivatives	 are	
useful	 “linchpins”	 that	 can	 be	 utilized	 for	 the	 preparation	 of	 an	 array	 of	 small	 molecules,	
including	 functionalized	 allylic	 amines	 and	 malonates,	 α-amino	 ketones,	 trisubstituted	 allylic	
esters	 and	 carbonates,	 and	 1,3-disubstituted	 allenes.	 	 A	 portion	 of	 this	work	 related	 to	 allylic	
substitution	 has	 been	 communicated.9	 	 In	 the	 present	 full	 report,	 we	 disclose	 the	 scope	 of	
Suzuki-Miyaura	cross-coupling	and	allene	formation.	
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FIGURE	 2.1.	 Catalytic	 cycles	 of	 Tsuji-Trost	 allylic	 substitution	 (right-hand	 cycle)	 and	 Suzuki-
Miyaura	cross-coupling	(left-hand	cycle).	
 
	
	 	
2.2.	Results	and	Discussion	
	 The	 application	 of	 multifunctional	 substrates	 in	 tandem	 reactions	 enables	 the	 rapid	
construction	of	diverse	chemical	arrays.	 	Key	 to	 the	 success	of	 such	 strategies	 is	 the	ability	 to	
control	 chemoselectivity	 by	 controlling	 the	 relative	 rates	 of	 processes	 that	 lead	 into	 different	
reaction	manifolds.	In	this	study,	we	have	embedded	a	vinyl	boronate	ester	in	an	allylic	acetate	
with	 the	 goal	 of	 controlling	 chemoselectivity	 between	 palladium-catalyzed	 Tsuji-Trost	 allylic	
substitution,	 Suzuki-Miyaura	 cross-coupling	 and	 allene-forming	 reactions	 (Figure	 2.2).	 	 Given	
that	 the	 same	 palladium	 catalysts	 promote	 allylic	 substitution,	 cross-coupling,	 and	 allene	
formation	 reactions,	 we	 focused	 on	 reaction	 conditions	 and	 reagents	 to	 control	
chemoselectivity.	
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	 A	 crucial	 step	 toward	 the	 development	 of	 new	 synthetic	 methods	 is	 introduction	 of	
reliable	and	scalable	procedures	to	prepare	the	substrates.	 	Using	our	stereodefined	1-alkenyl-
1,1-heterobimetallic	 reagents,	 the	 2-B(pin)-substituted	 allylic	 acetates	were	 easily	 prepared	 in	
one-pot	 from	readily	available	alkynyldioxaborolanes	 (Scheme	2.1).9-10	 	Thus,	hydroboration	of	
air-stable	 alkynyldioxaborolanes	 with	 dicyclohexylborane	 generates	 1-alkenyl-1,1-dibora	
intermediates	 as	 the	 only	 observable	 regioisomer	 (1H	 NMR).11	 	 Although	 neither	 B–C	 bond	 is	
very	nucleophilic,	the	boron	centers	are	electronically	quite	different	due	to	resonance	donation	
from	 the	 pinacolato	 group	 of	 the	 B(pin).	 	 The	 partially	 occupied	p-orbital	 of	 the	 B(pin)	 boron	
dramatically	raises	the	barrier	to	transmetallation,	and	the	vinyl–BCy2	undergoes	selective	B	to	
Zn	 transmetallation	 at	 –78	 °C	 to	 generate	 the	heterobimetallic	 intermediate.	 	 Addition	of	 the	
Zn–C	bond	to	aldehydes	and	quenching	the	resulting	alkoxides	with	acetic	anhydride	provided	2-
B(pin)-substituted	 (E)-allylic	 acetates	2.1	 in	 52–85%	 yield	 (Scheme	 2.1).	 	 The	 reaction	worked	
well	with	linear	and	branched	aliphatic	aldehydes	(67–85%	yield).	 	Likewise,	benzaldehyde	and	
its	derivatives	with	electron	withdrawing	or	donating	substituents	proved	 to	be	good	reaction	
partners	 (52–78%	 yield).	 	 Cinnamaldehyde	 gave	 60%	 yield	 of	 the	 rearranged	 dienyl	 product	
formed	 on	 isomerization	 of	 the	 acetate	 (see	 Supporting	 Information).	 	 The	
alkynyldioxaborolanes	can	be	derived	from	either	aliphatic,	aromatic,	or	functionalized	alkynes	
[R2	=	n-Bu,	(CH2)4Cl,	Ph].		The	scalability	of	this	method	was	demonstrated	in	the	synthesis	of	2-
B(pin)-substituted	 allylic	 acetates	 in	 gram	quantities,	 positioning	 us	 to	 explore	 their	 reactivity	
and	chemoselectivity	with	palladium	phosphine-based	catalysts.	
	
	
	
55	
	
	
Figure	2.2.		Potential	reactions	of	2-B(pin)-substituted	allylic	esters.		
	
	
Scheme	2.1.	One-pot	synthesis	of	2-B(pin)-substituted	allylic	acetates.	
	
	
2.2.1 Allylic	 Substitution	 of	 2-B(pin)-Substituted	 Allylic	 Acetates:	 Controlling	
Chemoselectivity	
	
	 At	the	outset	of	our	studies	we	were	concerned	about	the	ability	of	2-B(pin)-substituted	
allylic	acetates	to	undergo	the	Tsuji-Trost	allylic	substitution	successfully.		Although	most	acyclic	
allylic	acetate	substrates	are	mono-	or	disubstituted,4c	 leading	to	mono	or	1,3-disubstituted	π-
allyl	 intermediates,	 the	 reactivity	 of	 1,2,3-trisubstituted	 allylic	 derivatives	 toward	 allylic	
ionization	with	palladium	catalysts	has	been	relatively	unexplored.12	 	A	 few	examples	of	allylic	
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acetate	 derivatives	 containing	 a	 boron	 at	 the	 2-position13	 had	 been	 used	 in	 transition	metal-
catalyzed	 allylic	 substitution	 reactions,13b	 although	 some	 examples	 of	 3-boron	 substituted	
analogs	had	been	generated	or	proposed	as	intermediates.14	Despite	the	lack	of	clear	precedent,	
the	 conjugate	 base	 of	 dimethyl	 malonate	 and	 several	 primary	 and	 secondary	 amines	
participated	 in	 the	 allylic	 substitution.	 	 For	 example,	 2-B(pin)-substituted	 allylic	 acetate	 2.1a	
underwent	substitution	with	sodium	dimethyl	malonate	(Table	2.1,	entry	1)	to	furnish	2-B(pin)-
substituted	allylic	alkylation	product	2.2a	in	81%	yield.		Morpholine,	N-methylbenzylamine,	and	
piperidine	were	good	substrates,	affording	2-B(pin)-substituted	allylic	amines	2.2b–d	in	79–83%	
yield	(entries	2–4).	 	Benzylamine,	used	as	the	representative	primary	amine,	also	underwent	a	
single	 allylic	 substitution	 to	 produce	 2e	 in	 65%	 yield	 (entry	 5).	 The	 unsymmetrical	 dialkyl	
substrate	2.1c	underwent	substitution	with	morpholine	catalyzed	by	[Pd(allyl)Cl]2	and	PPh3	(1:4)	
with	nucleophilic	attack	at	the	less	hindered	position	of	the	π-allyl	with	excellent	regioselectivity	
(>20:1,	 entry	 6).	 	 Isomeric	 2-B(pin)-substituted	 allylic	 acetates	 2.1d	 and	 2.1f	 each	 underwent	
reaction	with	morpholine	and	NaCH(CO2Me)2	using	catalyst	generated	from	Pd(OAc)2	(10	mol	%)	
and	PPh3	(20	mol	%)	to	afford	the	same	regioisomer	of	allylic	substitution	products	2.2h	and	2.2i	
with	 ≥10:1	 regioselectivity	 (entries	 7–10).	 	 The	 styryl	 derivative	 2.1d	 was	 found	 to	 be	 less	
reactive	 than	 2.1f	 toward	 the	 same	 palladium	 catalyst,	 resulting	 in	 lower	 yields	 of	 the	
substitution	products	2.2g	and	2.2h	 (entries	7–10,	45	vs.	80%	and	51	vs.	79%).	 	 In	contrast	 to	
most	 π-allylpalladium	 complexes	 with	 a	 single	 aryl	 group	 at	 the	 terminus,	 allylic	 substitution	
took	 place	 at	 the	 benzylic	 position	 in	 each	 case.	 	 The	 reversal	 in	 regioselectivity	 is	 due	 to	
formation	 of	 the	 anti-aryl-π-allyl	 isomer,	 which	 exhibits	 enhanced	 reactivity	 at	 the	 benzylic	
position,	as	outlined	in	our	related	study.10d		Analogous	reactions	with	electron	withdrawing	or	
donating	 substituents	 on	 the	 aryl	 groups	 (2.1g–j)	 provided	 the	 benzylic	 substitution	 products	
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(2.2i–l)	 in	 75–92%	 isolated	 yield	 with	 >10:1	 regioselectivity	 (entries	 11–14).	 	 The	 unique	
regioselectivity	 observed	 with	 aryl	 substituted	 substrates	 enables	 the	 synthesis	 of	 benzylic	
amines,	which	are	common	structural	motifs	in	medicinal	chemistry.15		
	
Table	2.1.	Palladium-catalyzed	Allylic	Substitution	of	2-B(pin)-Substituted	Allylic	Acetates	
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2.2.2. Development	of	Tandem	Reactions	Initiated	with	Allylic	Substitution	
	 Tandem	 reactions	 are	 important	 in	 streamlining	 organic	 synthesis,	 enabling	 a	 rapid	
increase	 in	 molecular	 complexity	 while	 minimizing	 synthetic	 steps	 and	 isolations.16	 	 We,	
therefore,	undertook	development	of	tandem	processes	with	2-B(pin)	allylic	acetates	beginning	
with	allylic	substitutions	and	followed	by	reactions	of	the	vinyl	boronate	ester.17	
	
2.2.2.1. Tandem	Allylic	Substitution/Oxidation	Sequences	
	 One	of	the	most	utilized	transformations	of	the	B–C	bond	is	its	oxidation.		In	the	case	of	
vinyl	boronate	esters,	the	oxidation	products	are	ketones,	and	allylic	substitution/oxidation	will	
lead	 to	 α-functionalized	 ketones.	 	 For	 the	 tandem	 allylic	 substitution/oxidation	 process,	 the	
allylic	substitution	was	performed	as	outlined	in	Table	2.1.	
After	 the	 allylic	 substitution,	 the	 crude	 reaction	 mixture	 was	 treated	 with	 alkaline	 hydrogen	
peroxide	to	oxidize	the	B–C	bond.		When	NaCH(CO2Me)2	was	employed	as	the	nucleophile	in	the	
substitution,	subsequent	oxidation	generated	substituted	ketone	2.3a	 in	85%	yield	 in	this	one-
pot	 procedure	 (Table	 2.2,	 entry	 1).	 	 Secondary	 amines	 performed	 well	 in	 the	 tandem	 allylic	
substitution/oxidation	sequence	to	form	α-amino	ketones	2.3b–2.3e	in	65–82%	yield	(entries	2–
5).	 	Both	aliphatic	 (entries	1–4)	and	1-phenyl-2-B(pin)-substituted	allylic	acetates	 (entries	5–6)	
were	good	substrates	for	the	tandem	process.		A	milder	oxidation	with	NaBO3·H2O18	resulted	in	
an	increased	yield	of	2.3e	(compare	entries	5	and	6).		
	 It	is	noteworthy	that	the	tandem	allylic	substitution/oxidation	sequence	is	equivalent	to	
an	α-carbonyl	cation	synthon	and	represents	an	umpolung	ketone	(Scheme	2.2).19		α-Substituted	
ketones	 are	 difficult	 to	 synthesize	 with	 standard	 π-allyl	 chemistry.	 	 Trost	 and	 Gowland		
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Table	2.2.	One-pot	Synthesis	of	α-Substituted	Ketones	via	Tandem	Allylic	Substitution/Oxidation	
	
demonstrated	that	2-alkoxy	allylic	acetates	underwent	allylic	substitution	to	afford	enol	ethers	
that	 were	 hydrolyzed	 to	 afford	 ketones	 (Scheme	 2.3A).19a	 	 Organ	 and	 co-workers	 performed	
similar	chemistry	with	allylic	phenoxides	(Scheme	2.3B).19e	
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N
n-Bu
O
O
2.3a
2.3c
2.3d
2.3e
2.3b
2.3e
2.1 2.3
a Yield of purified and isolated products. b Allylic substitution carried out with Pd(OAc)2 (5 mol 
%) and PPh3 (10 mol %) at rt, and oxidation carried out with 3 equiv of NaBO3H2O in 
THF/H2O (1:1) at rt.
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Scheme	 2.2.	 	 2-B(pin)-substituted	 allylic	 substitution	 products	 as	 synthons	 for	α-electrophilic	
carbonyl	substrates.		
	
	
	
Scheme	 2.3.	 	 2-B(pin)-substituted	 allylic	 substitution	 products	 as	 synthons	 for	α-electrophilic	
carbonyl	substrates.	
`	
	 Enantioenriched	allylic	amines	are	valuable	synthetic	intermediates	and	are	common	in	
natural	products	and	compounds	with	biological	activity.15,20	 	One	possible	approach	to	access	
such	 compounds	 is	 via	 allylic	 substitutions	 of	 enantioenriched	 2-B(pin)-substituted	 allylic	
acetates.	 	With	 this	 in	mind,	2-B(pin)-substituted	allylic	acetate	1f	of	80%	ee	was	prepared	by	
OPh
OPh
Pd(PPh3)4 (5 mol %) OPh
L2Pd
OPh
CO2Me
CO2Me
Me
H2SO4
O
CO2Me
CO2Me
Me
OEt Pd(PPh3)4 
(10-15 mol %)
OEt
L2Pd
OEt SO2Ph
H2SO4
C6H13
OAc
C6H13
C6H13 CO2i-Pr
O SO2Ph
C6H13 CO2i-Pr
A.
B.
CO2i-Pr
SO2Ph
65 % yield
85% yield99% yield
CO2Me
Me
MeO2C
Na
99% yield
B(pin)
R2R1
Nu
O
R2R1
umpolung synthon
O
R2R1
X
X = halo
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Sharpless-Katsuki	kinetic	resolution21	of	2-B(pin)	allylic	alcohol	4a10a	and	subsequent	acetylation	
with	 acetic	 anhydride	 (Scheme	 2.4).9	 	 We	 then	 conducted	 the	 allylic	 substitution	 of	 1f	 and	
morpholine	 to	 form	 the	 2-B(pin)-substituted	 benzyl	 amine	 2.2b	 in	 82%	 yield	 without	 loss	 of	
enantiomeric	 excess	 (Scheme	 2.5).	 	 A	 tandem	 allylic	 substitution/B–C	 bond	 oxidation	 with	
NaBO3·H2O	generated	the	α-amino	ketone	with	77%	ee	in	80%	yield	(Scheme	5).		Unfortunately,	
employing	 alkaline	 H2O2	 in	 place	 of	 NaBO3·H2O	 for	 the	 oxidation	 led	 to	 racemization	 of	 the	
amino	ketone	product.	
	
Scheme	 2.4.	 	 Kinetic	 resolution	 of	 2-B(pin)-substituted	 allylic	 alcohol	 2.4	 to	 prepare	
enantioenriched	2-B(pin)-substituted	allylic	acetate	2.1f.	
	
Scheme	2.5.		Allylic	substitution	of	enantioenriched	2.1f	with	morpholine	followed	by	oxidation	
with	sodium	perborate.	
	
	
B(pin)
n-BuPh
OH Ti(Oi-Pr)4 (1.0 equiv)
(+)-DIPT (1.2 equiv)
4 Å MS, CH2Cl2 
–20 °C
Me2Zn (1.2 equiv) 
 Ac2O (1.5 equiv)
toluene, 0 °C
2.4
TBHP (0.6 equiv)
∗
B(pin)
n-BuPh
OH
∗
B(pin)
n-BuPh
OH
O
45% yield, 80% eeunstable
not isolated
∗
B(pin)
n-BuPh
OAc
2.1f (80% yield, 80% ee)
∗
B(pin)
n-BuPh
OH
2.4a (80% ee)
B(pin)
n-BuPh
OAc Pd(OAc)2 (5 mol %)
PPh3 (10 mol %)
THF, rt, 12 h
NaBO3•H2O
THF/H2O
B(pin)
n-BuPh
N
O
O
n-BuPh
N
O
2.1f (80% ee) 2.2b, 80% ee, 82% yield 2.4e, 77% ee, 80% yield
(one-pot from 2.1f)
NHO rt, 4 h
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2.2.2.2. Tandem	Allylic	Substitution/Suzuki-Miyaura	Cross-Coupling	
	 Allylic	amines	are	present	in	molecules	with	diverse	pharmacological	properties	such	as	
Acrivastine	 (Semprex),15,22	 Flunarizine	 (Sibelium,	 Ca	 channel	 blocker),23	 and	 several	 BA	 uptake	
inhibitors.24	 	 In	 the	synthesis	of	allylic	amines,	 it	 is	usually	 important	 that	 the	geometry	about	
the	C=C	bond	be	controlled	to	provide	a	single	product.		With	that	in	mind,	we	sought	to	achieve	
a	 one-pot	 allylic	 substitution/Suzuki-Miyaura	 cross-coupling	 reaction	 of	 2-B(pin)-substituted	
allylic	 acetates.	 	 As	 alluded	 to	 in	 Figure	 1,	 it	 is	 conceivable	 that	 the	 allylic	 substitution	 and	
Suzuki-Miyaura	cross-coupling	could	be	catalyzed	using	the	same	palladium	source.		One	of	the	
key	factors	to	turn	on	the	Suzuki-Miyaura	cross-coupling	will	be	the	activation	of	the	B–C	bond,	
initiated	 by	 hydrolysis	 to	 the	 boronic	 acid.	 	 It	 is	 noteworthy	 that	 a	 successful	 allylic	
substitution/cross-coupling	 sequence	 enables	 the	 synthesis	 of	 a	 variety	 of	 2-arylated	 allylic	
amines	 and	malonates	 from	easily	 accessible	 2-B(pin)-substituted	 allylic	 acetates,	 aryl	 halides,	
amines,	and	malonates.	 	The	allylic	substitution	of	2-B(pin)	allylic	acetate	2.1a	and	morpholine	
was	 performed	 following	 the	 conditions	 in	 Table	 2.1	 entry	 8.	 	 After	 completion	 of	 the	
substitution,	as	 judged	by	TLC,	the	reaction	mixture	was	diluted	with	THF/water	(10:1),	Cs2CO3	
and	aryl	halide	were	added,	and	the	reaction	mixture	was	heated	(Table	2.3).		After	workup,	2-
arylated	trisubstituted	allylic	amine	derivatives	2.5a–c	were	isolated	in	52–70%	yield	(entries	1–
3),	 including	 the	 3-pyridyl	 derivative.	 	 Likewise,	 unsymmetrical	 2-B(pin)-substituted	 allylic	
acetate	2.1f	underwent	the	tandem	allylic	substitution	with	morpholine/cross-coupling	to	yield	
trisubstituted	 benzylic	 amines	 2.5d–f	 in	 50–70%	 yield	 (entries	 4–7).	 	 Aryl	 bromide	 coupling	
partners	with	electron	donating	or	withdrawing	substituents	were	well	tolerated.		Iodobenzene	
gave	 a	 lower	 yield	 than	 the	 aryl	 bromides	 (entries	 4	 and	 5).	 	 Tandem	 Suzuki-Miyaura	 cross-
coupling	 of	 allylic	 substitution	 product	 2.2h	 with	 sodium	 malonate	 failed	 with	 iodobenzene,	
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recovering	 allylic	 substitution	 product	 2.2h	 (43%	 yield,	 entry	 8).	 	 In	 contrast,	 2.1f	 and	 2.1h	
underwent	tandem	allylic	substitution	with	NaCH(CO2Me)2/cross-couplings	with	bromobenzene	
in	51	and	61%	yield	 (entries	9	and	10).	 	 Importantly,	 in	 all	 cases,	 the	geometry	of	 the	double	
bond	was	maintained.	
	 Related	 palladium-catalyzed	 tandem	 reactions	 have	 been	 reported	 by	 the	 groups	 of	
Kazmaier	and	Pucheault.	 	Kazmaier	and	co-workers	established	one-pot	allylic	amination/Stille	
couplings	 of	 β-stannylated	 allylic	 carbonates	 to	 provide	 allylic	 amine	 derivatives	 (Scheme	
2.6A).25	 	 This	 approach	 provides	 disubstituted	 allylic	 amines	 and	 is	 complementary	 to	 the	
chemistry	 in	Table	2.3,	which	generates	 trisubstituted	products.	After	publication	of	our	 initial	
communication,9	Pucheault	and	co-workers	 followed	with	a	 tandem	palladium-catalyzed	Tsuji-
Trost	allylic	substitution/Suzuki-Miyaura	cross-couplings	of	γ-borylated	allylic	acetates	(Scheme	
2.6B).14k		This	reaction	provides	traditional	allylic	substitution	products	that	can	be	generated	in	
an	efficient	tandem	fashion.	With	respect	to	the	synthesis	of	compound	libraries,	our	approach	
furnishes	1,2,3-trisubstituted	allyl	products,	which	contain	an	additional	point	of	diversity	over	
those	 in	 Scheme	 2.6.	 	 To	 expand	 the	 synthetic	 utility	 of	 2-B(pin)-substituted	 allylic	 ester	
derivatives	 further,	we	next	set	out	 to	 reverse	 the	chemoselectivity	by	performing	the	Suzuki-
Miyaura	cross-coupling	in	the	presence	of	the	allylic	ester	derivatives.	
	
2.2.3. Chemoselective	 Suzuki-Miyaura	 Cross-Coupling	 in	 the	 Presence	 of	 Allylic	
Leaving	Groups	
	 As	demonstrated	 in	the	tables	above,	allylic	substitutions	of	2-B(pin)-substituted	allylic	
acetates	proceed	readily	despite	the	large	size	of	the	B(pin)	group.		We	then	asked	the	question	
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Table	 2.3.	 Tandem	 Allylic	 Substitution/Suzuki-Miyaura	 Cross-Coupling	 of	 2-B(pin)-substituted	
Allylic	Acetates	
	
Cs2CO3 (3 equiv)
Ar-X (3 equiv)
THF or toluene / H2O
100 °C, 24 h
B(pin)
n-BuR
OAc Pd(OAc)2 (10 mol %)
PPh3 (20 mol %)
THF, 40 °C, 10 h
Nu-/NuH
(3 equiv)
70
52
entry yield (%)a
4-Me-C6H4-Br
4-MeO-C6H4-Br
3-C5H3N-Br
1
2
3
65
n-Bu
N
n-Bu
Ar-X
O
Ar
allylic acetate
2.1a
50
59
4-MeO-C6H4-Br
4-O2N-C6H4-Br
4
6
7
69
2.1f 705
Ph-I
Ph-Br
51
8
9 n-Bu
Ph
61
CH(CO2Me)2
n-Bu
Ph
Ph-Br
Ph-Br
CH(CO2Me)2
Ph-I
CH(CO2Me)2
B(pin)
n-Bu 43
b
10
F3C
product
2.5a
2.5b
2.5c
2.5d
2.5d
2.5e
2.5f
2.5g
2.2h
2.5h
2.1a
2.1a
2.1f
2.1f
2.1f
2.1f
2.1f
2.1h
B(pin)
n-Bun-Bu
OAc
B(pin)
n-Bu
OAc
N
n-Bu
O
Ar
B(pin)
n-Bu
OAc
F3C
B(pin)
n-BuR
Nu
Ar
n-BuR
Nu
2.1 2.52.2
a Yield of purified and isolated products. b No cross-coupling product was observed.
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Scheme	 2.6.	 	 A.	 Kazmaier’s	 one-pot	 allylic	 amination/Stille	 couplings.	 B.	 Pucheault’s	 tandem	
Tsuji-Trost	allylic	substitution/Suzuki-Miyaura	cross-couplings.	
	
	
whether	the	Suzuki-Miyaura	cross-coupling	reaction	could	be	conducted	in	the	presence	of	the	
allylic	 ester	derivatives.	 	As	outlined	 in	 Figures	2.1	and	2.2,	 the	determining	 factor	 controlling	
bifurcation	between	the	two	reaction	manifolds	is	the	relative	rate	of	oxidative	ionization	of	the	
allylic	ester	vs.	oxidative	addition	of	the	aryl	halide.		Although	there	have	been	many	studies	on	
oxidative	addition	of	aryl	and	vinyl	halides	and	numerous	investigations	into	oxidative	ionization	
of	allylic	acetates,6,8	 very	 few	studies	compare	 the	 relative	 rates	of	 these	 two	processes.26	 	As	
pointed	out	by	Organ,19e,27	 	 in	 cases	where	a	 comparison	was	made,	 the	 substrates	employed	
were	 frequently	 biased	 by	 either	 steric	 effects	 or	 conformational	 restrictions	 that	 disfavor	
proper	orbital	alignment	needed	for	the	allylic	ionization	to	proceed.		
2.2.3.1. Precedents	 for	 Oxidative	 Addition	 of	 Aryl	 Halides	 in	 the	 Presence	 of	 Allylic	
Acetates	
	 The	 chemoselectivity	 of	 palladium-based	 catalysts	 has	 been	 investigated	 by	 several	
groups.28	 	 Lautens	 and	 co-workers	 developed	 a	 reductive	 coupling	 of	 allylic	 acetates	 that	
OAc
B
CH(CO2Me)2
B
O
O
O
O
CH(CO2Me)2
Ar
Pd(OAc)2 (1 mol %)
PPh3 (3 mol %)
NaCH(CO2Me)2
Ar-I
OCO2Et
SnBu3
R4
R5
R4
R5 R4R5
R3
NR1R2
[Pd(allyl)Cl]2 (1 mol %)
PPh3 (8 mol %)
R1R2NH SnBu3
NR1R2
R3-X
A.
B.
75 – 78% yields
34 – 96% yields
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involves	 β-OAc	 elimination	 (Scheme	 2.7A).29	 	 Jiao	 and	 co-workers	 demonstrated	 a	
complementary	Heck	reaction	of	allylic	acetates	that	undergo	traditional	β-hydride	elimination	
rather	 than	 β-acetate	 elimination	 (Scheme	 2.7B).30	 	 Genet	 and	 co-workers	 conducted	 a	
chemoselective	 Suzuki-Miyaura	 cross-coupling	 of	 γ-borylated	 allylic	 acetates	 with	 activated	
alkenyl	 iodides	 (Scheme	2.7C).31	 	 Kočovský	 and	 co-workers	 investigated	 Suzuki-Miyaura	 cross-
coupling	 reaction	 of	 simple	 γ-borylated	 allylic	 carbonates	 with	 aryl	 iodides	 (Scheme	 2.7D).14h		
The	cross-coupling	products	were	isolated	in	 low	to	moderate	yields	(32%	average	yield	for	15	
substrates),	and	the	reactions	failed	with	aryl	bromides.		Although	the	conditions	and	catalysts	
used	in	Scheme	2.7A–D	are	different,	the	trend	suggests	that	oxidative	addition	of	sp2	C–I	bonds	
is	 faster	than	 ionization	of	allylic	acetates,	but	the	 increased	reactivity	of	carbonates	results	 in	
low	cross-coupling	yields	(Scheme	2.7D).	
	 In	 the	 case	 of	 aryl	 bromides,	 Trost,	 Malhotra,	 and	 Chan	 recently	 found	 that	 Boc	
activated	allylic	alcohols	undergo	allylic	substitution	in	the	presence	of	an	aryl	bromide	(Scheme	
2.7E).32	 	 Interestingly,	 Organ	 demonstrated	 that	 the	 same	 palladium	 catalyst	 can	 be	 used	 to	
afford	 either	 the	 allylic	 substitution	 or	 vinylic	 cross-coupling	 products	 selectively	 from	
polyfunctionalized	 olefin	 building	 blocks	 (Scheme	 2.7F).19e,27	 	 Due	 to	 the	 diverse	 substrates,	
catalysts,	 and	 conditions	 employed	 in	 Scheme	 7,	 only	 a	 fragmented	 picture	 of	 the	 reactivity	
landscape	 is	 provided.	 	 A	 systematic	 study	 is	 necessary	 to	map	 the	 relative	 reactivity	 of	 aryl	
halides	in	the	Suzuki-Miyaura	cross-coupling	in	the	presence	of	allylic	ester	derivatives	of	varying	
reactivity.	
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Scheme	2.7.	Precedents	for	oxidative	addition	of	aryl	halides	in	the	presence	of	allylic	acetates.	
See	text	for	discussion.		
	
	
	
I
(3 equiv)
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C.
D.
E.
F.
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Scheme	2.8.	Suzuki-Miyaura	Cross-Coupling	of	2-B(pin)-substituted	Allylic	Acetate	2.1a.	
	
	
2.2.3.2. Development	 of	 Orthogonal	 Reaction	 Conditions	 for	 the	 Palladium-
Catalyzed	Allylic	Substitution	and	Suzuki-Miyaura	Cross-Coupling	
	 To	 favor	 the	 Suzuki-Miyaura	 cross-coupling	 manifold,	 the	 palladium(0)	 form	 of	 the	
catalyst	would	need	to	be	rapidly	captured	by	the	aryl	halide.			It	is	well	known	that	the	relative	
rate	of	oxidative	addition	of	a	homologous	series	of	aryl	halides	 is	Ar–I	>	Ar–Br	>	Ar–Cl.6-7	 	We	
envisioned	that	an	aryl	 iodide	would	rapidly	undergo	oxidative	addition	to	Pd(0)	to	generate	a	
Pd(II)	aryl	iodide	intermediate	that	is	unreactive	toward	oxidative	ionization	of	the	allylic	acetate	
(Figure	 2.1).	 	 To	 explore	 the	 possibility	 of	 conducting	 the	 Suzuki-Miyaura	 cross-coupling	 of	 2-
B(pin)-substituted	 allylic	 acetates,	 the	 di-n-butyl	 substrate	 2.1a	 was	 combined	 with	
iodobenzene,	Pd(OAc)2	 (15	mol	%),	PPh3	(30	mol	%),	and	Cs2CO3	 (3	equiv)	 in	a	10:1	THF/water	
reaction	 mixture	 (Scheme	 2.8).	 	 At	 70	 ˚C	 a	 clean	 reaction	 occurred	 to	 generate	 the	 2-aryl-
substituted	 allylic	 acetate	 2.6a	 in	 90%	 isolated	 yield.	 	 At	 lower	 catalyst	 loading,	 the	 cross-
coupling	was	incomplete	and	gave	diminished	yields.		With	the	result	in	Scheme	2.8,	we	set	out	
to	optimize	the	Suzuki-Miyaura	cross-coupling	reaction	of	2-B(pin)-substituted	allylic	acetates	to	
lower	the	catalyst	loading,	increase	the	yields,	and	develop	a	broad	substrate	scope.	
B(pin)
n-Bun-Bu
OAc
Pd(OAc)2 (15 mol %)
Cs2CO3 (3 equiv)
THF/H2O (10:1)
70 °C, 10 h
PPh3 (30 mol %)
n-Bun-Bu
OAc
(3 equiv)
I
2.1a
2.6a, 90% isolated yield
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2.2.3.3. Optimization	of	Suzuki-Miyaura	Cross-Coupling	of	2-B(pin)-Substituted	
Allylic	Acetates	
	 Lowering	the	catalyst	loading	from	15	mol	%	(Scheme	2.8	and	Table	2.4,	entry	1)	to	10	
mol	%	Pd	resulted	 in	decreased	yield	of	 the	cross-coupled	product	2.6a	 (Table	4,	entry	2).	 	To	
optimize	the	coupling,	different	phosphine	ligands	were	employed.		The	bulky	P(o-Tol)3	formed	
the	product	 in	 only	 20%	 yield	 (entry	 3).	 	 Bidentate	 phosphine	 ligands	 gave	poor	 yields	 of	 the	
arylated	allylic	acetates	(27–62%	yield,	entries	4–6).		Subjecting	the	di-n-butyl	allylic	acetate	2.1a	
to	 various	 Pd	 precursors	 showed	 that	 Pd(OAc)2/P(t-Bu)3,	 Pd(PPh3)4,	 and	 PdCl2(PPh3)2/PPh3	 all	
formed	suitable	catalysts	for	chemoselective	activation	of	 iodobenzene	vs.	oxidative	 ionization	
of	the	allylic	acetate	(entries	7–9).	 	Several	bases	were	screened	(Cs2CO3,	CsF,	and	K3PO4),	and	
Cs2CO3	was	found	to	give	the	highest	yield	(entries	10–12).		When	toluene	was	used	in	place	of	
THF	or	dioxane,	 the	catalyst	 loading	could	be	 lowered	 to	5	mol	%	with	 shorter	 reaction	 times	
and	up	 to	96%	yield	 (entries	13–16).	 	Further	decreasing	 the	catalyst	 loading,	however,	 led	 to	
incomplete	reactions	and	lower	yields.		We	found	a	1:3	ratio	of	Pd(OAc)2	to	PPh3	to	be	optimal	
for	catalyst	formation	(entries	13	and	14,	95–96%	yield)	and	suitable	for	evaluation	of	the	scope	
of	the	cross-coupling.	
2.2.3.3. Substrate	 Scope	 of	 Suzuki-Miyaura	 Cross-Coupling	 of	 2-B(pin)-
Substituted	Allylic	Acetates	with	Aryl	Iodides	
	 To	 determine	 the	 substrate	 scope	 for	 Suzuki-Miyaura	 cross-coupling	 of	 2-B(pin)-
substituted	 allylic	 acetates,	 we	 decided	 to	 vary	 the	 allylic	 acetate	 (R1	 and	 R2)	 as	 well	 as	 the	
coupling	partner	 (Ar–I).	 	Aliphatic	2-B(pin)-substituted	allylic	acetate	2.1a	 cleanly	provided	 the	
arylated	 allylic	 acetates	 2.6a–c	 in	 good	 to	 excellent	 yields	 with	 several	 aryl	 iodides	 bearing		
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Table	2.4.	Optimization	of	Pd-catalyzed	Suzuki-Miyaura	Cross-Coupling	of	2.1a	
	
	
entry baseb solventc
1
2
7
3
8
4
5
6
9
conc.(M)d yield (%)e
2.1a
B(pin)
n-Bun-Bu
OAc
Pd, ligand
base
solvent
n-Bun-Bu
OAcI
Pd/liganda
Pd(OAc)2/PPh3 
(15 mol %, 1:2) Cs2CO3 THF
time (h)
0.022 24 90f
Pd(OAc)2/PPh3 
(10 mol %, 1:2) Cs2CO3 THF 0.022 48 62
Cs2CO3 THF 0.022 48 80
Pd(OAc)2/P(o-tol)3 
(10 mol %, 1:2) Cs2CO3 THF 0.022 48 20
Pd(PPh3)4 
(10 mol %) Cs2CO3 THF 0.022 36 87
Pd(OAc)2/DPPP   
(10 mol %, 1:1) Cs2CO3 THF 0.022 48 32
Pd(OAc)2/DPPE   
(10 mol %, 1:1) Cs2CO3 THF 0.022 48 27
Pd(OAc)2/DPPF   
(10 mol %, 1:1) Cs2CO3 THF 0.022 48 62
PdCl2(PPh3)2/PPh3 
(10 mol %, 1:1) Cs2CO3 THF 0.08 24 71
10 PdCl2(PPh3)2/PPh3 (10 mol %, 1:1) Cs2CO3 Dioxane 0.08 18 61
11 PdCl2(PPh3)2/PPh3 (10 mol %, 1:1) CsF Dioxane 0.08 18 25
12 PdCl2(PPh3)2/PPh3 (10 mol %, 1:1)
K3PO4 toluene 0.08 24 52
13 Pd(OAc)2/PPh3 (10 mol %, 1:3) Cs2CO3 toluene 0.17 4 96
f
14 Pd(OAc)2/PPh3 (5 mol %, 1:3) Cs2CO3 toluene 0.17 18 95
f,g
15 PdCl2(PPh3)2/PPh3 (5 mol %, 1:1) Cs2CO3 toluene 0.17 18 93
f,g
16
Pd(PPh3)4 
(10 mol %) Cs2CO3 toluene 0.17 18 96
f,g
Pd(OAc)2/P(t-Bu)3 
(10 mol %, 1:1)
2.6a
a mol % of Pd and molar ratio of Pd to phosphine provided in parenthesis. b 3 equiv of base and 
iodobenzene used unless otherwise noted. c 10:1 ratio of solvent to H2O. d Ratio of 1a (mmol) / 
solvent (mL). e Yield determined by 1H NMR integration of the crude reaction mixture using 1,4-
dimethoxybenzene as the internal standard. f Yield of isolated and purified products.  g 2 equiv of 
Cs2CO3 and iodobenzene used.
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electron	withdrawing	 or	 electron	 donating	 groups	 (60–96%	 yield,	 Table	 2.5,	 entries	 1–3).	 	α–
Branching	is	tolerated	in	the	allylic	acetate	as	shown	from	the	reaction	of	the	allylic	acetate	2.1b	
with	iodobenzene	(67%	yield,	entry	4).		The	styryl	derived	allylic	acetate	2.1d	gave	92–99%	yield	
of	the	cross-coupled	products	2.6e	and	2.6f	(entries	5	and	6).		With	the	isomeric	allylic	acetate	
2.1f,	70–75%	yield	of	the	Suzuki-Miyaura	cross-coupled	products	2.6g	and	 2.6h	were	obtained	
(entries	7	and	8).	The	isomeric	pairs	in	entries	5	and	7	and	entries	6	and	8	each	undergo	Suzuki-
Miyaura	cross-coupling	with	no	scrambling	of	the	acetate	position.	 	These	results	 indicate	that	
the	oxidative	 ionization	of	 acetate	 is	 not	 reversible	 or	 does	not	 disrupt	 a	 tight	 ion	pair	 under	
these	 conditions.8	 	 To	 demonstrate	 scalability	 of	 the	 Suzuki-Miyaura	 cross-coupling	 2-B(pin)-
substituted	allylic	acetates	2.1e	was	subjected	to	cross-coupling	conditions	on	a	5	mmol	scale	to	
give	1.3	g	of	the	2-arylated	allylic	acetate	2.6i	in	80%	isolated	yield	(Scheme	2.9).			
	 Given	 that	 aryl	 iodides	 react	 faster	 with	 palladium(0)	 than	 allylic	 acetates,	 we	 next	
examined	 less	 reactive	 aryl	 bromides.	 	 We	 are	 aware	 of	 one	 study	 involving	 comparison	 of	
relative	 reactivity	 of	 sp2	 C–Br	 bonds	 vs.	 allylic	 acetates	 with	 palladium	 catalysts.	 	 Organ	
demonstrated	that	the	preference	of	palladium	was	dependent	on	the	nucleophile	(see	Scheme	
2.7F).27		
	 Subjecting	 the	2-B(pin)-substituted	allylic	 acetates	 to	 the	Suzuki-Miyaura	 conditions	 in	
entry	 13	 of	 Table	 2.4	 with	 various	 aryl	 and	 heteroaryl	 bromides	 resulted	 in	 chemoselective	
activation	of	the	aryl	bromides	over	the	allylic	acetates.		The	substituents	on	the	allylic	acetate	
(R1	and	R2)	and	the	aryl	bromide	coupling	partners	(Ar–Br)	were	varied	to	determine	the	scope	
of	 the	 chemoselective	 cross-coupling	 (Table	 2.6).	 	 2-B(pin)-substituted	 aliphatic	 allylic	 acetate	
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Table	 2.5.	 Chemoselective	 Suzuki-Miyaura	 Cross-Coupling	 of	 2-B(pin)-substituted	 Allylic	
Acetates	with	Aryl	Iodides	
	
	
	
Scheme	2.9.	Gram	scale	Suzuki-Miyaura	cross-coupling	reaction	of	2.1e.		
	
entry acetate product
1
2
B(pin)
R2R1
OAc
Pd(OAc)2 (5 mol %)
Cs2CO3 (3 equiv)
toluene/H2O (10:1)
4–18 h, 90 °C
PPh3 (15 mol %)
Ar
R2R1
OAc
(3 equiv)
Ar-I
yielda (%)Ar-I
1a Ph-I
n-Bun-Bu
OAc
96
1a 4-MeO-C6H4-I 60
n-Bun-Bu
OAc
OMe
n-Bun-Bu
OAc
NO2
3 1a 4-O2N-C6H4-I 92
4 1b 67n-Bui-Pr
OAc
5
6
1d Ph-I
Phn-Bu
OAc
1d 4-O2N-C6H4-I
Phn-Bu
OAc
NO2
n-BuPh
OAc
7 1f Ph-I
n-BuPh
OAc
NO2
8 1f 4-O2N-C6H4-IPh-I
6d
6a
6b
6c
99
92
70b
75b
6e
6f
6g
6h
entry acetate product yielda (%)Ar-I
a Yield of isolated and purified products. b The reaction was conducted at 75 °C in THF/H2O (10:1).
B(pin)
(CH2)4Cln-Bu
OAc
Ph
(CH2)4Cln-Bu
OAcPd(OAc)2 (10 mol %)
PPh3 (30 mol %)
PhI (3 equiv), Cs2CO3 (3 equiv)
2.1e
5 mmol scale 1.3 g, 80% isolated yield
2.6i
toluene/H2O (5:1), 90 °C, 6 h
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Table	 2.6.	 Chemoselective	 Suzuki-Miyaura	 Cross-Coupling	 of	 2-B(pin)-substituted	 Allylic	
Acetates	with	Aryl	Bromides	
	
	
	
2.2.4.5.	 Substrate	 Scope	 of	 Suzuki-Miyaura	 Cross-Coupling	 of	 2-B(pin)-Substituted	 Allylic	
Acetates	with	Aryl	Bromides	
entry acetate product
1
2
B(pin)
R2R1
OAc Pd(OAc)2 (5 mol %)
Cs2CO3 (3 equiv)
toluenel/H2O (10:1)
4–18 h, 90 °C
PPh3 (15 mol %)
Ar
R2R1
OAc
(3 equiv)
Ar-Br
Ar = aryl, heteroaryl
yielda (%)Ar-Br
1a Ph-Br
n-Bun-Bu
OAc
73
1a 4-MeO-C6H4-Br 54
n-Bun-Bu
OAc
OMe
n-Bun-Bu
OAc
NO2
3 1a 4-O2N-C6H4-Br 91
6 1b 87n-Bui-Pr
OAc
7 1d 4-O2N-C6H4-Br 90
Phn-Bu
OAc
NO2
n-BuPh
OAc
NO2
8 1f 4-O2N-C6H4-Br 80b
n-Bun-Bu
OAc
CF3
n-Bun-Bu
OAc
4 1a 4-F3C-C6H4-Br 85
5 1a 2-MeO-C6H4-Br 80
n-Bun-Bu
OAc
S
n-Bun-Bu
OAc
S
9 1a 74
10 1a 82
S
S
Br
Br
6d
6f
6h
6l
6m
6a
6b
6c
6j
6k
OMe
Ph-Br
entry acetate product yielda (%)Ar-Br
a Yield of isolated and purified products. b The reaction was conducted at 75 °C in THF/H2O (10:1).
1 6
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	 2.1a	 underwent	 cross-coupling	 with	 aryl	 bromides	 bearing	 electron	 withdrawing	 or	
electron	 donating	 groups	 with	 para-	 and	 ortho-substitution	 to	 provide	 the	 arylated	 allylic	
acetates	2.6a–c,	2.6j	and	2.6k	in	moderate	to	excellent	yields	(54–91%,	Table	2.6,	entries	1–5).		
α–Branching	is	tolerated	as	shown	in	the	reaction	of	the	allylic	acetate	2.1b	with	bromobenzene	
(87%	 yield,	 entry	 6).	 	 The	 styryl	 derived	 allylic	 acetate	2.1d	 gave	 excellent	 yield	 of	 the	 cross-
coupled	product	2.6f	with	1-bromo-4-nitrobenzene	(90%	yield,	entry	7).			
	 With	 the	 isomeric	 allylic	 acetate	 2.1f,	 the	 Suzuki-Miyaura	 cross-coupled	 product	 2.6h	
was	obtained	 in	 80%	yield	 (entry	 8)	with	no	observed	 scrambling	of	 the	 acetate	position.	 	 As	
shown	 in	 entries	 9	 and	 10,	 heteroaryl	 bromides	 such	 as	 2-	 or	 3-bromothiophene	 underwent	
cross-coupling	with	2.1a	in	74–82%	yield.		Having	demonstrated	that	aryl	iodides	and	bromides	
undergo	 oxidative	 addition	 faster	 than	 2-B(pin)-substituted	 allylic	 acetates	 undergo	 oxidative	
ionization	under	these	conditions,	we	wanted	to	determine	whether	this	trend	would	continue	
to	hold	with	more	reactive	allylic	substrates.	
	
2.2.3.5. Substrate	 Scope	 of	 Suzuki-Miyaura	 Cross-Coupling	 of	 2-B(pin)-
Substituted	Allylic	Benzoates	and	Carbonates		
	 To	 delineate	 further	 how	 differences	 in	 substrate	 reactivity	 impact	 the	 reaction	
outcome,	we	turned	our	attention	to	increasing	the	reactivity	of	the	allylic	moiety	by	using	more	
active	leaving	groups.		Allylic	benzoates	and	carbonates	are	known	to	be	more	reactive	in	allylic	
substitutions	than	acetates,	with	carbonates	up	to	200	times	more	reactive	than	acetates.8		We,	
therefore,	 prepared	 several	 2-B(pin)-substituted	 allylic	 benzoates	 and	 carbonates	 from	 the	
parent	 di-n-butyl-2-B(pin)-substituted	 allylic	 alcohol	 (see	 the	 Supporting	 Information).	 	 The	 2-
B(pin)-substituted	 allylic	 benzoates	 and	 carbonates	 were	 subjected	 to	 the	 optimal	 cross-
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coupling	 reaction	 conditions	 in	 entry	 13	 of	 Table	 2.4	with	 aryl	 iodides	 and	 bromides.	 	 The	 2-
B(pin)-substituted	allylic	benzoate	2.7a	underwent	cross-coupling	with	 iodobenzene	 to	 furnish	
the	2-aryl	substituted	allylic	benzoate	2.9a	in	96%	yield	(Table	2.7,	entry	1).		Bromobenzene,	on	
the	 other	 hand,	 resulted	 in	 low	 yield	 of	 the	 cross-coupled	 product	 2.9a	 (38%),	 with	multiple	
byproducts	(entry	2).		The	palladium	catalyst	likely	activates	the	allylic	benzoate	in	the	presence	
of	less	reactive	bromobenzene.		Electron	deficient	aryl	halides	are	known	to	undergo	oxidative	
addition	 more	 rapidly	 than	 analogous	 electron	 rich	 aryl	 halides.33	 	 With	 4-trifluoromethyl	
bromobenzene	 and	 allylic	 benzoate	2.7a	 the	 cross-coupled	 product	2.9b	 was	 isolated	 in	 76%	
yield	 (entry	 3).	 	 The	 2-B(pin)-substituted	 allylic	 carbonates	 2.8a	 and	 2.8b	 underwent	 cross-
coupling	with	both	aryl	iodides	and	electron	deficient	bromides	to	furnish	the	2-arylated	allylic	
carbonates	2.9c–f	in	57–91%	yield	(entries		4–8).		These	results	demonstrate	that	the	palladium	
catalyst	preferentially	oxidatively	adds	aryl	iodides	and	bromides	over	1,3-dialkyl-substituted	2-
B(pin)	allylic	benzoates	and	carbonates.			However,	more	reactive	1-phenyl-2-B(pin)-substituted	
allylic	benzoate	2.7b	and	carbonate	2.8c	were	decomposed	and	no	cross-coupling	product	was	
observed	(entries	9	and	10).	
	
2.2.4. Chemoselective	 Allene	 Formation	 from	 2-B(pin)-Substituted	 Allylic	 Acetates,	
Benzoates,	and	Carbonates	
	 As	 demonstrated	 in	 Table	 2.7,	 the	 efficiency	 of	 Suzuki-Miyaura	 cross-coupling	 of	 2-
B(pin)-substituted	allylic	substrates	is	related	to	the	ability	of	the	allylic	 leaving	group	to	ionize	
under	 palladium	 catalysis.	 	 Reactive	 substrates	 toward	 allylic	 ionization,	 such	 as	 benzoate,	
carbonates,	or	substrates	with	benzylic	acetates	(entries	9	and	10	in	Table	2.7)	tended	to	yield	
less	 cross-coupling	 products	 and	 more	 decomposition	 products.	 	 Analysis	 of	 1H	 NMR	
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spectroscopy	 of	 unpurified	 reaction	 mixtures	 suggested	 that	 decomposed	 products	 included	
	
Table	 2.7.	 Chemoselective	 Suzuki-Miyaura	 Cross-Coupling	 of	 2-B(pin)-substituted	 Allyl	
Benzoates	and	Carbonates	
	 	
	
allenes	and	dienes.	 	We	hypothesized	that	the	diene	products	were	generated	from	allene	via	
palladium-catalyzed	 isomerization	 or	 carbopalladation.34	 	 If	 this	 hypothesis	 is	 correct,	 a	 third	
manifold	of	reactivity	might	be	tapped	to	afford	an	additional	family	of	products	from	2-B(pin)-
B(pin)
R2R1
LG Pd(OAc)2 (10 mol %)
Cs2CO3 (3 equiv)
toluene/H2O (10:1)
90–110 °C, 12–24 h
PPh3 (30 mol %)
Ar
R2R1
LG
(3 equiv)
Ar-X
X =I, Br
entry 2 product
1
Ar-X
Ph-I
n-Bun-Bu
OBz
2.9a
2
4-CF3-C6H4-Br n-Bun-Bu
OBz
2.9b
4 Ph-I n-Bun-Bu
OCO2t-Bu
2.9c
8
Ph-I
n-Bun-Bu
OCO2Et 2.9f
Ph-Br 2.9a
3
CF3
n-Bun-Bu
OCO2t-Bu
NO2
5 4-NO2-C6H4-I 2.9d
6 4-NO2-C6H4-Br
2.9d
n-Bun-Bu
OCO2t-Bu
CF3
7
4-CF3-C6H4-Br
2.9e
9
Ph-I
10 Ph-I
2.7a
2.8a
yield (%)a
96
76
91
83
38
78
75
57
–b
–b
2.7a
2.7a
2.8a
2.8a
2.8a
2.8b
2.7b
2.8c
a Yield of isolated and purified products. b Starting materials were decomposed.
entry 2 productAr-X yield (%)a
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substituted	 allylic	 ester	 derivatives.	 	 We	 therefore	 set	 out	 to	 identify	 catalysts	 to	 promote	
chemoselective	elimination	of	2-B(pin)-substituted	allylic	substrates	to	provide	internal	allenes,	
which	are	important	synthetic	intermediates	and	common	in	natural	products.35		
	
2.2.4.1. Precedents	for	Catalytic	1,2-Elimination	to	Form	Allenes	
	 Tanaka	and	co-workers	reported	conversion	of	2-bromo-allylic	mesylate	derivatives	into	
allenes	 with	 a	 catalytic	 amount	 of	 palladium	 and	 2	 equiv	 of	 diethylzinc	 as	 reducing	 agent	
(Scheme	2.10A).36	 	More	 recently,	 Kazmaier	 and	 co-workers	 demonstrated	 that	β-stannylated	
allylic	 acetates	 or	 phenoxides	 undergo	 1,2-elimination	 reactions,	 providing	 Pd-allene	
intermediates	from	which	terminal	allenes	were	isolated	(Scheme	2.10B).37		An	advantage	of	our	
2-B(pin)-substituted	allylic	acetates	is	that	they	do	not	require	stoichiometric	reducing	agents	or	
highly	reactive	mesylates	and	they	provide	1,3-disubstituted	internal	allenes.	
	
Scheme	 2.10.	 A.	 Tanaka’s	 palladium-catalyzed	 elimination	 reaction	 with	 diethylzinc.	 B.	
Kazmaier’s	 2-Sn(n-Bu)3	 elimination	 of	 2-stannylated	 allylic	 acetates	 and	 phenoxides	 to	 form	
terminal	allenes.		
	
	
n-Oct
Br
OMs
n-Bu
Pd(PPh3)4 (10 mol %)
Et2Zn (2 equiv)
n-Oct • n-Bu
R1
OR2
SnBu3
Pd(PPh3)4 (2 mol %)
77% yield
94% yield
A.
B.
R1 = Ph, i-Pr, H
R2 = Ac, Ph
R1 = Ph, i-Pr, H
•
R1
PdLn
•
Ph
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2.2.4.2. Optimization	of	Allene	Formation	
	 We	set	out	to	screen	a	variety	of	palladium	precursors	and	ligands	to	identify	catalysts	
that	 would	 favor	 allene	 formation	 from	 1-phenyl-2-B(pin)-substituted	 allylic	 acetate	 2.1f.		
Subjecting	2.1f	to	catalytic	Pd(PPh3)4	in	THF/H2O	(5:1)	at	60	°C	resulted	in	20%	consumption	of	
2.1f	 with	 no	 allene	 formation	 (1H	 NMR,	 Table	 2.8,	 entry	 1).	 	 Using	 stoichiometric	 Pd(PPh3)4	
resulted	 in	 only	 4%	 allene	 2.10a	 with	 mostly	 decomposition	 products	 (entry	 2).	 	 We	 next	
examined	bases,	which	dramatically	changed	the	outcome	of	the	reaction.		Addition	of	1	equiv	
Cs2CO3	and	1	mol	%	Pd(PPh3)4	led	to	allene	formation	in	87%	yield,	while	Cs2CO3	alone	exhibited	
no	 reactivity	 (entries	 3	 and	 4).	 	With	 the	 conditions	 in	 entry	 3,	 other	 palladium	 sources	 and	
phosphines	were	examined	(entries	5–9).		Both	Pd(OAc)2/2PPh3	and		[Pd(allyl)Cl]2//4PPh3	formed	
suitable	catalysts	 for	allene	formation	(73	and	80%	yield,	 respectively,	entries	5	and	6).	 	Some	
diene	products	(<5%)	were	also	produced.		With	[Pd(allyl)Cl]2	and	4	equiv	DPPE,	the	reaction	did	
not	reach	completion	in	1.5	h	(72%	yield	of	2.10a	and	12%	remaining	2.1f,	entry	7).	Precatalyst	
[Pd(allyl)Cl]2/3	 equiv	 PCy3	 resulted	 in	 93%	 yield	 (entry	 8).	 	 Finally,	 [Pd(allyl)Cl]2/3	 equiv	
CyJohnPhos	and	1	equiv	of	Cs2CO3		at	60	°C	resulted	in	99%	assay	yield	of	allene	product	2.10a	
(entry	9).		Screening	Buchwald’s	phosphine	ligands	SPhos,	XPhos,	DavePhos	and	JohnPhos	with	
[Pd(allyl)Cl]2	 resulted	 in	 slower	 conversion	 to	 allenes.38	 	 In	 the	 absence	 of	 Cs2CO3	 at	 60	 °C	
[Pd(allyl)Cl]2/3	equiv	CyJohnPhos	resulted	 in	formation	of	only	7%	of	allene	product	2.10a	and	
90%	 unreacted	 2.1f	 (entry	 10).	 	 Lowering	 the	 Cs2CO3	 loading	 to	 0.5	 equiv	 did	 not	 affect	 the	
reactivity	significantly	(94%	yield,	entry	11),	and	3	equiv	of	Cs2CO3	rendered	the	reaction	slower	
(85%	yield	of	2.10a	and	15%	recovered	2.1f,	entry	12).	 	Bases	such	as	NaOAc⋅3H2O,	K2CO3	and	
NaHCO3	 were	 less	 effective	 (entries	 13–16).	 	 Ultimately,	 it	 was	 found	 that	 0.5	 mol	 %	 of	
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[Pd(allyl)Cl]2,	1.5	mol	%	of	CyJohnPhos,	and	1	equiv	of	Cs2CO3	gave	the	best	yield	(entry	9)	of	the	
conditions	examined.	
2.2.4.3. Substrate	Scope	for	Allene	Formation	from	2-B(pin)-Substituted	Allylic	
Acetates,	Benzoates	and	Carbonates	
	 Subjecting	 various	1-aryl-2-B(pin)-3-butyl	 allylic	 acetates	 to	 the	 condition	 in	entry	9	of	
Table	2.8	resulted	in	formation	of	allene	products.		For	example,	aryl	substrates	bearing	electron	
withdrawing	or	electron	donating	groups	at	the	para-position	provided	excellent	yields	of	allene	
products	2.10a–d	 (87–92%,	Table	2.9,	entries	1–4).	 	The	styryl	derived	allylic	acetate	2.1l	gave	
55%	yield	of	2.10e	without	noticeable	isomerization	of	the	vinyl	group	(entry	5).		Although	1,3-
di-n-butyl-2-B(pin)	 allylic	 acetate	 2.1a	 was	 not	 suitable	 for	 this	 transformation	 (entry	 6),	
benzoate	 substrates	2.7a	 and	2.7c	were	 converted	 to	allene	products	2.10f	 and	2.10g	 in	53%	
and	79%	isolated	yields	(entries	7	and	8).		With	the	dialkyl	2-B(pin)-substituted	derivatives,	the	
greater	leaving	group	ability	of	the	carbonates	2.8a	and	2.8d	resulted	in	higher	yields	of	allene	
products	2.10f	 and	2.10g	 (85	and	83%	yield,	 entries	9	 and	10).	 	 The	 results	 in	 Tables	8	 and	9	
indicate	that	proper	choice	of	catalyst,	substrates	and	conditions	enable	the	facile	generation	of	
allenes	from	2-B(pin)-substituted	allylic	esters	and	carbonates.	
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Table	2.8.	Optimization	of	Allene	Formation	from	2-B(pin)-substituted	Allylic	Acetate	2.1f		
	
	
	
	
	
	
	
Ph
OAc
B(pin)
n-Bu
THF/H2O (5:1)a, 60 °C
[Pd] (1 mol %), ligand
base Ph n-Bu
entry time 
(h)
13 NaOAc•3H2O (3) 1.0
15 NaHCO3 (3) 1.0
16 NaHCO3 (1) 1.0
9 Cs2CO3 (1) 1.0
CyJohnPhos (1.5)
CyJohnPhos (1.5)
CyJohnPhos (1.5)
CyJohnPhos (1.5)
2.10a2.1f
8 Cs2CO3 (1) 1.0PCy3 (1.5)
2
– 1.5–
5 Cs2CO3 (1) 1.5
6 Cs2CO3 (1) 1.5
PPh3 (2)
7 Cs2CO3 (1) 1.5DPPE (2)
PPh3 (2)
14 K2CO3 (3) 1.0CyJohnPhos (1.5)
ligand
(mol %)
[Pd(allyl)Cl]2
[Pd(allyl)Cl]2
[Pd(allyl)Cl]2
[Pd(allyl)Cl]2
[Pd(allyl)Cl]2
Pd(OAc)2
[Pd(allyl)Cl]2
[Pd(allyl)Cl]2
[Pd(allyl)Cl]2
4 Cs2CO3 (3) 1.5–
Pd(PPh3)4
–
yield (%)b
19
76
90
99
93
0
73
80
72
41
<2
[Pd]
3 Cs2CO3 (1) 1.5– 87Pd(PPh3)4
1
– 1.5Pd(PPh3)4c 4–
10 – 1.0CyJohnPhos (1.5) 7[Pd(allyl)Cl]2
11 Cs2CO3 (0.5) 1.0CyJohnPhos (1.5) 94[Pd(allyl)Cl]2
12 Cs2CO3 (3) 1.0CyJohnPhos (1.5) 85[Pd(allyl)Cl]2
78
0
0
0
0
80
0
0
12
59
95
0
0
90
0
15
base
(equiv) 2.10arecovered 2.1f
•
a Reactions conducted at 0.17 M concentration on 0.04 mmol scale.  ‚Ä®b Yield determined by 1H 
NMR integration of the crude reaction mixture using 1,4-dimethoxybenzene as the internal standard. 
c 1 equiv of Pd(PPh3)4.
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Table	 2.9.	 Allene	 Formation	 from	 2-B(pin)-substituted	 Allylic	 Acetates,	 Benzoates	 and	
Carbonates	
	
	
	
R1
OR3
B(pin)
R2
THF/H2O = 5:1, 60 °C, 40–180 min
[Pd(allyl)Cl]2 (0.5 mol %)
CyJohnPhos (1.5 mol %)
Cs2CO3 (1 equiv) R1 R2
OAc
B(pin)
n-Bu
Cl
B(pin)
n-Bu
OAc
F3C
B(pin)
n-Bu
OAc
Me
B(pin)
n-Bu
substrate product yield (%)a
B(pin)
n-Bu
n-Bu
B(pin)
OBz
n-Bu
B(pin)
OBz
n-Bu
B(pin)
OBoc
n-Bu
B(pin)
OBoc
n-Bu
B(pin)
OAc
entry
1
2
3
4
5
6
7
8
9
10
90
92
87
92
55
53
79
85
83
–b
2.10a
2.10b
2.10h
2.10d
2.10e
2.10f
2.10f
2.10g
2.10f
2.10g
2.1f
2.1i
2.1h
2.1k
2.1m
2.7a
2.7c
2.8a
2.8d
2.1a
OAc
•
n-Bu•
n-Bu•
Cl
n-Bu•
F3C
n-Bu•
Me
n-Bu•
n-Bu•
n-Bu•
n-Bu•
n-Bu•
n-Bu•
OAc
a Yield of isolated and purified products. b Starting material decomposed during course of the reaction.
83	
Figure	2.3.	Plausible	catalytic	cycle	for	allene	formation.	
	
	
2.2.4.4. Plausible	Catalytic	Cycle	of	Allene	Formation	Reaction	and	Rcemization	
of	Allene	
	 To	 rationalize	 the	 formation	 of	 allylic	 substitution	 vs.	 allene	 products,	 a	 plausible	
catalytic	cycle	for	allene	formation	is	illustrated	in	Figure	2.3.		Electron	donating	ligands,	such	as	
PCy3	 and	 CyJohnPhos,	 easily	 lead	 to	π-allylpalladium	 intermediates.	 	 In	 the	 presence	 of	 good	
nucleophiles,	 such	 as	 malonates	 or	 amines,	 allylic	 substitution	 occurs	 by	 addition	 of	 the	
nucleophile	 to	 the	π-allylpalladium.	 	 In	 contrast,	 in	 the	 absence	of	 a	 suitable	nucleophile,	 the	
base	 is	 proposed	 to	 attack	 the	 empty	 coordination	 site	 on	 boron	 or	 hydrolyze	 the	 boronate	
ester.	 	 Several	 possible	 explanations	 for	 the	 observed	 dependency	 on	 base	 strength	 can	 be	
considered.		The	stronger	bases	are	more	likely	to	promote	hydrolysis	of	the	B(pin)	group	to	the	
boronic	 acid.	 	Also,	more	 reactive	 carbonate	bases	are	harder	 and	will	 be	better	nucleophiles	
Pd(0)Ln
R1 R2
LG PdLn
B(pin)
R1 R2
B(pin)
Pd LL
R1 R2
B(pin)
LG
R1 R2
B(OR3)n
Pd LL
Cs2CO3/H2OR1 • R2
OR3 = OH, OAc, pin
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toward	boron	than	either	bicarbonate	or	acetate.		Finally,	elimination	of	3-coordinate	boron	can	
be	envisioned	to	lead	to	a	palladium-allene	π-complex	before	allene	dissociation.	
	 Optically	 active	 allenes	 are	 ubiquitous	 intermediates	 and	 targets	 for	 the	 synthesis	 of	
natural	products	and	biologically	active	compounds.39	 	To	investigate	the	possibility	of	chirality	
transfer	 in	 the	catalytic	 cycle	of	Figure	2.3,	we	performed	 the	allene	 formation	 reaction	using	
enantioenriched	2-B(pin)-allylic	acetate	2.1f	 to	generate	allene	product	2.10a.	 	The	reaction	of	
2.1f	 (60%	 ee)	 in	 the	 presence	 of	 the	 Pd/CyJohnPhos	 catalyst	 afforded	 enantioenriched	 allene	
2.10a	 with	 36%	 ee	 in	 18%	 yield	 in	 10	min	 (Table	 2.10,	 entry	 2).	 	When	 the	 reaction	 reached	
completion	in	35	min,	however,	a	significant	loss	of	ee	was	observed	(Table	2.10,	entries	3	and	
4).	 Finally,	 allene	 product	 2.10a	 was	 racemized	 completely	 in	 1	 h	 (Table	 2.10,	 entry	 6).	 	 It	 is	
noteworthy	 that	 B(pin)-substituted	 1f	 (60%	 ee)	 was	 not	 racemized	 during	 the	 course	 of	 the	
reaction.	 	 These	 results	 suggest	 that	 2-B(pin)-allylic	 acetate	 undergoes	 stereoselective	 allene	
formation,	 however,	 a	 competing	 racemization	 of	 the	 allene	 product	 in	 the	 presence	 of	 the	
palladium	catalyst,	probably	via	hydropalladation,	is	responsible	for	the	observed	loss	of	ee	over	
time.40	
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Table	2.10.	Palladium-catalyzed	allene	formation	reaction	of	enantioenriched	2.1f	
	
	
2.2. Conclusions	
	 Application	of	multicomponent	tandem	reactions	to	molecules	bearing	more	than	one	
reaction	site	 is	a	powerful	synthetic	strategy	for	rapid	generation	of	molecular	complexity	and	
diversity.	 	 Key	 to	 development	 of	 such	 a	methodology	 is	 to	 tailor	 the	 catalyst,	 reagents	 and	
conditions	 to	 afford	 chemoselective	 activation	 of	 the	 substrate.	 	 Toward	 this	 goal,	 we	
introduced	 a	 new	 class	 of	 bifunctional	 reagents	 that	 contain	 vinyl	 boronate	 esters	 embedded	
within	 allylic	 acetates.	 	 The	 requisite	 2-B(pin)-substituted	 allylic	 acetates	 are	 synthesized	 on	
gram	 scale	 in	 one-pot	 procedures	 from	 readily	 available	materials	 using	 the	 heterobimetallic	
chemistry	developed	in	our	laboratory.9-10		
	 To	 facilitate	 applications	 of	 our	 bifunctional	 substrates,	 methods	 to	 control	 the	
chemoselectivity	 of	 their	 activation	 is	 crucial.	 The	 challenge	 is	 to	 employ	 common	palladium-
Ph
OAc
B(pin)
n-Bu
THF/H2O = 5:1, 60 °C
[Pd(allyl)Cl]2 (0.5 mol %)
CyJohnPhos (1.5 mol %)
Cs2CO3 (1 equiv) Ph • n-Bu
2.10a2.1f (60% ee)
entry time (min) yield (%)a eeb of 2.10a
2.1f 2.10a
1
2
3
4
5
6
0
10
20
35
45
60
100
82
50
0
0
0
–
18
50
100
100
100
–
36
29
13
3
0
a Conversion yield determined by 1H NMR of aliquots of unpurified reaction mixture. 
b Enantiomeric excess of allene 2.10a was determined by HPLC analysis (see 
Supporting Information).
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phosphine-based	catalysts	and	modulate	their	activation	of	2-B(pin)-substituted	allylic	acetates	
through	manipulation	of	reagents,	substrates,	and	conditions.		In	the	case	of	allylic	substitutions,	
reactions	 were	 conducted	 under	 conditions	 where	 the	 B(pin)	 group	 was	 stable	 to	 hydrolysis	
(and	 palladium	 hydroxide	 intermediates	 are	 not	 likely	 formed),[13,102]	 inhibiting	 B	 to	 Pd	
transmetallation.	 	 Under	 such	 conditions,	 oxidative	 ionization	 of	 the	 acetate	 and	 nucleophilic	
addition	 to	 the	π-allylpalladium	 intermediate	were	much	 faster	 than	 transmetallation.	 	 In	 the	
Suzuki-Miyaura	 cross-coupling	 of	 2-B(pin)-substituted	 allylic	 acetates,	 we	 found	 that	 the	
chemoselectivity	of	 the	Pd(0)	 is	Ar–I	>	Ar–Br	>	allylic	acetate.	 	Once	 the	Pd(0)	 is	 converted	 to	
Pd(II)	by	the	aryl	halide,	 ionization	of	the	allylic	acetate	does	not	interfere	with	cross-coupling.		
Under	 conditions	 where	 the	 B(pin)	 group	 hydrolyzes	 to	 the	 boronic	 acid	 (or	 palladium	
hydroxides	can	form),	transmetallation	is	also	fast.	 	Detailed	study	of	this	system	indicates	the	
relative	order	of	 reactivity	 toward	Pd(0)	 is	Ar–I	>	Ar–Br	>	allylic	carbonate	>	allylic	benzoate	>	
allylic	acetate,	with	 the	 reactivity	of	allylic	 carbonates	approaching	 that	of	aryl	bromides.	 	 For	
allylic	acetates	with	the	acetate	in	benzylic	position,	the	allylic	acetate	is	more	reactive	then	aryl	
bromides	 in	 the	 presence	 of	 L2Pd.	 	 The	 observations	 outlined	 herein	 enabled	 a	 complete	
reversal	of	chemoselectivity	from	allylic	substitution	reactions	to	Suzuki-Miyaura	cross-coupling	
of	allylic	acetates,	benzoates,	and	carbonates.						
In	 the	 case	 of	 the	 third	 reaction	manifold,	 allene	 formation,	 oxidative	 ionization	 of	 the	 allylic	
acetate	occurs	to	generate	the	allylpalladium	intermediate.	 	 In	the	absence	of	nucleophile,	we	
hypothesize	that	hard	bases	(CO32–,	HCO3–,	AcO–)	or	hydroxide	generated	from	them,	attack	the	
unsaturated	boron	to	make	ate	complexes	that	can	undergo	elimination	of	3-coordinate	boron	
and	to	generate	an	intermediate	Pd(η2-allene).		The	rate	of	allene	formation	is	base	dependent,	
with	the	more	basic	carbonate	more	reactive	than	the	less	basic	acetate.	Our	method	provides	
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high	 yields	 of	 1,3-disubstituted	 allenes	 under	 mild	 conditions.	 	 While	 the	 allene	 formation	
reaction	 of	 enantioenriched	 2-B(pin)	 allylic	 acetate	 provided	 the	 enantioenriched	 allene,	
palladium-catalyzed	racemization	of	the	allene	resulted	in	the	racemic	product	over	time.	
With	 the	ability	 to	control	 chemoselectivity,	various	 tandem	reactions	were	 investigated.	 	The	
allylic	substitution	of	2-B(pin)-substituted	allylic	acetates	can	be	followed	with	a	Suzuki-Miyaura	
cross-coupling	 to	 afford	 (E)-trisubstituted	 allylic	 amines	 and	 malonates	 with	 four	 points	 of	
diversity.		Enantioenriched	2-B(pin)-substituted	allylic	acetates	undergo	allylic	substitution	with	
net	stereochemical	retention,	allowing	isolation	of	B(pin)-containing	substitution	products	or	α-
amino	 ketones	 with	 little	 or	 no	 loss	 of	 ee.	 	 Alternatively,	 the	 allylic	 substitution	 of	 2-B(pin)-
substituted	allylic	acetates	can	be	paired	with	oxidation	of	vinyl	boronates	to	provide	valuable	
α-amino	ketones	and	1,4-dicarbonyl	compounds.	
	 Given	 the	 high	 levels	 of	 control	 over	 chemoselectivity	 in	 our	 optimized	 palladium-
catalyzed	 reactions	 of	 2-B(pin)-substituted	 allylic	 acetate	 derivatives,	 we	 are	 optimistic	 that	
these	bifunctional	substrates	will	serve	as	useful	intermediates	in	synthesis.		
	
2.3. Experimental	Section	
General	Methods.		
All	 reactions	 were	 performed	 under	 a	 nitrogen	 atmosphere	 with	 oven-dried	 glassware.	 	 All	
manipulations	 involving	 dicyclohexylborane,	 dimethylzinc	 and	 diethylzinc	 were	 carried	 out	
under	an	inert	atmosphere	in	a	Vacuum	Atmospheres	drybox	with	an	attached	MO-40	Dritrain	
or	by	using	standard	Schlenk	or	vacuum	line	techniques.		Chemicals	were	obtained	from	Aldrich,	
Acros,	 or	 GFS	 Chemicals	 unless	 otherwise	 specified.	 	 Solvents	 were	 purchased	 from	 Fischer	
Scientific.	 	 Toluene	 was	 dried	 through	 an	 activated	 alumina	 column,	 and	 then	 thoroughly	
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degassed	prior	to	use.		Tetrahydrofuran	was	distilled	from	sodium	and	benzophenone	under	N2.		
B(pin)-substituted	 alkynes	 were	 prepared	 by	 literature	 methods.11a,11b	 	 Dimethylzinc	 and	
diethylzinc	 solutions	 (2.0	M	 in	 toluene)	were	 prepared	 and	 stored	 in	 a	 Vacuum	Atmospheres	
drybox.	 	 NMR	 spectra	were	 obtained	 on	 Brüker	 300,	 360,	 400	 or	 500	MHz	 Fourier	 transform	
spectrometers	at	the	University	of	Pennsylvania	NMR	facility.		1H	and	13C{1H}	NMR	spectra	were	
referenced	 to	 residual	 solvent.	 11B{1H}	 NMR	 spectra	 were	 referenced	 to	 BF3·OEt2.	 Analysis	 of	
enantiomeric	 excess	 was	 performed	 using	 a	 Hewlett-Packard	 1100	 Series	 HPLC	 and	 a	 chiral	
column.	 The	 infrared	 spectra	 were	 obtained	 using	 a	 Perkin-Elmer	 1600	 series	 spectrometer.		
HRMS	data	was	obtained	on	a	Waters	LC-TOF	mass	spectrometer	(model	LCT-XE	Premier)	using	
electrospray	 ionization	 in	 positive	 or	 negative	 mode,	 depending	 on	 analyte.	 Thin-layer	
chromatography	was	performed	on	Whatman	precoated	silica	gel	60	F-254	plates	and	visualized	
by	 ultraviolet	 light	 or	 by	 staining	 with	 ceric	 ammonium	molybdate	 or	 phosphomolybdic	 acid	
solutions	or	with	iodine.		Silica	gel	(Silicaflash,	P60,	40-63	μm,	Silicycle)	was	used	for	air-flashed	
chromatography,	and	deactivated	silica	gel	was	prepared	by	addition	of	15	mL	of	Et3N	to	1	L	of	
silica	gel.	Determination	of	regioisomeric	ratios	was	performed	by	analysis	of	1H	NMR	spectra	of	
unpurified	 reaction	 products.	 	 The	 vinyl	 boronate	 ester	 is	 susceptible	 to	 oxidation	 of	 the	 B–C	
bond	on	silica	under	air,	and	hence	a	rapid	purification	is	necessary	to	minimize	oxidation	to	the	
corresponding	ketone.	
						Caution.	Dialkylzinc	reagents	are	pyrophoric.	Care	must	be	used	when	handling	them.		
	
Synthesis	and	Characterization	of	2-B(pin)-substituted	Allylic	Acetates.	
General	 Procedure	 A:	 Synthesis	 of	 2-B(pin)-substituted	 Allylic	 Acetates.	 To	 a	 suspension	 of	
HBCy2	 (770	mg,	4.32	mmol)	 in	 toluene	 (4.0	mL)	equipped	with	a	 stir	bar	under	N2	was	added	
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alkyne-4,4,5,5-tetramethyl-1,3,2-dioxaborolane	 (4.32	 mmol),	 and	 the	 reaction	 mixture	 was	
stirred	at	rt	for	30	min,	after	which	it	was	homogeneous.	The	reaction	vessel	was	cooled	to	–78	
°C	in	a	dry	ice	bath,	treated	with	Me2Zn	(2.16	mL,	2.0	M	in	toluene,	4.32	mmol),	and	stirred	at	
that	temperature	for	30	min.	The	solution	was	then	warmed	to	–20	°C	by	placing	the	flask	in	a	–
20	°C	cold	bath,	and	aldehyde	(3.60	mmol)	was	added.	The	reaction	mixture	was	stirred	at	–20	
°C	until	TLC	showed	complete	consumption	of	 the	aldehyde	(usually	12	h).	When	the	reaction	
was	 complete,	 the	 reaction	 mixture	 was	 warmed	 to	 0	 °C	 in	 an	 ice	 bath,	 and	 distilled	 acetic	
anhydride	(1.10	g,	1.02	mL,	10.8	mmol)	was	slowly	added.	The	reaction	mixture	was	stirred	at	0	
°C	until	TLC	showed	complete	consumption	of	the	intermediate	allylic	alkoxide	(usually	4–6	h).	
The	reaction	mixture	was	then	diluted	with	EtOAc	(10	mL)	and	quenched	with	saturated	NH4Cl	
(15	mL)	at	0	°C.	The	organic	 layer	was	separated	and	the	aqueous	solution	was	extracted	with	
EtOAc	 (3	 x	 25	 mL).	 The	 combined	 organic	 solution	 was	 dried	 over	 MgSO4,	 filtered,	 and	 the	
solvent	was	 removed	 under	 reduced	 pressure	 to	 yield	 a	 colorless	 oil.	 The	 crude	 product	was	
purified	by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	97:3)	to	afford	the	allylic	
acetate	 as	 a	 colorless	 oil.	 Importantly,	 the	 2-B(pin)	 allylic	 acetate	 product	 is	 susceptible	 to	
oxidation	 of	 the	 B–C	 bond	 on	 silica	 under	 air,	 and	 hence	 a	 rapid	 purification	 is	 necessary	 to	
minimize	oxidation	 to	 the	ketone.	 The	allylic	 acetate	was	 stored	under	N2	at	0	 °C	 to	preserve	
their	purity.		
	
Compounds	2.1a,	2.1c,	2.1d,	2.1f,	2.1g,	2.1h,	and	2.1j	were	reported	in	the	previous	report.9	
	
(E)-2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-4-en-3-yl	
acetate	 (2.1b).	 	 The	 product	 was	 prepared	 by	 General	 Procedure	 A	 using	
i-Pr
OAc
B(pin)
n-Bu
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isobutyraldehyde	 (130	 mg,	 0.16	 mL,	 1.80	 mmol),	 2-hex-1-ynyl-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane	 (450	 mg,	 0.5	 mL,	 2.16	 mmol)	 and	 acetic	 anhydride	 (0.51	 mL,	 5.4	 mmol).	 The	
crude	product	was	purified	by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	97:3)	
to	afford	the	allylic	acetate	as	a	colorless	oil	(473	mg,	81%	yield).	1H	NMR	(500	MHz,	C6D6)	δ	6.31	
(t,	J	=	7.6	Hz,	1H),	5.35	(d,	J	=	7.4	Hz,	1H),	2.51	–	2.41	(m,	2H),	2.26	–	2.13	(m,	1H),	1.76	(s,	3H),	
1.42	–	1.23	(m,	4H),	1.06	(s,	12H),	0.97	(d,	J	=	6.7	Hz,	3H),	0.92	(d,	J	=	6.8	Hz,	3H),	0.85	(t,	J	=	7.1	
Hz,	 3H);	 13C{1H}	NMR	 (125	MHz,	 C6D6)	 δ	 169.7,	 148.9,	 83.4,	 83.0,	 32.7,	 31.4,	 25.3,	 25.1,	 22.9,	
21.3,	19.8,	19.0,	14.5	 (the	quaternary	vinyl	C	bearing	the	boron	group	 is	not	observed);	HRMS	
m/z	347.2374	[(M+Na)	+;	calcd	for	C18H33BO4Na:	347.2370].			
	
(E)-11-Chloro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)undec-6-
en-5-yl	acetate	(2.1e).	The	product	was	prepared	by	General	Procedure	A	
using	 n-pentanal	 (431	 mg,	 0.53	 mL,	 5.0	 mmol),	 2-(6-chlorohex-1-yn-1-yl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane	 (1.46	 g,	 6.0	 mmol)	 and	 acetic	 anhydride	 (1.42	mL,	 15	mmol).	 The	 crude	
product	was	purified	by	 flash	 column	 chromatography	on	 silica	 gel	 (hexanes:EtOAc	=	 97:3)	 to	
afford	the	allylic	acetate	as	a	colorless	oil	(1.55	g,	83%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	6.12	(t,	
J	=	7.6	Hz,	1H),	5.24	(t,	J	=	6.7	Hz,	1H),	3.51	(t,	J	=	6.7	Hz,	2H),	2.38	–	2.23	(m,	2H),	1.99	(s,	3H),	
1.77	–	1.68	(m,	2H),	1.66	–	1.58	(m,	2H),	1.53	–	1.44	(m,	2H),	1.33	–	1.12	(m,	16H),	0.85	(t,	J	=	7.1	
Hz,	3H);	 13C	{1H}	NMR	(125	MHz,	CDCl3)	δ	170.4,	145.7,	83.3,	78.0,	44.9,	34.6,	32.0,	30.0,	27.9,	
26.8,	 25.0,	 24.7,	 22.6,	 21.5,	 14.1	 (the	 quaternary	 vinyl	 C	 bearing	 the	 boron	 group	 is	 not	
observed);	 11B	 NMR	 (CDCl3,	 128	MHz)	 δ	 30.2;	 IR	 (neat)	 2978,	 2958,	 2933,	 2862,	 1738,	 1636,	
1410,	 1372,	 1346,	 1307,	 1242,	 1144,	 1018	 cm-1;	 HRMS	 m/z	 395.2130	 [(M+Na)+;	 calcd	 for	
C19H34BClO4Na:	395.2136].		
n-Bu
OAc
B(pin)
(CH2)4Cl
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(E)-1-(4-Chlorophenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hept-2-en-1-yl	 acetate	 (2.1i).	 The	 product	was	 prepared	 by	 General	
Procedure	A	using	p-chlorobenzaldehyde	(506	mg,	3.60	mmol),	2-hex-1-
ynyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane	(899	mg,	1.0	mL,	4.32	mmol)	and	acetic	anhydride	
(1.02	mL,	10.8	mmol).	The	crude	product	was	purified	by	flash	column	chromatography	on	silica	
gel	(hexanes:EtOAc	=	97:3)	to	afford	the	allylic	acetate	as	a	colorless	oil	 (1.13	g,	80%	yield).	 1H	
NMR	(500	MHz,	CDCl3)	δ	7.28	–	7.26	(m,	4H),	6.36	(s,	1H),	6.14	(t,	J	=	7.5	Hz,	1H),	2.40	–	2.30	(m,	
2H),	2.07	(s,	3H),	1.42	–	1.24	(m,	4H),	1.18	(s,	6H),	1.15	(s,	6H),	0.88	(t,	J	=	7.5	Hz,	3H);	 13C{1H}	
NMR	 (125	MHz,	CDCl3)	δ	170.0,	146.9,	139.0,	133.5,	129.3,	128.4,	83.4,	77.3,	32.0,	30.8,	24.9,	
24.8,	22.5,	21.5,	14.1	(the	quaternary	vinyl	C	bearing	the	boron	group	is	not	observed);	11B	NMR	
(CDCl3,	128	MHz)	δ	29.8;	IR	(neat)	2978,	2959,	2930,	2860,	1742,	1638,	1597,	1491,	1404,	1371,	
1310,	 1266,	 1232,	 1143,	 1090,	 1015,	 967	 cm-1;	 HRMS	 m/z	 415.1834	 [(M+Na)+;	 calcd	 for	
C21H30O4ClBNa:	415.1823].		
	
	(E)-2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(p-tolyl)hept-2-
en-1-yl	acetate	(2.1k).		The	product	was	prepared	by	General	Procedure	
A	 using	p-tolualdehyde	 (433	mg,	 0.42	mL,	 3.60	mmol),	 2-hex-1-ynyl-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane	 (899	mg,	 1.0	mL,	 4.32	mmol)	 and	 acetic	 anhydride	 (1.02	mL,	 10.8	mmol).	 The	
crude	product	was	purified	by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	97:3)	
to	afford	the	allylic	acetate	as	a	colorless	oil	(1.00	g,	75%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	7.22	
(d,	J	=	8.5	Hz,	2H),	7.10	(d,	J	=	8.5	Hz,	2H),	6.38	(s,	1H),	6.09	(t,	J	=	7.5	Hz,	1H),	2.38	–	2.26	(m,	5H),	
2.06	(s,	3H),	1.38	–	1.24	(m,	4H),	1.18	(s,	6H),	1.15	(s,	6H),	0.88	(t,	J	=	7.3	Hz,	3H);	13C{1H}	NMR	
OAc
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(125	MHz,	CDCl3)	δ	170.0,	146.0,	137.4,	137.3,	128.9,	127.9,	83.3,	77.9,	32.1,	30.9,	24.9,	24.8,	
22.5,	21.5,	21.3,	14.1	(the	quaternary	vinyl	C	bearing	the	boron	group	is	not	observed);	11B	NMR	
(CDCl3,	128	MHz)	δ	29.9;	IR	(neat)	2978,	2958,	2926,	2859,	1742,	1639,	1515,	1405,	1371,	1309,	
1266,	1143	cm-1;	HRMS	m/z	395.2376	[(M+Na)+;	calcd	for	C22H33O4BNa:	395.2370].			
	
(1E,3E)-1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nona-
1,3-dien-5-yl	 acetate	 (2.1l).	 The	 product	 was	 prepared	 by	 General	
Procedure	 A	 using	 cinnamaldehyde	 (476	 mg,	 0.45	 mL,	 3.60	 mmol),	 2-hex-1-ynyl-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane	 (899	mg,	 1.0	mL,	 4.32	mmol)	 and	 acetic	 anhydride	 (1.02	mL,	
10.8	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	
(hexanes:EtOAc	 =	 97:3)	 to	 afford	 the	 isomerized	 allylic	 acetate	 as	 a	 colorless	 oil	 (0.83	 g,	 60%	
yield).	1H	NMR	(500	MHz,	CDCl3)	δ7.60	(dd,	J	=	15.5,	11.0	Hz,	1H),	7.41	(dd,	J	=	7.0,	1.0	Hz,	2H),	
7.32	(t,	J	=	7.5	Hz,	2H),	7.23	(tt,	J	=	7.5,	1.0	Hz,	1H),	6.88	(d,	J	=	11.0	Hz,	1H),	6.64	(d,	J	=	15.5	Hz,	
1H),	5.44	(t,	J	=	6.5	Hz,	1H),	2.07	(s,	3H),	1.72	(td,	J	=	7.5,	6.5	Hz,	2H),	1.40	–	1.20	(m,	16H),	0.89	
(t,	 J	 =	 7.0	 Hz,	 3H);	 13C{1H}	 NMR	 (125	MHz,	 CDCl3)	 δ	 170.6,	 144.1,	 137.6,	 136.3,	 128.8,	 128.5,	
128.0,	126.9,	83.6,	77.4,	34.9,	27.9,	25.2,	24.9,	22.7,	21.6,	14.2	(the	quaternary	vinyl	C	bearing	
the	boron	group	is	not	observed);	11B	NMR	(CDCl3,128	MHz)	δ	29.9;	IR	(neat)	2977,	2958,	2932,	
2871,	2861,	1736,	1623,	1599,	1590,	1450,	1411,	1372,	1236,	1142,	1111,	1018	cm-1;	HRMS	m/z	
407.2377	[(M+Na)+;	calcd	for	C23H33BO4N	a:	407.2370].		
	
Palladium-Catalyzed	Allylic	Substitution	of	2-B(pin)-substituted	Allylic	Acetates		
General	 Procedure	 B:	 Palladium-Catalyzed	 Allylic	 Substitution	 of	 2-B(pin)-substituted	 Allylic	
Acetates	 with	 NaCH(CO2Me)2.	 To	 a	 Schlenk	 flask	 equipped	 with	 a	 stir	 bar	 was	 added	
B(pin)
n-Bu
OAc
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[Pd(allyl)Cl]2	(1.8	mg,	0.005	mmol,	5	mol	%)	and	PPh3	(5.3	mg,	0.02	mmol,	20	mol	%)	in	0.5	mL	of	
dry	 and	 degassed	 THF	 at	 rt	 under	 N2,	 and	 the	 solution	 was	 stirred	 at	 rt	 for	 30	 min.	 To	 this	
catalyst	 solution	was	 added	 2-B(pin)-substituted	 allylic	 acetate	 (0.10	mmol),	 and	 the	 reaction	
mixture	was	 stirred	 for	 an	 additional	 30	 –	 45	min.	 In	 a	 separate	 5	mL	 round	 bottomed	 flask	
equipped	with	a	stir	bar	and	condenser	was	added	sodium	hydride	(7.9	mg,	0.33	mmol)	 in	2.0	
mL	of	dry	 and	degassed	THF	under	N2,	 and	 the	 reaction	mixture	was	 cooled	 to	0	 °C	 in	 an	 ice	
bath.	 To	 this	 white	 suspension	 was	 added	 dropwise	 dimethyl	 malonate	 (35	 µL,	 39.6	mg,	 0.3	
mmol)	 at	 0	 °C,	 which	 was	 accompanied	 by	 rapid	 evolution	 of	 H2.	 The	 reaction	 soon	 became	
clear,	after	which	 it	was	heated	to	reflux	under	N2	 for	15	min.	The	dimethyl	malonate	sodium	
solution	 (3	 equiv)	 was	 cooled	 to	 rt,	 and	 then	 transferred	 via	 cannula	 into	 the	 Schlenk	 flask	
containing	 the	 catalyst	 and	 2-B(pin)-substituted	 allylic	 acetate	 solution	 at	 rt.	 The	 reaction	
mixture	was	warmed	 to	 40	 °C	 and	 stirred	 until	 TLC	 showed	 complete	 consumption	 of	 the	 2-
B(pin)	substituted	allylic	acetate.	The	reaction	mixture	was	then	cooled	to	rt,	diluted	with	EtOAc	
(4	mL),	 and	quenched	with	 saturated	NH4Cl	 (4	mL).	 The	organic	 layer	was	 separated,	 and	 the	
aqueous	solution	was	extracted	with	EtOAc	(3	x	5	mL).	The	combined	organic	solution	was	dried	
over	MgSO4,	 filtered	 through	 Celite	 and	 the	 solvent	was	 removed	 under	 reduced	 pressure	 to	
yield	a	pale	red	oil.	The	crude	product	was	dissolved	in	CDCl3,	and	the	ratio	of	regioisomers	was	
determined	by	1H	NMR	spectroscopy	of	unpurified	reaction	mixtures.	CDCl3	was	removed	under	
reduced	pressure,	and	the	crude	product	was	purified	by	flash	column	chromatography	on	silica	
gel.	The	vinyl	boronate	ester	is	susceptible	to	oxidation	of	the	B–C	bond	on	silica	under	air,	and	
hence	a	rapid	purification	is	necessary	to	minimize	oxidation	to	the	corresponding	ketone.		
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General	 Procedure	 C:	 Palladium-Catalyzed	 Allylic	 Substitution	 of	 2-B(pin)-substituted	 Allylic	
Acetates	with	Amines.	To	a	Schlenk	flask	with	a	stir	bar	was	added	[Pd(allyl)Cl]2	(1.8	mg,	0.005	
mmol,	5	mol	%)	or	Pd(OAc)2	(2.2	mg,	0.01	mmol,	10	mol	%)	and	PPh3	(5.3	mg,	0.02	mmol,	20	mol	
%)	in	1.0	mL	of	dry	and	degassed	THF	at	rt	under	N2	and	the	solution	stirred	for	30	–	45	min.	To	
this	 catalyst	 solution	 was	 added	 2-B(pin)-substituted	 allylic	 acetate	 (0.10	 mmol),	 and	 the	
reaction	mixture	was	stirred	for	an	additional	30	–	45	min,	after	which	the	amine	(3	–	5	equiv,	
dried,	distilled	and	degassed)	was	added	at	rt.	The	reaction	mixture	was	warmed	to	40	°C	and	
stirred	 until	 TLC	 showed	 complete	 consumption	 of	 the	 2-B(pin)	 substituted	 allylic	 acetate,	
typically	10	–	24	h.	In	the	case	of	Pd(OAc)2,	the	reaction	mixture	was	stirred	at	rt	for	24	h	or	until	
the	 reaction	 was	 complete	 by	 TLC.	 The	 reaction	mixture	 was	 then	 cooled	 to	 rt,	 diluted	 with	
EtOAc	(4	mL),	and	quenched	with	saturated	NH4Cl	(4	mL).	The	organic	layer	was	separated,	and	
the	aqueous	solution	was	extracted	with	EtOAc	(3	x	5	mL).	The	combined	organic	solution	was	
dried	over	MgSO4,	filtered	through	Celite	and	the	solvent	was	removed	under	reduced	pressure.	
The	crude	product	was	dissolved	in	CDCl3,	and	the	ratio	of	regioisomers	was	determined	by	1H	
NMR	spectroscopy	of	unpurified	reaction	mixtures.	CDCl3	was	removed	under	reduced	pressure,	
and	the	crude	product	was	purified	by	 flash	column	chromatography	on	deactivated	silica	gel.	
The	 allylic	 amine	 product	 is	 susceptible	 to	 oxidation	 of	 the	 B–C	 bond	 on	 silica	 under	 air,	 and	
hence	a	rapid	purification	is	necessary	to	minimize	oxidation	to	the	amino	ketone.	
	
General	 Procedure	 D:	 Palladium-Catalyzed	 Allylic	 Substitution	 of	 2-B(pin)-substituted	 Allylic	
Acetates	with	BSA,	CH2(CO2Me)2	and	catalytic	KOAc.	To	a	Schlenk	flask	equipped	with	a	stir	bar	
was	added	Pd(OAc)2	(2.2	mg,	0.01	mmol,	10	mol	%)	and	PPh3	(5.3	mg,	0.02	mmol,	20	mol	%)	in	
1.0	mL	of	dry	and	degassed	THF	at	rt	under	N2,	and	the	solution	stirred	at	rt	for	30	min.	To	this	
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catalyst	 solution	 was	 added	 2-B(pin)-substituted	 allylic	 acetate	 (0.10	mmol)	 and	 the	 reaction	
mixture	was	stirred	for	an	additional	15	min,	after	which	N,O-bis(trimethylsilyl)acetamide	(BSA)	
(73	µL,	61.0	mg,	0.30	mmol,	3	equiv)	and	dimethyl	malonate	(34	µL,	39.6	mg,	0.3	mmol,	3	equiv)	
were	added	at	 rt	 followed	by	catalytic	KOAc.	The	 reaction	mixture	was	warmed	 to	40	 °C,	and	
stirred	 until	 TLC	 showed	 complete	 consumption	 of	 the	 2-B(pin)	 substituted	 allylic	 acetate	
(typically	10	–	12	h).	The	reaction	mixture	was	then	cooled	to	rt,	diluted	with	EtOAc	(4	mL)	and	
filtered	 through	 a	 plug	 of	 silica,	 and	 the	 solvent	 was	 removed	 under	 reduced	 pressure.	 The	
crude	product	was	dissolved	in	CDCl3,	and	the	ratio	of	regioisomers	was	determined	by	1H	NMR	
spectroscopy	of	unpurified	reaction	mixtures.	CDCl3	was	removed	under	reduced	pressure,	and	
the	crude	product	was	purified	by	flash	column	chromatography	on	silica	gel.		
	
	Dimethyl	 (E)-2-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)undec-6-en-
5-yl)malonate	 (2.2a).	The	 compound	was	prepared	by	General	Procedure	C	
and	the	result	was	reported	in	our	preliminary	communication.9	
	
	(E)-4-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)undec-6-en-5-
yl)morpholine	 (2.2b).	 The	compound	was	prepared	by	General	Procedure	C	
and	the	result	was	reported	in	our	preliminary	communication.9	
	
	
	(E)-N-Benzyl-N-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)undec-6-en-5-amine	 (2.2c).	 The	 compound	 was	 prepared	 by	 General	
Procedure	C	and	the	result	was	reported	in	our	preliminary	communication.9	
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	(E)-1-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)undec-6-en-5-
yl)piperidine	 (2.2d).	 The	 compound	 was	 prepared	 by	 General	 Procedure	 C	
and	the	result	was	reported	in	our	preliminary	communication.9	
	
	(E)-N-Benzyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)undec-6-en-5-
amine	 (2.2e).	The	compound	was	prepared	by	General	Procedure	C	and	the	
result	was	reported	in	our	preliminary	communication.9	
	
	(E)-4-(1-Cyclohexyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hept-1-
en-3-yl)morpholine	 (2.2f).	 The	 compound	 was	 prepared	 by	 General	
Procedure	C	and	the	result	was	reported	in	our	preliminary	communication.9	
	
	(E)-4-(1-Phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hept-2-en-
1-yl)morpholine	(2.2g).	The	compound	was	prepared	by	General	Procedure	
C	and	the	result	was	reported	in	our	preliminary	communication.9	
	
Dimethyl	 (E)-2-(1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hept-2-en-1-yl)malonate	(2.2h).	The	compound	was	prepared	by	General	
Procedure	D	and	the	result	was	reported	in	our	preliminary	communication.9	
	
	(E)-4-(1-(4-fluorophenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hept-2-en-1-yl)morpholine	 (2.2i).	 The	 compound	 was	 prepared	 by	
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General	Procedure	C	and	the	result	was	reported	in	our	preliminary	communication.9	
		
Dimethyl	 (E)-2-(1-(4-fluorophenyl)-2-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)hept-2-en-1-yl)malonate	 (2.2j).	 The	 compound	 was	
prepared	 by	 General	 Procedure	 D	 and	 the	 result	 was	 reported	 in	 our	 preliminary	
communication.9	
	
Dimethyl	 (E)-2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(4-
(trifluoromethyl)phenyl)hept-2-en-1-yl)malonate	 (2.2k).	 The	
compound	was	prepared	by	General	Procedure	D	and	the	result	was	reported	in	our	preliminary	
communication.9	
	
Dimethyl	 (E)-2-(1-(4-methoxyphenyl)-2-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)hept-2-en-1-yl)malonate	 (2.2l).	The	compound	was	
prepared	 by	 General	 Procedure	 D	 and	 the	 result	 was	 reported	 in	 our	 preliminary	
communication.9	
	
Tandem	Palladium-Catalyzed	Allylic	Substitution	and	Oxidation	
General	 Procedure	 E:	 Tandem	 Palladium-Catalyzed	 Allylic	 Substitution	 and	 Oxidation	 with	
H2O2/NaOH	
	To	a	 Schlenk	 flask	with	a	 stir	bar	was	added	 [Pd(allyl)Cl]2	(1.8	mg,	0.005	mmol,	 5	mol	%)	 and	
PPh3	(5.3	mg,	0.02	mmol,	20	mol	%)	in	1.0	mL	of	dry	and	degassed	THF	at	rt	under	N2,	and	the	
solution	was	 stirred	 for	 30	 –	 45	min.	 To	 this	 catalyst	 solution	was	 added	 2-B(pin)-substituted	
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allylic	acetate	(0.10	mmol),	and	the	reaction	mixture	was	stirred	for	an	additional	30	–	45	min,	
after	which	 the	 nucleophile	 (3	 –	 5	 equiv),	 either	 amines	 or	 dimethyl	malonate	 sodium	anion,	
was	 added	 at	 rt.	 The	 reaction	 mixture	 was	 warmed	 to	 40	 °C	 and	 stirred	 until	 TLC	 showed	
complete	consumption	of	the	2-B(pin)-substituted	allylic	acetate.	The	reaction	mixture	was	then	
cooled	to	0	°C,	diluted	with	THF	(2	mL),	and	30%	aqueous	H2O2	(200	µL)	followed	by	aqueous	2.0	
M	NaOH	(200	µL)	was	added,	and	the	reaction	was	stirred	at	0	°C	until	TLC	showed	completion	
of	 the	 oxidation	 reaction.	 The	 reaction	 was	 diluted	 with	 EtOAc	 (4	 mL),	 followed	 by	 distilled	
water	 (3	mL).	 The	 organic	 layer	was	 separated,	 and	 the	 aqueous	 solution	was	 extracted	with	
EtOAc	(3	x	5	mL).	The	combined	organic	solution	was	dried	over	MgSO4,	filtered	through	Celite	
and	the	solvent	was	removed	under	reduced	pressure.	The	crude	product	was	purified	by	flash	
column	chromatography	on	deactivated	silica	gel	in	the	case	of	amines,	and	regular	silica	gel	for	
dimethyl	malonate	substituted	products.		
	
Dimethyl	 2-(6-oxoundecan-5-yl)malonate	 (2.3a).	 The	 compound	 was	
prepared	 by	 General	 Procedure	 E	 and	 the	 result	 was	 reported	 in	 our	
preliminary	communication.9		
	
	5-Morpholinoundecan-6-one	 (2.3b).	 The	 compound	 was	 prepared	 by	
General	 Procedure	 E	 and	 the	 result	 was	 reported	 in	 our	 preliminary	
communication.9	
	
5-(Benzyl(methyl)amino)undecan-6-one	(2.3c).	The	compound	was	prepared	
by	 General	 Procedure	 E	 and	 the	 result	 was	 reported	 in	 our	 preliminary	
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communication.9		
	
	Dimethyl	 2-(6-oxoundecan-5-yl)malonate	 (2.3d).	 The	 compound	 was	
prepared	 by	 General	 Procedure	 E	 and	 the	 result	 was	 reported	 in	 our	
preliminary	communication.9	
	
	
General	 Procedure	 F:	 Tandem	 Palladium-Catalyzed	 Allylic	 Substitution	 and	 Oxidation	 with	
NaBO3·H2O.	To	a	Schlenk	flask	equipped	with	a	stir	bar	was	added	Pd(OAc)2	(2.2	mg,	0.01	mmol,	
10	mol	%)	and	PPh3	(5.3	mg,	0.02	mmol,	20	mol	%)	in	1.0	mL	of	dry	and	degassed	THF	at	rt	under	
N2,	and	 the	solution	was	stirred	 for	30	–	45	min.	To	 this	catalyst	 solution	was	added	2-B(pin)-
substituted	allylic	acetate	1f	(0.10	mmol),	and	the	reaction	mixture	was	stirred	for	an	additional	
30	 –	 45	min,	 after	 which	 the	 amine	 nucleophile	 (3	 equiv)	 was	 added	 at	 rt,	 and	 the	 reaction	
mixture	was	 stirred	 for	24	h	at	 rt	or	until	 TLC	 showed	complete	 consumption	of	 the	2-B(pin)-
substituted	allylic	acetate.	The	reaction	mixture	was	then	diluted	with	THF	(1	mL)	and	distilled	
H2O	(2	mL),	and	NaBO3·H2O	(29.9	mg,	0.30	mmol,	3	equiv)	was	added.	The	reaction	mixture	was	
stirred	at	rt	for	3	–	4	h	or	until	TLC	showed	completion	of	the	oxidation	reaction.	The	reaction	
was	 diluted	 with	 diethyl	 ether	 (4	 mL).	 The	 organic	 layer	 was	 separated,	 and	 the	 aqueous	
solution	was	extracted	with	diethyl	ether	(3	x	5	mL).	The	combined	organic	solution	was	dried	
over	MgSO4,	filtered	through	Celite,	and	the	solvent	was	removed	under	reduced	pressure.	The	
crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 deactivated	 silica	 gel	
(hexanes:EtOAc	=	95:5)	to	afford	the	desired	product.	
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1-Morpholino-1-phenylheptan-2-one	 (2.3e).	 The	 compound	was	 prepared	 by	
General	 Procedure	 F,	 and	 the	 result	 was	 reported	 in	 our	 preliminary	
communication.9		
	
Tandem	Palladium-Catalyzed	Allylic	Substitution	and	Suzuki-Miyaura	cross-coupling	
General	Procedure	G:	Tandem	Palladium-Catalyzed	Allylic	Substitution	with	Amine	and	Suzuki-
Miyaura	cross-coupling	
To	a	Schlenk	flask	was	added	[Pd(allyl)Cl]2	(1.8	mg,	0.005	mmol,	5	mol	%)	and	PPh3	(5.3	mg,	0.02	
mmol,	20	mol	%)	in	1.0	–	2.0	mL	of	dry	and	degassed	THF	at	rt	under	N2,	and	the	solution	was	
stirred	 for	 30	 –	 45	 min	 at	 rt,	 and	 the	 solution	 was	 stirred	 for	 30	 –	 45	 min.	 To	 this	 catalyst	
solution	was	 added	 2-B(pin)-substituted	 allylic	 acetate	 (0.10	mmol),	 and	 the	 reaction	mixture	
was	stirred	for	an	additional	30	–	45	min,	after	which	the	amine	(3	equiv)	was	added	at	rt.	The	
reaction	mixture	was	warmed	to	40	°C	and	stirred	until	TLC	showed	complete	consumption	of	
the	 2-B(pin)-substituted	 allylic	 acetate,	 typically	 10	 –	 24	 h.	 The	 reaction	 mixture	 was	 then	
diluted	with	degassed	THF/H2O	(10:1,	4	mL)	 followed	by	addition	of	Cs2CO3	 (3	equiv,	97.7	mg,	
0.30	mmol)	and	an	aryl	halide	(3	equiv,	0.30	mmol).	The	reaction	mixture	was	heated	in	an	oil	
bath	at	75	°C	until	the	allylic	substitution	product	had	been	consumed	by	TLC,	typically	24	–	48	
h.	 The	 reaction	 was	 cooled	 to	 rt,	 diluted	 with	 EtOAc	 (5	 mL),	 and	 saturated	 aqueous	 NH4Cl	
solution	 (5	 mL)	 was	 added.	 The	 organic	 layer	 was	 separated,	 and	 the	 aqueous	 solution	 was	
extracted	with	EtOAc	(3	x	5	mL).	The	combined	organic	solution	was	washed	with	brine,	dried	
over	MgSO4,	filtered	through	Celite	and	the	solvent	was	removed	under	reduced	pressure.	The	
crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 deactivated	 silica	 to	 afford	
tandem	product.	
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The	results	of	compounds	2.5a–c	were	reported	in	our	preliminary	communication.9	
	
	(E)-4-(1,2-Diphenylhept-2-enyl)morpholine	 (2.5d).	 The	 product	 was	
prepared	by	General	Procedure	G	using	(E)-1-phenyl-2-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)hept-2-enyl	 acetate	 2.1f	 (50.0	 mg,	 0.14	 mmol),	
Pd(OAc)2	(3.1	mg,	0.014	mmol,	10	mol	%),	PPh3	(7.3	mg,	0.028	mmol,	20	mol	
%),	morpholine	(61	µL,	61.0	mg,	0.70	mmol),	Cs2CO3	(137	mg,	0.42	mmol),	and	bromobenzene	
(45	µL,	65.9	mg,	0.42	mmol).	The	crude	product	was	purified	by	flash	column	chromatography	
on	deactivated	silica	gel	(hexanes:EtOAc	=	90:10)	to	afford	the	trisubstituted	allylic	amine	as	an	
oil	(32.9	mg,	70%	yield).	With	iodobenzene	(47	µL,	85.7	mg,	0.42	mmol)	as	the	coupling	partner,	
the	title	compound	was	isolated	in	50%	yield	(23.5	mg).		1H	NMR	(500	MHz,	CDCl3)	δ	7.23	–	7.13	
(m,	6H),	7.13	–	7.05	(m,	2H),	6.85	–	6.78	(m,	2H),	5.98	(t,	J	=	7.4	Hz,	1H),	3.81	–	3.68	(m,	5H),	2.78	
–	2.60	(m,	2H),	2.41	–	2.30	(m,	2H),	1.95	–	1.85	(m,	2H),	1.39	–	1.17	(m,	4H),	0.82	(t,	J	=	7.2	Hz,	
3H);	 13C{1H}	 NMR	 (125	MHz,	 CDCl3)	 δ	 140.7,	 140.4,	 139.9,	 130.7,	 129.5,	 129.1,	 128.0,	 127.7,	
127.1,	 126.6,	 79.5,	 67.5,	 53.1,	 32.2,	 28.7,	 22.6,	 14.1;	 IR	 (neat)	 3080,	 2959,	 1600,	 1492,	 1451,	
1273,	1273,	1119	cm-1;	HRMS	m/z	336.2336	[(M+H)+;	calcd	for	C23H30NO:	336.2327].		
	
	(E)-4-(2-(4-Methoxyphenyl)-1-phenylhept-2-enyl)morpholine	 (2.5e).	 The	
product	was	prepared	by	General	Procedure	G	using	(E)-1-phenyl-2-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)hept-2-enyl	acetate	2.1f	 (50.0	mg,	0.14	
mmol),	Pd(OAc)2	(3.1	mg,	0.014	mmol,	10	mol	%),	PPh3	(7.3	mg,	0.028	mmol,	
20	 mol	 %),	 morpholine	 (61	 µL,	 61.0	 mg,	 0.70	 mmol),	 Cs2CO3	 (137	 mg,	 0.42	 mmol),	 and	 4-
bromoanisole	 (53	 µL,	 78.6	mg,	 0.42	mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 column	
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chromatography	on	deactivated	 silica	 gel	 (hexanes:EtOAc	=	90:10)	 to	 afford	 the	 trisubstituted	
allylic	amine	as	an	oil	(35.3	mg,	69%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	7.21	–	7.13	(m,	3H),	7.11	
–	7.04	(m,	2H),	6.81	–	6.70	(m,	4H),	5.93	(t,	J	=	7.4	Hz,	1H),	3.78	(s,	3H),	3.77	–	3.68	(m,	5H),	2.87	
–	2.55	(m,	2H),	2.45	–	2.28	(m,	2H),	1.95	–	1.87	(m,	2H),	1.37	–	1.27	(m,	2H),	1.26	–	1.20	(m,	2H),	
0.82	(t,	J	=	7.3	Hz,	3H);	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	158.4,	140.6,	140.2,	132.0,	130.8,	130.6,	
129.1,	 128.0,	 127.0,	 113.2,	 79.8,	 67.5,	 55.3,	 53.1,	 32.3,	 28.7,	 22.6,	 14.2;	 IR	 (neat)	 3027,	 2957,	
1607,	 1510,	 1451,	 1285,	 1245	 cm-1;	 HRMS	 m/z	 366.2430	 [(M+H)+;	 calcd	 for	 C24H32NO2:	
366.2433].		
	
	(E)-4-(2-(4-Nitrophenyl)-1-phenylhept-2-enyl)morpholine	 (2.5f).	 The	
product	 was	 prepared	 by	 General	 Procedure	 G	 using	 2.1f	 (50.0	 mg,	 0.14	
mmol),	Pd(OAc)2	(3.1	mg,	0.014	mmol,	10	mol	%),	PPh3	(7.3	mg,	0.028	mmol,	
20	mol	%),	morpholine	(61	µL,	 61.0	mg,	 0.70	mmol),	 Cs2CO3	(137	mg,	 0.42	
mmol),	and	1-bromo-4-nitrobenzene	(84.8	mg,	0.42	mmol).	The	crude	product	was	purified	by	
flash	 column	 chromatography	 on	 deactivated	 silica	 gel	 (hexanes:EtOAc	 =	 90:10)	 to	 afford	 the	
trisubstituted	 allylic	 amine	 as	 an	 oil	 (31.4	mg,	 59%	 yield)	 along	with	 some	 inseparable	minor	
impurity.	1H	NMR	(500	MHz,	CDCl3)	δ	8.06	(d,	J	=	8.8	Hz,	2H),	7.21	–	7.13	(m,	3H),	7.05	–	6.93	(m,	
4H),	6.04	(t,	J	=	7.5	Hz,	1H),	3.87	–	3.70	(m,	5H),	2.64	(s,	2H),	2.49	–	2.33	(m,	2H),	1.95	–	1.79	(m,	
2H),	1.41	–	1.15	(m,	4H),	0.82	(t,	J	=	7.2	Hz,	3H);	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	146.9,	146.8,	
139.3,	139.2,	132.7,	130.5,	128.9,	128.3,	127.5,	123.0,	79.3,	67.3,	53.0,	32.0,	28.8,	22.5,	14.1;	IR	
(neat)	3028,	2958,	1729,	1597,	1519,	1952,	1344	cm-1;	HRMS	m/z	381.2170	 [(M+H)+;	calcd	 for	
C23H29N2O3:	381.2178].		
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Preparation	of	Pd/2PPh3	stock	solution	in	THF	(0.014	M).	
To	an	oven-dried	microwave	vial	equipped	with	a	stir	bar	was	charged	with	Pd(OAc)2	(11.2	mg,	
0.05	mmol)	and	PPh3	(26.2	mg,	0.10	mmol)	under	air.		The	vial	was	then	capped	with	a	septum	
and	purged	under	a	nitrogen	atmosphere.		Dry	and	degassed	THF	(3.5	mL)	was	added	to	the	vial,	
and	the	resulting	stock	solution	was	stirred	at	rt	for	30	min	before	use.	
	
Preparation	of	NaCH(CO2Me)2	stock	solution	in	THF	(0.1	M).			
To	an	oven-dried	microwave	vial	equipped	with	a	stir	bar	was	charged	with	NaH	(dry,	95%)	(48	
mg,	2.0	mmol).	The	vial	was	capped	with	a	septum	and	purged	with	N2.	To	the	vial	was	added	
dry	and	degassed	THF	(1.77	mL)	at	rt,	and	the	reaction	mixture	was	cooled	to	0	°C	in	an	ice	bath.	
To	this	white	suspension	was	added	dropwise	dimethyl	malonate	(229	µL,	264	mg,	2.0	mmol).	
Upon	addition	of	the	dimethyl	malonate,	rapid	evolution	of	a	gas,	presumably	H2,	was	observed.	
Once	the	H2	evolution	ceased,	the	resulting	solution	was	heated	to	reflux	for	1	min.	The	stock	
solution	was	cooled	and	stirred	at	rt	for	10	min	before	use.	
	
General	 Procedure	 H:	 Tandem	 Palladium-Catalyzed	 Allylic	 Substitution	 with	 NaCH(CO2Me)2	
and	Suzuki-Miyaura	cross-coupling	
To	an	oven-dried	microwave	vial	equipped	with	a	stir	bar	was	charged	with	the	allylic	acetate	1f	
(71.7	mg,	0.2	mmol),	and	the	vial	was	capped	with	a	septum	and	purged	with	N2.	To	the	vial	was	
added	a	stock	solution	of	Pd(OAc)2/2PPh3	(0.014	M	in	THF,	1.4	mL,	10	mol	%	Pd	and	20	mol	%	
PPh3)	by	a	 syringe,	 and	 the	 reaction	mixture	was	 stirred	at	 rt	 for	30	min.	 	A	 stock	 solution	of	
NaCH(CO2Me)2	(0.1	M	in	THF,	0.6	mL,	0.6	mmol)	was	added	into	the	vial	via	a	syringe	at	rt.		The	
sealed	 vial	 was	 then	 warmed	 in	 an	 oil	 bath	 to	 40	 °C	 and	 stirred	 until	 TLC	 showed	 complete	
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consumption	 of	 allylic	 acetate.	 	 Aliquots	 for	 TLC	 were	 taken	 under	 a	 positive	 pressure	 of	
nitrogen.		After	completion	of	the	reaction,	the	reaction	mixture	was	then	diluted	with	degassed	
toluene	 (1.8	 mL)	 and	 H2O	 (0.2	 mL)	 followed	 by	 addition	 of	 Cs2CO3	 (3	 equiv,	 195.5	 mg,	 0.60	
mmol)	and	an	aryl	halide	(3	equiv,	0.60	mmol).		The	reaction	mixture	was	heated	in	an	oil	bath	
at	 90	 °C	 until	 the	 allylic	 substitution	 product	 had	 been	 consumed	 by	 TLC,	 typically	 24	 h.	 The	
reaction	was	cooled	to	rt,	diluted	with	EtOAc	 (5	mL)	and	saturated	aqueous	NH4Cl	 (5	mL)	was	
added.	The	organic	layer	was	separated,	and	the	aqueous	solution	was	extracted	with	EtOAc	(3	
x	 5	 mL).	 The	 combined	 organic	 solution	 was	 washed	 with	 brine,	 dried	 over	 MgSO4,	 filtered	
through	Celite	and	the	solvent	was	removed	under	reduced	pressure	to	yield	a	colorless	oil.	The	
crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	 to	 afford	 tandem	
product.	
	
	(Z)-Dimethyl	 2-(1,2-diphenylhept-2-en-1-yl)malonate	 (2.5g).	 The	 product	
was	 prepared	 by	 General	 Procedure	 H	 using	 2.1f	 (71.7	 mg,	 0.2	 mmol),	 a	
stock	solution	of	Pd(OAc)2/2PPh3	(0.014	M	in	THF,	1.4	mL,	10	mol%	Pd	and	
20	mol	%	PPh3),	sodium	malonate	(0.1	M	THF,	0.6	mL,	0.6	mmol),	toluene	(1.8	mL),	H2O	(0.2	mL),	
Cs2CO3	 (195.5	 mg,	 0.6	 mmol),	 and	 bromobenzene	 (63.2	 µL,	 94.2	 mg,	 0.6	 mmol).	 The	 crude	
product	was	purified	by	 flash	 column	 chromatography	on	 silica	 gel	 (hexanes:EtOAc	=	 95:5)	 to	
afford	the	desired	product	as	an	oil	(38.8	mg,	51%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	7.22	–	7.13	
(m,	6H),	7.04	(app	d,	J	=	7.5	Hz,	2H),	6.86	–	6.80	(m,	2H),	5.67	(t,	J	=	7.5	Hz,	1H),	4.35	(d,	J	=	12.5	
Hz,	1H),	4.13	(d,	J	=	12.5	Hz,	1H),	3.80	(s,	3H),	3.43	(s,	3H),	1.90	–	1.75	(m,	2H),	1.35	–	1.10	(m,	
4H),	0.79	(t,	J	=	7.0	Hz,	3H);	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	168.7,	168.3,	141.3,	140.2,	139.2,	
129.3,	128.6,	128.4,	128.3,	127.9,	127.1,	126.8,	56.8,	53.6,	52.8,	52.6,	32.2,	28.7,	22.3,	14.1;	 IR	
CH(CO2Me)2
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(neat)	 3029,	 2954,	 2929,	 2856,	 1761,	 1740,	 1600,	 1493,	 1454,	 1434,	 1318,	 1244,	 1193,	 1142,	
1030	cm-1;	HRMS	m/z	403.1882	[(M+Na)+;	calcd	for	C24H28O4Na:	403.1885].	
The	 tandem	 Suzuki-Miyaura	 cross-coupling	 of	 allylic	 substitution	 product	 2.2h	 with	 sodium	
malonate	failed	with	iodobenzene	(66.9	µL,	122.4	mg,	0.6	mmol)	(entry	9,	Table	2.3).	
	
	(Z)-Dimethyl	 2-(2-phenyl-1-(4-(trifluoromethyl)phenyl)hept-2-en-1-
yl)malonate	(2.5h).	The	product	was	prepared	by	General	Procedure	H	
using	 2.1h	 (85.3	 mg,	 0.2	 mmol),	 a	 stock	 solution	 of	 Pd(OAc)2/2PPh3	
(0.014	M	in	THF,	1.4	mL,	10	mol%	Pd	and	20	mol	%	PPh3),	sodium	malonate	(0.1	M	THF,	0.6	mL,	
0.6	mmol),	 toluene	 (1.8	mL),	 H2O	 (0.2	mL),	 Cs2CO3	(195.5	mg,	 0.6	mmol),	 and	 bromobenzene	
(63.2	µL,	94.2	mg,	0.6	mmol).	The	crude	product	was	purified	by	flash	column	chromatography	
on	silica	gel	(hexanes:EtOAc	=	95:5)	to	afford	the	desired	product	as	an	oil	(54.7	mg,	61%	yield).	
1H	NMR	(500	MHz,	CDCl3)	δ	7.44	(app	d,	J	=	8.5	Hz,	2H),	7.24		–	7.18	(m,	3H),	7.04	(app	d,	J	=	8.0	
Hz,	2H),	6.86	–	6.78	(m,	2H),	5.71	(t,	J	=	7.5	Hz,	1H),	4.44	(d,	J	=	12.5	Hz,	1H),	4.15	(d,	J	=	12.5	Hz,	
1H),	3.82	(s,	3H),	3.45	(s,	3H),	1.90	–	1.76	(m,	2H),	1.35	–	1.10	(m,	4H),	0.79	(t,	J	=	7.0	Hz,	3H);	
13C{1H}	NMR	(125	MHz,	CDCl3)	δ	168.3,	168.0,	143.6,	140.6,	139.6,	129.5,	129.4	(q,	J	=	32.2	Hz),	
129.2,	128.9,	128.1,	127.1,	125.3	 (q,	 J	=	3.8	Hz),	124.3	 (q,	 J	=	270.6	Hz),	56.3,	53.5,	53.0,	52.8,	
32.1,	 28.8,	 22.3,	 14.1;	 IR	 (neat)	 3053,	 3021,	 2956,	 2930,	 2857,	 1762,	 1741,	 1618,	 1435,	 1325,	
1276,	 1248,	 1165,	 1125,	 1069,	 1019,	 1043	 cm-1;	 HRMS	 m/z	 449.1949	 [(M+H)+;	 calcd	 for	
C25H28O4F3:	449.1940].	
Suzuki-Miyaura	cross-coupling	of	2-B(pin)-substituted	Allylic	Acetates	
General	Procedure	I:	Suzuki-Miyaura	cross-coupling	of	2-B(pin)-substituted	Allylic	Acetates	in	
dilute	THF/H2O	Conditions	
CH(CO2Me)2
n-Bu
F3C
106	
	
	(E)-6-Phenylundec-6-en-5-yl	acetate	(2.6a).	To	a	Schlenk	flask	equipped	with	
a	 stir	 bar	was	 added	 Pd(OAc)2	(4	mg,	 0.018	mmol)	 and	 PPh3	(9.4	mg,	 0.036	
mmol)	in	5	mL	of	dry	and	degassed	THF	at	rt	under	N2,	and	the	solution	was	
stirred	 for	30	–	45	min.	To	 this	catalyst	 solution	was	added	2-B(pin)	 substituted	allylic	acetate	
2.1a	(39	mg,	0.12	mmol),	immediately	followed	by	Cs2CO3	(117	mg,	0.36	mmol),	1	mL	of	distilled	
degassed	 H2O,	 and	 iodobenzene	 (40.1	 µL,	 73.4	 mg,	 0.36	 mmol).	 The	 reaction	 mixture	 was	
heated	in	an	oil	bath	at	75	°C	for	10	h.	The	reaction	was	cooled	to	rt,	and	diluted	with	EtOAc	(5	
mL)	followed	by	saturated	aqueous	NH4Cl	solution	(5	mL).	The	organic	layer	was	separated,	and	
the	aqueous	solution	was	extracted	with	EtOAc	(3	x	5	mL).	The	combined	organic	solution	was	
washed	 with	 brine,	 dried	 over	MgSO4,	 filtered	 through	 Celite,	 and	 the	 solvent	 was	 removed	
under	 reduced	pressure.	 The	 crude	product	was	purified	by	 flash	 column	 chromatography	on	
silica	 gel	 (hexanes:EtOAc	=	98:2)	 to	afford	 the	 trisubstituted	allylic	 acetate	as	 an	oil	 (29.9	mg,	
90%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	7.35	–	7.29	(m,	2H),	7.28	–	7.23	(m,	1H),	7.18	–	7.11	(m,	
2H),	5.67	(t,	J	=	7.4	Hz,	1H),	5.37	(t,	J	=	6.7	Hz,	1H),	2.05	(s,	3H),	1.92	–	1.82	(m,	2H),	1.54	–	1.44	
(m,	2H),	1.35	–	1.13	(m,	8H),	0.87	–	0.71	(m,	6H);	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	170.6,	139.9,	
138.4,	 131.0,	 129.5,	 128.2,	 127.1,	 78.6,	 33.2,	 32.0,	 28.4,	 27.9,	 22.6,	 22.4,	 21.6,	 14.2,	 14.1;	 IR	
(neat)	 2959,	 2930,	 2860,	 1742,	 1601,	 1575,	 1495,	 1466,	 1371,	 1235,	 1019	 cm-1;	 HRMS	 m/z	
229.1955	[(M–OAc)+;	calcd	for	C17H25:	229.1956].	
	
General	Procedure	J:	Suzuki-Miyaura	cross-coupling	of	2-B(pin)-substituted	Allylic	Acetates	in	
Concentrated	toluene/H2O	Conditions	
n-Bu
OAc
n-Bu
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Into	 a	 oven-dried	microwave	 vial	 equipped	with	 a	 stir	 bar	 were	 charged	 2-B(pin)-substituted	
allylic	 acetate	 2.1a	 (25.0	mg,	 0.074	mmol),	 Pd(OAc)2	 (1.7	mg,	 7.4	 x	 10-3	mmol),	 PPh3	 (5.8	mg,	
22.2	x	10-3	mmol)	and	Cs2CO3	(72.3	mg,	0.22	mmol).	The	vial	was	capped	and	purged	with	N2.	To	
the	 vial	 was	 added	 degassed	 toluene	 (0.4	 mL),	 H2O	 (40	 µL)	 and	 iodobenzene	 (24.8	 µL,	 0.22	
mmol),	and	the	reaction	mixture	was	stirred	at	90	 °C	 in	an	oil	bath	until	TLC	showed	complete	
consumption	 of	 the	 2-B(pin)-substituted	 allylic	 acetate	 2.1a.	 The	 reaction	 mixture	 was	 then	
cooled	to	rt	and	diluted	with	EtOAc	(2	mL).	The	solution	was	filtered	through	MgSO4	and	a	short	
silica	 pad,	 and	 the	 filtrate	was	 concentrated	 under	 reduced	 pressure.	 The	 crude	 product	was	
purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	 98:2)	 to	 afford	 the	
trisubstituted	allylic	acetate	2.6a	as	an	oil	(27.7	mg,	96%	yield).	With	2.1a	(25.0	mg,	0.074	mmol)	
and	bromobenzene	(23.2	µL,	0.22	mmol),	the	product	2.6a	was	isolated	in	73%	yield	(21.1	mg).	
	
Reactions	are	 typically	conducted	 in	0.074	–	0.15	mmol	scale	with	3	equiv	of	each	Cs2CO3	and	
aryl	halide	coupling	partner.	Concentration	of	 the	 reactions	are	 typically	 in	 the	 range	of	0.17–
0.20	M.	
	
	(E)-6-(4-Methoxyphenyl)undec-6-en-5-yl	 acetate	 (2.6b).	 The	 product	 was	
prepared	by	General	Procedure	J	in	a	0.1	mmol	scale.	With	2.1a	(33.8	mg,	0.1	
mmol)	 and	 4-iodoanisole	 (70.2	mg,	 0.3	mmol)	 as	 the	 coupling	 partner,	 the	
title	 compound	 was	 isolated	 in	 60%	 yield	 (19.1	 mg).	 With	 2.1a	 (33.8	 mg,	 0.1	 mmol)	 and	 4-
bromoanisole	(37.6	µL,	56.1	mg,	0.3	mmol)	as	the	coupling	partner,	the	product	was	isolated	in	
54%	yield	(17.2	mg).	1H	NMR	(500	MHz,	CDCl3)	δ	7.09	(d,	J	=	8.5	Hz,	2H),	6.87	(d,	J	=	8.5	Hz,	2H),	
5.66	(t,	J	=	7.2	Hz,	1H),	5.35	(t,	J	=	6.8	Hz,	1H),	3.82	(s,	3H),	2.07	(s,	3H),	1.92	–	1.86	(m,	2H),	1.53	
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–	1.46	(m,	2H),	1.33	–	1.18	(m,	8H),	0.84	(t,	J	=	7.0	Hz,	3H),	0.81	(t,	J	=	7.0	Hz,	3H);	13C{1H}	NMR	
(125	MHz,	CDCl3)	δ	170.6,	158.7,	139.3,	130.9,	130.6,	129.5,	113.6,	78.8,	55.4,	33.2,	32.1,	28.4,	
27.9,	22.6,	22.5,	21.7,	14.2,	14.1.	
	
	(E)-6-(4-Nitrophenyl)undec-6-en-5-yl	 acetate	 (2.6c).	 The	 product	 was	
prepared	by	General	Procedure	J	in	a	0.1	mmol	scale.	With	2.1a	(33.8	mg,	0.1	
mmol)	 and	 1-iodo-4-nitrobenzene	 (74.7	 mg,	 0.3	 mmol)	 as	 the	 coupling	
partner,	the	title	compound	was	isolated	in	92%	yield	(30.7	mg).	With	2.1a	(33.8	mg,	0.1	mmol)	
and	 1-bromo-4-nitrobenzene	 (60.6	 mg,	 0.3	 mmol)	 as	 the	 coupling	 partner,	 the	 product	 was	
isolated	in	91%	yield	(30.3	mg).	1H	NMR	(500	MHz,	CDCl3)	δ	8.22	(d,	J	=	8.7	Hz,	2H),	7.37	(d,	J	=	
8.7	Hz,	2H),	5.82	(t,	J	=	7.4	Hz,	1H),	5.39	(t,	J	=	6.7	Hz,	1H),	2.09	(s,	3H),	1.96	–	1.75	(m,	2H),	1.51	–	
1.36	(m,	2H),	1.37	–	1.15	(m,	8H),	1.00	–	0.67	(m,	6H);	13C	NMR	(125	MHz,	CDCl3)	δ	170.5,	147.2,	
145.7,	138.4,	133.1,	130.5,	123.6,	77.9,	33.3,	31.8,	28.5,	27.9,	22.5,	22.4,	21.5,	14.1,	14.1;	HRMS	
m/z	356.1799	[(M+Na)+;	calcd	for	C19H27NO4Na:	356.1838]		
	
	(E)-2-Methyl-4-phenylnon-4-en-3-yl	 acetate	 (2.6d).	 The	 product	 was	
prepared	by	General	Procedure	J	in	a	0.1	mmol	scale.	With	2.1b	(32.4	mg,	0.1	
mmol)	and	iodobenzene	(33.6	µL,	61.2	mg,	0.3	mmol)	as	the	coupling	partner,	
the	 title	 compound	was	 isolated	 in	 67%	 yield	 (18.4	mg).	With	2.1b	 (32.4	mg,	 0.1	mmol)	 and	
bromobenzene	(31.6	µL,	47.1	mg,	0.3	mmol)	as	the	coupling	partner,	the	product	was	isolated	in	
87%	yield	(23.9	mg).	1H	NMR	(500	MHz,	CDCl3)	δ	7.38	–	7.30	(m,	2H),	7.29	–	7.24	(m,	1H),	7.22	–	
7.16	(m,	2H),	5.65	(t,	J	=	7.3	Hz,	1H),	5.18	(d,	J	=	7.0	Hz,	1H),	2.11	(s,	3H),	1.98	–	1.84	(m,	2H),	
1.77	–	1.66		(m,	1H),	1.36	–	1.11	(m,	4H),	0.86	(d,	J	=	6.7	Hz,	6H),	0.81	(t,	J	=	7.3	Hz,	3H);	13C	{1H}	
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NMR	(125	MHz,	CDCl3)	δ	170.6,	138.7,	138.6,	131.8,	129.5,	128.2,	127.1,	83.3,	32.1,	30.1,	28,4,	
22.4,	 21.5,	 19.5,	 17.8,	 14.1;	 IR	 (neat)	 2961,	 2923,	 2873,	 1743,	 1600,	 1575,	 1494,	 1467,	 1369,	
1238,	1021	cm-1;	HRMS	m/z	297.1835	[(M+Na)+;	calcd	for	C18H26O2Na:	297.1831].	
	
	(E)-1,2-Diphenylhept-1-en-3-yl	 acetate	 (2.6e).	 The	 product	 was	 prepared	 by	
General	Procedure	 J	 in	a	0.1	mmol	 scale.	With	2.1d	 (35.8	mg,	0.1	mmol)	and	
iodobenzene	 (33.6	µL,	 61.2	mg,	 0.3	mmol)	 as	 the	 coupling	 partner,	 the	 title	
compound	was	isolated	in	99%	yield	(30.5	mg).	1H	NMR	(300	MHz,	CDCl3)	δ	7.41	–	7.30	(m,	3H),	
7.28	–	7.21	(m,	2H),	7.14	–	7.05	(m,	3H),	6.97	–	6.87	(m,	2H),	6.64	(s,	1H),	5.55	(t,	J	=	6.6	Hz,	1H),	
2.13	(s,	3H),	1.71	–	1.55	(m,	2H),	1.44	–	1.23	(m,	4H),	0.88	(t,	J	=	7.0	Hz,	3H);	13C	{1H}	NMR	(75	
MHz,	CDCl3)	δ	170.6,	141.6,	138.5,	136.5,	129.6,	129.5,	128.8,	128.3,	128.1,	127.7,	127.1,	78.9,	
33.1,	27.9,	22.6,	21.6,	14.2;	HRMS	m/z	331.1674	[(M+Na)+;	calcd	for	C21H24O2Na:	331.1674]		
	
	(E)-2-(4-Nitrophenyl)-1-phenylhept-1-en-3-yl	 acetate	 (2.6f).	 The	product	was	
prepared	by	General	Procedure	J	 in	a	0.1	mmol	scale.	With	2.1d	(35.8	mg,	0.1	
mmol)	and	1-iodo-4-nitrobenzene	(74.7	mg,	0.3	mmol)	as	the	coupling	partner,	
the	title	compound	was	isolated	in	92%	yield	(32.5	mg).	With	2.1d	 (35.8	mg,	0.1	mmol)	and	1-
bromo-4-nitrobenzene	(60.6	mg,	0.3	mmol)	as	the	coupling	partner,	the	product	was	isolated	in	
90%	yield	(31.8	mg).	1H	NMR	(300	MHz,	CDCl3)	δ	1H	NMR	(300	MHz,	CDCl3)	δ	8.29	–	8.13	(m,	2H),	
7.53	–	7.39	(m,	2H),	7.18	–	7.06	(m,	3H),	7.02	–	6.84	(m,	2H),	6.77	(s,	1H),	5.53	(dd,	J	=	7.4,	5.9	
Hz,	1H),	2.13	 (s,	3H),	1.74	–	1.51	 (m,	2H),	1.46	–	1.20	 (m,	4H),	0.87	 (t,	 J	=	7.0	Hz,	3H);	 13C	 {1H}	
NMR	 (75	MHz,	 CDCl3)	 δ	 170.6,	 141.6,	 138.5,	 136.5,	 129.6,	 129.5,	 128.8,	 128.3,	 128.1,	 127.7,	
Phn-Bu
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127.1,	78.9,	33.1,	27.9,	22.6,	21.6,	14.2;	HRMS	m/z	376.1514	[(M+Na)+;	calcd	for	C21H23NO4Na:	
376.1525].		
	
	(E)-1,2-Diphenylhept-2-en-1-yl	 acetate	 (2.6g).	 The	 product	was	 prepared	 by	
General	Procedure	J	in	a	0.1	mmol	scale	and	the	reaction	was	conducted	at	75	
°C	 in	 THF	 (0.4	 mL)	 and	 H2O	 (40	 µL).	 With	 2.1f	 (35.8	 mg,	 0.1	 mmol)	 and	
iodobenzene	(33.6	µL,	61.2	mg,	0.3	mmol)	as	the	coupling	partner,	the	product	was	isolated	in	
70%	yield	(21.6	mg).	1H	NMR	(500	MHz,	CDCl3)	δ	7.30	–	7.16	(m,	8H),	6.98	–	6.92	(m,	2H),	6.44	(s,	
1H),	5.80	(t,	J	=	7.5	Hz,	1H),	2.09	(s,	3H),	1.97	–	1.85	(m,	2H),	1.36	–	1.14	(m,	4H),	0.81	(t,	J	=	7.2	
Hz,	3H);	13C	{1H}	NMR	(125	MHz,	CDCl3)	δ	170.1,	139.9,	138.9,	138.1,	130.9,	129.6,	128.3,	128.0,	
127.9,	127.5,	127.1,	79.4,	32.0,	28.5,	22.5,	21.5,	14.1;	HRMS	m/z	376.1514	[(M+Na)+;	calcd	 for	
C21H23NO4Na:	376.1525]		
	
	(E)-2-(4-Nitrophenyl)-1-phenylhept-2-enyl	 acetate	 (2.6h).	 The	 product	 was	
prepared	 by	 General	 Procedure	 J	 in	 a	 0.1	mmol	 scale,	 and	 the	 reaction	was	
conducted	at	 75	 °C	 in	 THF	 (0.4	mL)	 and	H2O	 (40	µL).	With	2.1f	 (35.8	mg,	 0.1	
mmol)	 and	 1-iodo-4-nitrobenzene	 (74.7	 mg,	 0.3	 mmol)	 as	 the	 coupling	 partner,	 the	 title	
compound	 was	 isolated	 in	 75%	 yield	 (26.5	 mg).	 With	 2.1f	 (35.8	 mg,	 0.1	 mmol)	 and	
bromobenzene	(31.6	µL,	47.1	mg,	0.3	mmol)	as	the	coupling	partner,	the	product	was	isolated	in	
80%	yield	(27.3	mg).	1H	NMR	(500	MHz,	CDCl3)	δ	8.19	–	8.03	(m,	2H),	7.36	–	7.04	(m,	7H),	6.46	(s,	
1H),	5.94	(t,	J	=	7.5	Hz,	1H),	2.12	(s,	3H),	1.96	–	1.79	(m,	2H),	1.42	–	1.13	(m,	4H),	0.82	(t,	J	=	7.2	
Hz,	3H);	13C	{1H}	NMR	(125	MHz,	CDCl3)	δ	169.9,	147.2,	145.2,	138.3,	138.1,	132.9,	130.6,	128.6,	
128.3,	127.1,	123.4,	78.9,	31.7,	28.6,	22.4,	21.4,	14.1;	 IR	 (neat)	2957,	2930,	2858,	1741,	1597,	
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1518,	1370,	1345,	1230,	1107,	1018	cm-1;	HRMS	m/z	376.1508	[(M+Na)+;	calcd	for	C21H23NO4Na:	
376.1525].		
	
	(E)-11-Chloro-6-phenylundec-6-en-5-yl	 acetate	 (2.6i).	 Into	 a	 oven-dried	
microwave	vial	equipped	with	a	stir	bar	were	charged	with	2.1e	 (1.86	g,	
5.0	mmol),	 Pd(OAc)2	 (112	mg,	 0.5	mmol),	 PPh3	 (262	mg,	 1.5	mmol)	 and	
Cs2CO3	 (3.26	mg,	 10	mmol).	 The	 vial	was	 capped	 and	 purged	with	N2.	 To	 the	 vial	was	 added	
degassed	toluene	(12	mL),	H2O	(2.4	mL)	and	iodobenzene	(1.11	mL,	10	mmol),	and	the	reaction	
mixture	was	stirred	 in	an	oil	bath	at	90	 °C	 for	6	h.	The	 reaction	was	cooled	 to	 rt,	diluted	with	
EtOAc	 (10	mL),	 followed	by	 saturated	 aqueous	NH4Cl	 solution	 (20	mL).	 The	 organic	 layer	was	
separated	 and	 the	 aqueous	 solution	 was	 extracted	 with	 EtOAc	 (3	 x	 15	 mL).	 The	 combined	
organic	 solution	 was	 washed	 with	 brine,	 dried	 over	 MgSO4,	 filtered	 and	 the	 solvent	 was	
removed	 under	 reduced	 pressure.	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	 (hexanes:EtOAc	=	98:2)	to	afford	the	trisubstituted	allylic	acetate	
as	an	oil	(1.3	g,	80%	yield).	1H	NMR	(300	MHz,	CDCl3)	δ	7.42	–	7.25	(m,	3H),	7.20	–	7.12	(m,	2H),	
5.67	(t,	J	=	7.4	Hz,	1H),	5.38	(t,	J	=	6.6	Hz,	1H),	3.42	(t,	J	=	6.6	Hz,	2H),	2.08	(s,	3H),	1.99	–	1.85	(m,	
2H),	1.75	–	1.61	(m,	2H),	1.55	–	1.40	(m,	4H),	1.36	–	1.13	(m,	4H),	0.84	(t,	J	=	6.9	Hz,	3H);	13C	{1H}	
NMR	 (75	MHz,	CDCl3)	δ	 170.6,	140.8,	138.1,	129.7,	129.4,	128.3,	127.3,	78.4,	45.0,	33.1,	32.1,	
27.9,	 27.8,	 26.9,	 22.6,	 21.6,	 14.2;	 IR	 (neat)	 3080,	 3056,	 3021,	 2956,	 2934,	 2861,	 1739,	 1600,	
1494,	1456,	1442,	1370,	1235,	1020	cm-1;	HRMS	m/z	345.1587	[(M+Na)+;	calcd	for	C19H27ClO2Na:	
345.1597].		
	
(CH2)4Cln-Bu
OAc
112	
	(E)-6-(4-(Trifluoromethyl)phenyl)undec-6-en-5-yl	acetate	(2.6j).	The	product	
was	prepared	by	General	Procedure	J	in	a	0.1	mmol	scale.	With	2.1a	(33.8	mg,	
0.1	 mmol)	 and	 4-bromobenzotrifluoride	 (42.0	 µL,	 67.5	 mg,	 0.3	 mmol),	 the	
title	compound	was	isolated	in	85%	yield	(27.4	mg).	1H	NMR	(500	MHz,	CDCl3)	δ	7.60	(app	d,	J	=	
8.0	Hz,	2H),	7.29	(app	d,	J	=	8.0	Hz,	2H),	5.77	(t,	J	=	7.5	Hz,	1H),	5.38	(t,	J	=	6.8	Hz,	1H),	2.07	(s,	
3H),	1.93	–	1.80	(m,	2H),	1.56	–	1.45	(m,	2H),	1.36	–	1.16	(m,	8H),	0.85	(t,	J	=7.0	Hz,	3H),	0.81	(t,	J	
=	7.2	Hz,	3H);	 13C	{1H}	NMR	(125	MHz,	CDCl3)	δ	170.5,	142.3,	138.9,	132.3,	129.9,	129.4	(q,	J	=	
32.0	Hz),	 125.2	 (q,	 J	 =	3.7	Hz),	 124.5	 (q,	 J	 =	272.0	Hz),	 78.2,	33.2,	31.9,	28.4,	27.9,	22.6,	22.4,	
21.5,	14.1,	14.0;	 IR	 (neat)	3052,	2959,	2934,	2862,	1742,	1617,	1467,	1371,	1326,	1234,	1166,	
1128,	1108,	1067,	1019	cm-1;	HRMS	m/z	379.1880	[(M+Na)+;	calcd	for	C20H27F3O2Na:	379.1861].	
		
(E)-6-(2-Methoxyphenyl)undec-6-en-5-yl	 acetate	 (2.6k).	 The	 product	 was	
prepared	by	General	Procedure	J	in	a	0.1	mmol	scale.	With	2.1a	(33.8	mg,	0.1	
mmol)	and	2-bromoanisole	(34.0	µL,	51.6	mg,	0.3	mmol),	the	title	compound	
was	isolated	in	80%	yield	(25.5	mg).	1H	NMR	(300	MHz,	CDCl3)	δ	7.32	–	7.21	(m,	1H),	7.06	–	6.99	
(m,	1H),	6.97	–	6.85	(m,	2H),	5.76	(t,	J	=	7.2	Hz,	1H),	5.50	–	5.39	(m,	1H),	3.77	(s,	3H),	2.04	(s,	3H),	
1.84	–	1.71	(m,	2H),	1.63	–	1.47	(m,	2H),	1.37	–	1.16	(m,	8H),	0.91	–	0.74	(m,	6H);	13C	{1H}	NMR	
(75	MHz,	CDCl3)	δ	 170.6,	157.3,	135.9,	131.4,	128.6	 (two	overlapping	 resonances),	 120.3	 (two	
overlapping	resonances),	110.7,	77.9,	55.4,	33.0,	31.7,	28.6,	27.8,	22.7,	22.5,	21.6,	14.2,	14.1;	IR	
(neat)	2957,	2932,	1737,	1598,	1578,	1492,	1460,	1369,	1245,	1029	cm-1;	HRMS	m/z	341.2085	
[(M+Na)+;	calcd	for	C20H30O3Na:	341.2093].	
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	(E)-6-(Thiophen-3-yl)undec-6-en-5-yl	 acetate	 (2.6l).	 The	 product	 was	
prepared	by	General	Procedure	 J	 in	a	0.15	mmol	 scale.	With	2.1a	 (50.7	mg,	
0.15	mmol)	 and	3-bromothiophene	 (42.2	µL,	 73.4	mg,	0.45	mmol),	 the	 title	
compound	was	isolated	in	74%	yield	(32.7	mg).	1H	NMR	(500	MHz,	CDCl3)	δ	7.29	(dd,	J	=	4.9,	3.0	
Hz,	1H),	7.08	(dd,	J	=	3.0,	1.2,	1H),	6.99	(dd,	J	=	4.9,	1.2	Hz,	1H),	5.72	(t,	J	=	7.4	Hz,	1H),	5.37	(t,	J	=	
6.9	Hz,	1H),	2.07	(s,	3H),	2.00	(dt,	J	=	7.4,	7.3	Hz,	2H),	1.57	–	1.42	(m,	2H),	1.37	–	1.14	(m,	8H),	
0.84	 (t,	 J	=	7.0	Hz,	3H),	0.83	 (t,	 J	=	7.2	Hz,	3H);	 13C	 {1H}	NMR	(125	MHz,	CDCl3)	δ	170.5,	137.9,	
134.6,	 132.7,	 129.1,	 124.8,	 123.2,	 78.8,	 33.2,	 32.1,	 28.7,	 27.9,	 22.6,	 22.5,	 21.7,	 14.2,	 14.1;	 IR	
(neat)	 2958,	 2930,	 2872,	 2860,	 1739,	 1466,	 1370,	 1235,	 1081,	 1235,	 1018	 cm-1;	 HRMS	m/z	
317.1552	[(M+Na)+;	calcd	for	C17H26O2SNa:	317.1551].	
	
	(Z)-6-(Thiophen-2-yl)undec-6-en-5-yl	 acetate	 (2.6m).	 The	 product	 was	
prepared	by	General	Procedure	 J	 in	a	0.15	mmol	 scale.	With	2.1a	 (50.7	mg,	
0.15	mmol)	 and	2-bromothiophene	 (43.6	µL,	 73.4	mg,	0.45	mmol),	 the	 title	
compound	was	isolated	in	82%	yield	(36.2	mg).	1H	NMR	(500	MHz,	CDCl3)	δ	7.28	(dd,	J	=	5.1,	1.1	
Hz,	1H),	7.02	(dd,	J	=	5.1,	3.5	Hz,	1H),	6.89	(dd,	J	=	3.5,	1.1	Hz,	1H),	5.83	(t,	J	=	7.5	Hz,	1H),	5.38	(t,	
J	=	7.0	Hz,	1H),	2.11	(dt,	J	=	7.5,	7.5	Hz,	2H),	2.08	(s,	3H),	1.64	–	1.48	(m,	2H),	1.41	–	1.16	(m,	8H),	
0.85	(m,	6H);	13C	{1H}	NMR	(125	MHz,	CDCl3)	δ	170.5,	138.2,	135.1,	132.4,	127.0,	126.7,	125.4,	
78.9,	33.0,	32.0,	28.9,	27.9,	22.6,	22.5,	21.6,	14.2,	14.1;	IR	(neat)	2958,	2931,	2860,	1741,	1466,	
1437,	1370,	1234,	1019	cm-1;	HRMS	m/z	317.1538	[(M+Na)+;	calcd	for	C17H26O2SNa:	317.1551].			
	
Synthesis	and	Characterization	of	2-B(pin)-substituted	Allylic	Benzoates	and	Carbonates	
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2-B(pin)-substituted	 Allylic	 Benzoates	 and	 Carbonates	 were	 prepared	 according	 to	 literature	
procedures.10a		
General	Procedure	K:	Synthesis	of	2-B(pin)-substituted	Allylic	Benzoate	(2.7a	–	c).	
	
To	a	flame-dried	round-bottomed	flask	equipped	with	a	stir	bar	was	added	2-B(pin)-substituted	
allylic	alcohol	(2	mmol)	and	the	flask	was	purged	with	N2.	To	the	flask	was	added	CH2Cl2	(5	mL)	
and	pyridine	(485	µL,	6	mmol,	3	equiv)	at	rt.	The	reaction	mixture	was	stirred	for	5	min.	Benzoyl	
chloride	(697	µL,	6	mmol,	3	equiv)	was	added	dropwise,	and	the	reaction	mixture	was	stirred	at	
rt	for	18	h.	The	reaction	mixture	was	diluted	with	CH2Cl2	(15	mL)	and	quenched	with	saturated	
NH4Cl	 (15	mL).	 The	organic	 layer	was	 separated	and	 the	aqueous	 solution	was	extracted	with	
CH2Cl2	(2	x	15	mL).	The	combined	organic	layers	were	washed	with	saturated	aqueous	NaHCO3	
(15	mL)	and	brine	(10	mL),	and	dried	over	MgSO4,	filtered,	and	the	solvent	was	removed	under	
reduced	 pressure	 to	 yield	 a	 colorless	 oil.	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	to	afford	the	allylic	benzoate	as	a	colorless	oil.	
	
	(E)-6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)undec-6-en-5-yl	
benzoate	 (2.7a).	 The	product	was	 prepared	by	General	 Procedure	 K	 using	
(E)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)undec-6-en-5-ol41	 (592	 mg,	 2	 mmol).	 The	
crude	product	was	purified	by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	97:3)	
to	afford	the	allylic	benzoate	as	a	colorless	oil	(601	mg,	75%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	
8.10	(m,	2H),	7.55	–	7.50	(m,	1H),	7.45	–	7.38	(m,	2H),	6.29	(t,	J	=	7.5	Hz,	1H),	5.53	(t,	J	=	6.2	Hz,	
1H),	2.34	(dt,	J	=	7.5,	7.0	Hz,	2H),	1.90	–	1.70	(m,	2H),	1.41	–	1.17	(m,	8H),	1.27	(s,	6H),	1.27	(s,	
R
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6H),	0.89	(t,	J	=	6.7	Hz,	3H),	0.80	(t,	J	=	7.2	Hz,	3H);	13C	{1H}	NMR	(125	MHz,	CDCl3)	δ	166.0,	147.5,	
132.6,	 131.5,	 129.8,	 128.3,	 83.2,	 79.2,	 34.9,	 32.1,	 30.8,	 28.0,	 25.2,	 24.9,	 22.7,	 22.4,	 14.2,	 14.1	
(the	quaternary	vinyl	C	bearing	the	boron	group	is	not	observed);	11B	NMR	(CDCl3,	128	MHz)	δ	
29.4;	IR	(neat)	2958,	2931,	2860,	1718,	1632,	1603,	1585,	1451,	1412,	1372,	1348,	1314,	1270,	
1214,	1144,	1112,	1070,	1027;	HRMS	m/z	399.2717	[(M-H)+;	calcd	for	C24H36BO4:	399.2707].	
	
	(E)-6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)undec-6-en-5-yl	 benzoate	
(2.7b).	The	product	was	prepared	by	General	Procedure	K	using	(E)-1-phenyl-4-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-4-en-3-ol10a	 (632	 mg,	 2	 mmol).	 The	 crude	
product	was	purified	by	 flash	 column	 chromatography	on	 silica	 gel	 (hexanes:EtOAc	=	 97:3)	 to	
afford	the	allylic	benzoate	as	a	colorless	oil	(605	mg,	72%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.14	
–	8.10	(m,	2H),	7.53	(tt,	J	=	7.5,	1.5	Hz,	1H),	7.45	–	7.39	(m,	4H),	7.30	(tt,	J	=	7.5,	1.5	Hz,	2H),	7.23	
(tt,	J	=	7.5,	1.5	Hz,	1H),	6.66	(s,	1H),	6.27	(t,	J	=	7.5	Hz,	1H),	2.45	–	2.31	(m,	2H),	1.40	–	1.24	(m,	
4H),	1.14	(s,	12H),	0.88	(t,	J	=	7.5	Hz,	3H);	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	165.6,	146.9,	140.5,	
132.9,	 131.1,	 123.0,	 128.4,	 128.3,	 127.8,	 127.7,	 83.4,	 78.9,	 32.1,	 30.9,	 24.8,	 22.5,	 14.1	 (the	
quaternary	vinyl	C	bearing	the	boron	group	is	not	observed);	11B	NMR	(CDCl3,128	MHz)	δ	30.3;	IR	
(neat)	 3064,	 3033,	 2977,	 2958,	 2929,	 2859,	 1722,	 1635,	 1602,	 1494,	 1451,	 1408,	 1314,	 1263,	
1143,	1109,	1069,	1026	cm-1;		HRMS	m/z	443.2378	[(M+Na)+;	calcd	for	C26H33BO4Na:	443.2370].	
	
	(E)-1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-4-en-
3-ol	(2.7c-ol).	To	a	suspension	of	HBCy2	(770	mg,	4.32	mmol)	in	toluene	
(4.0	mL)	 equipped	with	 a	 stir	 bar	 under	N2	was	 added	 2-hex-1-ynyl-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane	 (899	mg,	1.0	mL,	4.32	mmol)	 	and	 the	 reaction	mixture	was	stirred	at	 rt	 for	30	
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n-BuPh
OBz
B(pin)
n-Bu
OH
116	
min,	after	which	it	was	homogeneous.	The	reaction	vessel	was	cooled	to	–78	°C	in	a	dry	ice	bath,	
treated	with	Me2Zn	(2.16	mL,	2.0	M	in	toluene,	4.32	mmol),	and	stirred	at	that	temperature	for	
30	min.	The	solution	was	then	warmed	to	–20	°C	by	placing	the	flask	in	a	–20	°C	cold	bath,	and	
hydrocinnamaldehyde	(483	mg,	474	µL,	3.60	mmol)	was	added.	The	reaction	mixture	was	stirred	
at	–20	°C	for	12	h.	The	reaction	mixture	was	then	diluted	with	EtOAc	(10	mL)	and	quenched	with	
saturated	 NH4Cl	 (15	 mL).	 The	 organic	 layer	 was	 separated	 and	 the	 aqueous	 solution	 was	
extracted	with	EtOAc	(3	x	5	mL).	The	combined	organic	solution	was	dried	over	MgSO4,	filtered	
through	 celite	 and	 the	 solvent	 was	 removed	 under	 reduced	 pressure.	 The	 combined	 organic	
solution	was	dried	over	MgSO4,	filtered,	and	the	solvent	was	removed	under	reduced	pressure	
to	yield	a	colorless	oil.	The	crude	product	was	purified	by	flash	column	chromatography	on	silica	
gel	(hexanes:EtOAc	=	95:5)	to	afford	the	allylic	alcohol	as	a	colorless	oil	(587	mg,	75%	yield).	1H	
NMR	(500	MHz,	CDCl3)	δ	7.32	–7.14	(m,	5H),	6.17	(t,	J	=	7.5,	Hz,	1H),	4.02	(dt,	J	=	8.5,	6.8	Hz,	1H),	
2.70	(ddd,	J	=	13.5,	10.5,	6.5	Hz,	1H),	2.62	(ddd,	J	=	13.5,	10.5,	6.5	Hz,	1H),	2.50	(d,	J	=	8.5	Hz,	1H),	
2.36	(dt,	J	=	7.5,	6.5	Hz,	2H),	1.99	–	1.89	(m,	1H),	1.87	–	1.77	(m,	1H),	1.41	–	1.27	(m,	4H),	1.28	(s,	
6H),	1.27	 (s,	6H),	0.90	 (t,	 J	=	7.0	Hz,	3H);	 13C{1H}	NMR	(125	MHz,	CDCl3)	δ	148.1,	142.6,	128.6,	
128.4,	 125.7,	 83.4,	 77.9,	 40.0,	 32.6,	 32.0,	 30.6,	 25.1,	 24.8,	 22.4,	 14.1	 (the	 quaternary	 vinyl	 C	
bearing	 the	 boron	 group	 is	 not	 observed);	 11B	 NMR	 (CDCl3,128	MHz)	 δ	 29.4;	 IR	 (neat)	 3451,	
2977,	 2956,	 2928,	 2859,	 1634,	 1604,	 1496,	 1454,	 1408,	 1300,	 1214,	 1143,	 1109,	 1060	 cm-1;	
HRMS	m/z	367.2407	[(M+Na)+;	calcd	for	C21H33O3BNa:	367.2420].	
	
		(E)-1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-4-
en-3-yl	 benzoate	 (2.7c).	 The	 product	 was	 prepared	 by	 General	
Procedure	 K	 using	 (E)-1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-4-en-3-ol	
B(pin)
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2.7c-ol	(689	mg,	2	mmol).	The	crude	product	was	purified	by	flash	column	chromatography	on	
silica	gel	 (hexanes:EtOAc	=	97:3)	 to	afford	 the	allylic	benzoate	as	a	 colorless	oil	 (699	mg,	80%	
yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.09	–	8.04	(m,	2H),	7.56	–	7.51	(m,	1H),	7.45	–	7.39	(m,	2H),	
7.29	–	7.13	(m,	5H),	6.31	(t,	J	=	7.5,	Hz,	1H),	5.58	(t,	J	=	6.5,	Hz,	1H),	2.73	–	2.62	(m,	2H),	2.39	–	
2.31	(m,	2H),	2.24	–	2.08	(m,	2H),	1.41	–	1.27	(m,	4H),	1.27	(s,	6H),	1.26	(s,	6H),	0.88	(t,	J	=	7.0	Hz,	
3H);	 13C{1H}	 NMR	 (125	MHz,	 CDCl3)	 δ	 165.9,	 148.1,	 142.1,	 132.7,	 131.2,	 129.8,	 128.6,	 128.5,	
128.3,	 125.9,	 83.2,	 78.7,	 36.7,	 32.2,	 32.0,	 30.8,	 25.1,	 24.8,	 22.4,	 14.1	 (the	 quaternary	 vinyl	 C	
bearing	 the	 boron	 group	 is	 not	 observed);	 11B	NMR	 (CDCl3,	 128	MHz)	 δ	 30.1;	 IR	 (neat)	 3063,	
3028,	 2977,	 2958,	 2929,	 2860,	 1722,	 1715,	 1634,	 1603,	 1585,	 1496,	 1452,	 1412,	 1348,	 1313,	
1268,	1214,	1143,	1102,	1069,	1026	cm-1;	HRMS	m/z	471.2668	[(M+Na)+;	calcd	for	C28H37O4BNa:	
471.2683].	
	
General	Procedure	L:	Synthesis	of	2-B(pin)-substituted	Allylic	Carbonate.	
To	a	 flame-dried	round-bottomed	flask	equipped	with	a	stir	bar	under	N2	was	added	2-B(pin)-
substituted	allylic	alcohol	(2	mmol)	and	toluene	(10	mL).	The	solution	was	cooled	to	0	°C	in	an	
ice	 bath,	 and	 Et2Zn	 2.0	 M	 in	 toluene	 (1.2	 mL,	 2.4	 mmol)	 was	 added	 dropwise.	 The	 reaction	
mixture	was	stirred	at	this	temperature	for	10	min.	 tert-Butyl	1H-imidazole-1-carboxylate	(673	
mg,	 4	mmol)	 in	 toluene	 (3	mL)	was	 transferred	 to	 the	 reaction	mixture	 by	 a	 syringe	with	 an	
additional	2	mL	of	 toluene.	The	 reaction	mixture	was	 then	 stirred	at	 rt	 for	18	h.	 The	 reaction	
mixture	was	diluted	with	hexanes	(10	mL)	and	quenched	with	saturated	aqueous	NH4Cl	(15	mL).	
The	organic	 layer	was	 separated,	 and	 the	 aqueous	 solution	was	 extracted	with	 EtOAc	 (2	 x	 20	
mL).	 The	 combined	organic	 layers	were	washed	with	 saturated	 aqueous	NaHCO3	 (20	mL)	 and	
brine	(20	mL),	and	then	dried	over	MgSO4.	The	combined	organic	solution	was	filtered,	and	the	
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solvent	was	 removed	 under	 reduced	 pressure	 to	 yield	 a	 colorless	 oil.	 The	 crude	 product	was	
purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	 to	 afford	 the	 allylic	 carbonate	 as	 a	
colorless	oil.	
	
	(E)-tert-Butyl	 (6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)undec-6-en-5-
yl)	carbonate	(2.8a).	The	product	was	prepared	by	General	Procedure	L	using	
(E)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)undec-6-en-5-ol41	 (592	 mg,	 2	 mmol).	 The	
crude	product	was	purified	by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	97:3)	
to	afford	the	allylic	carbonate		as	a	colorless	oil	(601	mg,	75%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	
6.21	(t,	J	=	7.6	Hz,	1H),	5.07	(t,	J	=	6.5	Hz,	1H),	2.40	–	2.26	(m,	2H),	1.73	–	1.60	(m,	2H),	1.46	(s,	
9H),	1.41	–	1.18	(m,	8H),	1.26	(s,	6H),	1.26	(s,	6H),	0.95	–	0.79	(m,	6H);	13C	{1H}	NMR	(125	MHz,	
CDCl3)	δ	153.3,	146.5,	83.2,	81.3,	80.8,	35.0,	32.0,	30.7,	28.1,	28.0,	25.1,	24.8,	22.7,	22.3,	14.2,	
14.1	 (the	 quaternary	 vinyl	 C	 bearing	 the	 boron	 group	 is	 not	 observed);	 11B	 NMR	 (CDCl3,	 128	
MHz)	δ	29.3;	IR	(neat)	2978,	2958,	2932,	2873,	2861,	1739,	1635,	1468,	1411,	1369,	1277,	1255,	
1215,	1168,	1145,	1115,	1091,	1037	cm-1;	HRMS	m/z	419.2964	[(M+Na)+;	calcd	for	C22H41BO5Na:	
419.2945].	
		
	(E)-Ethyl	 (6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)undec-6-en-5-yl)	
carbonate	 (2.8b).	 The	 product	was	 prepared	 by	General	 Procedure	 K	 using	
(E)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)undec-6-en-5-ol41	 (376	 mg,	 1.27	 mmol),	
pyridine	(308	µL,	3.81	mmol,	3	equiv),	and	ethyl	chloroformate	(364	µL,	6	mmol,	3	equiv).	The	
crude	product	was	purified	by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	97:3)	
to	afford	the	allylic	carbonate	as	a	colorless	oil	(388	mg,	83%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	
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6.23	(t,	J	=	7.6	Hz,	1H),	5.11	(t,	J	=	6.7	Hz,	1H),	4.15	(q,	J	=	7.2	Hz,	2H),	2.33	(dt,	J	=	7.6,	7.2	Hz,	
2H),	1.76	–	1.62	(m,	2H),	1.40	–	1.11	(m,	8H),	1.28	(t,	J	=	7.2	Hz,	3H),	1.26	(s,	6H),	1.25	(s,	6H),	
0.88	 (t,	 J	=	6.9	Hz,	3H),	0.87	 (t,	 J	=	6.9	Hz,	3H);	 13C	 {1H}	NMR	(125	MHz,	CDCl3)	δ	154.9,	147.4,	
83.3,	81.9,	63.6,	34.9,	32.0,	30.8,	27.9,	25.1,	24.9,	22.6,	22.4,	14.5,	14.1,	14.0	 (the	quaternary	
vinyl	C	bearing	 the	boron	group	 is	not	observed);	 11B	NMR	 (CDCl3,	 128	MHz)	δ	 29.0;	 IR	 (neat)	
2978,	2959,	2931,	2873,	2861,	1745,	1636,	1467,	1412,	1372,	1349,	1307,	1257,	1145,	1109	cm-
1.	
	
	(E)-tert-Butyl	 (1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hept-
2-en-1-yl)	carbonate	(2.8c).	The	product	was	prepared	by	General	Procedure	L	
using	 (E)-1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-4-en-3-ol10a	 (632	 mg,	 2	
mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	
(hexanes:EtOAc	=	97:3)	to	afford	the	allylic	carbonate	as	a	colorless	oil	(375	mg,	45%	yield).	 1H	
NMR	(500	MHz,	CDCl3)	δ	7.37	–	7.33	(m,	2H),	7.32	–	7.26	(m,	2H),	7.26	–	7.21	(m,	1H),	6.21	(s,	
1H),	6.16	(td,	J	=	7.5,	1.5	Hz,	1H),	2.40	–	2.29	(m,	2H),	1.45	(s,	9H),	1.39	–	1.24	(m,	4H),	1.17	(s,	
6H),	1.13	 (s,	6H),	0.87	 (t,	 J	=	7.0	Hz,	3H);	 13C{1H}	NMR	(125	MHz,	CDCl3)	δ	153.0,	146.0,	140.0,	
128.2,	128.0,	127.8,	83.3,	81.8,	80.7,	32.0,	30.8,	28.0,	24.9,	24.7,	22.4,	14.1	(the	quaternary	vinyl	
C	bearing	the	boron	group	 is	not	observed);	 11B	NMR	(CDCl3,	128	MHz)	δ	30.3;	 IR	(neat)	2979,	
2931,	2872,	1743,	1638,	1456,	1370,	1310,	1276,	1253,	1166,	1144,	1092,	1032	cm-1;	HRMS	m/z	
439.2630	[(M+Na)+;	calcd	for	C24H37BO5Na:	439.2632].			
	
	(E)-tert-Butyl	 (1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)non-4-en-3-yl)	 carbonate	 (2.8d).	 The	 product	 was	 prepared	 by	
B(pin)
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General	 Procedure	 L	 using	 (E)-1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-4-
en-3-ol	 2.7c-ol	 (689	 mg,	 2	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	 (hexanes:EtOAc	=	97:3)	to	afford	the	allylic	acetate	as	a	colorless	
oil	(693	mg,	78%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	7.30	–	7.23	(m,	2H),	7.20	–	7.14	(m,	3H),	6.24	
(t,	J	=	7.5	Hz,	1H),	5.13	(t,	J	=	6.5	Hz,	1H),	2.73	–	2.57	(m,	2H),	2.38	–	2.31	(m,	2H),	2.09	–	1.93	(m,	
2H),	1.43	(s,	9H),	1.41	–	1.10	(m,	4H),	1.26	(s,	6H),	1.25	(s,	6H),	0.88	(t,	J	=	7.0	Hz,	3H);	13C{1H}	
NMR	 (125	MHz,	CDCl3)	δ	153.2,	147.0,	142.1,	128.6,	128.4,	125.8,	83.2,	81.4,	80.2,	36.9,	32.2,	
32.0,	 30.7,	 28.0,	 25.1,	 24.8,	 22.2,	 14.1	 (the	quaternary	 vinyl	 C	bearing	 the	boron	group	 is	 not	
observed);	 11B	 NMR	 (CDCl3,	 128	MHz)	 δ	 30.0;	 IR	 (neat)	 2982,	 2935,	 2873,	 1811,	 1773,	 1757,	
1459,	1396,	1372,	1308,	1263,	1213,	1120,	1071	cm-1;	HRMS	m/z	467.2939	[(M+Na)+;	calcd	for	
C26H41O5BNa:	467.2945].			
	
Suzuki-Miyaura	cross-coupling	of	2-B(pin)-substituted	Allylic	Benzoates	and	Carbonates		 	
Suzuki-Miyaura	 cross-coupling	 of	 2-B(pin)-substituted	 Allylic	 Acetates	 in	 Concentrated	
toluene/H2O	Conditions	
	(E)-6-Phenylundec-6-en-5-yl	 benzoate	 (2.9a).	The	product	was	prepared	by	
General	Procedure	J	in	a	0.074	mmol	scale.	With	2.7a	(29.6	mg,	0.074	mmol)	
and	 iodobenzene	 (24.8	 µL,	 0.22	 mmol)	 as	 the	 coupling	 partner,	 the	 title	
compound	 was	 isolated	 in	 96%	 yield	 (24.9	 mg).	 With	 2.7a	 (29.6	 mg,	 0.074	 mmol)	 and	
bromobenzene	 (23.2	µL,	0.22	mmol),	 the	product	was	 isolated	 in	38%	yield	 (9.9	mg).	 1H	NMR	
(500	MHz,	CDCl3)	δ	8.12	–	8.00	(m,	2H),	7.60	–	7.51	(m,	1H),	7.48	–	7.40	(m,	2H),	7.38	–	7.31	(m,	
2H),	7.31	–	7.26	(m,	1H),	7.24	–	7.19	(m,	2H),	5.80	(t,	J	=	7.5	Hz,	1H),	5.65	(t,	J	=	7.0	Hz,	1H),	1.96	
–	1.83	(m,	2H),	1.73	–	1.57	(m,	2H),	1.48	–	1.13	(m,	8H),	0.85	(t,	J	=	7.0	Hz,	3H),	0.78	(t,	J	=	7.3	Hz,	
n-Bun-Bu
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3H);	 13C	 {1H}	 NMR	 (125	MHz,	 CDCl3)	 δ	 165.8,	 139.5,	 138.1,	 132.7,	 131.0,	 130.8,	 129.5,	 129.4,	
128.3,	 127.9,	 126.8,	 78.9,	 33.0,	 31.7,	 28.1,	 27.6,	 22.3,	 22.1,	 13.9,	 13.8;	 IR	 (neat)	 2957,	 2931,	
2860,	1717,	1601,	1494,	1451,	1314,	1269,	1109,	1069,	1026	cm-1;	HRMS	m/z	351.2320	[(M+H)+;	
calcd	for	C24H31O2:	351.2324].			
	
	(E)-6-(4-(Trifluoromethyl)phenyl)undec-6-en-5-yl	 benzoate	 (2.9b).	 The	
product	was	 prepared	 by	 General	 Procedure	 I	 in	 a	 0.074	mmol	 scale.	With	
2.7a	 (29.6	mg,	0.074	mmol)	and	4-bromobenzotrifluoride	 (32.5	µL,	49.5	mg,	
0.22	mmol)	as	the	coupling	partner,	the	title	compound	was	isolated	in	76%	yield	(23.5	mg).	1H	
NMR	(500	MHz,	CDCl3)	δ	8.04	(dd,	J	=	8.4,	1.3	Hz,	2H),	7.62	(d,	J	=	7.9	Hz,	2H),	7.60	(tt,	J	=	7.4,	1,3	
Hz,	1H),	7.49-7.43	(m,	2H),	7.34	(d,	J	=	7.9	Hz,	2H),	5.87	(t,	J	=	7.5	Hz,	1H),	5.64	(dd,	J	=	7.5,	6.0	
Hz,	1H),	1.92	–	1.80	(m,	2H),	1.72	–	1.56	(m,	2H),	1.44	–	1.15	(m,	8H),	0.86	(t,	J	=	7.0	Hz,	3H),	0.79	
(t,	 J	 =	 7.3	Hz,	 3H);	 13C	 {1H}	NMR	 (125	MHz,	 CDCl3)	δ	 166.1,	 142.3,	 138.8,	 133.2,	 132.6,	 130.9,	
130.0,	129.8,	129.5	(q,	J	=	32.8	Hz),	128.7,	125.3	(q,	J	=	3.9	Hz),	124.5	(q,	J	=	272.0	Hz),	78.8,	33.4,	
31.9,	28.5,	28.0,	22.6,	22.4,	14.2,	14.1;	IR	(neat)	2959,	2932,	2861,	1721,	1616,	1603,	1585,	1491,	
1452,	1405,	1325,	1269,	1167,	1127,	1108,	1068,	1026	cm-1;	HRMS	m/z	417.2023	[(M–H)+;	calcd	
for	C25H28O2F3:	417.2041].	
	
	(E)-tert-Butyl	 (6-phenylundec-6-en-5-yl)	 carbonate	 (2.9c).	The	 product	was	
prepared	by	General	Procedure	J	in	a	0.074	mmol	scale.	With	2.8a	 (29.3	mg,	
0.074	mmol)	and	iodobenzene	(24.8	µL,	0.22	mmol)	as	the	coupling	partner,	
the	title	compound	was	isolated	in	91%	yield	(23.3	mg).	1H	NMR	(500	MHz,	CDCl3)	δ	7.36	–	7.29	
(m,	2H),	7.29	–	7.23	(m,	1H),	7.21	–	7.16	(m,	2H),	5.71	(t,	J	=	7.5	Hz,	1H),	5.12	(t,	J	=	6.5	Hz,	1H),	
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1.99	–	1.84	(m,	2H),	1.60	–	1.43	(m,	2H),	1.50	(s,	9H)	1.41	–	1.11	(m,	8H),	0.83	(t,	J	=	6.5	Hz,	3H),	
0.79	(t,	J	=	7.4	Hz,	3H);	13C	{1H}	NMR	(125	MHz,	CDCl3)	δ	153.1,	139.7,	138.1,	130.1,	129.3,	127.9,	
126.8,	81.5,	81.3,	38.0,	31.7,	28.0,	27.8,	27.6,	22.3,	22.0,	13.9,	13.8;	IR	(neat)	2958,	2932,	2861,	
1740,	1600,	1574,	1494,	1458,	1443,	1394,	1369,	1343,	1276,	1255,	1168,	1114,	1091,	1037	cm-
1;	HRMS	m/z	369.2408	[(M+Na)+;	calcd	for	C22H34O3Na:	369.2406].		
	
				(E)-tert-Butyl	 (6-(4-nitrophenyl)undec-6-en-5-yl)	 carbonate	 (2.9d).	 The	
product	was	 prepared	 by	General	 Procedure	 J	 in	 a	 0.074	mmol	 scale.	With	
2.8a	(29.3	mg,	0.074	mmol)	and	1-iodo-4-nitrobenzene	(54.8	mg,	0.22	mmol)	
as	the	coupling	partner,	the	title	compound	was	isolated	in	78%	yield	(22.6	mg).	With	2.7a	(29.3	
mg,	 0.074	mmol)	 and	1-bromo-4-nitrobenzene	 (44.4	mg,	 0.22	mmol)	 as	 the	 coupling	 partner,	
the	product	was	isolated	in	75%	yield	(21.7	mg).	1H	NMR	(500	MHz,	CDCl3)	δ	8.21	(d,	J	=	8.8	Hz,	
2H),	7.38	(d,	J	=	8.8	Hz,	2H),	5.85	(t,	J	=	7.6	Hz,	1H),	5.12	(dd,	J	=	7.8,	5.7	Hz,	1H),	1.97	–	1.84	(m,	
2H),	1.64	–	1.42	(m,	2H),	1.50	(s,	9H),	1.40	–	1.14	(m,	8H),	0.84	(t,	J	=	7.0	Hz,	3H),	0.80	(t,	J	=	7.2	
Hz,	3H);	13C	{1H}	NMR	(125	MHz,	CDCl3)	δ	153.30,	147.3,	145.6,	138.6,	132.8,	130.6,	123.6,	82.3,	
80.8,	33.5,	31.7,	28.4,	28.1,	27.9,	22.5,	22.3,	14.1,	14.0;	IR	(neat)	2957,	2931,	2857,	1740,	1598,	
1522,	 1464,	 1456,	 1346,	 1275,	 1255,	 1163,	 1111,	 1086	 cm-1;	 HRMS	m/z	 414.2268	 [(M+Na)+;	
calcd	for	C22H33NO5Na:	414.2256].		
	
	(E)-tert-Butyl	 (6-(4-(trifluoromethyl)phenyl)undec-6-en-5-yl)	 carbonate	
(2.9e).	 The	 product	was	 prepared	 by	 General	 Procedure	 J	 in	 a	 0.074	mmol	
scale.	With	 2.8a	 (29.3	mg,	 0.074	mmol)	 and	 4-bromobenzotrifluoride	 (32.5	
µL,	49.5	mg,	0.22	mmol)	as	the	coupling	partner,	the	title	compound	was	isolated	in	57%	yield	
n-Bun-Bu
OCO2t-Bu
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(17.5	mg).	1H	NMR	(300	MHz,	CDCl3)	δ	7.59	(d,	J	=	8.0	Hz,	2H),	7.31	(d,	J	=	8.0	Hz,	2H),	5.79	(t,	J	=	
7.5	Hz,	1H),	5.11	(dd,	J	=	7.5,	5.8	Hz,	1H),	1.99	–	1.80	(m,	2H),	1.60	–	1.45	(m,	2H),	1.49	(s,	9H),	
1.42	–	1.14	(m,	8H),	0.84	(t,	J	=	6.8	Hz,	3H),	0.79	(t,	J	=	7.1	Hz,	3H);	13C	{1H}	NMR	(75	MHz,	CDCl3)	
δ	153.3,	142.2,	139.0,	131.8,	130.0,	129.4	(q,	J	=	29.9	Hz),	125.3	(q,	J	=	3.8	Hz),	124.5	(q,	J	=	271.6	
Hz),	82.1,	81.1,	33.4,	31.8,	28.3,	28.0,	27.9,	22.6,	22.3,	14.2,	14.1;	 IR	 (neat)	2959,	2933,	2874,	
2861,	 1741,	 1617,	 1457,	 1369,	 1325,	 1276,	 1256,	 1166,	 1128,	 1067,	 1020,	 cm-1;	 HRMS	m/z	
437.2260	[(M+Na)+;	calcd	for	C23H33F3O3Na:	437.2279].		
	
	(E)-Ethyl	 (6-phenylundec-6-en-5-yl)	 carbonate	 (2.9f).	 The	 product	 was	
prepared	by	General	Procedure	 J	 in	a	0.10	mmol	scale.	With	2.8b	 (36.8	mg,	
0.10	mmol)	 and	 iodobenzene	 (24.8	µL,	0.30	mmol)	 as	 the	 coupling	partner,	
the	title	compound	was	isolated	in	83%	yield	(26.4	mg).	1H	NMR	(500	MHz,	CDCl3)	δ	7.40	–	7.30	
(m,	2H),	7.30	–	7.24	(m,	1H),	7.22	–	7.12	(m,	2H),	5.75	(t,	J	=	7.4	Hz,	1H),	5.20	(t,	J	=	6.5	Hz,	1H),	
4.21	(qd,	J	=	7.2,	2.5	Hz,	2H),	1.99	–	1.84	(m,	2H),	1.62	–	1.47	(m,	2H),	1.36	–	1.18	(m,	8H),	1.32	(t,	
J	=	7.2	Hz,	3H),	0.84	(t,	J	=	6.8	Hz,	3H),	0.80	(t,	J	=	7.2	Hz,	3H);	13C	{1H}	NMR	(125	MHz,	CDCl3)	δ	
155.0,	 139.6,	 138.1,	 131.2,	 129.5,	 128.3,	 127.2,	 82.5,	 63.9,	 33.3,	 32.0,	 28.4,	 27.8,	 22.6,	 22.4,	
14.6,	14.1,	14.0;	 IR	 (neat)	2958,	2932,	2873,	2861,	1744,	1495,	1466,	1443,	1371,	1260,	1107,	
1035,	1011	cm-1;	HRMS	m/z	341.2081	[(M+Na)+;	calcd	for	C20H30O3Na:	341.2093].		
	
Palladium-Catalyzed	Allene	Formation	of	2-B(pin)-substituted	Allylic	Derivatives	
General	 Procedure	 M:	 Allene	 Formation	 Reaction	 of	 2-B(pin)-substituted	 Allylic	 Acetates,	
Benzoates,	and	Carbonates	in	THF/H2O	Conditions.		
n-Bun-Bu
OCO2Et
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The	 synthesis	of	hepta-1,2-dien-1-ylbenzene	 (2.10a)	 is	 representative	of	General	Procedure	M	
and	is	outlined	below.	Reactions	are	typically	conducted	in	0.08–0.2	mmol	scale	with	0.5	mol	%	
of	 [Pd(allyl)Cl]2,	 1.5	 mol	 %	 of	 CyJohnPhos,	 and	 1	 equiv	 of	 Cs2CO3	 in	 THF/H2O	 condition.	
Concentration	of	the	reactions	are	typically	in	the	range	of	0.1	–	0.2	M.		
	
Preparation	of	Pd	/	CyJohnPhos	stock	solution	in	THF.	
To	an	oven-dried	microwave	vial	equipped	with	a	stir	bar	was	charged	with	[Pd(allyl)Cl]2	(3.7	mg,	
0.01	mmol)	and	CyJohnPhos	(10.5	mg,	0.03	mmol)	inside	a	glove	box	followed	by	20	mL	of	THF.	
The	vial	was	then	capped	with	a	septum.	The	vial	was	brought	out	of	the	glove	box	and	the	stock	
solution	was	stirred	at	rt	for	10	min	under	a	nitrogen	atmosphere	before	use.	
	
Hepta-1,2-dien-1-ylbenzene	 (2.10a).	 To	 an	 oven-dried	 microwave	 vial	
equipped	with	a	stir	bar	was	charged	the	allylic	acetate	2.1f	(38.8	mg,	0.10	
mmol),	 and	 the	 vial	 was	 capped	 and	 purged	 with	 N2.	 To	 the	 vial	 was	 added	 the	
palladium/phosphine	stock	solution	in	THF	(0.5	mL,	[Pd(allyl)Cl]2,	5	x	10-4	mmol	and	CyJohnPhos,	
1.5	x	10-3	mmol)	and	1	M	solution	of	Cs2CO3		in	H2O	(0.1	mL,	0.1	mmol).	The	reaction	mixture	was	
stirred	in	an	oil	bath	at	60	°C	until	TLC	showed	complete	consumption	of	the	2-B(pin)-substituted	
allylic	 acetate	2.1f.	 The	 reaction	mixture	was	 cooled	 to	 rt	 and	 diluted	with	 EtOAc	 (2	mL)	 and	
saturated	aqueous	NH4Cl	(2	mL).	The	organic	layer	was	separated	and	the	aqueous	solution	was	
extracted	with	EtOAc	(3	x	5	mL).	The	combined	organic	solution	was	washed	with	brine	(10	mL),	
dried	 over	MgSO4,	 and	 the	 solvent	was	 removed	 under	 reduced	 pressure.	 The	 crude	 product	
was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	 (hexanes)	 to	 afford	 allene	 as	 a	
colorless	oil	(15.8	mg,	92%	yield).	The	NMR	spectral	data	match	the	previously	published	data.42	
n-Bu•
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1-Chloro-4-(hepta-1,2-dien-1-yl)benzene	 (2.10b).	 The	 product	 was	
prepared	by	General	Procedure	M	using	2.1i	(39.3	mg,	0.01	mmol),	and	
the	 title	 compound	was	 isolated	 as	 a	 colorless	 oil	 in	 92%	 yield	 (19.0	mg).	 1H	NMR	 (500	MHz,	
CDCl3)	δ	7.25	(d,	J	=	8.5	Hz,	2H),	7.20	(d,	J	=	8.5	Hz,	2H),	6.07	(dt,	J	=	6.5,	3.0	Hz,	1H),	5.72	(td,	J	=	
6.8,	6.5	Hz,	1H),	2.13	(tdd,	J	=	7.4,	6.8,	3.0	Hz,	2H),	1.51	–	1.34	(m,	4H),	0.91	(t,	J	=	7.2	Hz,	3H);	13C	
{1H}	NMR	(125	MHz,	CDCl3)	δ	205.4,	134.0,	132.3,	128.9,	127.9,	95.7,	93.9,	31.5,	28.6,	22.5,	14.1;	
IR	(neat)	2959,	2928,	2872,	2858,	1951,	1491,	1092	cm-1;	HRMS	m/z	207.0938	[(M+H)+;	calcd	for	
C13H16Cl:	207.0941].	
	
1-(Hepta-1,2-dien-1-yl)-4-(trifluoromethyl)benzene	 (2.10c).	 The	
product	 was	 prepared	 by	 General	 Procedure	 M	 using	 2.1h	 (42.6	 mg,	
0.01	mmol).	The	title	compound	was	isolated	as	a	colorless	oil	 in	87%	yield	(20.9	mg).	1H	NMR	
(500	MHz,	CDCl3)	δ	7.53	(d,	J	=	8.5	Hz,	2H),	7.37	(d,	J	=	8.5	Hz,	2H),	6.14	(dt,	J	=	6.0,	3.0	Hz,	1H),	
5.63	(td,	J	=	7.0,	6.0	Hz,	1H),	2.15	(tdd,	J	=	7.3,	7.0,	3.0	Hz,	2H),	1.51	–	1.34	(m,	4H),	0.90	(t,	J	=	7.5	
Hz,	3H);	13C	{1H}	NMR	(125	MHz,	CDCl3)	δ	206.3,	139.4,	128.7	(q,	J	=	32.8	Hz),	126.9,	125.7	(q,	J	=	
not	 available),	 124.5	 (q,	 J	 =	272.0	Hz),	 95.9,	 94.0,	 31.4,	 28.4,	 22.4,	 14.1;	 IR	 (neat)	2960,	2931,	
2874,	2860,	1950,	1616,	1326,	1165,	1125,	1067,	1017	cm-1;	HRMS	m/z	240.1117	[M+;	calcd	for	
C14H15F3:	240.1126].	
	
1-(Hepta-1,2-dien-1-yl)-4-methylbenzene	 (2.10d).	 The	 product	 was	
prepared	by	General	Procedure	M	using	2.1k	(37.2	mg,	0.01	mmol).	The	
title	compound	was	isolated	as	a	colorless	oil	in	92%	yield	(17.1	mg).	1H	NMR	(500	MHz,	CDCl3)	δ	
n-Bu•
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7.18	(d,	J	=	7.5	Hz,	2H),	7.10	(d,	J	=	7.5	Hz,	2H),	6.09	(dt,	J	=	6.0,	3.0	Hz,	1H),	5.54	(td,	J	=	7.0,	6.0	
Hz,	1H),	2.32	(s,	3H),	2.13	(tdd,	J	=	7.3,	7.0,	3.0	Hz,	2H),	1.50	–	1.34	(m,	4H),	0.90	(t,	J	=	7.2	Hz,	
3H);	 13C	 {1H}	NMR	(125	MHz,	CDCl3)	δ	205.1,	136.5,	132.4,	129.5,	126.7,	95.2,	94.5,	31.5,	28.8,	
22.5,	 21.4,	 14.1;	 IR	 (neat)	 3021,	 2958,	 2926,	 2859,	 1947,	 1512,	 1465,	 1458	 cm-1;	 HRMS	m/z	
186.1409	[M+;	calcd	for	C14H18:	186.1409].	
	
	(E)-Nona-1,3,4-trien-1-ylbenzene	 (2.10e).	 The	 product	 was	 prepared	
by	 General	 Procedure	 M	 using	 2.1l	 (38.4	 mg,	 0.10	 mmol).	 The	 title	
compound	was	isolated	as	a	colorless	oil	 in	55%	yield	(10.9	mg).	The	NMR	spectral	data	match	
the	previously	published	data.43		
	
	Undeca-5,6-diene	 (2.10f).	 The	 product	 was	 prepared	 by	 General	
Procedure	M	using	2.7a	(40.0	mg,	0.10	mmol).	The	title	compound	was	isolated	as	a	colorless	oil	
in	53%	yield	 (8.1	mg).	With	2.8a	 (39.6	mg,	0.10	mmol),	 the	product	was	 isolated	 in	85%	yield	
(12.9	mg).	The	NMR	spectral	data	match	the	previously	published	data.44	
		
Nona-3,4-dien-1-ylbenzene	 (2.10g).	 The	 product	 was	 prepared	 by	
General	 Procedure	 M	 using	 2.7c	 (44.8	 mg,	 0.10	 mmol).	 The	 title	
compound	 was	 isolated	 as	 a	 colorless	 oil	 in	 79%	 yield	 (15.8	 mg).	 With	 2.8d	 (44.4	 mg,	 0.10	
mmol),	 the	 product	 was	 isolated	 in	 83%	 yield	 (16.6	 mg).	 The	 NMR	 spectral	 data	 match	 the	
previously	published	data.43b	
	
Palladium-Catalyzed	Allene	Formation	of	Enantioenriched	2.1f.	
n-Bu•
n-Bu•
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The	 allene	 formation	 reaction	 in	 Table	 10	 was	 performed	 by	 General	
procedure	M	using	enantioenriched	2.1f	 (60%	ee).	The	conversion	yield	was	determined	by	1H	
NMR	of	an	aliquot	of	an	unpurified	reaction	mixture	in	10,	20,	35,	35,	and	60	min.	Enantiomeric	
excess	of	allene	(S)-2.10a	was	determined	by	HPLC	with	a	Chiralcel	OD-H	column	(The	condition	
for	the	resolution	of	the	racemates	is	described.		(hexanes	100%,	flow	rate	=	0.25	mL/min,	tr	(1)	
=	23.2	min,	tr	(2)	=	26.2	min).	The	absolute	configuration	of	2.10a	was	assigned	with	previously	
published	data.42	
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CHAPTER	3	
Palladium-Catalyzed	Benzylic	C–H	Arylation	of	Azaarylmethylamine	
Adapted	 with	 permission	 from	 Org.	 Lett.	 2015,	 17,	 5788–5791	 Copyright	 2015	 American	
Chemical	Society.	
		
3.1. Introduction	
	 Pyridine	 and	 quinoline	 derivatives	 are	 important	 heterocycles	 that	 are	 present	 in	 a	
broad	range	of	biologically	active	natural	products	and	pharmaceutically	relevant	compounds.1		
Aryl(azaaryl)methylamines	are	prominent	in	biologically	active	small	molecules,	exhibiting	anti-
tumor,2	 anti-virus,3	 anti-HIV4	 and	 anti-histamine	 activities5	 (Figure	 3.1).	 	 Furthermore,	 recent	
statistical	studies	indicate	that	the	prominence	of	heteroaromatic	rings	in	marketed	oral	drugs	is	
increasing.6	
	
Figure	3.1.	Selected	pharmacologically	active	compounds	containing	aryl(azaaryl)methylamines.	
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	 Figure	 3.2.	 Representative	 synthetic	 intermediates	 with	 directing	 groups	 (A,B)	 and	
activating	groups	(C–F)	employed	in	metal-catalyzed	C–H	functionalization	adjacent	to	nitrogen.	
	
	
	 Conventional	approaches	to	the	synthesis	of	1,1-diarylmethylamine	derivatives7	include	
substitution	 reactions	 with	 amine	 nucleophiles,	 addition	 of	 aryl	 or	 azaaryl	 organometallic	
reagents	 to	 imines,	 and	 reduction	 of	 imines.8	 	 Despite	 the	 popularity	 of	 these	methods,	 they	
involve	 prefunctionalized	 electrophiles	 or	 nucleophiles.	 	 Transition	 metal-catalyzed	 cross-
coupling	reactions	also	represent	an	attractive	approach.7d	 	The	direct	C–H	functionalization	of	
amino	alkyl	moieties	(R’CH2NR2),	however,	is	challenging.9		Therefore,	activated	substrates,	such	
as	 Boc	 protected	 amines,	 ketimines	 and	 (η6-benzylamine)Cr(CO)3	 complexes	 have	 been	
employed	 to	 facilitate	 deprotonation	 of	 C–H	 bonds	 adjacent	 to	 nitrogen	 (Figure	 3.2).10	 	 The	
activating	 groups	 necessary	 in	 Figure	 3.2	 to	 increase	 reactivity	 are	 often	 subsequently	
transformed	into	the	desired	functional	groups	or	excised	from	the	product	entirely,	decreasing	
the	synthetic	efficiency.	
	 Considering	 the	 importance	 of	 aryl(azaaryl)methylamines,	 the	 development	 of	 in	 situ	
deprotonation/arylation	 strategies	 for	 their	 synthesis	 that	 do	 not	 employ	 activating	 groups	
would	 be	 valuable.	 	 Based	 on	 our	 experience	 in	 deprotonative	 cross-coupling	 reactions10c-f,15	
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with	 weakly	 acidic	 substrates,	 we	 hypothesized	 that	 the	 reversible	 deprotonation	 of	
(aminomethyl)-pyridines	in	the	presence	of	a	palladium	catalyst	should	be	possible.	
	 Herein,	 we	 report	 a	 practical	 method	 to	 prepare	 aryl(azaaryl)methylamines	 from	
(aminomethyl)-pyridines	and	aryl	halides	using	a	Pd-NIXANTPHOS-based	catalyst	(Scheme	3.1).		
This	 approach	 affords	 single-step	 access	 to	 aryl(azaaryl)methylamines	 from	 simple	 starting	
materials.	 	Notably,	 to	the	best	of	our	knowledge,	 the	direct	 functionalization	of	aminomethyl	
azaarenes	has	not	been	successfully	achieved	prior	to	this	work.	
	
Scheme	3.1.	Palladium-catalyzed	benzylic	C–H	arylation	with	azaarylmethylamines.	
	
	
3.2. Results	and	Discussion	
	 We	anticipated	 two	challenges	 to	advancing	a	 successful	deprotonative	cross-coupling	
process	(DCCP)	with	(aminomethyl)-pyridine	derivatives:	(1)	introduction	of	conditions	for	the	in	
situ	deprotonation	of	the	weakly	acidic	C–H’s	of	the	substrate	and	(2)	identification	of	a	catalyst	
capable	 of	 promoting	 coupling	 of	 the	 resulting	 organolithium,	 -sodium,	 or	 -potassium	
derivatives	with	aryl	halides.		In	the	latter	case,	we	have	found	that	palladium	complexes	of	van	
Leeuwen’s	 NIXANTPHOS	 ligand16	 outperform	 other	 Pd-phosphine	 complexes	 in	 this	 class	 of	
reactions.		As	such,	it	has	become	our	“go	to”	ligand	for	new	substrate	classes.	Concerning	the	
deprotonation	 step,	 the	 pKa	 of	 the	 sp3-hybridized	 C–H’s	 of	 2-(aminomethyl)-pyridines	 are	
unknown,	although	that	of	2-methylpyridine	has	been	determined	to	be	34	in	THF.17	 	The	high	
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pKa	 value	 of	 these	 substrates	 suggests	 that	 alkoxide	 and	 silylamide	 bases	 are	 good	 starting	
points.	 	 Additionally,	 palladium	 catalyzed	 benzylic	 arylations	 of	 pyridine	 derivatives	 have	
become	a	powerful	method	to	construct	aryl(azaaryl)methane	derivatives.11-14,18	
	
3.2.1. Optimization	of	Palladium-Catalyzed	Arylation	
	 We	initially	tested	the	reactions	of	2-(morpholinomethyl)-pyridine	(3.1a)	with	1-bromo-
4-tert-butylbenzene	using	Pd(OAc)2	(5	mol	%)	and	NIXANTPHOS	(7.5	mol	%)	in	THF	at	65	°C.		Six	
bases	 [LiOtBu,	NaOtBu,	KOtBu,	 LiN(SiMe3)2,	NaN(SiMe3)2	 and	KN(SiMe3)2]	were	employed,	and	
the	results	are	displayed	in	entries	1–6	of	Table	3.1.		
	 Although	MOtBu	bases	[M	=	Li,	Na,	K]	did	not	generate	the	desired	product	3.3a	(entries	
1–3),	MN(SiMe3)2	 bases	 [M	=	 Li,	Na,	 K]	were	 all	 very	 promising,	 affording	 80–87%	assay	 yield	
(AY)	of	the	cross-coupling	product	3.3a	 (entries	4–6).	 	The	most	promising	result	was	obtained	
with	LiN(SiMe3)2	(87%	AY	as	determined	by	1H	NMR,	entry	4).		We	next	screened	other	ethereal	
solvents	 [DME,	CPME,	1,4-dioxane]	 (entries	7–9).	 	Of	 these,	 1,4-dioxane	 led	 to	90%	AY	of	 the	
desired	product	(entry	9).		Examination	of	the	stoichiometry	indicated	use	of	a	1	:	1.2	:	2	ratio	of	
pyridylmethylamine	(3.1a)	:	1-bromo-4-tert-butylbenzene	(3.2a)	:	LiN(SiMe3)2		rendered	98%	AY	
of	3a,	 leading	to	92%	 isolated	yield	 (entry	11).	 	Use	of	a	stoichiometric	amount	of	1-bromo-4-
tert-butylbenzene	 (3.2a)	 or	 lower	 catalyst	 loading	 [2.5	 mol	 %	 Pd(OAc)2	 and	 3.75	 mol	 %	 of	
NIXANTPHOS]	 resulted	 in	 incomplete	 conversion	 at	 65	 °C	 after	 12	 h	 (entries	 12–13).	 	 The	
optimized	conditions	(entry	11,	Table	3.1)	were	then	used	to	define	the	substrate	scope.	
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Table	3.1.	Selected	optimization	of	Pd-catalyzed	C(sp3)-H	arylation	of	3.1a	with	3.2a.		
	
entry	 base	 3.1a:	3.2a:base	 solvent[a]	 yield	[%]	
1	 LiOtBu	 1:1.5:3	 THF	 –	
2	 NaOtBu	 1:1.5:3	 THF	 –	
3	 KOtBu	 1:1.5:3	 THF	 –	
4	 LiN(SiMe3)2	 1:1.5:3	 THF	 87	
5	 NaN(SiMe3)2	 1:1.5:3	 THF	 80	
6	 KN(SiMe3)2	 1:1.5:3	 THF	 83	
7	 LiN(SiMe3)2	 1:1.5:3	 DME	 82	
8	 LiN(SiMe3)2	 1:1.5:3	 CPME	 85	
9	 LiN(SiMe3)2	 1:1.5:3	 1,4-dioxane	 90	
10	 LiN(SiMe3)2	 1:1.5:2	 1,4-dioxane	 92	
11	 LiN(SiMe3)2	 1:1.2:2	 1,4-dioxane	 98	(92)[c]	
12	 LiN(SiMe3)2	 1:1:1.5	 1,4-dioxane	 73[d]	
13	 LiN(SiMe3)2	 1:1.2:2	 1,4-dioxane	 64[e]	
aTetrahydrofuran	 (THF),	 1,2-dimethoxyethane	 (DME),	 cyclopentyl	 methyl	 ether	 (CPME),	 1,4-
dioxane	(dioxane).	bYields	determined	by	1H	NMR	analysis	of	unpurified	reaction	mixtures	with	
internal	standard	CH2Br2.	cIsolated	yield.	d14%	of	3.1a	remained.	e2.5	mol	%	of	Pd(OAc)2	and	3.75	
mol	%	NIXANTPHOS.	
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3.2.2. Substrate	Scope	of	of	2-(Cyclic	Amino)	Methyl-Pyridines	
	 The	 scope	 of	 the	 arylation	was	 initially	 explored	with	 2-(cyclic	 amino)methylpyridines	
(3.1)	using	aryl	bromides	(Scheme	3.2).		Morpholine,	pyrrolidine,	and	N-methyl	piperazine	were	
coupled	 with	 aryl	 bromides	 bearing	 various	 substituents,	 generating	 aryl(2-
pyridyl)methylamines	 in	 good	 to	 excellent	 isolated	 yields	 (65–98%).	 	 The	 arylated	 products	
3.3b–d	were	obtained	 in	 78–83%	yield	with	bromobenzene	and	1-bromonaphthalene.	 	Under	
the	 same	 reaction	 conditions,	 chlorobenzene	 was	 also	 a	 suitable	 coupling	 partner,	 providing	
3.3b	 in	 78%	 yield.	 	 Aryl	 bromides	 bearing	 electron-donating	 4-NMe2	 and	 4-OMe	 resulted	 in	
coupling	products	3.3e–h	in	71–94%	yield.		Aryl	bromides	with	electron-withdrawing	4-F	and	3-
CF3	 groups	 were	 well	 tolerated	 and	 provided	 aryl(2-pyridyl)methylamines	 3.3i–k	 in	 71–84%	
yield.	 	 Heterocyclic	 3-bromopyridine	 was	 also	 a	 suitable	 coupling	 partner	 to	 generate	
dipyridylmethyl	morpholine	 3.3l	 in	 65%	 yield.	 	 The	 reactions	 with	 1	mol	 %	 catalyst	 generally	
occurred	 in	good	yields	 (71–75%	yield,	3.3d,	3.3g	and	3.3i).	 	To	 illustrate	 the	scalability	of	our	
method,	 we	 conducted	 coupling	 of	 2-(morpholinomethyl)-pyridine	 (3.1a,	 10	 mmol)	 with	 1-
bromo-4-fluorobenzene	using	4	mol	%	catalyst.		The	coupling	product	3.3m	was	isolated	in	96%	
yield	(2.61	g).		
	
3.2.3. Substrate	Scope	of	of	2-(Acyclic	Amino)	Methyl-Pyridines	
	 Next,	 we	 turned	 our	 attention	 to	 acyclic	 amines.	 	 The	 optimized	 arylation	 conditions	
employed	 with	 cyclic	 amines	 were	 easily	 transferable	 to	 N,N-dimethyl-	 or	 -diethylamine	
derivatives	 with	 a	 variety	 of	 aryl	 bromides.	 Thus,	 aryl	 bromides	 with	 neutral	 (4-tBu,	 3-Me),	
electron-donating	(4-OMe,	and	4-NMe2),	or	electron	withdrawing	(4-F,	4-Cl,	3-OMe,	and	3-CF3)		
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Scheme	 3.2.	 Pd-catalyzed	 C(sp3)-H	 arylation	 of	 2-pyridylmethylamines	 3.1	 with	 aryl	 bromides		
3.2.a	
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Scheme	 3.3.	 Benzylic	 cross-coupling	 of	 2-dialkylaminomethyl-pyridine	 3.1	 with	 aryl	 bromides	
3.2.a	
	
	
substituents	 coupled	with	2-(N,N-dimethylaminomethyl)-pyridine,	providing	 the	 cross-coupling	
products	3.4a–3.4o	in	60–98%	yield	(Scheme	3).		The	yields	with	N,N-dimethylamine	derivatives	
are	 slightly	 higher	 than	 those	with	 cyclic	 amines.	 	 Several	 relatively	 challenging	 substrates	 (1-
bromo-4-trifluoromethylbenzene	 and	 5-bromobenzofuran)	 were	 also	 competent	 coupling	
partners,	 albeit	 in	 reduced	 yields	 (3.4i–3.4j,	 60–66%	 yield).	 	 While	 1-bromonaphthalene	
furnished	 coupling	 product	 3.4k	 in	 69%	 yield,	 the	 sterically	 more	 hindered	 2-bromotoluene	
failed	 to	 provide	 the	 desired	 product	 (<2%	 yield).	 2-(3-Bromophenyl)-1,3-dioxolane	 generated	
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acetal-protected	aldehyde	product	3.4l	in	60%	yield.		When	the	same	conditions	were	applied	to	
2-(N,N-diethylaminomethyl)-pyridine,	the	desired	products	3.4m–3.4o	were	isolated	in	66–69%	
yield.		Sterically	more	hindered	2-(N-benzyl-N-methylaminomethyl)-pyridine	did	not	react	(<2%	
yield).	 	 Similar	 results	 were	 observed	 in	 related	 reactions	 by	 Baudoin	 and	 our	 groups	 with	
bulkier	substituents	on	nitrogen.15o,19	
	
Scheme	3.4.	Benzylic	cross-coupling	of	azaarene	derivatives.a	
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3.5id, 52%
OMe N
N
3.5jd,e, 65%
Me
O
N
N R
O
3.5a, R = p-Me, 91%
3.5b, R = H,  92% (X = Cl, 85%)
3.5c, R = p-tBu, 85%
N
N R
Me
N 3.5d, R = p-tBu, 81%
3.5e, R = p-OMe, 74% (88%)
3.5f, R = p-F, 55% (88%)
NMe2
N R
3.5g, R = H,  63%
3.5h, R = p-tBu, 68%
aIsolated yields. bX = Br unless noted. c1 mol % of Pd(OAc)2 and 1.5 mol % of NIXANTPHOS and 
the yields in parentheses with 5 mol % of Pd(OAc)2 and 7.5 mol % of NIXANTPHOS. d 5 mol % of 
Pd(OAc)2 and 10 mol % of NIXANTPHOS. eThe reaction was conducted in THF at 110 °C with 
KN(SiMe3)2 instead of LiN(SiMe3)2.
Azaaryl
NR2
Azaaryl
NR2
Ar
Pd(OAc)2/NIXANTPHOSc
LiN(SiMe3)2 (2 equiv)
1,4-dioxane (0.2 M), 65 °C, 12 h
+ Ar-X
b
(1.2 equiv)
141	
pyridylmethylamines	are	not	reported,	4-methylpyridine	has	a	pKa	of	32.2	in	THF.17		As	shown	in	
Scheme	 3.4,	 4-pyridylmethylamine	 derivatives	 were	 excellent	 substrates,	 providing	 coupling	
products	in	52–92%	yield	(3.5a–3.5h)	with	1	mol	%	catalyst	loading.		These	results	indicate	that	
chelation	of	 the	base	 to	 the	2-pyridyl	 group	 is	not	necessary	 for	 the	 reversible	deprotonation	
step	of	this	DCCP.			
	 Additional	heterocycles	were	also	amenable	to	the	DCCP.		Under	the	conditions	used	for	
2-pyridylamines,	a	2-aminomethyl-quinoline	derivative	underwent	the	direct	arylation	reaction	
in	52%	yield	(3.5i).		The	least	acidic	substrate	tested	in	this	study	was	the	3-pyridylmethylamine	
derivative.		The	pKa	of	3-methylpyridine	is	37.7	in	THF.17		After	extensive	optimization	of	bases,	
solvents,	 and	 temperature	 we	 were	 able	 to	 achieve	 coupling	 in	 the	 presence	 of	 2	 equiv	 of	
KN(SiMe3)2	in	THF	at	110	°C,	resulting	in	arylation	product	3.5j	in	65%	yield.	
	
3.3. Conclusions	
	 In	summary,	we	report	the	first	direct	palladium	catalyzed	benzylic	C(sp3)–H	arylation	of	
cyclic	 and	 acyclic	 aminomethyl	 substituted	 azaarenes	 with	 aryl	 bromides.	 	 A	 variety	 of	
aryl(azaaryl)methylamines	 were	 prepared	 in	 good	 to	 excellent	 yields	 from	 readily	 accessible	
tertiary	aminomethyl	azaarenes.		It	is	noteworthy	that	addition	and	removal	of	directing	groups	
was	 not	 necessary	 with	 these	 substrates,	 facilitating	 their	 streamlined	 synthesis.	 	 This	 new	
method	enables	the	rapid	preparation	of	drug-like	molecules	using	straightforward	techniques	
that	are	ideal	for	applications	in	medicinal	chemistry.16			
	
3.4. Experimental	Section	
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General	Methods.	 	All	 reactions	were	 conducted	 under	 an	 inert	 atmosphere	 of	 dry	 nitrogen.		
Anhydrous	 1,4-dioxane	 and	 cyclopentyl	 methyl	 ether	 (CPME)	 were	 purchased	 from	 Sigma-
Aldrich	 and	 used	 without	 further	 purification.	 	 Dimethoxyethane	 (DME)	 and	 tetrahydrofuran	
(THF)	 were	 dried	 through	 activated	 alumina	 columns	 under	 nitrogen.	 	 Other	 solvents	 were	
commercially	 available	 and	 used	 as	 received	without	 further	 purification.	 	 Bases	 [LiN(SiMe3)2,	
NaN(SiMe3)2,	KN(SiMe3)2,		LiOtBu,	NaOtBu,	KOtBu]	were	purchased	from	Sigma-Aldrich	and	used	
without	 further	 purification.	 	 Chemicals	 were	 purchased	 from	 Sigma-Aldrich,	 Acros,	 Fisher	
Scientific	 or	 Matrix	 Scientific,	 and	 solvents	 were	 obtained	 from	 Fisher	 Scientific.	 	 Thin-layer	
chromatography	was	performed	on	Whatman	precoated	silica	gel	60	F-254	plates	and	visualized	
by	ultraviolet	light.		Flash	chromatography	was	performed	with	silica	gel	(Silicaflash,	P60,	40-63	
μm,	 Silicycle).	 	 NMR	 spectra	 were	 obtained	 using	 a	 Brüker	 500	MHz	 Fourier-transform	 NMR	
spectrometer	at	the	University	of	Pennsylvania	NMR	facility.		1H	and	13C	chemical	shifts	in	parts	
per	million	(δ)	were	referenced	to	internal	tetramethylsilane	(TMS).		The	infrared	spectra	were	
obtained	 with	 KBr	 plates	 using	 a	 Perkin-Elmer	 Spectrum	 1600	 Series	 spectrometer.	 	 High-
resolution	 mass	 spectrometry	 (HRMS)	 data	 were	 obtained	 on	 a	 Waters	 LC-TOF	 mass	
spectrometer	 (model	 LCT-XE	Premier)	 using	 chemical	 ionization	 (CI)	 or	 electrospray	 ionization	
(ESI)	in	positive	or	negative	mode,	depending	on	the	analyte.		Melting	points	were	determined	
on	 a	 Unimelt	 Thomas-Hoover	 melting	 point	 apparatus	 and	 are	 uncorrected.	 	 2-
(Chloromethyl)pyridine	hydrochloride	 (98%)	 and	4-(chloromethyl)pyridine	hydrochloride	 (98%)	
were	purchased	from	CHEM-IMPEX	INT’L	INC.	and	used	as	received.		
	
Preparation	of	Azaarylmethylamines.	
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General	 Procedure	 A:	 In	 a	 50	 mL	 two-necked	 flask	 was	 added	 the	 2-(chloromethyl)pyridine	
hydrochloride	(3.28	g,	20	mmol),	sodium	iodide	(300	mg,	2.0	mmol),	K2CO3	(13.8	g,	100	mmol)	in	
50	mL	of	CH3CN.		The	heterogeneous	solution	was	stirred	for	5	min	at	room	temperature.	To	the	
reaction	mixture	was	added	dropwise	amine	(50	mmol),	and	the	resulting	solution	was	stirred	at	
room	 temperature	 for	 12	 h	 until	 TLC	 showed	 complete	 consumption	 of	 2-
(chloromethyl)pyridine.		The	reaction	mixture	was	filtered	over	a	pad	of	Celite,	and	the	pad	was	
rinsed	with	additional	ethyl	acetate	(30	mL),	and	then	the	solution	was	concentrated	 in	vacuo.		
The	crude	product	was	further	purified	by	flash	column	chromatography	on	silica	gel.	
	
	4-(Pyridin-2-ylmethyl)morpholine	 (3.1a).	 The	 product	 was	 prepared	 by	 General	
Procedure	 A	 using	 2-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	 mmol),	
sodium	iodide	(300	mg,	2.0	mmol),	K2CO3	(13.8	g,	100	mmol)	and	morpholine		(4.2	
mL,	50.0	mmol).		The	crude	product	was	purified	by	flash	column	chromatography	on	silica	gel	
(only	EtOAc)	to	afford	the	product	as	a	brown	oil	(3.21	g,	90%	yield).	1H	NMR	(500	MHz,	CDCl3):	
δ	8.56	(ddd,	J	=	4.9,	2.0,	1.0,	1H),	7.64	(td,	J	=	7.6,	1.8	Hz,	1H),	7.39	(app	d,	J	=	7.8	Hz,	1H),	7.17	–	
7.14	(m,	1H),	3.73	(t,	J	=	4.7	Hz,	4H),	3.65	(s,	2H),	2.50	(t,	J	=	4.7	Hz,	4H)	ppm;	13C{1H}	NMR	(125	
MHz,	CDCl3)	δ	158.3,	149.4,	136.5,	123.4,	122.2,	67.1,	65.1,	53.9	ppm;	IR	(thin	film):	3036,	2958,	
2855,	 2812,	 1674,	 1590,	 1571,	 1475,	 1455,	 1434,	 1351,	 1333,	 1303,	 1286,	 1263,	 1207,	 1116,	
1070,	1035,	1048,	1010	cm-1;	HRMS	m/z	179.1189	[(M+H)+;	calcd	for	C10H15N2O:	179.1184].	The	
NMR	spectral	data	match	the	previously	published	data.20	
	
2-(Pyrrolidin-1-ylmethyl)pyridine	 (3.1b).	 The	 product	 was	 prepared	 by	 General	
Procedure	 A	 using	 2-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	 mmol),	
N
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sodium	 iodide	 (300	mg,	2.0	mmol),	K2CO3	 (13.8	g,	100.0	mmol)	and	pyrrolidine	 	 (4.1	mL,	50.0	
mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	
(hexanes:EtOAc	=	50:50)	to	give	the	product	as	an	orange	oil	(1.81	g,	56%	yield).	1H	NMR	(500	
MHz,	CDCl3):	δ	8.56	(ddd,	J	=	5.0,	2.0,	1.0,	1H),	7.64	(td,	J	=	7.8,	2.0	Hz,	1H),	7.39	(app	d,	J	=	8.0	
Hz,	1H),	7.14	(ddd,	J	=	7.8,	5.0,	1.0	Hz,	1H),	3.78	(s,	2H),	2.56	(t,	J	=	4.7	Hz,	4H),	1.81	(t,	J	=	4.7	Hz,	
4H)	 ppm;	 13C{1H}	NMR	 (125	MHz,	 CDCl3)	δ	 159.5,	 149.1,	 136.3,	 122.9,	 121.8,	 62.3,	 54.3,	 23.6	
ppm;	IR	(thin	film):	2974,	1609,	1588,	1433,	1337,	1104,	699	cm-1;	HRMS	m/z	163.1230	[(M+H)+;	
calcd	for	C10H15N2:	163.1235].	The	NMR	spectral	data	match	the	previously	published	data.21	
	
1-Methyl-4-(pyridin-2-ylmethyl)piperazine	 (3.1c).	 The	 product	 was	 prepared	 by	
General	 Procedure	 A	 using	 2-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	
mmol),	 sodium	 iodide	 (600	 mg,	 4.0	 mmol),	 potassium	 carbonate	 (13.8	 g,	 100.0	
mmol)	 and	 1-methylpiperazine	 	 (5.5	 mL,	 50.0	 mmol).	 The	 crude	 product	 was	
purified	by	flash	column	chromatography	on	silica	gel	(EtOAc)	to	give	the	product	as	a	yellow	oil	
(2.98	g,	78%	yield).	1H	NMR	(500	MHz,	CDCl3):	δ	8.56	(ddd,	J	=	5.0,	2.0,	1.0,	1H),	7.64	(td,	J	=	8.0,	
2.0	Hz,	1H),	7.39	(app	d,	J	=	8.0	Hz,	1H),	7.15	(ddd,	J	=	7.5,	5.0,	1.0	Hz,	1H),	3.67	(s,	2H),	2.90	–	
2.20	 (m,	 8H),	 2.29	 (s,	 3H)	 ppm;	 13C{1H}	 NMR	 (125	MHz,	 CDCl3)	 δ	 158.6,	 149.3,	 136.3,	 123.2,	
122.0,	64.6,	55.1,	53.3,	46.1	ppm;	IR	(thin	film):	2944,	2810,	1656,	1595,	1571,	1459,	1437,	1353,	
1286,	 1163,	 1150,	 1136,	 1051,	 1009	 cm-1;	 HRMS	 m/z	 192.1484	 [(M+H)+;	 calcd	 for	 C11H18N3:	
192.1501]	(only	choice).		The	NMR	spectral	data	match	the	previously	published	data.22	
	
N,N-Dimethyl-1-(pyridin-2-yl)methanamine	 (3.1d).	The	product	was	prepared	by	
General	 Procedure	 A	 using	 2-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	
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mmol),	 sodium	 iodide	 (300	 mg,	 2.0	 mmol),	 K2CO3	 (13.8	 g,	 100.0	 mmol)	 and	 dimethylamine	
solution	5.6	M	in	ethanol	(8.9	mL,	50.0	mmol).	The	crude	product	was	purified	by	flash	column	
chromatography	on	silica	gel	(hexanes:EtOAc	=	30:70)	to	give	the	product	as	a	yellow	oil	(1.63	g,	
60%	yield).	1H	NMR	(500	MHz,	CDCl3):	δ	8.56	(ddd,	J	=	5.0,	2.0,	1.0,	1H),	7.64	(td,	J	=	8.0,	2.0	Hz,	
1H),	7.39	(app	d,	J	=	8.0	Hz,	1H),	7.16	(ddd,	J	=	7.5,	5.0,	1.0	Hz,	1H),	3.59	(s,	2H),	2.30	(s,	6H)	ppm;	
13C{1H}	NMR	(125	MHz,	CDCl3)	δ	159.4,	149.4,	136.5,	123.2,	122.1,	66.0,	45.8	ppm;	IR	(thin	film):	
3067,	 2975,	 2945,	 2860,	 2822,	 2776,	 1591,	 1570,	 1474,	 1456,	 1436,	 1361,	 1258,	 1173,	 1152,	
1097,	1040	cm-1;	HRMS	m/z	137.1078	[(M+H)+;	calcd	for	C8H13N2:	137.1079].	The	NMR	spectral	
data	match	the	previously	published	data.23	
	
N-Ethyl-N-(pyridin-2-ylmethyl)ethanamine	 (3.1e).	 The	 product	 was	 prepared	 by	
General	 Procedure	 A	 using	 2-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	
mmol),	 sodium	 iodide	 (599.6	mg,	 4.0	mmol),	 potassium	 carbonate	 (13.8	 g,	 100.0	mmol)	 and	
diethylamine	 	 (3.66	 g,	 5.2	 mL,	 50.0	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	(hexanes:EtOAc	=	50:50)	to	give	the	product	as	an	orange	oil	(2.89	
g,	88%	yield).	1H	NMR	(500	MHz,	CDCl3):	δ	8.53	(ddd,	J	=	5.0,	2.0,	1.0	Hz,	1H),	7.63	(td,	J	=	8.0,	2.0	
Hz,	1H),	7.47	(app	d,	J	=	8.0	Hz,	1H),	7.12	(ddd,	J	=	7.5,	5.0,	1.0	Hz,	1H),	3.72	(s,	2H),	2.58	(q,	J	=	
7.2	Hz,	4H),	1.05	 (t,	 J	=	7.2	Hz,	6H)	ppm;	 13C{1H}	NMR	(125	MHz,	CDCl3)	δ	160.9,	149.1,	136.3,	
122.0,	 121.7,	 59.8,	 47.5,	 12.0	 ppm;	 The	 NMR	 spectral	 data	 match	 the	 previously	 published	
data.24	
	
N-Benzyl-N-methyl-1-(pyridin-2-yl)methanamine	 	 (3.1f).	 The	 product	 was	
prepared	 by	 General	 Procedure	 A	 using	 2-(chloromethyl)pyridine	 hydrochloride	
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(3.28	 g,	 20.0	 mmol),	 sodium	 iodide	 (300	 mg,	 2.0	 mmol),	 K2CO3	 (13.8	 g,	 100.0	 mmol)	 and	
benzylmethylamine	(6.06	g,	6.5	mL,	50.0	mmol).	The	crude	product	was	purified	by	flash	column	
chromatography	on	silica	gel	(hexanes:EtOAc	=	50:50)	to	give	the	product	as	a	yellow	oil	(3.27	g,	
77%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.54	(dt,	J	=	4.8,	0.8	Hz,	1H),	7.65	(td,	J	=	7.7,	1.8	Hz,	1H),	
7.51	(d,	J	=	7.9	Hz,	1H),	7.37	(d,	J	=	7.0	Hz,	2H),	7.32	(t,	J	=	7.5	Hz,	2H),	7.26	–	7.23	(m,	1H),	7.15	–	
7.13	(m,	1H),	3.70	(s,	2H),	3.59	(s,	2H),	2.25	(s,	3H);	 13C	NMR	(125	MHz,	CDCl3)	δ	160.0,	149.2,	
139.3,	 136.6,	 129.1,	 128.4,	 127.2,	 123.1,	 122.1,	 63.7,	 62.3,	 42.7;	 IR	 (neat)	 3061,	 3028,	 2978,	
2944,	 2924,	 2838,	 2790,	 1590,	 1570,	 1495,	 1474,	 1454,	 1433,	 1364,	 1244	 cm-1;	 HRMS	 m/z	
213.1389	[(M+H)+;	calcd	for	C14H18N2:	213.1392].	 	The	NMR	spectral	data	match	the	previously	
published	data.25	
	
	4-(Pyridin-4-ylmethyl)morpholine	 (3.1g).	 	 The	 product	 was	 prepared	 by	 General	
Procedure	 A	 using	 4-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	 mmol),	
sodium	iodide	(599.6	mg,	4.0	mmol),	potassium	carbonate	(13.8	g,	100.0	mmol)	and	
morpholine	 	 (4.3	 mL,	 50.0	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	(EtOAc)	to	afford	the	product	as	a	brown	oil	(3.28	g,	92%	yield).	1H	
NMR	(500	MHz,	CDCl3):	δ	8.54	(app	d,	J	=	4.5	Hz,	2H),	7.28	(app	d,	J	=	4.5	Hz,	2H),	3.72	(t,	J	=	4.6	
Hz,	4H),	3.50	(s,	2H),	2.45	(t,	J	=	4.5	Hz,	4H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	149.9,	147.3,	
123.9,	67.0,	62.0,	53.8	ppm;	HRMS	m/z	179.1183	[(M+H)+;	calcd	for	C10H15N2O:	179.1184].		The	
NMR	spectral	data	match	the	previously	published	data.20	
	
1-Methyl-4-(pyridin-4-ylmethyl)piperazine	 (3.1h).	 The	 product	 was	 prepared	 by	
General	 Procedure	 A	 using	 4-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	
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mmol),	sodium	iodide	(599.6	mg,	4.0	mmol),	potassium	carbonate	(13.8	g,	100.0	mmol)	and	1-
methylpiperazine	 	 (5.0	g,	5.5	mL,	50.0	mmol).	The	crude	product	was	purified	by	flash	column	
chromatography	on	silica	gel	(only	EtOAc)	to	give	the	product	as	a	yellow	oil	(3.06	g,	80%	yield).	
1H	NMR	(500	MHz,	CDCl3)	δ	8.54	(dd,	J	=	4.4,	1.6	Hz,	2H),	7.27	–	7.26	(m,	2H),	3.50	(s,	2H),	2.53	–	
2.42	(m,	8H),	2.29	(s,	3H);	13C	NMR	(125	MHz,	CDCl3)	δ	149.8,	147.7,	123.8,	61.7,	55.1,	53.2,	46.1;	
IR	(neat)	2942,	2884,	2808,	1604,	1562,	1458,	1418,	1372,	1356,	1323,	1294,	1284,	1223	cm-1;	
HRMS	m/z	192.1501	[(M+H)+;	calcd	for	C11H18N3:	192.1501].	
	
N,N-Dimethyl-1-(pyridin-4-yl)methanamine	 (3.1i).	 The	product	was	prepared	by	
General	 Procedure	 A	 using	 4-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	
mmol),	 sodium	 iodide	 (300	 mg,	 2.0	 mmol),	 K2CO3	 (13.8	 g,	 100.0	 mmol)	 and	
dimethylamine	solution	5.6	M	in	ethanol	(8.9	mL,	50.0	mmol).	The	crude	product	was	purified	
by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	30:70)	to	give	the	product	as	a	
yellow	oil	(1.83	g,	67%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.52	(d,	J	=	5.0	Hz,	2H),	7.22	(d,	J	=	5.0	
Hz,	2H),	3.39	(s,	2H),	2.22	(s,	6H);	 13C	NMR	(125	MHz,	CDCl3)	δ	150.0,	148.3,	124.0,	63.3,	45.7.	
The	1H	NMR	spectral	data	match	the	previously	published	data.23	
	
N,N-Dimethyl-1-(quinolin-2-yl)methanamines	 (3.1j).	 The	 product	 was	
prepared	 by	 General	 Procedure	 A	 using	 2-(chloromethyl)quinoline	
hydrochloride	 (0.64	 g,	 3.0	 mmol),	 sodium	 iodide	 (89.9	 mg,	 0.6	 mmol),	 potassium	 carbonate	
(2.10	 g,	 15.0	mmol)	 and	 dimethylamine	 solution	 5.6	M	 in	 ethanol	 	 (1.34	mL,	 7.5	mmol).	 The	
crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	
50:50)	to	give	the	product	as	a	yellow	oil	 (0.47	g,	84%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.11	
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(dd,	J	=	13.4,	8.5	Hz,	2H),	7.78	(dd,	J	=	8.1,	0.8	Hz,	1H),	7.69	(ddd,	J	=	8.4,	7.0,	1.4	Hz,	1H),	7.58	(d,	
J	=	8.5	Hz,	1H),	7.50	(ddd,	J	=	8.4,	7.0,	1.4	Hz,	1H),	3.77	(s,	2H),	2.34	(s,	6H);	13C	NMR	(125	MHz,	
CDCl3)	δ	160.2,	147.9,	136.6,	129.5,	129.3,	127.7,	127.6,	126.3,	121.3,	66.8,	46.0;	IR	(neat)	3060,	
2974,	 2943,	 2858,	 2820,	 2772,	 1615,	 1601,	 1561,	 1504,	 1455,	 1425,	 1376,	 1362,	 1311,	 1259,	
1225	cm-1;	HRMS	m/z	187.1236	[(M+H)+;	calcd		for	C12H15N2:	187.1235.	
	
	4-(Pyridin-3-ylmethyl)morpholine	 (3.1k).	 	 The	 product	 was	 prepared	 by	 General	
Procedure	 A	 using	 3-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	 mmol),	
sodium	iodide	(599.6	mg,	4.0	mmol),	potassium	carbonate	(13.8	g,	100.0	mmol)	and	
morpholine	 	 (4.3	 mL,	 50.0	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	 (EtOAc)	 to	afford	 the	product	as	a	brown	oil	 (3.03	g,	85%	yield).	
The	NMR	spectral	data	match	the	previously	published	data.26	
	
Palladium-Catalyzed	C(sp3)-H	Arylation	of	Azaarylmethylamines	
Preparation	of	Pd(OAc)2/NIXANTPHOS	Stock	Solution.		An	oven-dried	20	mL	vial	with	a	stir	bar	
under	 a	 nitrogen	 atmosphere	 was	 charged	 with	 Pd(OAc)2	 (22.5	 mg,	 0.1	 mmol),	 NIXANTPHOS	
(82.7	mg,	0.15	mmol)	and	1,4-dioxane	(10	mL)	(1	mL	of	the	stock	solution	was	used	for	0.2	mmol	
scale).		The	solution	was	stirred	for	5	mins	before	use.	
	
General	Procedure	B:	An	oven-dried	10	mL	reaction	vial	was	equipped	with	a	stir	bar	in	a	glove	
box	 under	 a	 nitrogen	 atmosphere.	 1	 mL	 of	 Pd(OAc)2/NIXANTPHOS	 stock	 solution	 (5	 mol	 %	
Pd(OAc)2/	 7.5	mol	 %	 NIXANTPHOS)	 was	 taken	 up	 by	 syringe,	 and	 added	 to	 the	 reaction	 vial.		
LiHMDS	(66.9	mg,	0.4	mmol,	2	equiv)	was	added	to	the	vial.		The	vial	was	capped,	removed	from	
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the	glove	box,	and	the	solution	was	stirred	for	5	minutes.		The	azaarylmethylamine	(0.2	mmol)	
and	aryl	halide	(0.24	mmol)	were	added	to	the	solution.	 	Note	that	aryl	bromide	 in	solid	 form	
was	added	to	the	reaction	vial	prior	to	LiN(SiMe3)2.		The	reaction	mixture	was	heated	to	65	°C	in	
an	 oil	 bath,	 and	 stirred	 for	 12	 hours	 until	 TLC	 showed	 complete	 consumption	 of	
azaarylmethylamines.	 	The	sealed	vial	was	cooled	to	room	temperature,	and	3	drops	of	water	
were	added.	The	reaction	mixture	was	diluted	with	diethyl	ether	(3	mL)	or	ethyl	acetate	(3	mL)	
and	filtered	over	a	short	pad	of	Celite.		The	pad	was	rinsed	with	additional	diethyl	ether	(5	mL)	
or	ethyl	acetate	 (5	mL),	and	the	solution	was	concentrated	 in	vacuo	 to	yield	a	brown	oil.	 	The	
crude	material	was	loaded	onto	a	silica	gel	column	and	purified	by	flash	chromatography.		
	
		4-((4-(tert-Butyl)phenyl)(pyridin-2-yl)methyl)morpholine	 (3.3a).	 The	
product	 was	 prepared	 by	 General	 Procedure	 B	 using	 4-(pyridin-2-
ylmethyl)morpholine	 3.1a	 (35.6	 mg,	 0.2	 mmol)	 and	 1-bromo-4-tert-
butylbenzene	(51.2	mg,	41.6	µL,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.		The	
crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	
50:50)	to	give	the	product	as	a	yellow	oil	(57.1	mg,	92%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.50	
(ddd,	J	=	5.0,	2.0,	1.0	Hz,	1H),	7.63	–	7.55	(m,	2H),	7.39	(d,	J	=	8.4	Hz,	2H),	7.28	(d,	J	=	8.4	Hz,	2H),	
7.07	(ddd,	J	=	6.9,	5.1,	1.7	Hz,	1H),	4.38	(s,	1H),	3.72	(t,	J	=	4.7	Hz,	4H),	2.50	–	2.28	(m,	4H),	1.25	
(s,	9H)	ppm;	13C	NMR	(125	MHz,	CDCl3)	δ	162.0,	150.3,	149.2,	137.4,	136.8,	128.0,	125.6,	122.3,	
122.1,	 78.1,	 67.2,	 52.7,	 34.5,	 31.4	 ppm;	 IR	 (neat)	 3052,	 3006,	 2960,	 2905,	 2854,	 2811,	 2762,	
1716,	 1589,	 1570,	 1508,	 1469,	 1344,	 1395,	 1364,	 1280,	 1204,	 1118,	 1012	 cm-1;	 HRMS	 m/z	
225.1525	[(M-C4H7NO)+;	calcd	for	C16H19N:	225.1517].		
Alternation:	53.4	mg,	86%	yield	with	Pd(OAc)2	(1	mol	%),	NIXANTPHOS	(1.5	mol	%)		
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		4-(Phenyl(pyridin-2-yl)methyl)morpholine	 (3.3b).	 The	 product	 was	 prepared	
by	General	Procedure	B	using	4-(pyridin-2-ylmethyl)morpholine	 3.1a	 (35.6	mg,	
0.2	 mmol)	 and	 bromobenzene	 (37.7	 mg,	 25.4	 µL,	 0.24	 mmol)	 with	 5	 mol%	
Pd(OAc)2/	 7.5	 mol%	 NIXANTPHOS.	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	(hexanes:EtOAc	=	50:50)	to	give	the	product	as	a	yellow	solid	(41.2	
mg,	81%	yield	with	bromobenzene),	m.p.=	72	–	74	ºC.	1H	NMR	(500	MHz,	CDCl3)	δ	8.51	(ddd,	J	=	
5.0,	2.0,	1.0	Hz,	1H),	7.62	(tt,	J	=	7.5,	1.5	Hz,	1	H),	7.56	(dd,	J	=	7.5,	1.0	Hz,	1H),	7.50		(d.	J	=	7.5	Hz,	
2H),	7.31	–	7.25	(m,	2H),	 	7.23	–	7.17		(m,	1H),	7.09	(ddt,	J	=	7.0,	5.0,	1.0	Hz,	1H),	4.41	(s,	1H),	
3.73	(t,	J	=	4.5	Hz,	4H),	2.60	–	2.25	(m,	4H)	ppm;	13C	NMR	(125	MHz,	CDCl3)	δ	161.9,	149.5,	140.8,	
136.9,	128.8,	128.6,	127.6,	122.4,	122.3,	78.6,	67.2,	52.9	ppm;	IR	(neat)	3061,	2958,	2851,	2811,	
2762,	1587,	1570,	1493,	1470,	1451,	1432,	1395,	1279,	1246,	1117,	1070,	1012	cm-1;	HRMS	m/z	
255.1498	[(M+H)+;	calcd	for	C16H19N2O:	255.1497].		
Alternation:	39.7	mg,	78%	yield	with	chlorobenzene	(27.0	mg,	24.3	µL,	0.24	mmol)			
	
4-(Naphthalen-1-yl(pyridin-2-yl)methyl)morpholine	 (3.3c).	 The	 product	was	
prepared	 by	 General	 Procedure	 B	 using	 4-(pyridin-2-ylmethyl)morpholine	
3.1a	 (35.6	mg,	 0.2	mmol)	 and	1-bromonaphthalene	 (49.7	mg,	 33.6	µL,	 0.24	
mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.		The	crude	product	was	purified	by	flash	
column	chromatography	on	silica	gel	(hexanes:EtOAc	=	50:50)	to	afford	the	product	as	a	yellow	
solid	(48.7	mg,	80%	yield),	m.p.=	98	–	100	ºC.	1H	NMR	(300	MHz,	CDCl3)	δ	8.57	(d,	J	=	8.7	Hz,	1H),	
8.51	(ddd,	J	=	4.8,	1.5,	1.2	Hz,	1H),		8.01	(dd,	J	=	7.2,	0.9	Hz,	1H),	7.81	(ddd,	J	=	7.8,	1.5,	0.9	Hz,	
1H),	7.74	(d,	J	=	8.1	Hz,	1H),	7.58	–	7.39	(m,	5H),	7.10	–	7.00	(m,	1H)	5.29	(s,	1H),	3.86	–	3.60	(m,	
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4H),	 	 2.70	–	2.50	 (m,	2H),	 2.50	–	2.30	 (m,	2H)	ppm;	 13C	NMR	 (75	MHz,	CDCl3)	δ	 161.4,	 149.2,	
136.8,	 136.7,	 134.2,	 132.1,	 128.9,	 128.1,	 126.2,	 125.8,	 125.7,	 125.6,	 124.2,	 123.2	 122.2,	 73.9,	
67.4,	 53.1	ppm;	 IR	 (neat)	3050,	2958,	2853,	2811,	1588,	1570,	1511,	1452,	1432,	1396,	1310,	
1275,	1117	cm-1;	HRMS	m/z	305.1648	[(M+H)+;	calcd	for	C20H21N2O:	305.1654].		
	
	2-(Phenyl	 (pyrrolidin-1-yl)methyl)pyridine	 (3.3d).	 The	 product	 was	 prepared	
by	 General	 Procedure	 using	 2-(pyrrolidin-1-ylmethyl)pyridine	 3.1b	 (32.5	 mg,	
0.20	 mmol)	 and	 bromobenzene	 (37.7	 mg,	 25.3	 µL,	 0.24	 mmol)	 with	 5	 mol%	
Pd(OAc)2/	 7.5	 mol%	 NIXANTPHOS.	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	(hexanes:EtOAc	=	50:50)	to	give	the	product	as	a	yellow	solid	(39.6	
mg,	83%	yield),	m.p.=	76	–	78	ºC.	1H	NMR	(500	MHz,	CDCl3)	δ	8.49	(dt,	J	=	4.8,	1.2	Hz,	1H),	7.61	–	
7.53	(m,	4H),	7.29	–	7.25	(m,	2H),	7.20	–	7.17	(m,	1H),	7.07	(ddd,	J	=	6.9,	5.1,	1.5	Hz,	1H),	4.37	(s,	
1H),	2.48	–	2.43	(m,	4H),	1.80	–	1.77	(m,	4H);	13C	NMR	(125	MHz,	CDCl3)	δ	163.3,	149.2,	142.9,	
136.8,	128.6,	128.1,	127.3,	122.2,	122.1,	78.3,	53.6,	23.7.	IR	(neat)	3060,	3028,	3006,	2967,	2933,	
2875,	 2792,	 1588,	 1570,	 1492,	 1468,	 1453,	 1432,	 1332,	 1320,	 1195,	 1128	 cm-1;	 HRMS	 m/z	
239.1547	[(M+H)+;	calcd	for	C16H19N2:	239.1548].	
Alternation:	35.8	mg,	75%	yield	with	Pd(OAc)2	(1	mol	%),	NIXANTPHOS	(1.5	mol	%).	
	
	4-((4-Methoxyphenyl)(pyridin-2-yl)methyl)morpholine	 (3.3e).	 The	
product	 was	 prepared	 by	 General	 Procedure	 B	 using	 4-(pyridin-2-
ylmethyl)morpholine	 3.1a	 (35.6	mg,	0.2	mmol)	and	4-bromoanisole	(44.9	
mg,	30.1	µL,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	
purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	 50:50)	 to	 give	 the	
N
N
O
OMe
N
N
152	
product	as	a	yellow	oil	(46.1	mg,	81%	yield).	1H	NMR	(300	MHz,	CDCl3)	δ	8.51	(ddd,	J	=	4.8,	1.8,	
0.9	Hz,	1H),	7.62	(td,	J	=	7.8,	1.8	Hz,	1H),	7.54	(d,	J	=	7.8	Hz,	1H),	7.39	(app	d,	J	=	9.0	Hz,	2H),	7.09	
(ddd,	J	=	7.2,	4.8,	1.5	Hz,	1H),	6.82	(d,	J	=	9.0	Hz,	2H),	4.36	(s,	1H),	3.75	(s,	3H),	3.72	(t,	J	=	4.8	Hz,	
4H),	2.54	–	2.30	 (m,	4H);	 13C	NMR	 (75	MHz,	CDCl3)	δ	 162.3,	159.1,	149.5,	136.9,	132.9,	129.6,	
122.3,	122.2,	114.2,	77.9,	67.3,	55.4,	52.8	ppm;	 IR	 (neat)	3050,	3004,	2910,	2957,	2851,	2810,	
1610,	1588,	1510,	1468,	1432,	1289,	1250,	1174,	1117,	1034,	1010	cm-1;	HRMS	m/z	285.1599	
[(M+H)+;	calcd	for	C17H21N2O2:	285.1603].	
	
1-((4-Methoxyphenyl)(pyridin-2-yl)methyl)-4-methylpiperazine	 (3.3f).	
The	 product	 was	 prepared	 by	 General	 Procedure	 B	 using	 1-methyl-4-
(pyridin-2-ylmethyl)piperazine	 3.1c	 (38.3	 mg,	 0.20	 mmol)	 and	 4-
bromoanisole	(44.9	mg,	30.1	µL,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	
crude	product	was	purified	by	flash	column	chromatography	on	silica	gel	(CH2Cl2:CH3OH	=	90:10)	
to	give	the	product	as	a	yellow	oil	(55.9	mg,	94%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.50	(ddd,	J	
=	4.8,	1.8,	0.9	Hz,	1H),	7.61	(td,	J	=	7.7,	1.8	Hz,	1H),	7.51	(d,	J	=	8.0	Hz,	1H),	7.40	–	7.37	(m,	2H),	
7.08	(ddd,	J	=	7.4,	4.9,	1.1	Hz,	1H),	6.83	–	6.80	(m,	2H),	4.37	(s,	1H),	3.75	(s,	3H),	2.54	(m,	8H),	
2.33	 (s,	3H)	ppm;	13C	NMR	(125	MHz,	CDCl3)	δ	162.4,	159.0,	149.4,	136.8,	133.8,	129.5,	122.4,	
122.3,	 122.1,	 114.1,	 77.2,	 55.3,	 55.1,	 51.6,	 45.7	ppm;	 IR	 (neat)	3036,	2936,	2804,	1609,	1588,	
1569,	1510,	1461,	1433,	1291,	1248,	1175,	1143,	1033,	1008	cm-1;	HRMS	m/z	298.1921	[(M+H)+;	
calcd	for	C18H24N3O:	298.1919].	
	
2-((4-Methoxyphenyl)(pyrrolidin-1-yl)methyl)pyridine	(3.3g).	The	product	
was	 prepared	 by	 General	 Procedure	 B	 using	 2-(pyrrolidin-1-
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ylmethyl)pyridine	3.1b	(32.5	mg,	0.20	mmol)	and	4-bromoanisole	(44.9	mg,	30.1	µL,	0.24	mmol)	
with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	flash	column	
chromatography	on	silica	gel	 (hexanes:EtOAc	=	50:50)	to	give	the	product	as	a	yellow	oil	 (43.5	
mg,	81%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.49	(d,	J	=	4.5	Hz,	1H),	7.60	(t,	J	=	7.6	Hz,	1H),	7.54	
(d,	J	=	7.9	Hz,	1H),	7.44	(d,	J	=	8.6	Hz,	2H),	7.06	(t,	J	=	6.0	Hz,	1H),	6.81	(d,	J	=	8.6	Hz,	2H),	4.31	(s,	
1H),	3.75	(s,	3H),	2.44		(m,	4H),	1.78		(m,	4H);	13C	NMR	(125	MHz,	CDCl3)	δ	163.5,	158.8,	149.2,	
136.7,	135.1,	129.1,	122.0,	113.9,	77.5,	55.3,	53.6,	23.7;	IR	(neat)	3060,	3003,	2965,	2933,	2875,	
2834,	2798,	1609,	1588,	1569,	1510,	1468,	1433,	1329,	1302,	1247,	1174,	1129,	1105,	1035	cm-
1;	HRMS	m/z	269.1658	[(M+H)+;	calcd	for	C17H21N2O:	269.1654].	
Alternation:	38.1	mg,	71%	yield	with	Pd(OAc)2	(1	mol	%),	NXANTPHOS	(1.5	mol	%).	
	
N,N-Dimethyl-4-(morpholino(pyridin-2-yl)methyl)aniline	 (3.3h).	 The	
product	 was	 prepared	 by	 General	 Procedure	 B	 using	 4-(pyridin-2-
ylmethyl)morpholine	 3.1a	 (35.6	 mg,	 0.2	 mmol)	 and	 4-bromo-N,N-
dimethylaniline	(48.0	mg,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.		The	crude	
product	was	purified	by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	50:50)	to	
give	the	product	as	a	yellow	solid	(46.4	mg,	78%	yield),	m.p.=	101	–	103	ºC.	1H	NMR	(500	MHz,	
CDCl3)	δ	8.50	(ddd,	J	=	4.8,	1.8,	0.9	Hz,	1H),	7.65	–	7.51	(m,	2H),		7.37	(app	d,	J	=	9.0	Hz,	2H),	7.06	
(ddd,	J	=	6.9,	4.8,	1.5	Hz,	1H),	6.65	(app	d,	J	=	9.0	Hz,	2H),	4.30	(s,	1H),	3.72	(t,	J	=	4.8	Hz,	4H),	
2.89		(s,	6H),	2.51	–	2.30	(m,	4H)	ppm;	13C	NMR	(125	MHz,	CDCl3)	δ	162.7,	150.1,	149.4,	136.8,	
129.3,	128.4,	122.2,	122.0,	112.7,	78.0,	67.3,	52.9,	40.7	ppm;	IR	(neat)	2955,	2923,	2852,	2807,	
1613,	1589,	1569,	1521,	1470,	1451,	1432,	1350,	1281,	1165,	1118,	1069,	1014	cm-1;	HRMS	m/z	
298.1913	[(M+H)+;	calcd	for	C18H24N3O:	298.1919].		
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2-((4-Fluorophenyl)(pyrrolidin-1-yl)methyl)pyridine	 (3.3i).	 The	 product	was	
prepared	 by	 General	 Procedure	 B	 using	 2-(pyrrolidin-1-ylmethyl)pyridine	
3.1b	(32.5	mg,	0.20	mmol)	and	1-bromo-4-fluorobenzene	(42.0	mg,	26.4	µL,	
0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	
flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	 50:50)	 to	 give	 the	 product	 as	 a	
yellow	oil	(44.6	mg,	87%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.50	(d,	J	=	4.8	Hz,	1H),	7.61	(tt,	J	=	
7.6,	1.6	Hz,	1H),	7.54	–	7.49	(m,	3H),	7.10	–	7.07	(m,	1H),	6.96	(t,	J	=	8.5	Hz,	2H),	4.36	(s,	1H),	2.44	
(m,	4H),	1.78	 (m,	4H)	ppm;	 13C	NMR	 (125	MHz,	CDCl3)	δ	 163.0,	162.1	 (d,	 J	 =	243.8	Hz),	149.2,	
138.6	(d,	J	=	3.8	Hz),	136.8,	129.5	(d,	J	=	8.8	Hz),	122.2,	122.0,	115.3	(d,	J	=	21.2	Hz),	77.3,	53.5,	
23.7	ppm;	 IR	 (neat)	3051,	3007,	2967,	2876,	2798,	1603,	1589,	1570,	1506,	1469,	1433,	1417,	
1362,	1324,	1293,	1220,	1155,	1128,	1093,	1049,	1015	cm-1;	HRMS	m/z	257.1450	[(M+H)+;	calcd	
for	C16H18FN2:	257.1454].		
Alternation:	36.4	mg,	71%	yield	with	Pd(OAc)2	(1	mol	%),	NXANTPHOS	(1.5	mol	%).	
	
	1-((4-Fluorophenyl)(pyridin-2-yl)methyl)-4-methylpiperazine	 (3.3j).	 The	
product	was	 prepared	 by	General	 Procedure	B	 using	 1-methyl-4-(pyridin-2-
ylmethyl)piperazine	 3.1c	 (38.3	 mg,	 0.20	 mmol)	 and	 1-bromo-4-
fluorobenzene	 (42.0	mg,	 26.4	µL,	 0.24	mmol)	with	 5	mol%	Pd(OAc)2/	 7.5	mol%	NIXANTPHOS.	
The	crude	product	was	purified	by	 flash	column	chromatography	on	silica	gel	 (CH2Cl2:CH3OH	=	
90:10)	to	give	the	product	as	a	yellow	oil	(53.6	mg,	94%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.51	
(ddd,	J	=	5.0,	2.0,	1.0,	Hz,	1H),	7.62	(td,	J	=	7.8,	1.7	Hz,	1H),	7.50	(d,	J	=	7.8	Hz,	1H),	7.45	(dd,	J	=	
9.0,	5.5	Hz,	2H),	7.10	(ddd,	J	=	7.0,	5.0,	1.0	Hz,	1H),	6.96	(t,	J	=	9.0	Hz,	2H),	4.41	(s,	1H),	2.85	–	
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2.15	 (m,	 8H),	 2.33	 (s,	 3H);	 13C	NMR	 (125	MHz,	 CDCl3)	δ	 162.2	 (d,	 J	 =	 244.8	Hz),	 161.7,	 149.6,	
136.9,	136.8	(d,	J	=	3.2	Hz),	129.9	(d,	J	=	8.1	Hz),	122.4,	122.3,	115.5	(d,	J	=	21.0	Hz),	77.0,	55.1,	
51.5,	 45.7	ppm;	 IR	 (neat)	3067,	2961,	2941,	2807,	1603,	1591,	1571,	1507,	1471,	1459,	1434,	
1292,	 1221,	 1158,	 1145,	 1095,	 1050,	 1008	 cm-1;	 HRMS	 m/z	 286.1721	 [(M+H)+;	 calcd	 for	
C17H21FN3:	286.1720].	
	
4-(Pyridin-2-yl(3-(trifluoromethyl)phenyl)methyl)morpholine	 (3.3k)	
.	The	product	was	prepared	by	General	Procedure	B	using	4-(pyridin-2-
ylmethyl)morpholine	 3.1a	 (35.6	 mg,	 0.2	 mmol)	 and	 3-
bromobenzotrifluoride	 (54.0	 mg,	 33.5	 μL,	 0.24	 mmol)	 with	 5	 mol%	 Pd(OAc)2/	 7.5	 mol%	
NIXANTPHOS.	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	
(hexanes:EtOAc	=	50:50)	to	give	the	product	as	a	yellow	oil	(54.2	mg,	84%	yield).	1H	NMR	(300	
MHz,	CDCl3)	δ	8.54	(ddd,	J	=	5.0,	2.0,	1.0,	Hz,	1H),	7.78	(s,	1H),	7.72	(d,	J	=	7.5	Hz,	1H),	7.65	(td,	J	
=	7.5,	1.5	Hz,	1H),	7.53	(d,	J	=	8.0	Hz,	1H),	7.47	(d,	J	=	7.5	Hz,	1H),	7.41	(t,	J	=	7.8	Hz,	1H),	7.13	
(ddd,	J	=	7.5,	5.0,	1.0	Hz,	1H),	4.50	(s,	1H),	3.75	(t,	J	=	4.8	Hz,	4H),	2.50	–	2.34	(m,	4H);	13C	NMR	
(125	MHz,	CDCl3)	δ	160.9,	149.7,	141.9,	137.1,	132.0,	131.1	(q,	J	=	32.0	Hz),	129.2,	125.2	(q,	J	=	
3.8	Hz),	 124.5	 (q,	 J	 =	 3.8	Hz),	 124.2	 (q,	 J	 =	 270.7	Hz),	 122.6,	 122.5,	 78.0,	 67.1,	 52.7;	 IR	 (neat)	
3054,	 2959,	 2854,	 2813,	 2769,	 1588,	 1571,	 1470,	 1449,	 1433,	 1327,	 1277,	 1166,	 1118,	 1073,	
1014	cm-1;	HRMS	m/z	323.1358	[(M+H)+;	calcd	for	C17H18N2OF3:	323.1371].	
	
4-	 (Pyridin-2-yl(pyridin-3-yl)methyl)morpholine	 (3.3l).	 The	 product	 was	
prepared	by	General	Procedure	B	using	4-(pyridin-2-ylmethyl)morpholine	3.1a	
(35.6	mg,	0.20	mmol)	and	3-bromopyridine	(37.9	mg,	23.1	µL,	0.24	mmol)	with	
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5	 mol%	 Pd(OAc)2/	 7.5	 mol%	 NIXANTPHOS.	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	 on	 silica	 gel	 hexanes:EtOAc	 =	 60:40	 to	 only	 EtOAc)	 to	 give	 the	 product	 as	 a	
yellow	oil	(33.2	mg,	65%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.72	(d,	J	=	2.0	Hz,	1H),	8.55	–	8.54	
(m,	1H),	8.47	(dd,	J	=	4.8,	1.5	Hz,	1H),	7.86	(dt,	J	=	7.9,	1.9	Hz,	1H),	7.66	(td,	J	=	7.7,	1.7	Hz,	1H),	
7.53	(d,	J	=	7.9	Hz,	1H),	7.23	(dd,	J	=	7.9,	4.7	Hz,	1H),	7.16	–	7.13	(m,	1H),	4.47	(s,	1H)	3.74	(t,	J	=	
4.7	Hz,	4H),	2.46	–	2.38	(m,	4H);	13C	NMR	(125	MHz,	CDCl3)	δ	160.6,	150.1,	149.8,	149.1,	137.1,	
136.3,	136.2,	123.8,	122.7,	122.6,	76.0,	67.1,	52.7;	IR	(neat)	3053,	2958,	2916,	2854,	2813,	1589,	
1571,	 1472,	 1453,	 1433,	 1396,	 1305,	 1286,	 1273,	 1251,	 1211,	 1117,	 1070,	 1029,	 1012	 cm-1;	
HRMS	m/z	256.1456	[(M+H)+;	calcd	for	C15H18N3O:	256.1450].	
	
4-((4-Fluorophenyl)(pyridin-2-yl)methyl)morpholine	 (3.3m).	 The	 product	
was	prepared	by	General	Procedure	using	4-(pyridin-2-ylmethyl)morpholine	
3.1a	 (1.78	 g,	 10	mmol)	 and	 1-bromo-4-fluorobenzene	 (2.10	 g,	 1.32	mL,	 12	
mmol)	with	4	mol%	Pd(OAc)2/	6	mol%	NIXANTPHOS.	 	The	crude	product	was	purified	by	 flash	
column	chromatography	on	silica	gel	hexanes:EtOAc	=	60:40)	to	give	the	product	as	a	brown	oil	
(2.61	g,	96%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.50	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	7.61	(td,	J	=	
7.5,	2.0	Hz,	1H),	7.51	(d,	J	=	8.0	Hz,	1H),	7.45	(dd,	J	=	9.0,	5.5	Hz,	2H),	7.09	(ddd,	J	=	8.0,	5.0,	1.0	
Hz,	1H),	6.96	(t,	J	=	9.0	Hz,	2H),	4.39	(s,	1H),	3.71	(t,	J	=	4.8	Hz,	4H),	2.50	–	2.28	(m,	4H);	13C	NMR	
(125	MHz,	CDCl3)	δ	162.2	(d,	J	=	244.5	Hz),	161.6,	149.6,	136.9,	136.5	(d,	J	=	3.4	Hz),	130.0	(d,	J	=	
8.0	Hz),	122.35,	122.31,	115.6,	 (d,	 J	=	21.1	Hz),	77.7,	67.2,	52.7;	HRMS	m/z	273.1398	 [(M+H)+;	
calcd	for	C16H18N2OF:	273.1403].	
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1-(4-(tert-Butyl)phenyl)-N,N-dimethyl-1-(pyridin-2-yl)methanamine	
(3.4a).	 	 The	 product	 was	 prepared	 by	 General	 Procedure	 B	 using	 N,	 N-
dimethyl-1-(pyridin-2-yl)methanamine	 3.1d	 (27.2	 mg,	 0.20	 mmol)	 and	 1-bromo-4-tert-
butylbenzene	(51.2	mg,	41.6	µL,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	
crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	
50:50)	to	give	the	product	as	a	yellow	solid	(51.0	mg,	95%	yield),	m.p.=	102	–	104	ºC.	1H	NMR	
(500	MHz,	CDCl3)	δ	8.51	(dt,	J	=	4.9,	0.9	Hz,	1H),	7.58	(td,	J	=	7.6,	1.7	Hz,	1H),	7.52	(d,	J	=	11.9	Hz,	
1H),	7.42	(d,	J	=	8.4	Hz,	2H),	7.29	(d,	J	=	8.4	Hz,	2H),	7.06	(ddd,	J	=	7.1,	4.9,	1.2	Hz,	1H),	4.23	(s,	
1H),	 2.21	 (s,	 6H),	 1.26	 (s,	 9H);	 13C	NMR	 (125	MHz,	 CDCl3)	δ	 163.1,	 150.2,	 149.3,	 138.9,	 136.7,	
127.9,	125.5,	122.3,	120.0,	79.5,	44.9,	34.6,	31.5;	IR	(neat)	2953,	2862,	2816,	2770,	1586,	1568,	
1507,	1467,	1435,	1363,	1254,	1180,	1154,	1118,	1030	cm-1;	HRMS	m/z	269.2018	[(M+H)+;	calcd	
for	C18H25N2:	269.2018].	
	
N,	 N-Dimethyl-1-(pyridin-2-yl)-1-(m-tolyl)methanamine	 (3.4b).	 The	
product	 was	 prepared	 by	 General	 Procedure	 B	 using	 N,	 N-dimethyl-1-
(pyridin-2-yl)methanamine	3.1d	 (27.2	mg,	0.20	mmol)	 and	3-bromotoluene	 (41.1	mg,	29.1	µL,	
0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	
flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	 50:50)	 to	 give	 the	 product	 as	 a	
yellow	solid	(44.4	mg,	98%	yield),	m.p.=	88	–	90	ºC.	1H	NMR	(500	MHz,	CDCl3)	δ	8.51	(d,	J	=	4.8	
Hz,	1H),	7.59	(td,	J	=	7.7,	1.5	Hz,	1H),	7.53	(d,	J	=	7.9	Hz,	1H),	7.33	(s,	1H),	7.30	(d,	J	=	7.8	Hz,	1H),	
7.16	(t,	J	=	7.6	Hz,	1H),	7.07	–	7.05	(m,	1H),	7.00	(d,	J	=	7.4	Hz,	1H),	4.21	(s,	1H),	2.30	(s,	3H),	2.21	
(s,	6H);	13C	NMR	(125	MHz,	CDCl3)	δ	162.9,	149.3,	142.0,	138.2,	136.7,	129.0,	128.5,	128.2,	125.3,	
122.2,	122.0,	79.8,	44.8,	21.6;	IR	(neat)	2982,	2949,	2863,	2819,	2773,	1607,	1587,	1568,	1467,	
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1431,	1330,	1255,	1180,	1153,	1095,	1028	cm-1;	HRMS	m/z	227.1545	[(M+H)+;	calcd	for	C15H18N2:	
227.1548].	
	
1-(3-Methoxyphenyl)-N,	N-dimethyl-1-(pyridin-2-yl)methanamine	 (3.4c).	
The	product	was	prepared	by	General	Procedure	B	using	N,	N-dimethyl-1-
(pyridin-2-yl)methanamine	3.1d	 (27.2	mg,	 0.20	mmol)	 and	 3-bromoanisole	 (44.9	mg,	 30.4	µL,	
0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	
flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	 50:50)	 to	 give	 the	 product	 as	 a	
yellow	oil	(41.2	mg,	85%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.53	–	8.51	(m,	1H),	7.60	(dt,	J	=	7.7,	
1.7	Hz,	1H),	7.52	(d,	J	=	8.0	Hz,	1H),	7.19	(t,	J	=	7.7	Hz,	1H),	7.10	–	7.08	(m,	3H),	6.75	–	6.73	(m,	
1H),	 4.22	 (s,	 1H),	 3.78	 (s,	 3H),	 2.22	 (s,	 6H);	 13C	 NMR	 (125	MHz,	 CDCl3)	δ	 162.7,	 159.9,	 149.3,	
143.7,	 136.8,	 129.6,	 122.3,	 122.1,	 120.7,	 113.6,	 113.2,	 79.7,	 55.4,	 44.8;	 IR	 (neat)	 3053,	 2987,	
2952,	 2859,	 2821,	 2775,	 1587,	 1569,	 1488,	 1470,	 1455,	 1434,	 1319,	 1282,	 1257,	 1181,	 1147,	
1094,	1043	cm-1;	HRMS	m/z	243.1492	[(M+H)+;	calcd	for	C15H19N2O:	243.1497].	
	
1-(4-Methoxyphenyl)-N,	N-dimethyl-1-(pyridin-2-yl)methanamine	 (3.4d).	
The	product	was	prepared	by	General	Procedure	B	using	N,	N-dimethyl-1-
(pyridin-2-yl)methanamine	3.1d	 (27.2	mg,	 0.20	mmol)	 and	 4-bromoanisole	 (44.9	mg,	 30.1	µL,	
0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	
flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	 50:50)	 to	 give	 the	 product	 as	 a	
yellow	oil	(45.1	mg,	93%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.51	(d,	J	=	4.8	Hz,	1H),	7.60	(t,	J	=	7.7	
Hz,	1H),	7.52	(d,	J	=	7.4	Hz,	1H),	7.41	(d,	J	=	8.5	Hz,	2H),	7.08	–	7.06	(m,	1H),	6.82	(d,	J	=	8.5	Hz,	
2H),	 4.30	 (s,	 1H),	 3.74	 (s,	 3H),	 2.21	 (s,	 6H);	 13C	 NMR	 (125	MHz,	 CDCl3)	δ	 163.0,	 158.9,	 149.3,	
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136.8,	134.0,	129.4,	122.1,	122.0,	114.0,	78.8,	55.3,	44.7.	IR	(neat)	3051,	2988,	2951,	2863,	2818,	
2773,	1610,	1588,	1569,	1508,	1466,	1433,	1302,	1284,	1248,	1179,	1153,	1109,	1094,	1037	cm-
1;	HRMS	m/z	243.1492	[(M+H)+;	calcd	for	C15H19N2O:	243.1497].	
	
4-((Dimethylamino)(pyridin-2-yl)methyl)-N,	 N-dimethylaniline	 (3.4e).	
The	product	was	prepared	by	General	Procedure	B	using	N,	N-dimethyl-1-
(pyridin-2-yl)methanamine	3.1d	 (27.2	mg,	0.20	mmol)	and	4-bromo-N,	N-dimethylaniline	 (48.0	
mg,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	
by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	50:50)	to	give	the	product	as	a	
yellow	solid	(47.0	mg,	92%	yield),	m.p.=	72	–	74	ºC.	1H	NMR	(500	MHz,	CDCl3)	δ	8.50	(dt,	J	=	4.9,	
0.8	Hz,	1H),	7.58	(td,	J	=	7.6,	1.1	Hz,	1H),	7.51	(dd,	J	=	7.9,	0.8	Hz,	1H),	7.34	(d,	J	=	8.5	Hz,	2H),	
7.06	–	7.04	(m,	1H),	6.65	(d,	J	=	8.5	Hz,	2H),	4.15	(s,	1H),	2.89	(s,	6H),	2.21	(s,	6H);	13C	NMR	(125	
MHz,	CDCl3)	δ	163.6,	150.0,	149.3,	136.7,	130.0,	129.1,	122.0,	121.8,	112.7,	79.2,	44.9,	40.7;	IR	
(neat)	 3047,	 2985,	 2948,	 2861,	 2815,	 2772,	 1613,	 1589,	 1568,	 1521,	 1470,	 1433,	 1348,	 1227,	
1185,	1163,	1025	cm-1;	HRMS	m/z	254.1669	(only	peak)	[(M–H)+;	calcd	for	C16H20N3:	254.1657].		
	
	1-(4-Fluorophenyl)-N,	 N-dimethyl-1-(pyridin-2-yl)methanamine	 (3.4f).	
The	product	was	prepared	by	General	Procedure	B	using	N,	N-dimethyl-1-
(pyridin-2-yl)methanamine	3.1d	 (27.2	mg,	0.20	mmol)	and	1-bromo-4-fluorobenzene	(42.0	mg,	
26.4	 µL,	 0.24	mmol)	 with	 5	 mol%	 Pd(OAc)2/	 7.5	 mol%	 NIXANTPHOS.	 The	 crude	 product	 was	
purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	 50:50)	 to	 give	 the	
product	as	a	yellow	oil	(42.4	mg,	92%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.52	(dt,	J	=	4.8,	0.9	Hz,	
1H),	7.61	(td,	J	=	7.7,	1.7	Hz,	1H),	7.50	–	7.46	(m,	3H),	7.11	–	7.09	(m,	1H),	6.97	(t,	J	=	8.6	Hz,	2H),	
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4.24	(s,	1H),	2.20	(s,	6H);	13C	NMR	(125	MHz,	CDCl3)	δ	162.6,	162.2	(d,	J	=	244.0	Hz),	149.5,	137.8	
(d,	J	=	3.4	Hz),	136.8,	129.8	(d,	J	=	7.8	Hz),	122.20,	122.17,	115.5	(d,	J	=	21.1	Hz),	78.8,	44.7;	IR	
(neat)	 3052,	 2982,	 2952,	 2867,	 2821,	 2776,	 1602,	 1589,	 1570,	 1507,	 1471,	 1433,	 1325,	 1293,	
1221,	 1179,	 1156,	 1097,	 1041,	 1027	 cm-1;	 HRMS	m/z	 231.1301	 [(M+H)+;	 calcd	 for	 C14H16FN2:	
231.1298].	
	
1-(4-Chlorophenyl)-N,	N-dimethyl-1-(pyridin-2-yl)methanamine	 (3.4g).	The	
product	 was	 prepared	 by	 General	 Procedure	 B	 using	 N,	 N-dimethyl-1-
(pyridin-2-yl)methanamine	3.1d	(27.2	mg,	0.20	mmol)	and	1-bromo-4-chlorobenzene	(46.0	mg,	
0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	
flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	 50:50)	 to	 give	 the	 product	 as	 a	
yellow	oil	(47.4	mg,	96%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.52	(dt,	J	=	4.9,	0.9	Hz,	1H),	7.61	(td,	
J	=	7.7,	1.7	Hz,	1H),	7.48	(d,	J	=	7.9	Hz,	1H),	7.45	(d,	J	=	8.4	Hz,	2H),	7.25	(d,	J	=	8.9	Hz,	2H),	7.11	–	
7.09	(m,	1H),	4.24	(s,	1H),	2.21	(s,	6H);	13C	NMR	(125	MHz,	CDCl3)	δ	162.3,	149.5,	140.6,	136.9,	
133.1,	129.7,	128.8,	122.3,	122.2,	78.9,	44.7.	IR	(neat)	3050,	2987,	2952,	2865,	2821,	2776,	1588,	
1570,	1487,	1470,	1432,	1407,	1325,	1291,	1253,	1181,	1152,	1089,	1028,	1014	cm-1;	HRMS	m/z	
247.1007	[(M+H)+;	calcd	for	C14H16ClN2:	247.1002].	
	
N,	 N-dimethyl-1-(pyridin-2-yl)-1-(3-
(trifluoromethyl)phenyl)methanamine	 (3.4h).	 The	 product	 was	
prepared	by	General	 Procedure	B	using	N,	N-dimethyl-1-(pyridin-2-yl)methanamine	3.1d	 (27.2	
mg,	 0.20	 mmol)	 and	 3-bromobenzotrifluoride	 (54.0	 mg,	 33.5	 µL,	 0.24	 mmol)	 with	 5	 mol%	
Pd(OAc)2/	 7.5	 mol%	 NIXANTPHOS.	 The	 crude	 product	 was	 purified	 by	 flash	 column	
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chromatography	on	silica	gel	(hexanes:EtOAc	=	50:50)	to	give	the	product	as	a	yellow	solid	(48.8	
mg,	87%	yield),	m.p.=	60	–	62	ºC.	1H	NMR	(500	MHz,	CDCl3)	δ	8.54	(dt,	J	=	4.8,	0.9	Hz,	1H),	7.79	
(s,	1H),	7.71	(d,	J	=	7.7	Hz,	1H),	7.63	(td,	J	=	7.7,	1.6	Hz,	1H),	7.48	(dd,	J	=	7.8,	1.4	Hz,	2H),	7.40	(t,	J	
=	7.7	Hz,	1H),	7.12	(dd,	J	=	7.4,	4.9	Hz,	1H),	4.33	(s,	1H),	2.22	(s,	6H);	13C	NMR	(125	MHz,	CDCl3)	δ	
161.9,	149.6,	143.1,	137.0,	131.8,	131.0	(q,	J	=	37.5	Hz),	129.1,	125.1	(q,	J	=	3.8	Hz),	124.4	(q,	J	=	
271.0	Hz),	124.3	(q,	J	=	3.8	Hz),	122.4,	122.4,	79.1,	44.7;	IR	(neat)	3056,	2989,	2955,	2868,	2825,	
2779,	1673,	1588,	1571,	1470,	1450,	1433,	1326,	1266,	1165,	1125,	1098,	1073,	1042,	1029	cm-
1;	HRMS	m/z	281.1264	[(M+H)+;	calcd	for	C15H16F3N2:	281.1266].	
	
N,	 N-Dimethyl-1-(pyridin-2-yl)-1-(4-
(trifluoromethyl)phenyl)methanamine	 (3.4i).	 The	product	was	prepared	
by	General	 Procedure	B	 using	N,	N-dimethyl-1-(pyridin-2-yl)methanamine	3.1d	 (27.2	mg,	 0.20	
mmol)	and	4-bromobenzotrifluoride	(54.0	mg,	33.6	µL,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	
mol%	NIXANTPHOS.	The	crude	product	was	purified	by	 flash	column	chromatography	on	silica	
gel	 (hexanes:EtOAc	=	50:50)	 to	give	 the	product	as	a	 yellow	oil	 (33.6	mg,	60%	yield).	 1H	NMR	
(500	MHz,	CDCl3)	δ	8.53	(dt,	J	=	4.9,	0.9	Hz,	1H),	7.65	–	7.61	(m,	3H),	7.54	(d,	J	=	8.2	Hz,	2H),	7.50	
(d,	 J	=	7.5	Hz,	1H),	7.12	(dd,	J	=	7.4,	4.9	Hz,	1H),	4.33	(s,	1H),	2.21	(s,	6H);	 13C	NMR	(125	MHz,	
CDCl3)	δ	161.9,	149.6,	146.1,	137.0,	129.7	(q,	J	=	32.1	Hz),	128.7,	125.7	(q,	J	=	3.7	Hz),	124.4	(q,	J	
=	270.5	Hz),	122.5,	122.4,	79.2,	44.7.	IR	(neat)	3055,	2989,	2955,	2869,	2824,	2779,	1619,	1588,	
1571,	1470,	1434,	1418,	1326,	1164,	1124,	1067,	1041,	1029,	1018	cm-1;	HRMS	m/z	281.1270	
[(M+H)+;	calcd	for	C15H16F3N2:	281.1266].	
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1-(Benzofuran-5-yl)-N,	N-dimethyl-1-(pyridin-2-yl)methanamine	(3.4j).	The	
product	 was	 prepared	 by	 General	 Procedure	 B	 using	 N,	 N-dimethyl-1-
(pyridin-2-yl)methanamine	3.1d	 (27.2	mg,	0.20	mmol)	 and	5-bromobenzofuran	 (47.3	mg,	30.1	
µL,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	
by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	50:50)	to	give	the	product	as	a	
yellow	oil	(33.3	mg,	66%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.51	(d,	J	=	4.8	Hz,	1H),	7.74	(s,	1H),	
7.62	–	7.56	(m,	3H),	7.47	(d,	J	=	8.5	Hz,	1H),	7.40	(d,	J	=	8.5	Hz,	1H),	7.08	–	7.05	(m,	1H),	6.70	(s,	
1H),	 4.35	 (s,	 1H),	 2.24	 (s,	 6H);	 13C	NMR	 (125	MHz,	 CDCl3)	δ	 163.2,	 154.5,	 149.4,	 145.4,	 136.8,	
127.7,	 124.6,	 122.2,	 122.0,	 120.9,	 111.5,	 106.9,	 79.7,	 44.9.	 IR	 (neat)	 3053,	 2986,	 2950,	 2862,	
2820,	2774,	1588,	1569,	1465,	1432,	1327,	1261,	1181,	1153,	1124,	1108,	1030	cm-1;	HRMS	m/z	
253.1336	[(M+H)+;	calcd	for	C16H17N2O:	253.1341].	
	
N,	N-Dimethyl-1-(naphthalen-1-yl)-1-(pyridin-2-yl)methanamine	 (3.4k).	 The	
product	was	prepared	by	General	Procedure	B	using	N,	N-dimethyl-1-(pyridin-
2-yl)methanamine	3.1d	(27.2	mg,	0.20	mmol)	and	1-bromonaphthalene	(49.7	mg,	33.6	µL,	0.24	
mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	flash	
column	chromatography	on	silica	gel	(hexanes:EtOAc	=	50:50)	to	give	the	product	as	a	yellow	oil	
(36.2	mg,	69%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.58	(d,	J	=	8.6	Hz,	1H),	8.51	(dd,	J	=	4.8,	1.1	Hz,	
1H),	8.02	(d,	J	=	7.3	Hz,	1H),	7.80	(d,	J	=	8.1	Hz,	1H),	7.73	(d,	J	=	8.1	Hz,	1H),	7.53	–	7.48	(m,	4H),	
7.42	 (t,	 J	 =	7.5	Hz,	1H),	7.04	 (q,	 J	 =	4.5	Hz,	1H),	5.13	 (s,	1H),	2.29	 (s,	6H);	 13C	NMR	 (125	MHz,	
CDCl3)	δ	162.5,	148.9,	138.0,	136.6,	134.1,	131.9,	128.9,	127.8,	126.1,	125.8,	125.5,	124.3,	122.9,	
122.0,	74.9,	45.1.	IR	(neat)	3050,	2986,	2950,	2863,	2820,	2764,	1588,	1569,	1511,	1470,	1434,	
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1394,	1328,	1256,	1177,	1153,	1118,	1043	cm-1;	HRMS	m/z	263.1544	[(M+H)+;	calcd	for	C18H19N2:	
263.1548].	
	
1-(3-(1,3-Dioxolan-2-yl)phenyl)-N,	 N-dimethyl-1-(pyridin-2-
yl)methanamine	(3.4l).	The	product	was	prepared	by	General	Procedure	
B	 using	 N,	 N-dimethyl-1-(pyridin-2-yl)methanamine	 3.1d	 (27.2	 mg,	 0.20	 mmol)	 and	 2-(3-
bromophenyl)-1,3-dioxolane	 (55.0	mg,	 36.3	µL,	 0.24	mmol)	 with	 5	mol%	 Pd(OAc)2/	 7.5	mol%	
NIXANTPHOS.	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	
(hexanes:EtOAc	=	50:50)	to	give	the	product	as	a	yellow	oil	(50.1	mg,	88%	yield).	 1H	NMR	(500	
MHz,	CDCl3)	δ	8.50	(d,	J	=	4.2	Hz,	1H),	7.61	–	7.60	(m,	1H),	7.58	(d,	J	=	7.6	Hz,	1H),	7.54	(dd,	J	=	
7.1,	1.3	Hz,	1H),	7.51	(d,	J	=	7.8	Hz,	1H),	7.37	–	7.28	(m,	2H),	7.08	–	7.06	(m,	1H),	5.76	(s,	1H),	
4.29	(s,	1H),	4.13	–	4.07	(m,	2H),	4.04	–	3.98	(m,	2H),	2.21	(s,	6H);	13C	NMR	(125	MHz,	CDCl3)	δ	
162.5,	 149.3,	 142.2,	 138.2,	 136.8,	 129.2,	 128.8,	 126.6,	 125.6,	 122.3,	 122.1,	 103.9,	 79.6,	 65.5,	
65.4,	44.8;	 IR	(neat)	3027,	2961,	2636,	2836,	2797,	2691,	1609,	1596,	1561,	1510,	1458,	1413,	
1376,	1301,	1293,	1249,	1176,	1160,	1144,	1105,	1034,	1008	cm-1;	HRMS	m/z	285.1602	[(M+H)+;	
calcd	for	C17H21N2O2:	285.1603].	
	
N-Ethyl-N-(phenyl(pyridin-2-yl)methyl)ethanamine	 (3.4m).	 The	 product	 was	
prepared	 by	 General	 Procedure	 B	 using	 N-ethyl-N-(pyridin-2-
ylmethyl)ethanamine	 3.1e	 (32.8	 mg,	 0.20	mmol)	 and	 bromobenzene	 (37.7	 mg,	 25.3	 µL,	 0.24	
mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	flash	
column	chromatography	on	silica	gel	 ((hexanes:EtOAc	=	50:50)	to	give	the	product	as	a	yellow	
oil	(33.2	mg,	69%	yield).		The	NMR	spectral	data	match	the	previously	published	data.27	
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N-Ethyl-N-((4-methoxyphenyl)(pyridin-2-yl)methyl)ethanamine	 (3.4n).	
The	 product	 was	 prepared	 by	 General	 Procedure	 B	 using	 N-Ethyl-N-
(pyridin-2-ylmethyl)ethanamine	3.1e	 (32.8	mg,	0.20	mmol)	and	4-bromoanisole	 (44.9	mg,	30.0	
µL,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	
by	flash	column	chromatography	on	silica	gel	((hexanes:EtOAc	=	50:50)	to	give	the	product	as	a	
yellow	oil	(35.6	mg,	66%	yield).		1H	NMR	(500	MHz,	CDCl3)	δ	8.48	(dd,	J	=	5.0,	1.0	Hz,	1H),	7.61	–	
7.56	(m,	2H),	7.40	(d,	J	=	8.8	Hz,	2H),	7.06	(ddd,	J	=	6.7,	4.9,	1.8	Hz,	1H),	6.83	–	6.80	(m,	2H),	4.81	
(s,	1H),	3.75	 (s,	3H),	2.65	–	2.54	 (m,	4H),	0.97	 (t,	 J	 =	7.1	Hz,	6H);	 13C	NMR	 (125	MHz,	CDCl3)	δ	
163.7,	 158.7,	 149.1,	 136.6,	 134.3,	 129.6,	 122.3,	 121.8,	 113.9,	 73.0,	 55.3,	 42.9,	 10.8.	 IR	 (neat)	
3051,	 2969,	 2932,	 2871,	 2835,	 1610,	 1588,	 1569,	 1509,	 1467,	 1432,	 1373,	 1302,	 1247,	 1173,	
1108,	1036	cm-1;	HRMS	m/z	271.1801	[(M+H)+;	calcd	for	C17H23N2O:	271.1810].	
	
N-Ethyl-N-((4-fluorophenyl)(pyridin-2-yl)methyl)ethanamine	 	 	 (3.4o).	 The	
product	was	prepared	by	General	Procedure	B	using	N-ethyl-N-(pyridin-2-
ylmethyl)ethanamine	 3.1e	 (32.8	 mg,	 0.20	 mmol)	 and	 1-bromo-4-
fluorobenzene	 (42.0	mg,	 26.4	µL,	 0.24	mmol)	with	 5	mol%	Pd(OAc)2/	 7.5	mol%	NIXANTPHOS.	
The	crude	product	was	purified	by	flash	column	chromatography	on	silica	gel	((hexanes:EtOAc	=	
50:50)	to	give	the	product	as	a	yellow	oil	(34.1	mg,	66%	yield).		1H	NMR	(500	MHz,	CDCl3)	δ	8.49	
(d,	J	=	4.8	Hz,	1H),	7.62	–	7.59	(m,	1H),	7.54	(d,	J	=	2.1	Hz,	1H),	7.46	(dd,	J	=	5.7,	8.4	Hz,	2H),	7.08	
–	7.06	(m,	1H),	6.95	(t,	J	=	8.7	Hz	2H),	4.86	(s,	1H),	2.64	–	2.53	(m,	4H),	0.97	(t,	J	=	7.1	Hz,	6H);	13C	
NMR	(125	MHz,	CDCl3)	δ	163.0,	162.0	(d,	J	=	243.8	Hz),	149.2,	137.9	(d,	J	=	2.5	Hz),	136.6,	130.0	
(d,	J	=	7.5	Hz),	122.4,	122.0,	115.3	(d,	J	=	21.2	Hz),	72.8,	42.9,	10.8;	IR	(neat)	3051,	2971,	2934,	
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2873,	2827,	1602,	1589,	1570,	1506,	1469,	1433,	1374,	1293,	1221,	1156,	1096,	1055,	1015	cm-
1;	HRMS	m/z	259.1602	[(M+H)+;	calcd	for	C16H20FN2:	259.1611].	
	
4-(Pyridin-4-yl(p-tolyl)methyl)morpholine	 (3.5a).	 The	 product	 was	
prepared	 by	 General	 Procedure	 B	 using	 4-(pyridin-4-ylmethyl)morpholine	
3.1f	 (35.6	 mg,	 0.20	 mmol)	 and	 4-bromotoluene	 (41.0	 mg,	 29.5	 µL,	 0.24	
mmol)	with	1	mol%	Pd(OAc)2/	1.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	flash	
column	chromatography	on	silica	gel	(hexanes:EtOAc	=	50:50	to	only	EtOAc)	to	give	the	product	
as	a	yellow	oil	(48.8	mg,	91%	yield).		1H	NMR	(500	MHz,	CDCl3)	δ	8.49	(d,	J	=	5.5	Hz,	2H),	7.37	(d,	J	
=	5.5	Hz,	2H),	7.24	(d,	J	=	8.2	Hz,	2H),	7.10	(d,	J	=	8.2	Hz,	2H),	4.16	(s,	1H),	3.71	(t,	J	=	4.5	Hz,	4H),	
2.40	–	2.32	(m,	4H),	2.29	(s,	3H);	13C	NMR	(125	MHz,	CDCl3)	δ	151.9,	150.2,	137.7,	137.5,	129.7,	
128.2,	123.1,	75.6,	67.2,	52.6,	21.2;	 IR	(neat)	3023,	2958,	2853,	2808,	1595,	1560,	1511,	1452,	
1412,	 1305,	 1274,	 1118,	 1070,	 1011	 cm-1;	 HRMS	 m/z	 268.1582	 [(M)+;	 calcd	 for	 C17H20N2O:	
268.1576].	
	
4-(Phenyl(pyridin-4-yl)methyl)morpholine	 (3.5b).	 The	 product	 was	 prepared	
by	General	Procedure	B	using	4-(pyridin-4-ylmethyl)morpholine	3.1f	 (35.6	mg,	
0.20	mmol)	 and	 bromobenzene	 (37.7	 mg,	 25.4	 µL,	 0.24	mmol)	 with	 1	 mol%	
Pd(OAc)2/	 1.5	 mol%	 NIXANTPHOS.	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	 silica	 gel	 (hexanes:EtOAc	 =	 50:50	 to	 only	 EtOAc)	 to	 give	 the	 product	 as	 a	
yellow	oil	(46.8	mg,	92%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.49	(dd,	J	=	5.0,	1.5	Hz,	2H),	7.40	–	
7.35	(m,	4H),	7.29	(app	t,	J	=	7.0	Hz,	2H),	7.22	(app.	t,	J	=	7.0	Hz,	1H),	4.20	(s,	1H),	3.72	(t,	J	=	5.0	
Hz,	 4H),	 2.42	 –	 2.35	 (m,	 4H);	 13C	 NMR	 (125	MHz,	 CDCl3)	 δ	 151.6,	 150.3,	 140.6,	 129.0,	 128.3,	
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128.0,	123.2,	75.9,	67.3,	52.7;	IR	(neat)	3028,	2959,	2853,	2810,	1724,	1668,	1593,	1361,	1493,	
1451,	 1412,	 1306,	 1279,	 1117,	 1070,	 1011	 cm-1;	 HRMS	 m/z	 255.1502	 [(M+H)+;	 calcd	 for	
C16H19N2O:	255.1497].	
Alternation:	43.2	mg,	85%	yield	with	chlorobenzene	(27.0	mg,	24.3	µL,	0.24	mmol),	Pd(OAc)2	(5	
mol	%),	NIXANTPHOS	(7.5	mol	%).	
	
4-((4-(tert-Butyl)phenyl)(pyridin-4-yl)methyl)morpholine	 (3.5c).	 The	
product	 was	 prepared	 by	 General	 Procedure	 B	 using	 4-(pyridin-4-
ylmethyl)morpholine	 3.1f	 (35.6	 mg,	 0.20	 mmol)	 and	 1-bromo-4-(tert-
butyl)benzene	 (51.2	mg,	 41.6	µL,	 0.24	mmol)	with	 1	mol%	 Pd(OAc)2/	 1.5	mol%	NIXANTPHOS.	
The	crude	product	was	purified	by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	
50:50	to	only	EtOAc)	to	give	the	product	as	a	white	solid	(52.8	mg,	85%	yield),	m.p.=	82	–	84	ºC.		
1H	NMR	(500	MHz,	CDCl3)	δ	8.49	(dd,	J	=	4.5,	1.5	Hz,	2H),	7.38	(dd,	J	=	4.5,	1.5	Hz,	2H),	7.32	–	
7.25	(m,	4H),	4.17	(s,	1H),	3.71	(t,	J	=	4.5	Hz,	4H),	2.43	–	2.31	(m,	4H),	1.27	(s,	9H);	13C	NMR	(125	
MHz,	 CDCl3)	δ	 151.8,	 150.8,	 150.2,	 137.3,	 127.9,	 125.8,	 123.2,	 75.5,	 67.2,	 52.6,	 34.6,	 31.4;	 IR	
(neat)	3027,	2961,	2906,	2855,	2808,	1595,	1561,	1510,	1395,	1414,	1364,	1305,	1274,	1116	cm-
1;	HRMS	m/z	311.2121	[(M+H)+;	calcd	for	C20H27N2O:	311.2123].	
	
1-((4-(tert-Butyl)phenyl)(pyridin-4-yl)methyl)-4-methylpiperazine	 (3.5d).	
The	 product	 was	 prepared	 by	 General	 Procedure	 B	 using	 1-methyl-4-
(pyridin-4-ylmethyl)piperazine	3.1g	 (38.3	mg,	0.20	mmol)	and	1-bromo-4-
(tert-butyl)benzene	 (51.2	 mg,	 41.6	 µL,	 0.24	 mmol)	 with	 1	 mol%	 Pd(OAc)2/	 1.5	 mol%	
NIXANTPHOS.	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	
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(hexanes:EtOAc	=	50:50	to	only	EtOAc)	to	give	the	product	as	a	yellow	oil	(52.4	mg,	81%	yield).		
1H	NMR	(500	MHz,	CDCl3)	δ	8.50	(app	d.,	J	=	6.5	Hz,	2H),	7.36	(app.	d,	J	=	5.6	Hz,	2H),	7.30	(d,	J	=	
8.0	Hz,	2H),	7.25	(d,	J	=	8.0	Hz,	2H),	4.24	(s,	1H),	2.90	–	2.20	(m,	8H),	2.42	(s,	3H),	1.27	(s,	9H);	13C	
NMR	(125	MHz,	CDCl3)	δ	151.9,	150.9,	150.3,	137.3,	127.8,	125.9,	123.1,	74.8,	55.2,	51.0,	45.4,	
34.7,	31.5;	 IR	(neat)	3026,	2963,	2797,	1595,	1561,	1509,	1458,	1414,	1292,	1160,	1143,	1113,	
1009	cm-1;	HRMS	m/z	324.2424	[(M+H)+;	calcd	for	C21H30N3:	324.2440].	
	
	1-((4-Methoxyphenyl)(pyridin-4-yl)methyl)-4-methylpiperazine	 (3.5e).	
The	 product	 was	 prepared	 by	 General	 Procedure	 B	 using	 1-methyl-4-
(pyridin-4-ylmethyl)piperazine	 3.1g	 (38.3	 mg,	 0.20	 mmol)	 and	 4-
bromoanisole	(44.9	mg,	30.0	µL,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	
crude	product	was	purified	by	flash	column	chromatography	on	silica	gel	(CH2Cl2:CH3OH	=	90:10)	
to	give	the	product	as	a	yellow	oil	(52.3	mg,	88%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.48	(d,	J	=	
5.5	Hz,	2H),	7.34	(d,	J	=	5.6	Hz,	2H),	7.25	(d,	J	=	8.6	Hz,	2H),	6.81	(d,	J	=	8.6	Hz,	2H),	4.17	(s,	1H),	
3.75	(s,	3H),	2.50	–	2.43	(m,	8H),	2.31	(s,	3H);	13C	NMR	(125	MHz,	CDCl3)	δ	159.1,	152.3,	150.1,	
132.8,	129.2,	122.9,	114.2,	74.5,	55.3,	55.2,	51.5,	45.7.	IR	(neat)	3027,	2961,	2936,	2836,	2797,	
2691,	 1609,	 1596,	 1561,	 1510,	 1458,	 1413,	 1376,	 1301,	 1293,	 1249,	 1176,	 1160,	 1144,	 1105,	
1034,	1008	cm-1;	HRMS	m/z	298.1924	[(M+H)+;	calcd	for	C18H24N3O:	298.1919].	
Alternation:	44.0	mg,	74%	yield	with	Pd(OAc)2	(1	mol	%),	NIXANTPHOS	(1.5	mol	%).	
	
1-((4-Fluorophenyl)(pyridin-4-yl)methyl)-4-methylpiperazine	 (3.5f).	 The	
product	was	prepared	by	General	Procedure	B	using	1-methyl-4-(pyridin-4-
ylmethyl)piperazine	 3.1g	 (38.3	 mg,	 0.20	 mmol)	 and	 1-bromo-4-
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fluorobenzene	 (42.0	mg,	 26.4	µL,	 0.24	mmol)	with	 5	mol%	Pd(OAc)2/	 7.5	mol%	NIXANTPHOS.	
The	crude	product	was	purified	by	 flash	column	chromatography	on	silica	gel	 (CH2Cl2:CH3OH	=	
90:10)	to	give	the	product	as	a	yellow	oil	(48.5	mg,	85%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.49	
(dd,	J	=	4.5,	1.5	Hz,	2H),	7.33	–	7.31	(m,	4H),	6.98	(t,	J	=	8.6	Hz,	2H),	4.22	(s,	1H),	2.51	–	2.42	(m,	
8H),	2.32	(s,	3H)	ppm;	13C	NMR	(125	MHz,	CDCl3)	δ	162.3	(d,	J	=	245.1	Hz),	151.6,	150.3,	136.5	(d,	
J	=	3.2	Hz),	129.7	(d,	J	=	7.8	Hz),	123.0,	115.9	(d,	J	=	21.4	Hz),	74.4,	55.2,	51.4,	45.7	ppm;	IR	(neat)	
3070,	 2964,	 2939,	 2805,	 2694,	 1600,	 1563,	 1507,	 1458,	 1415,	 1377,	 1293,	 1222,	 1158,	 1144,	
1095,	1065,	1009	cm-1;	HRMS	m/z	286.1719	[(M+H)+;	calcd	for	C17H21FN3:	286.1720].	
Alternation:	31.4	mg,	55%	yield	with	Pd(OAc)2	(1	mol	%),	NIXANTPHOS	(1.5	mol	%).	
	
N,N-Dimethyl-1-phenyl-1-(pyridin-4-yl)methanamine	 (3.5g).	 The	 product	was	
prepared	by	General	Procedure	B	using	N,N-dimethyl-1-(pyridin-4-yl)	3.1h	(27.2	
mg,	0.20	mmol)	and	bromobenzene	(37.7	mg,	25.4	µL,	0.24	mmol)	with	1	mol%	Pd(OAc)2/	1.5	
mol%	NIXANTPHOS.	The	crude	product	was	purified	by	 flash	column	chromatography	on	silica	
gel	 (hexanes:EtOAc	 =	 50:50	 to	 only	 EtOAc)	 to	 give	 the	 product	 as	 a	 yellow	 oil	 (26.7	mg,	 63%	
yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.49	(dd,	J	=	4.5,	15	Hz,	2H),	7.39	–	7.35	(m,	4H),	7.29	(t,	J	=	
7.8	Hz,	2H),	7.24	–	7.18	 (m,	1H),	4.07	 (s,	1H),	2.19	 (s,	6H);	 13C	NMR	(125	MHz,	CDCl3)	δ	152.5,	
150.2,	 141.7,	 128.9,	 128.1,	 127.7,	 123.0,	 77.1,	 44.6;	 IR	 (neat)	 3062,	 3026,	 2987,	 2952,	 2864,	
2820,	 2775,	 1594,	 1561,	 1492,	 1454,	 1411,	 1310,	 1180,	 1152,	 1040,	 1022	 cm-1;	 HRMS	 m/z	
213.1389	[(M+H)+;	calcd	for	C14H17N2:	213.1392].	
	
1-(4-(tert-Butyl)phenyl)-N,N-dimethyl-1-(pyridin-4-yl)methanamine	
(3.5h).	 The	 product	 was	 prepared	 by	 General	 Procedure	 B	 using	 N,N-
N
NMe2
N
NMe2
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dimethyl-1-(pyridin-4-yl)	 3.1h	 (27.2	 mg,	 0.20	 mmol)	 and	 1-bromo-4-(tert-butyl)benzene	 (51.2	
mg,	41.6	µL,	0.24	mmol)	with	1	mol%	Pd(OAc)2/	1.5	mol%	NIXANTPHOS.	The	crude	product	was	
purified	by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	50:50	to	only	EtOAc)	to	
give	 the	 product	 as	 a	white	 solid	 (36.5	mg,	 68%	 yield),	m.p.=	 70	 –	 72	 ºC.	 1H	NMR	 (500	MHz,	
CDCl3)	δ	8.49	(app.	d,	J	=	6.0	Hz,	2H),	7.37	(app.	d,	J	=	6.0	Hz,	2H),	7.32	–	7.26	(m,	4H),		4.04	(s,	
1H),	 2.18	 (s,	 6H),	 1.27	 (s,	 9H);	 13C	NMR	 (125	MHz,	 CDCl3)	δ	 152.8,	 150.6,	 150.1,	 138.5,	 127.7,	
125.7,	123.0,	76.8,	44.7,	34.6,	31.5;	 IR	(neat)	3026,	2959,	2904,	2866,	2819,	2774,	1595,	1562,	
1509,	1461,	1412,	1394,	1296,	1272,	1152,	1027,	1016	cm-1;	HRMS	m/z	269.2012	[(M+H)+;	calcd	
for	C18H25N2:	269.2018].	
	
1-(4-Methoxyphenyl)-N,N-dimethyl-1-(quinolin-2-yl)methanamine	
(3.5i).	 The	 product	 was	 prepared	 by	 General	 Procedure	 B	 using	 1-
(isoquinolin-3-yl)-N,	 N-dimethylmethanamine	 3.1i	 (37.3	 mg,	 0.20	
mmol)	 and	 4-bromoanisole	 (44.9	 mg,	 30.0	 µL,	 0.24	 mmol)	 with	 5	 mol%	 Pd(OAc)2/	 7.5	 mol%	
NIXANTPHOS.	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	
(hexanes:EtOAc	=	65:35)	to	give	the	product	as	a	yellow	oil	(30.4	mg,	52%	yield).	1H	NMR	(500	
MHz,	CDCl3)	δ	8.07	(dd,	J	=	15.3,	8.5	Hz,	2H),	7.70	(dd,	J	=	16.3,	8.3	Hz,	2H),	7.65	(t,	J	=	7.7	Hz,	
1H),	7.51	(d,	J	=	8.7	Hz,	2H),	7.46	(t,	J	=	7.5	Hz,	1H),	6.82	(d,	J	=	8.7	Hz,	2H),	4.41	(s,	1H),	3.73	(s,	
3H),	2.26	 (s,	6H);	 13C	NMR	 (125	MHz,	CDCl3)	δ	163.5,	159.0,	147.8,	136.9,	134.0,	129.5,	129.4,	
127.6,	127.6,	126.3,	120.2,	114.1,	79.7,	55.4,	44.9.	IR	(neat)	3060,	2950,	2932,	2863,	2821,	2775,	
1608,	 1599,	 1563,	 1510,	 1462,	 1440,	 1426,	 1303,	 1291,	 1248,	 1178,	 1152,	 1115,	 1031	 cm-1;	
HRMS	m/z	293.1646	[(M+H)+;	calcd	for	C19H21N2O:	293.1654].	
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4-(Pyridin-3-yl(p-tolyl)methyl)morpholine	 (3.5j).	 The	 product	 was	
prepared	 by	 General	 Procedure	 B	 (Pd(OAc)2/NIXANTPHOS	 stock	 solution	
was	 prepared	 in	 THF)	 using	 4-(pyridin-3-ylmethyl)morpholine	 3.1j	 (35.6	
mg,	0.20	mmol),	4-bromotoluene	(41.0	mg,	29.5	µL,	0.24	mmol)	and	KN(SiMe3)2	(59.8	mg,	0.30	
mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.		The	crude	product	was	purified	by	flash	
column	chromatography	on	silica	gel	hexanes:EtOAc	=	60:40)	to	give	the	product	as	a	colourless	
oil	(34.9	mg,	65%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.66	(d,	J	=	1.3	Hz,	1H),	8.43	(d,	J	=	3.6	Hz,	
1H),	7.74	(dt,	J	=	7.9,	1.7	Hz,	1H),	7.28	(d,	J	=	8.1	Hz,	2H),	7.20	(dd,	J	=	7.9,	4.8	Hz,	1H),	7.10	(d,	J	=	
7.8	Hz,	2H),	4.22	(s,	1H),	3.71	(t,	J	=	4.7	Hz,	4H),	2.41	–	2.33	(m,	4H),	2.29	(s,	3H);	13C	NMR	(125	
MHz,	 CDCl3)	 δ	 149.7,	 148.7,	 138.3,	 138.3,	 137.4,	 135.5,	 129.7,	 128.0,	 123.8,	 74.1,	 67.3,	 52.7,	
21.2.	IR	(neat)	3028,	2958,	2920,	2854,	2808,	1661,	1606,	1586,	1576,	1511,	1453,	1426,	1307,	
1281,	 1252,	 1179,	 1117,	 1070,	 1026,	 1009	 cm-1;	 HRMS	 m/z	 269.1652	 [(M+H)+;	 calcd	 for	
C17H21N2O:	269.1654].	
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Chapter	4	
Chemoselective	Palladium-Catalyzed	Deprotonative	Arylation/[1,2]-Wittig	Rearrangement	of	
Pyridylmethyl	Ethers	
Adapted	 with	 permission	 from	 Chem.	 Sci.	 2016,	 7,	 976–983	 Copyright	 2016	 Royal	 Society	 of	
Chemistry.		
	
 Introduction	4.1.
	 The	synthesis	of	diverse	chemical	structures	 is	an	 important	endeavor	 in	the	discovery	
of	 new	medications.	 	 Forging	 structural	 diversity	 from	 a	 common	 set	 of	 organic	 substrates	 is	
extremely	desirable	in	this	venture,	but	is	quite	difficult	to	achieve	with	high	selectivity.1		This	is	
particularly	 challenging	 when	 tandem	 reactions	 are	 employed,	 wherein	 several	 chemical	
transformations	are	performed	without	isolation	of	intermediates,	addition	of	new	reagents,	or	
modification	of	reaction	parameters.	
	
Figure	4.1.	Structures	of	drugs	derived	from	the	aryl(pyridin-2-yl)	core.		
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	 In	considering	the	synthesis	of	a	family	of	drug-like	molecules	based	on	the	aryl(pyridin-
2-yl)methanol	core	(I,	Figure	4.1),	we	envisioned	a	unified	approach	to	access	these	 important	
structural	 motifs	 based	 on	 a	 non-traditional	 umpolung	 approach.2	 Our	 strategy	 (Figure	 2)	
entailed	a	palladium-catalyzed	deprotonative	cross-coupling	process	(DCCP)	with	pyridylmethyl	
ethers	and	aryl	bromides	to	generate	arylated	secondary	ethers	4.4	while	the	tertiary	alcohols	
4.5	would	be	accessed	via	a	tandem	DCCP/[1,2]-Wittig	rearrangement.	
	
Figure	 4.2.	 Chemoselective	 [1,2]-Wittig	 rearrangement	 to	 give	 4.3,	 arylation	 to	 give	 4.4,	 and	
tandem	arylation/[1,2]-Wittig	rearrangement	to	afford	4.5.	
	
	 	
	 Upon	 examination	 of	 the	 reactions	 in	 Figure	 4.2,	 several	 challenges	 are	 evident.		
Reversible	 deprotonation	 of	 ether	 4.1	 generates	 the	 intermediate	 carbanion	 4.2.3	 	 a-Alkoxy	
carbanions	 are	 known	 to	 undergo	 [1,2]-Wittig	 rearrangements	 to	 generate	 alcohols	 4.3.4	 	 If	
anion	4.2	could	be	intercepted	by	a	palladium	catalyst	via	rapid	transmetallation,5	arylation	may	
outcompete	 the	 [1,2]-Wittig	 rearrangement	 of	 4.2	 to	 generate	 the	 desired	 aryl(pyridine-2-
yl)methyl	ether	core,	4.4.		Compound	4.4,	possessing	a	more	acidic	benzylic	hydrogen	than	4.2,	
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may	 undergo	 deprotonation	 under	 the	 basic	 reaction	 conditions	 followed	 by	 [1,2]-Wittig	
rearrangement	to	form	tertiary	alcohols	4.5.	 	Because	structures	4.4	and	4.5	are	both	valuable	
intermediates	to	furnish	bioactive	molecules	and	commercialized	drugs	(Figure	4.1),	conditions	
that	inhibit	and	facilitate	the	tandem	[1,2]-Wittig	rearrangement	of	intermediate	4.4	are	crucial	
for	obtaining	high	selectivity	and	for	the	realization	of	this	strategy.	 	 If	 the	selectivity	could	be	
controlled	 in	 the	 DCCP/[1,2]-Wittig	 rearrangement	 in	 Figure	 2,	 the	 core	 structures	 of	 the	
antihistamines	Doxylamine,6	Carbinoxamine,7	Bepotastine,8	Triprolidine9	(Figure	4.1)	and	related	
pyridines10	could	be	accessed	followed	by	further	organic	transformations.			
	 Herein	 we	 disclose	 general	 and	 highly	 selective	 methods	 for	 the	 arylation	 of	
pyridylmethyl	ethers	4.1	to	give	4.4	as	well	as	the	tandem	arylation/[1,2]-Wittig	rearrangement	
to	furnish	tertiary	alcohols	4.5.		
	
 Results	and	Discussion	4.2.
	 Given	 the	 importance	of	pyridines	 in	medicinal	 chemistry	and	materials	 science,11	 it	 is	
not	 surprising	 that	 palladium	 catalyzed	 C–H	 functionalization	 reactions	 involving	 benzylic	
arylation	of	 pyridines	 and	derivatives	 have	 attracted	 significant	 attention.12	 	Difficulties	 in	 the	
direct	 benzylic	 arylation	 of	 2-substituted	 pyridines,	 however,	 have	 been	 encountered	 and	 are	
attributed	 to	 the	 ability	 of	 pyridyl	 nitrogens	 to	 act	 as	 ligands.12j,13	 	 Successful	 strategies	 to	
circumvent	 this	potential	problem	 include	addition	of	 Lewis	acids	 to	bind	 the	pyridyl	nitrogen	
and	increase	the	reactivity	of	the	benzylic	C–H’s.12j		Notably,	acceleration	of	palladium	catalyzed	
reactions	 of	 pyridine	 derivatives	 by	 addition	 of	 Lewis	 acids	 has	 been	 described	 by	 Nolan,14	
Hartwig,15	and	Trost.16		Other	workarounds	include	use	of	substrates	with	directing	groups,	such	
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as	 2-(2-pyridyl)acetic	 acids,12h	 2-(2-pyridyl)ethanols,12b	 pyridine	 N-oxides,12d,12f	 and	 N-
iminopyridines.12e	 	 We	 previously	 used	 2-benzylpyridine	 (pKa	 =	 28.3–28.7	 in	 THF),	 where	 the	
benzylic	hydrogens	are	estimated	to	about	6	orders	of	magnitude	more	acidic	than	those	in	2-
picoline	 (pKa	 =	34	 in	THF).17	 	 2-Benzylpyridines	are	also	expected	 to	be	at	 least	 four	orders	of	
magnitude	more	acidic	than	the	pyridylmethyl	ether	substrates	that	are	the	focus	of	the	current	
investigation.18	 	Over	 the	 last	decade,	direct	C–H	 functionalization	of	benzylic	ethers	has	been	
reported	 via	 cross	 dehydrogenative-coupling	 (CDC)	 reactions	 and	 photoredox-mediated	
reactions.19	
	
4.2.1. Optimization	of	Reactions.		
	 	In	 the	course	of	our	studies20	 in	 the	DCCP	of	a	variety	of	weakly	acidic	substrates,	we	
discovered	that	palladium	complexes	of	van	Leeuwen’s	NIXANTPHOS	ligand21	(Table	4.1)	enable	
a	 wide	 variety	 of	 transformations,	 whereas	 other	 ligands	 are	 much	 less	 effective.	 	 Thus,	 we	
employed	 a	 Pd(OAc)2	(5	mol	%)/NIXANTPHOS	 (7.5	mol	%)	 based	 catalyst	 to	 initiate	 the	 direct	
arylation	of	2-pyridylmethyl	ethyl	ether	4.1a	with	bromobenzene	 in	combination	with	6	bases	
[LiO-tBu,	NaO-tBu,	KO-tBu,	LiN(SiMe3)2,	NaN(SiMe3)2,	and	KN(SiMe3)2].	 	Both	LiO-tBu	and	NaO-
tBu	 resulted	 in	 no	 product,	 while	 KO-tBu	 afforded	 a	 low	 yield	 of	 the	 arylation/[1,2]-Wittig	
rearrangement	 product.	 	 Interestingly,	 LiN(SiMe3)2	 generated	 the	 arylation/[1,2]-Wittig	
rearrangement	product	4.5aa	exclusively	in	48%	assay	yield	(AY,	entry	1).		Although	NaN(SiMe3)2	
gave	a	mixture	of	arylation	4.4aa	and	arylation/[1,2]-Wittig	rearrangement	4.5aa	in	25	and	38%	
AY,	 respectively	 (entry	 2),	 KN(SiMe3)2	 afforded	 traces	 of	 4.4aa	 and	 the	 arylation/[1,2]-Wittig	
rearrangement	product	4.5aa	in	33%	AY	(entry	3).	
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Table	 4.1.	 Optimization	 of	 the	 reactions	 of	 2-pyridylmethyl	 ethyl	 ether	 4.1a	 with	
bromobenzene.[a]	
	
entry	 M	 solvent[b]	 time	(h)	 temp	(°C)	 4.4aa	(%)[c]	 4.5aa	(%)[c]	
1	 Li	 THF	 12	 45	 0	 48	
2	 Na	 THF	 12	 45	 25	 38	
3	 K	 THF	 12	 45	 trace	 33	
4	 Na	 dioxane	 12	 45	 31	 17	
5	 Na	 CPME	 12	 45	 33	 65	
6	 Na	 DME	 12	 45	 64	 30	
7	 Na	 DME	 12	 23	 95[d]	 0	
8	 Li	 dioxane	 12	 45	 16	 15	
9	 Li	 DME	 12	 45	 68	 25	
10	 Li	 CPME	 12	 45	 38	 56	
11	 Li	 CPME	 24	 45	 0	 85[d]	
12[e]	 Li	 CPME	 24	 45	 0	 83[d]	
	
[a]	 Reaction	 conditions:	 4.1a	 (0.1	 mmol),	 Ph–Br	 (0.12	 mmol),	 base	 (0.3	 mmol),	
Pd(OAc)2/NIXANTPHOS	 (5	mol	%/7.5	mol	%),	 solvent	 (1.0	mL).	 [b]	 tetrahydrofuran	 (THF),	 1,4-
dioxane	 (dioxane),	 cyclopentyl	 methyl	 ether	 (CPME),	 1,2-dimethoxyethane	 (DME).	 [c]	 Yield	
determined	 by	 1H	 NMR	 spectroscopy	 of	 the	 crude	 reaction	 mixture.	 [d]	 Isolated	 yield.	 [e]	
Pd(OAc)2/	NIXANTPHOS	(2.5	mol	%/3.75	mol	%).	
	
N
O
Et
Pd(OAc)2 (5 mol %)
NIXANTPHOS (7.5 mol %)
  Ph–Br
MN(SiMe3)2 
"Reaction Condotions"
N
O
Et
Ph
N
Et
Ph
OH
+
4.4aa
4.5aa
4.1a
O
H
N
PPh2 PPh2
NIXANTPHOS
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	 Given	 the	 higher	 yield	 afforded	 by	 NaN(SiMe3)2,	 we	 set	 out	 to	 examine	 different	
solvents	with	this	base.		Employing	NaN(SiMe3)2	at	45	°C	in	dioxane,	CPME	and	DME	(entries	4–
6)	 resulted	 in	 assay	 yields	 of	 up	 to	 64%	 arylation	 (4.4aa)	 and	 30%	 arylation/[1,2]-Wittig	
rearrangement	(4.5aa)	 in	DME.	 	To	our	surprise,	 lowering	the	temperature	to	23	°C	 in	DME	to	
minimize	the	 [1,2]-Wittig	 rearrangement	actually	prevented	 it,	providing	 the	arylation	product	
in	95%	 isolated	yield	 (entry	7).	 	With	a	highly	 selective	protocol	 for	 the	arylation	 in	place,	we	
desired	to	perform	the	tandem	arylation/[1,2]-Wittig	rearrangement.			
	 The	 [1,2]-Wittig	 rearrangement	of	a-alkoxy	carbanions	has	attracted	much	attention.22		
Despite	significant	 interest,	 relatively	harsh	reaction	conditions	are	still	 the	norm.23	 	There	are	
only	 a	 few	examples	 of	 the	 [1,2]-Wittig	 rearrangement	 in	 tandem	 reactions.	 	 Recently,	Wolfe	
and	 co-workers	 introduced	 highly	 stereoselective	 tandem	 [1,2]-Wittig	 rearrangement/aldol	 or	
Mannich	 reactions.24	 	 Dudley	 and	 co-workers	 reported	 pyridine-directed	 organolithium	
additions	to	enol	ethers.	 	The	resulting	intermediates	then	undergo	anionic	rearrangements	to	
afford	tertiary	pyridyl	carbinols.25		These	examples	indicate	that	the	use	of	a-alkoxy	carbanions	
in	 tandem	 reactions	 can	 be	 an	 effective	 strategy	 to	 generate	 multiple	 C–C	 bonds	 and	 forge	
complex	molecular	structures.	
	 To	 develop	 the	 tandem	 arylation/[1,2]-Wittig	 rearrangement	 process,	 we	 focused	 on	
LiN(SiMe3)2	base	in	dioxane,	DME	and	CPME	(entries	8–10).	 	Of	these	solvents,	CPME	gave	the	
best	results	(4.4aa	:	4.5aa,	38:56),	but	exhibited	incomplete	[1,2]-Wittig	rearrangement	after	12	
h	 (entry	 10).	 	 With	 a	 24	 h	 reaction	 time,	 the	 tandem	 arylation/[1,2]-Wittig	 rearrangement	
product	 4.5aa	 was	 isolated	 in	 85%	 yield	 (entry	 11).	 	 As	 shown	 in	 entry	 12,	 the	
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palladium/NIXANTPHOS	loading	could	be	lowered	to	2.5	and	3.75	mol	%,	respectively,	without	a	
significant	drop	in	yield	(83%).	
	
Table	4.2.	Scope	of	aryl	bromides	in	the	arylation	of	2-pyridylmethyl	ethyl	ether	4.1a.[a]	
	
	
4.2.2. Arylation	of	2-Pyridylmethyl	Ethers.	
	 Based	on	the	optimized	arylation	conditions	(Table	4.1,	entry	7),	we	examined	a	variety	
of	aryl	bromides	in	the	DCCP	(Table	4.2).		In	general,	the	direct	arylation	of	2-pyridylmethyl	ethyl	
ether	(4.1a)	exhibited	excellent	selectivity	and	good	yields	with	a	range	of	aryl	bromides.	 	Aryl	
bromides	bearing	electron-donating	groups,	such	as	4-tBu,	4-OMe,	or	4-NMe2,	 resulted	 in	88–
N
O
Et
Pd(OAc)2  (5 mol %)
NIXANTPHOS (7.5 mol %)+
N
O
Et
Ar
NaN(SiMe3)2 (3.0 equiv) 
DME, RT, 12 h
Ar–Br
4.1a 4.4
2-Py O
Et
2-Py O
Et
tBu
2-Py O
Et
OMe
2-Py O
Et
NMe2
2-Py O
Et
F
2-Py O
Et
Me
2-Py O
Et
N
Me
2-Py O
Et
O
4.4aa 95% 4.4ab 90%
(5 mmol, 83%)
4.4ac 88% 4.4ad 99%
4.4ae 82% 4.4af 75% 4.4ag 82% 4.4ah 83%
 [a] Reaction conditions: 4.1a (0.2 mmol), Ar–Br (0.24 mmol), NaN(SiMe3)2 (0.6 mmol), 
Pd(OAc)2/NIXANTPHOS (5 mol %/7.5 mol %), DME (2.0 mL); Isolated yield.
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99%	yields.	1-Bromo-4-fluorobenzene	provided	the	product	in	82%	yield.		Sterically	hindered	2-
bromotoluene	 coupled	 in	 75%	 yield.	 	 Heterocyclic	 N-methyl	 5-bromo	 indole	 and	 5-bromo	
benzofuran	underwent	coupling	to	provide	the	products	in	82–83%	yield.		It	is	noteworthy	that	
when	 the	 reaction	of	4.1a	 and	4-tert-butyl	bromobenzene	was	 conducted	on	a	5	mmol	 scale,	
the	arylation	product	4.4ab	was	isolated	in	83%	yield	(1.12	g).		
	
Table	4.3.	Scope	of	2-pyridylmethyl	ethers	in	the	chemoselective	arylation.[a]	
	
	
N
O
Pd(OAc)2  (5 mol%)
NIXANTPHOS (7.5 mol%)
+ N
O
R
ArNaN(SiMe3)2 (3.0 equiv)DME, RT, 12 h
R
4.1 4.4
N
O
Me
NMe2
N
O
NMe2
N
O
tBu
NMe2
N
O
NMe2
4.4cd 92%
N
O
Me
F
N
O
F
N
O
tBu
F
N
O
F
F
N
O
F
tBu
4.4bd 83% 4.4dd 88% 4.4ed 82% 4.4be 85%
4.4ce 88% 4.4de 80% 4.4fe 82% 4.4ge 80%
R
Br
R = NMe2, 4.6d
R = F, 4.6e
[a] Reaction conditions: 4.1 (0.2 mmol), Ar–Br (0.24 mmol), NaN(SiMe3)2 (0.6 mmol), 
Pd(OAc)2/NIXANTPHOS (5 mol %/7.5 mol %), DME (2.0 mL); Isolated yield.
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	 The	 substrate	 scope	 of	 2-pyridylmethyl	 ethers	 was	 next	 explored	 (Table	 4.3)	 with	
electron-donating	 4-bromo-N,N-dimethylaniline	 (entries	 1–4)	 and	 with	 1-bromo-4-
fluorobenzene	 (entries	 5–9).	 	 In	 general,	 all	 the	 2-pyridylmethyl	 alkyl	 or	 aryl	 ethers	 exhibited	
80−92%	yield	and	excellent	selectivity,	with	no	[1,2]-Wittig	product	observed	by	1H	NMR	of	the	
crude	reaction	mixtures.		2-Pyridylmethyl	alkyl	ethers,	including	methyl	ether	(4.1b),	cyclohexyl	
ether	(4.1c)	and	tert-butyl	ether	(4.1d)	showed	good	reactivity	in	the	arylation	reaction	with	4-
bromo-N,N-dimethylaniline	 and	 1-bromo-4-fluorobenzene	 to	 furnish	 arylated	 ether	 products	
4.4bd–4.4dd	 (83−92%)	 and	 4.4be–4.4de	 (80−88%).	 	 In	 addition,	 2-pyridylmethyl	 aryl	 ethers,	
including	 phenyl	 (4.1e),	 4-fluorophenyl	 (4.1f)	 and	 4-tert-butylphenyl	 ether	 (4.1g)	 coupled	 via	
DCCP	to	provide	the	corresponding	products	4.4ed	(82%),	4.4fe	(82%)	and	4.4ge	(80%).	
	
4.2.3. Tandem	Arylation/[1,2]-Wittig	Rearrangement.	
	 Having	demonstrated	the	broad	scope	of	the	arylation,	we	then	focused	on	the	tandem	
arylation/[1,2]-Wittig	 rearrangement.	 	 Employing	 the	 optimized	 conditions	 in	 Table	 4.1	 (entry	
12)	with	LiN(SiMe3)2	in	CPME	at	45	°C,	reaction	of	2-pyridylmethyl	ethyl	ether	with	aryl	bromides	
was	investigated	(Table	4.4).		Electron	neutral	1-bromo-4-tert-butylbenzene	and	bromobenzene	
furnished	 the	 desired	 products	 4.5aa	 and	 4.5ab	 in	 85	 and	 78%	 yields,	 respectively.	 	 Aryl	
bromides	bearing	electron-donating	4-OMe	and	4-NMe2	groups	 led	to	the	coupled/rearranged	
products	4.5ac	 and	4.5ad	 in	 75	and	78%	yield,	 respectively.	 	Heterocyclic	 5-bromobenzofuran	
and	 5-bromo-1-methyl-1H-indole,	 also	 gave	 the	 compounds	 4.5ag	 and	 4.5ah	 in	 70	 and	 72%	
yield.		When	the	reaction	of	4.1a	and	1-bromo-4-fluorobenzene	was	performed	on	5	mmol	scale	
with	LiN(SiMe3)2	 in	CPME,	the	arylation/[1,2]-Wittig	rearrangement	product	4.5ae	was	isolated	
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in	74%	yield	(0.86	g).	 	3-Bromophenol	was	also	examined,	however,	analysis	of	1H	NMR	of	the	
crude	reaction	mixtures	showed	no	sign	of	arylation	product	or	tandem	product.		Less	than	10%	
of	the	pyridylmethyl	ether	was	recovered,	indicating	decomposition	of	starting	materials	and/or	
products.	
	
Table	4.4	Tandem	arylation/[1,2]-Wittig	rearrangement	of	2-pyridylmethyl	ethyl	ether	4.1a	with	
aryl	bromides.[a]	
	
	
	 The	 scope	 in	 the	 migrating	 O–R	 group	 in	 the	 tandem	 arylation/[1,2]-Wittig	
rearrangement	 was	 investigated	 with	 various	 aryl	 groups.	 	 The	 2-pyridylmethyl	 ethers	 with	
primary	migrating	 groups	 (Table	 4.4),	methyl,	 secondary,	 and	 tertiary	 alkyl	 ethers	 (Table	 4.5,	
N
Pd(OAc)2  (2.5 mol %)
NIXANTPHOS (3.75 mol %)
+
LiN(SiMe3)2 (3.0 equiv)
CPME, 45 oC, 24 h
BrArO
Et
4.1a 4.5
4.5aa 85% 4.5ab 78% 4.5ac 75% 4.5ad 72%
4.5ai 83%4.5aj 78% 4.5ah 70%4.5ag 72%
HO Et
Ar
2-Py
HO Et
Ph 2-Py
HO Et
tBu
2-Py
HO Et
OMe
2-Py
HO Et
NMe2
2-Py
HO Et
F
4.5ae 88%
(5 mmol, 74%)
2-Py
HO Et
NMe
2-Py
HO Et
O
2-Py
HO Et
Cl
2-Py
HO Et
CF3
N
[a] Reaction conditions: 4.1a (0.2 mmol), Ar–Br (0.24 mmol), LiN(SiMe3)2 (0.6 mmol), 
Pd(OAc)2/NIXANTPHOS (2.5 mol %/3.75 mol %), CPME (2.0 mL); Isolated yields.
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entries	 1–6)	 gave	 arylation/[1,2]-Wittig	 rearranged	 products	 in	 60−85%	 yield.	 	 To	 examine	
selectivity	 in	 the	 oxidative	 addition	 step	 (aryl	 bromide	 vs.	 chloride)	 2-pyridylmethyl	 tert-butyl	
ether	 was	 coupled	 with	 1-bromo-4-chlorobenzene	 (entry	 6).	 	 The	 arylation/[1,2]-Wittig	
rearrangement	product	4.5di	was	obtained	 in	60%	 isolated	yield,	despite	 the	known	ability	of	
the	catalyst	 to	activate	aryl	 chlorides	at	 rt.20p	 	Amino	ethyl-containing	R	groups	also	migrated,	
giving	the	desired	amines	in	64–74%	yield	(entries	7–10).		
	
Table	4.5.	Tandem	arylation/[1,2]-Wittig	rearrangement	of	2-pyridylmethyl	alkyl	ethers	with	aryl	
bromides.[a]	
	
	
R = Meb 72% (4.5bd)
R = Cy 82% (4.5cd)
R = tBu 65% (4.5dd)
60% (4.5di)R = Meb 75% (4.5be)
R = Cy 85% (5ce)
N
Pd(OAc)2  (2.5 mol %)
NiXantphos (3.75 mo l%)
+
LiN(SiMe3)2 (3.0 equiv)
CPME, 60 oC, 24 h
BrArO
R N
4.1 4.54.6
Ar
HO R
N
HO R
NMe2
N
HO R
F
N
HO tBu
Cl
4.5ia; NR12 = NMe2, R2 = H, 74% yield
4.5ii; NR12 = NMe2, R2 = Cl, 74% yield
4.5ja; NR12 = N(CH2)4, R2 =H, 64% yield
4.5jk; NR12 = N(CH2)4, R2 =Me, 71% yield
N
OH
R2
NR12
[a] Reaction conditions: 4.1 (0.2 mmol), Ar–Br (0.24 mmol), LiN(SiMe3)2 (0.6 mmol), 
Pd(OAc)2/NIXANTPHOS (2.5 mol %/3.75 mol %), CPME (2.0 mL); Isolated yields; no arylated 
ethers observed by 1H NMR of crude reaction mixture. [b] 45 °C.
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4.2.4. Arylation	of	4-Pyridylmethyl	Ethers.	
	 Our	 focus	 on	 the	 arylation	 and	 tandem	 arylation/[1,2]-Wittig	 rearrangement	 of	 2-
pyridylmethyl	ethers	stems	from	their	utility	in	the	preparation	of	biologically	active	compounds	
(Figure	 4.1).	 	 At	 this	 juncture,	 we	 were	 curious	 if	 the	 2-pyridyl	 group	 was	 required	 for	 the	
deprotonation	 and	 arylation	 outlined	 above.	 	 To	 probe	 this	 question,	 as	well	 as	 broaden	 the	
scope	of	our	coupling	chemistry,	we	examined	reactions	of	4-pyridylmethyl	alkyl	ethers	(4.1j	and	
4.1k,	Table	4.6)	with	various	aryl	bromides.		
		Under	 our	 standard	 arylation	 conditions	 [NaN(SiMe3)2	 in	 DME	 at	 23	 °C],	 arylation	 of	 4-
pyridylmethyl	 alkyl	 ethers	 (4.1j	 and	 4.1k)	 with	 aryl	 bromides	 provided	 the	 arylated	 products	
4.4jd,	 4.4kb	 and	 4.4kc	 in	 85–88%	 yield	 (Table	 4.6),	 demonstrating	 that	 chelation	 is	 not	 a	
prerequisite	to	deprotonation	or	arylation.		The	increased	reactivity	of	the	4-pyridyl	derivatives	
over	 the	2-pyridyl	 analogues	enabled	us	 to	 reduce	 the	palladium	 loading	 to	1	mol	%	 in	 these	
cases.		
	 To	 our	 surprise,	 conducting	 the	 reaction	 under	 the	 tandem	 arylation/[1,2]-Wittig	
rearrangement	 conditions	 [LiN(SiMe3)2	 in	 CPME	 at	 60	 °C]	 did	 not	 provide	 the	 tandem	
arylation/rearranged	products	4.5,	but	instead	furnished	the	arylated	ether	products	in	80–88%	
yield.		While	the	tandem	arylation/[1,2]-Wittig	reaction	of	4.1j	with	LiN(SiMe3)2	in	CPME	at	60	°C	
resulted	in	arylation	product	4.4je	in	Table	6,	the	same	condition	at	80	°C	for	24	h	showed	10%	
of	 tandem	 arylation/[1,2]-Wittig	 rearrangement	 product	 and	 72%	 of	 arylation	 product	 4.4je.		
Higher	reaction	temperatures	resulted	in	decomposition.		These	results	suggest	that	[1,2]-Wittig	
rearrangement	of	4-pyridylmethyl	ethers	are	possible,	but	require	higher	activation	energy.	This	
difference	 in	 reactivity	 between	 2-	 and	 4-pyridylmethyl	 ethers	 most	 likely	 stems	 from	 the	
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increased	 stability	 of	 the	 deprotonated	 4-pyridylmethyl	 ethers.	 	 We	 are	 aware	 of	 a	 few	
examples	 of	 [1,2]-Wittig	 rearrangements	 of	 4-pyridyl	 methyl	 ethers	 in	 the	 literature.26	 	 The	
mechanism	 of	 [1,2]-Wittig	 rearrangement	 proceeds	 via	 radical	 intermediates.	 	 The	 radical	
intermediates	 derived	 from	 4-pyridylmethyl	 ethers	 are	 expected	 to	 be	 higher	 in	 energy	 than	
those	generated	from	2-pyridylmethyl	ethers.27	
	
Table	4.6.	Scope	of	4-pyridylmethyl	ethers	in	the	chemoselective	arylation.	
	
N
O
Et
NMe2
N
O
tBu
tBu
N
O
tBu
OMe
4.4kb
(23 oC, 86% y)[a]
(60 oC, 84% y)[b]
4.4jd
(23 oC, 85% y)[a]
4.4kc
(23 oC, 88% y)[a]
N
O
Et
F
N
O
Et
OMe
N
O
tBu
F
N
O
Et
4.4jc
(60 oC, 88% y)[b]
4.4je
(60 oC, 87% y)[b]
4.4ke
(60 oC, 80% y)[b]
4.4jf
(60 oC, 88% y)[b]
Me
N
O
R
+
N
O
R
Ar
Ar–Br
4.1 4.4
Conditions[a],[b]
Pd(OAc)2  (1 mol %)
NIXANTPHOS (1.5 mol %)
[a] Conditions A: 4.1 (0.2 mmol), Ar–Br (0.24 mmol), NaN(SiMe3)2 (0.6 mmol), 
Pd(OAc)2/NIXANTPHOS (1 mol %/1.5 mol %), DME (2.0 mL) at 23 °C. [b] Conditions B: 4.1 
(0.2 mmol), Ar–Br (0.24 mmol), LiN(SiMe3)2 (0.6 mmol), Pd(OAc)2/NIXANTPHOS (1 mol 
%/1.5 mol %), CPME (2.0 mL) at 60 °C.
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4.2.5. Comparative	Studies.	
	 While	the	scope	of	the	substrates	in	Tables	2–6	is	very	good,	some	substrates	were	not	
compatible	with	the	optimized	conditions.		This	occurred	when	the	O–R	substituent	was	allyl	or	
benzyl	 (Scheme	 4.1A).	 	 These	 substrates	 underwent	 [1,2]-Wittig	 rearrangement	 faster	 than	
arylation,	highlighting	the	fine	line	in	chemoselectivity	between	the	[1,2]-Wittig	rearrangement	
of	 the	 carbanion	 4.2	 relative	 to	 transmetallation	 to	 palladium	 (Figure	 4.2).	 	 Additionally,	 2-
pyridylmethyl	aryl	ethers	did	not	undergo	the	[1,2]-Wittig	rearrangement.	 	These	observations	
are	in	accord	with	the	mechanism	of	[1,2]-Wittig	rearrangement,	which	proceeds	via	free	radical	
intermediates.22a	 	 The	 general	 order	 of	 reactivity	 of	 migrating	 groups	 in	 the	 Wittig	
rearrangement	 is	dictated	by	the	stability	of	the	corresponding	radicals:	allyl	~	benzyl	>	alkyl	>	
aryl.28		
	 To	 probe	 the	 order	 of	 the	 reactions	 leading	 to	 the	 tertiary	 alcohols	 4.5,	 (pyridin-2-
yl)propan-1-ol	4.3a	was	prepared	by	[1,2]-Wittig	rearrangement	of	4.1a	with	n-BuLi	in	THF	at	–
40	°C.4d		When	alcohol	4.3a	was	subjected	to	our	arylation	conditions,	no	arylation	product	was	
observed	 (Scheme	 4.1B),	 and	 starting	 material	 was	 recovered.	 	 In	 contrast,	 ether	 4.4ad	
underwent	 [1,2]-Wittig	 rearrangement	 upon	 exposure	 to	 LiN(SiMe3)2	 in	 the	 absence	 of	 the	
Pd(NIXANTPHOS)-based	 catalyst	 in	 80%	 yield	 (Scheme	 4.1C).	 	 Thus,	 the	 [1,2]-Wittig	
rearrangement	does	not	require	palladium	to	occur.		Taken	together,	these	results	suggest	that	
arylation	occurs	before	[1,2]-Wittig	rearrangement.	
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Scheme	 4.1.	 Probing	 the	 order	 of	 the	 tandem	arylation/[1,2]-Wittig	 rearrangement.	 	 A.	 [1,2]-
Wittig	rearrangement	of	allyl	and	benzyl	ethers	 is	 faster	 than	Pd-catalyzed	arylation	reactions.		
B.	 [1,2]-Wittig	 rearrangement	 product	 does	 not	 undergo	 arylation.	 	 C.	 [1,2]-Wittig	
rearrangement	takes	place	in	the	absence	of	the	Pd-catalyst.	
	
4.2.6. Impact	of	Li	and	Na	on	[1,2]-Wittig	Rearrangements.	
	 [1,2]-Wittig	 rearrangements	 are	 known	 to	 be	 influenced	 by	 combinations	 of	 alkali	
metals	and	solvents.23d,29		Although	a	full	mechanistic	study	of	the	[1,2]-Wittig	rearrangement	is	
beyond	 the	 scope	 of	 this	 manuscript,	 we	 hoped	 to	 gain	 some	 insight	 into	 the	 reactivity	
differences	in	the	[1,2]-Wittig	rearrangement	with	lithium	and	sodium	silyl	amide	bases.		Thus,	
we	decided	to	explore	the	rearrangement	of	isolated	arylation	product	4.4ab	(Table	4.7).		In	this	
N
OH
Et
Pd(OAc)2  (5 mol %)
NIXANTPHOS (7.5 mol %)
NaN(SiMe3)2 (3 equiv) 
DME, RT, 24 h
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O
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LiN(SiMe3)2 (2 equiv)
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NIXANTPHOS (7.5 mol %)
+
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R
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4.1l: R = CH2CH=CH2 
4.1m: R = CH2Ph
4.3l 80%: R = CH2CH=CH2 
4.3m 80%: R = CH2Ph
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+
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study,	2	bases	[LiN(SiMe3)2		and	NaN(SiMe3)2],	2	solvents	[DME	and	CPME],		and	2	additives	[12-
crown-4	 and	 15-crown-5]	were	 examined.	 	 Reactions	were	 conducted	 at	 45	 °C	 to	 give	 higher	
amounts	of	[1,2]-Wittig	rearrangement	product	than	reactions	conducted	at	room	temperature	
(as	 in	 Tables	 4.1–4.3).	 	 Reactions	 were	 intentionally	 quenched	 before	 completion	 to	 assess	
reaction	 progress.	 The	 quantities	 of	 starting	 materials	 and	 products	 were	 determined	 by	 1H	
NMR	integration	of	reaction	mixtures	against	an	internal	standard.		
	 The	 results	of	 this	 study	are	 illustrated	 in	 Table	4.7.	 	 Reactions	 in	CPME	promoted	by	
LiN(SiMe3)2	 and	 NaN(SiMe3)2	 undergo	 relatively	 fast	 [1,2]-Wittig	 rearrangements	 at	 45	 °C	
(entries	 1	 and	 2).	 	 In	 DME	 both	 bases	 are	 less	 capable	 of	 promoting	 the	 rearrangement,	 but	
NaN(SiMe3)2	 is	 significantly	 slower	 than	 LiN(SiMe3)2	 (9	 vs.	 27%	 [1,2]-Wittig	 rearrangement	
product,	entries	3	and	4,	respectively).		This	result	suggested	that	coordinating	DME	retards	the	
rearrangement	with	the	sodium	counterion	more	so	than	with	the	lithium	counterion.		To	probe	
this	hypothesis,	reactions	were	conducted	in	the	presence	of	12-crown-4	and	15-crown-5	in	the	
less	coordinating	CPME.		The	impact	of	12-crown-4/CPME	on	the	LiN(SiMe3)2	reaction	is	a	slight	
decrease	in	the	conversion	(47	vs.	64%,	entry	5	vs.	1).		In	contrast,	crown	ethers	12-crown-4	and	
15-crown-5	strongly	inhibited	the	[1,2]-Wittig	rearrangement	with	NaN(SiMe3)2,	resulting	in	only	
7	 and	 13%	 product	 formation	 (entries	 6–7,	 respectively)	 compared	 to	 75%	 in	 CPME	 in	 the	
absence	 of	 crown	 ether	 (entry	 2).	 	 Thus,	 we	 conclude	 that	 coordinating	 solvent	 (DME)	 and	
coordinating	additives	 (12-crown-4	and	15-crown-5)	both	 inhibit	 the	 reaction	with	 the	sodium	
base	 to	a	much	greater	extent	 than	with	 the	 lithium	base.	 	 These	observations	are	consistent	
with	the	results	in	Table	4.1.		
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Table	 4.7.	 Effect	 of	 Alkali	 Metals,	 Solvents,	 and	 Additives	 in	 [1,2]-Wittig	 Rearrangement	 of	
4.4ab.	
	
entry	 solvent	 M	 additive	 4ab	(%)[b]	 5ab	(%)[b]	
1	 CPME	 Li	 –	 37	 64	
2	 CPME	 Na	 –	 24	 75	
3	 DME	 Li	 –	 72	 27	
4	 DME	 Na	 –	 85	 9	
5	 CPME	 Li	 12-Crown-4	 53	 47	
6	 CPME	 Na	 12-Crown-4	 90	 7	
7	 CPME	 Na	 15-Crown-5	 86	 13	
	 	 	 	 	
	[a]	Reaction	conditions:	4.4ab	(0.05	mmol),	MN(SiMe3)2	(0.075	mmol),	Additive	(0.075	mmol)	in	
solvent	(0.25	mL)	at	45	°C.	[b]	Yield	determined	by	1H	NMR	spectroscopy	of	the	crude	reaction	
mixture.	
	
 Conclusions	4.3.
In	 summary,	 we	 have	 developed	 a	 unified	 approach	 for	 the	 synthesis	 of	 structurally	 diverse	
pyridines,	 which	 are	 among	 the	most	 important	 heterocycles	 and	 are	 found	 in	many	 natural	
products	 and	 pharmaceutically	 relevant	molecules	 (Figure	 4.1).	 	 The	 key	 to	 achieving	 skeletal	
diversity	 from	 a	 single	 starting	 material	 is	 to	 effect	 either	 the	 arylation	 or	 tandem	
arylation/[1,2]-Wittig	rearrangement	with	high	selectivity.		Despite	the	remarkable	similarity	of	
the	 reaction	 parameters	 for	 these	 processes,	 both	 being	 promoted	 by	 silylamide	 bases	 and	 a	
(NIXANTPHOS)Pd-based	 catalyst,	 we	 have	 successfully	 identified	 conditions	 to	 favor	 strongly	
N
O
Et
tBu
4ab
MN(SiMe3)2 (1.5 equiv)
Additive (1.5 equiv)
Solvent (0.2 M)
45 oC, 1 h
N Et
tBu
5ab
OH
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either	 reaction.	 The	 exceptional	 selectivity	 between	 secondary	 pyridyl	 ethers	 and	 their	
rearranged	tertiary	alcohol	 isomers	 is	governed	by	 the	choice	of	main	group	metal	 (Na	vs.	Li),	
solvent,	and	temperature.		We	anticipate	that	these	practical	methods	will	be	applicable	for	the	
synthesis	of	a	broad	array	of	pyridyl-containing	ethers	and	alcohols.		
	
 Experimental	Section	4.4.
General	Methods.	 	All	 reactions	were	 conducted	 under	 an	 inert	 atmosphere	 of	 dry	 nitrogen.	
Anhydrous	 dioxane	 and	 cyclopentyl	methyl	 ether	 (CPME)	were	 purchased	 from	 Sigma-Aldrich	
and	used	without	further	purification.	Dimethoxyethane	(DME)	and	tetrahydrofuran	(THF)	were	
dried	through	activated	alumina	columns	under	nitrogen.		Solvents	were	commercially	available	
and	 used	 as	 received	 without	 further	 purification.	 	 Chemicals	 were	 purchased	 from	 Sigma-
Aldrich,	 Acros,	 Fisher	 Scientific	 or	 Matrix	 Scientific,	 and	 solvents	 were	 obtained	 from	 Fisher	
Scientific.		Thin-layer	chromatography	was	performed	on	Whatman	precoated	silica	gel	60	F-254	
plates	and	visualized	by	ultraviolet	 light.	 	Flash	chromatography	was	performed	with	 silica	gel	
(Silicaflash,	 P60,	 40-63	 μm,	 Silicycle).	 	 NMR	 spectra	 were	 obtained	 using	 a	 Brüker	 500	 MHz	
Fourier-transform	NMR	spectrometer	at	the	University	of	Pennsylvania	NMR	facility.		1H	and	13C	
chemical	shifts	in	parts	per	million	(δ)	were	referenced	to	internal	tetramethylsilane	(TMS).		The	
designation	“ABq”	for	a	1H	NMR	resonances	indicates	that	the	particular	peak	was	one	partner	
of	 an	 AB	 quartet;	 if	 additional	 splittings	 were	 evident,	 they	 are	 noted	 following	 the	 ABq	
designation	 (e.g.,	 ABqq).	 	 The	 infrared	 spectra	were	 obtained	with	 KBr	 plates	 using	 a	 Perkin-
Elmer	 Spectrum	 1600	 Series	 spectrometer.	 	 High-resolution	 mass	 spectrometry	 (HRMS)	 data	
were	obtained	on	a	Waters	LC-TOF	mass	spectrometer	(model	LCT-XE	Premier)	using	chemical	
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ionization	 (CI)	 or	 electrospray	 ionization	 (ESI)	 in	 positive	or	 negative	mode,	 depending	on	 the	
analyte.		Melting	points	were	determined	on	a	Unimelt	Thomas-Hoover	melting	point	apparatus	
and	are	uncorrected.		2-(Chloromethyl)pyridine	hydrochloride	(98%)	was	purchased	from	Matrix	
Scientific	and	used	as	received.		
	
Preparation	of	pyridylmethyl	ethers	
General	Procedure	A	using	sodium	alkoxide:	An	oven-dried	25	mL	two-neck	flask	equipped	with	
a	stir	bar	was	charged	with	NaOEt	(2.04	g,	30	mmol)	inside	a	glove	box,	and	the	flask	was	capped	
with	a	reflux	condenser	and	a	septum	and	brought	out	of	the	glove	box.	To	the	flask	was	added	
EtOH	 (5	 mL,	 86	 mmol)	 and	 2-(chloromethyl)pyridine	 hydrochloride	 (2.0	 g,	 12	 mmol)	 under	
positive	pressure	of	N2	at	room	temperature,	and	the	reaction	mixture	was	stirred	and	heated	
to	refluxe	for	4–8	h	until	TLC	showed	complete	consumption	of	2-(chloromethyl)pyridine.	Next,	
the	remaining	EtOH	was	removed	under	reduced	pressure,	and	the	residue	was	purified	by	flash	
column	chromatography	on	silica	gel	to	afford	the	desired	products.1		
	
General	 Procedure	 B	 using	 sodium	 hydride	 and	 alcohols:	 An	 oven-dried	 100	mL	one-necked	
flask	with	a	stir	bar	was	charged	with	NaH	(dry,	95%)	(0.73	g,	30	mmol)	under	N2.	The	flask	was	
capped	with	a	septum.	To	the	flask	was	added	dry	THF	(25	mL)	at	rt,	and	the	reaction	mixture	
was	cooled	to	0	°C	in	an	ice	bath.	To	this	white	suspension	was	added	dropwise	cyclohexanol	(5	
mL,	48	mmol).	Upon	addition	of	the	cyclohexanol,	rapid	evolution	of	a	gas	was	observed.	Once	
the	H2	 evolution	 ceased,	 2-(chloromethyl)pyridine	 hydrochloride	 (2.0	 g,	 12	mmol)	was	 added,	
and	the	resulting	solution	was	heated	to	reflux	for	8	h	until	TLC	showed	complete	consumption	
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of	 2-(chloromethyl)pyridine.	 Next,	 the	 remaining	 cyclohexanol	 was	 removed	 under	 reduced	
pressure,	and	the	residue	was	purified	by	 flash	column	chromatography	on	silica	gel	 to	afford	
the	desired	products.1		
	
General	Procedure	C	using	sodium	hydroxide	and	phenol	derivatives:	 In	a	25	mL	two-necked	
flask	equipped	with	a	stir	bar	was	added	the	2-(chloromethyl)pyridine	hydrochloride	(2.0	g,	12	
mmol),	 sodium	 hydroxide	 (1.2	 g,	 30	 mmol),	 phenol	 (12	 mmol)	 and	 toluene	 (5	 mL)	 at	 room	
temperature.	The	flask	was	capped	with	a	reflux	condenser	and	a	septum.	The	resulting	biphasic	
mixture	was	stirred	and	heated	to	reflux	for	4–8	h	until	TLC	showed	complete	consumption	of	2-
(chloromethyl)pyridine.	 Then	 toluene	was	 removed	 under	 reduced	 pressure.	 The	 residue	was	
purified	by	flash	column	chromatography	on	silica	gel	to	afford	desired	products.2		
	
	2-(Ethoxymethyl)pyridine	 (4.1a).	The	reaction	was	performed	following	General	
Procedure	 A	 with	 2-(chloromethyl)pyridine	 hydrochloride	 (2.0	 g,	 12	 mmol),	
sodium	 ethoxide	 (2.04	 g,	 30	mmol)	 and	 ethanol	 (5	mL,	 86	mmol).	 The	 reaction	mixture	 was	
stirred	and	refluxed	for	4	h.	The	crude	product	was	purified	by	flash	chromatography	on	silica	
gel	 (eluted	with	EtOAc:hexanes	=	1:6)	to	afford	the	product	(1.32	g,	80%	yield)	as	a	yellow	oil.	
The	1H	and	13C{1H}	NMR	data	for	this	compound	match	the	literature	data.3		
	
2-(Methoxymethyl)pyridine	 (4.1b).	 The	 reaction	 was	 performed	 following	
General	 Procedure	 A	 with	 2-(chloromethyl)pyridine	 hydrochloride	 (2.0	 g,	 12	
mmol),	 sodium	methoxide	 (1.62	 g,	 30	mmol)	 and	methanol	 (5	mL).	 The	 reaction	mixture	was	
N
OMe
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stirred	and	refluxed	for	4	h.	The	crude	product	was	purified	by	flash	chromatography	on	silica	
gel	(eluted	with	EtOAc:hexanes	=	1:6)	to	afford	the	product	(1.25	g,	85%	yield)	as	a	colorless	oil.	
The	1H	and	13C{1H}	NMR	data	for	this	compound	match	the	literature	data.4		
	
	2-((Cyclohexyloxy)methyl)pyridine	 (4.1c).	 The	 reaction	 was	 performed	
following	 General	 Procedure	 B	 with	 2-(chloromethyl)pyridine	 hydrochloride	
(2.0	 g,	 12	 mmol),	 sodium	 hydride	 (0.73	 g,	 30	 mmol)	 and	 cyclohexanol	 (5	 mL).	 The	 reaction	
mixture	 was	 stirred	 and	 refluxed	 for	 8	 h.	 The	 crude	 product	 was	 purified	 by	 flash	
chromatography	on	 silica	gel	 (eluted	with	EtOAc:hexanes	=	1:6)	 to	afford	 the	product	 (2.00	g,	
88%	yield)	as	a	yellow	oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.47	(d,	J	=	4.0	Hz,	1H),	7.62	(t,	J	=	8.0	Hz,	
1H),	 7.44	 (d,	 J	 =	 8.0	 Hz,	 1H),	 7.10	(t,	 J	 =	 6.5	 Hz,	1H),	4.61	(s,	 2H),	3.37	 –	 3.34	(m,	 1H),	1.95	 –	
1.90	(m,	 2H),	1.69	 –	 1.72	(m,	 2H),	1.49	 –	 1.21	(m,	 6H)	 ppm;	 13C{1H}	 NMR	 (125	 MHz,	 CDCl3):	
δ	159.5,	 148.7,	 136.3,	 121.9,	 121.1,	 77.6,	 70.7,	 32.1,	 25.7,	 23.9	 ppm;	 HRMS	 m/z	 192.1383	
[(M+H)+;	calcd	for	C12H18NO:	192.1388].	
	
	2-(tert-Butoxymethyl)pyridine	 (4.1d).	 The	 reaction	 was	 performed	 following	
General	 Procedure	 A	 with	 2-(chloromethyl)pyridine	 hydrochloride	 (2.0	 g,	 12	
mmol),	 sodium	 tert-butoxide	 (2.88	g,	 30	mmol)	 and	 tert-butanol	 (5	mL).	 The	 reaction	mixture	
was	 stirred	and	 refluxed	 for	8	h.	 The	 crude	product	was	purified	by	 flash	 chromatography	on	
silica	gel	(eluted	with	EtOAc:hexanes	=	1:6)	to	afford	the	product	(1.78	g,	90%	yield)	as	a	yellow	
oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.46	(d,	J	=	5.0	Hz,	1H),	7.60	(t,	J	=	8.0	Hz,	1H),	7.43	(d,	J	=	8.0	Hz,	
1H),	7.09	–	7.06	(m,	1H),	4.54	(s,	2H),		1.28	(s,	9H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	160.1,	
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148.6,	 136.3,	 121.7,	 121.0,	 73.6,	 65.2,	 27.5	 ppm;	 HRMS	 m/z	 166.1226	 [(M+H)+;	 calcd	 for	
C10H16NO:	166.1232].	
	
	2-(Phenoxymethyl)pyridine	 (4.1e).	 The	 reaction	 was	 performed	 following	
General	 Procedure	C	with	 2-(chloromethyl)pyridine	hydrochloride	 (2.0	 g,	 12	
mmol),	phenol	 (1.13	g,	12	mmol),	sodium	hydroxide	(1.2	g,	30	mmol)	and	toluene	(5	mL).	The	
reaction	 mixture	 was	 stirred	 and	 refluxed	 for	 4	 h.	 The	 crude	 product	 was	 purified	 by	 flash	
chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	1:6)	to	afford	the	product	(2.0	g,	90%	
yield)	as	a	yellow	oil.	The	1H	and	13C{1H}	NMR	data	for	this	compound	match	the	literature	data.5		
	
	2-((4-Fluorophenoxy)methyl)pyridine	 (4.1f).	The	reaction	was	performed	
following	 General	 Procedure	 C	 with	 2-(chloromethyl)pyridine	
hydrochloride	(2.0	g,	12	mmol),	4-fluorophenol	(1.34	g,	12	mmol),	sodium	hydroxide	(1.2	g,	30	
mmol)	 and	 toluene	 (5	mL).	 The	 reaction	mixture	was	 stirred	 and	 refluxed	 for	 6	 h.	 The	 crude	
product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	1:6)	to	
afford	 the	product	 (2.09	g,	86%	yield)	 as	a	white	 solid.	m.p.	=	52	–	55	 °C;	 1H	NMR	 (500	MHz,	
CDCl3):	δ	8.57	(d,	J	=	5.0	Hz,	1H),	7.69	(t,	J	=	8.0	Hz,	1H),	7.48	(d,	J	=	8.0	Hz,	1H),	7.21	–	7.19	(m,	
1H),		6.96	–	6.88	(m,	4H),	5.14	 (s,	 2H)	ppm;	 13C{1H}	NMR	 (125	MHz,	CDCl3):	δ	157.4	 (d,	 J	 =	250	
Hz),	 157.0,	 154.4	 (d,	 J	 =	 1.75	Hz),	 149.1,	 136.7,	 122.6,	 121.2,	 115.9,	 115.7	 (d,	 J	 =	 25	Hz),	 71.1	
ppm;	HRMS	m/z	204.0819	[(M+H)+;	calcd	for	C12H11NOF:	204.0825].	
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	2-((4-(tert-Butyl)phenoxy)methyl)pyridine	 (4.1g).	 The	 reaction	 was	
performed	following	General	Procedure	C	with	2-(chloromethyl)pyridine	
hydrochloride	(2.0	g,	12	mmol),	4-tert-butylphenol	(1.8	g,	12	mmol),	sodium	hydroxide	(1.2	g,	30	
mmol)	 and	 toluene	 (5	mL).	 The	 reaction	mixture	was	 stirred	 and	 refluxed	 for	 8	 h.	 The	 crude	
product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	1:6)	to	
afford	the	product	(2.17	g,	76%	yield)	as	a	thin	yellow	oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.56	(br.	
s,	1H),	7.66	(br	s,	1H),	7.51	(br	s,	1H),	7.28	(d,	J	=	9.0	Hz,	2H),	7.18	(br	s.	1H),	6.90	–	(d,	J	=	9.0	Hz,	
2H),	5.17	(s,	2H),	1.27	(s,	9H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	157.5,	156.0,	149.0,	143.7,	
136.7,	 126.2,	 122.4,	 121.2,	 114.1,	 70.5,	 34.5,	 31.4	 ppm.	 The	 1H	NMR	data	 for	 this	 compound	
match	the	literature	data.6		
	
	N,N-Dimethyl-2-(pyridin-2-ylmethoxy)ethan-1-amine	 (4.1h).	 To	 an	 oven-
dried	 round-bottomed	 flask	 equipped	 with	 a	 stir	 bar	 was	 added	 sodium	
tert-butoxide	(3.36	g.	30	mmol)	and	THF	(20	mL)	in	a	dry	box	under	N2	at	room	temperature	and	
the	flask	was	then	capped	with	a	septum.	The	flask	was	brought	out	of	 the	glove	box	and	the	
reaction	 vessel	 was	 cooled	 to	 0	 °C	 in	 an	 ice	 bath	 and	 stirred	 for	 5	 min	 under	 a	 nitrogen	
atmosphere.	N,N-Dimethylethanolamine	(1.81	mL,	18	mmol)	was	added	dropwise,	after	which	
the	reaction	vessel	was	stirred	for	10	min	at	0	°C.	To	the	reaction	vessel	was	added	dropwise	2-
(chloromethyl)pyridine	(2.55	g,	20	mmol)	in	THF	(10	mL).	The	reaction	mixture	was	stirred	at	0	
°C	 for	 10	min,	 the	 ice	 bath	 was	 removed	 and	 the	 reaction	mixture	 stirred	 for	 12	 h	 at	 room	
temperature.	 The	 reaction	 mixture	 was	 diluted	 with	 EtOAc	 (20	 mL)	 and	 quenched	 with	
saturated	 aqueous	NH4Cl	 (30	mL).	 The	 organic	 layer	was	 separated	 and	 the	 aqueous	 solution	
N O N
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was	extracted	with	EtOAc	(4	x	20	mL).	The	combined	organic	layer	was	washed	with	saturated	
aqueous	NaHCO3	solution	(30	mL)	and	then	brine	(30	mL),	dried	over	MgSO4,	 filtered,	and	the	
solvent	 was	 removed	 in	 vacuo	 to	 yield	 a	 yellow	 oil.	 The	 crude	 product	 was	 purified	 by	 flash	
column	chromatography	on	silica	gel	(dichloromethane	to	dichloromethane:methanol	=	10:1)	to	
afford	the	product	as	a	brown	oil	(2.34	g,	72%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.52	(ddd,	J	=	
5.0,	1.5,	1.0	Hz,	1H),	7.66	(td,	J	=	7.5,	1.2	Hz,	1H),	7.43	(d,	J	=	5.0	Hz,	1H),	7.18	–	7.13	(m,	1H),	
4.64	(s,	2H),	3.64	(t,	J	=	5.8	Hz,	2H),	2.56	(t,	J	=	5.8	Hz,	2H),	2.26	(s,	6H)	ppm;	13C{1H}	NMR	(125	
MHz,	CDCl3)	δ	158.7,	149.2,	136.8,	122.5,	121.6,	74.2,	69.0,	59.0,	46.0	ppm;	IR	(neat)	3438,	3067,	
3012,	2942,	2862,	2819,	2769,	1591,	1572,	1457,	1435,	1353,	1269,	1192,	1046	cm-1;	HRMS	m/z	
180.1341	[(M+H)+;	calcd	for	C10H17N2O:	181.1341].	
	
	2-((2-(Pyrrolidin-1-yl)ethoxy)methyl)pyridine	 (4.1i).	 The	 reaction	 was	
performed	 following	 the	 procedure	 for	 4.1h	 with	 sodium	 tert-butoxide	
(3.36	g.	30	mmol),	N-(2-hydroxyethyl)pyrrolidine	(2.10	mL,	18	mmol),	2-(chloromethyl)pyridine	
(2.55	 g,	 20	 mmol)	 and	 THF	 (30	 mL).	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	(dichloromethane	to	dichloromethane:methanol	=	10:1)	to	afford	
the	product	(2.52	g,	72%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.52	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	
7.66	(td,	J	=	7.5,	1.5	Hz,	1H),	7.43	(d,	J	=	5.0	Hz,	1H),	7.18	–	7.12	(m,	1H),	4.66	(s,	2H),	3.68	(t,	J	=	
6.0	Hz,	2H),	2.75	(t,	J	=	6.0	Hz,	2H),	2.61	–	2.51	(m,	4H),	1.82	–	1.72	(m,	4H)	ppm;	13C{1H}	NMR	
(125	MHz,	CDCl3)	δ	158.8,	149.2,	136.7,	122.4,	121.5,	74.2,	70.0,	55.8,	54.8,	23.6	ppm;	IR	(neat)	
3468,	 3065,	 3011,	 2963,	 2931,	 2874,	 2782,	 1683,	 1591,	 1571,	 1476,	 1460,	 1435,	 1351,	 1292,	
1147,	1121,	1088,	1047	cm-1;	HRMS	m/z	207.1498	[(M+H)+;	calcd	for	C12H19N2O:	207.1497].	
N O N
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	4-(Ethoxymethyl)pyridine	 (4.1j).	The	reaction	was	performed	following	General	
Procedure	 A	 with	 4-(chloromethyl)pyridine	 hydrochloride	 (2.0	 g,	 12	 mmol),	
sodium	ethoxide	 (2.04	 g,	 30	mmol)	 and	ethanol	 (5	mL).	 The	 reaction	mixture	was	 stirred	 and	
refluxed	 for	4	h.	The	crude	product	was	purified	by	 flash	chromatography	on	silica	gel	 (eluted	
with	EtOAc:hexanes	=	1:2)	 to	afford	 the	product	 (1.32	g,	80%	yield)	as	a	 thin	 red	oil.	 1H	NMR	
(500	MHz,	CDCl3):	δ	8.23	(m,	2H),	7.23	(m,	2H),	4.48	(s,	2H),	3.56	–	3.52	(m,	2H),	1.25	–	1.22	(m,	
3H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	149.8,	147.8,	121.7,	70.9,	65.3,	15.1	ppm.	
	
	4-(tert-Butoxymethyl)pyridine	 (4.1k).	 The	 reaction	 was	 performed	 following	
General	 Procedure	 A	 with	 4-(chloromethyl)pyridine	 hydrochloride	 (2.0	 g,	 12	
mmol),	sodium	tert-butoxide	(2.9	g,	30	mmol)	and	tert-butanol	(5	mL).	The	reaction	mixture	was	
stirred	and	refluxed	for	8	h.	The	crude	product	was	purified	by	flash	chromatography	on	silica	
gel	(eluted	with	EtOAc:hexanes	=	1:2)	to	afford	the	product	(1.43	g,	72%	yield)	as	a	yellow	oil.	1H	
NMR	(500	MHz,	CDCl3):	δ	8.50	 (dd,	 J	=	4.5,	1.5	Hz,	2H),	7.24	 (m,	2H),	4.43	 (s,	2H),	1.25	 (s,	9H)	
ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	149.5,	149.2,	121.6,	73.8,	62.5,	27.5	ppm.	IR	(neat)	3029,	
2975,	 2934,	 2874,	 1722,	 1605,	 1562,	 1472,	 1415,	 1391,	 1364,	 1322,	 1298,	 1235,	 1195,	 1099,	
1075,	1066,	1027,	993	cm-1	
	
2-(Allyloxymethyl)pyridine	 (4.1l).	 The	 reaction	 was	 performed	 following	
General	 Procedure	C	with	 2-(chloromethyl)pyridine	 hydrochloride	 (2.0	 g,	 12	
mmol),	prop-2-en-1-ol	(0.7	g,	12	mmol),	sodium	hydroxide	(1.2	g,	30	mmol)	and	toluene	(5	mL).	
N
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The	reaction	mixture	was	stirred	and	refluxed	for	6	h.	The	crude	product	was	purified	by	flash	
chromatography	on	 silica	gel	 (eluted	with	EtOAc:hexanes	=	1:5)	 to	afford	 the	product	 (1.16	g,	
65%	yield)	as	a	yellow	oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.54	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	7.70	–	
7.67	(m,	1H),	7.46	(d,	J	=	8.0	Hz,	1H),	7.18	(dt,	J	=	8.0,	5.0	Hz,	1H),	6.01	–	5.94	(m,	1H),	5.34	(dd,	J	
=	 17.5,	 1.5	Hz,	 1H),	 5.34	 (dd,	 J	 =	 10.0,	 1.5	Hz,	 1H),	 4.65	 (s,	 2H),	 4.13	 (d,	 J	 =	 5.5	Hz,	 2H)	 ppm;	
13C{1H}	NMR	(125	MHz,	CDCl3):	δ	158.4,	149.0,	136.5,	134.3,	122.2,	121.2,	117.2,	72.9,	71.7	ppm.	
The	1H	NMR	data	for	this	compound	match	the	literature	data.	7		
	
2-(Benzyloxymethyl)pyridine	 (4.1m).	 The	 reaction	 was	 performed	
following	General	Procedure	C	with	2-(chloromethyl)pyridine	hydrochloride	
(2.0	 g,	 12	 mmol),	 benzyl	 alcohol	 (1.3	 g,	 12	 mmol),	 sodium	 hydroxide	 (1.2	 g,	 30	 mmol)	 and	
toluene	 (5	mL).	The	 reaction	mixture	was	 stirred	and	 refluxed	 for	4	h.	The	crude	product	was	
purified	by	 flash	chromatography	on	silica	gel	 (eluted	with	EtOAc:hexanes	=	1:4)	 to	afford	 the	
product	(2.0	g,	85%	yield)	as	a	yellow	oil.	The	1H	and	13C{1H}	NMR	data	for	this	compound	match	
the	literature	data.8		
		
Procedure	 and	 characterization	 of	 Pd-catalyzed	 chemoselective	 C(sp3)–H	 arylation	 of	 2-
pyridylmethyl	ethers	(Table	4.2	and	4.3).	
	
General	Procedure	D	for	the	Pd-catalyzed	chemoselective	C(sp3)–H	arylation	of	pyridylmethyl	
ethers:	
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An	oven-dried	10	mL	reaction	vial	equipped	with	a	stir	bar	was	charged	with	pyridylmethyl	ether	
(4.1,	 0.2	mmol,	 1.0	 equiv),	 aryl	 bromide	 (4.6,	 0.24	mmol,	 1.2	 equiv)	 and	dry	DME	 (1	mL)	 in	 a	
glove	box	under	a	nitrogen	atmosphere	at	room	temperature.	NaN(SiMe3)2	(110	mg,	0.6	mmol,	
3.0	 equiv)	was	 added	 to	 the	 reaction	mixture.	 A	 solution	 (from	 a	 stock	 solution)	 of	 Pd(OAc)2	
(2.24	mg,	0.01	mmol,	5	mol	%)	and	NIXANTPHOS	(8.28	mg,	0.015	mmol,	7.5	mol	%)	in	1	mL	of	
dry	DME	was	taken	up	by	syringe,	and	added	to	the	reaction	vial.	The	vial	was	capped,	removed	
from	the	glove	box,	and	stirred	for	12	h	at	room	temperature	(23	°C)	until	TLC	showed	complete	
consumption	 of	 pyridylmethyl	 ether.	 The	 reaction	 mixture	 was	 quenched	 with	 four	 drops	 of	
H2O,	diluted	with	3	mL	of	ethyl	acetate,	and	filtered	over	a	pad	of	MgSO4	and	silica.	The	pad	was	
rinsed	with	 additional	 ethyl	 acetate	 (2	mL),	 and	 the	 solution	was	 concentrated	 in	 vacuo.	 The	
crude	material	was	loaded	onto	a	silica	gel	column	and	purified	by	flash	chromatography.			
	
2-(Ethoxy(phenyl)methyl)pyridine	(4.4aa).	The	reaction	was	performed	following	
General	 Procedure	 D	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	 27.4	 mg,	 28	 uL,	 0.2	
mmol)	and	bromobenzene	(25.2	uL,	0.24	mmol).	The	crude	product	was	purified	
by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	10:90)	to	afford	the	product	
(48.5	mg,	95%	yield)	as	a	yellow	oil.	The	1H	and	13C{1H}	NMR	data	for	this	compound	match	the	
literature	data.3		
	
2-((4-(tert-Butyl)phenyl)(ethoxy)methyl)pyridine	 (4.4ab).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 D	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
27.4	mg,	28	uL,	0.2	mmol)	and	1-bromo-4-tert-butylbenzene	(42.0	uL,	0.24	mmol).	
N
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The	 crude	 product	 was	 purified,	 by	 flash	 chromatography	 on	 silica	 gel	 (eluted	 with	
EtOAc:hexanes	=	10:90)	to	afford	the	product	(48.4	mg,	90%	yield)	as	a	yellow	oil.	1H	NMR	(500	
MHz,	CDCl3):	δ	8.52	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	7.66	(ddd,	J	=	8.0,	7.5,	1.5	Hz,	1H),	7.54	(ddd,	J	
=	8.0,	1.5,	1.0	Hz,	1H),	7.37	–	7.32	(m,	4H),	7.12	(ddd,	J	=	7.5,	5.0,	1.0	Hz,	1H),	5.47	(s,	1H),		3.56	
(ABqq,	ΔνAB	=	22.2	Hz,	J	=	9.0,	7.0	Hz,	2H),	1.28	(s,	9H),	1.27	(t,	J	=	7.0	Hz,	3H)	ppm;	13C{1H}	NMR	
(125	MHz,	 CDCl3):	 δ	162.2,	 150.3,	 148.9,	 138.3,	 136.7,	 126.6,	 125.3,	 122.2,	 120.6,	 84.6,	 64.7,	
34.4,	31.3,	15.3	ppm;	IR	(thin	film):	2965,	2869,	1589,	1512,	1469,	1433,	1363,	1269,	1102,	993,	
815,	749,	615	cm-1;	HRMS	calculated	for	C18H24NO,	270.1858,	found	270.1860	[M+H]+.	
	
5	mmol	Scale:	An	oven-dried	100	mL	round	bottom	flask	equipped	with	a	stir	bar	was	charged	
with	 2-(ethoxymethyl)pyridine	 (4.1a,	 686	 mg,	 5.0	 mmol),	 1-bromo-4-tert-butylbenzene	
(1.04	mL,	 6.0	mmol)	 and	 DME	 (25	mL)	 in	 a	 glove	 box	 under	 a	 nitrogen	 atmosphere	 at	 room	
temperature.	 To	 the	 mixture	 was	 added	 NaN(SiMe3)2	 (2.75	 g,	 15	 mmol),	 and	 the	 flask	 was	
stirred	for	10	min.	In	a	separate	50	mL	round	bottomed	flask	equipped	with	a	stir	bar	was	added	
Pd(OAc)2	 (41.5	mg,	0.185	mmol)	 and	NIXANTPHOS	 (154	mg,	0.28	mmol)	 in	DME	 (20	mL).	 The	
Pd/NIXANTPHOS	solution	was	stirred	for	10	min	and	was	transferred	to	the	reaction	flask	by	a	
syringe,	 and	 the	 flask	 was	 rinsed	 with	 additional	 DME	 (5	 mL).	 The	 flask	 was	 capped	 with	 a	
rubber	septum,	removed	from	the	glove	box,	and	stirred	for	12	h	at	room	temperature	(23	°C)	
until	TLC	showed	complete	consumption	of	4.1a.	The	reaction	mixture	was	quenched	with	H2O	
(300	mL),	 diluted	with	 30	mL	of	 ethyl	 acetate,	 and	 filtered	over	 a	 pad	of	 Celite.	 The	pad	was	
rinsed	with	 additional	 ethyl	 acetate	 (60	mL)	 and	 the	 solution	was	 concentrated	 in	 vacuo.	 The	
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crude	material	was	loaded	onto	a	silica	gel	column	and	purified	by	flash	chromatography	(eluted	
with	EtOAc:hexanes	=	5:95)	to	afford	the	product	4.4ab	(1.12	g,	83%)	yield	as	a	yellow	oil.	
	
2-(Ethoxy(4-methoxyphenyl)methyl)pyridine	 (4.4ac).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 D	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
27.4	mg,	 28	uL,	 0.2	mmol)	 and	4-bromoanisole	 (30.0	uL,	 0.24	mmol).	 The	 crude	
product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	10:90)	
to	afford	the	product	(42.7	mg,	88%	yield)	as	a	yellow	oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.51	(ddd,	
J	=	5.0,	1.5,	1.0	Hz,	1H),	7.66	(td,	J	=	7.5,	1.5	Hz,	1H),	7.53	(ddd,	J	=	7.5,	1.5,	1.0	Hz,	1H),	7.37	–	
7.32	(m,	2H),	7.12	(ddd,	J	=	7.5,	5.0,	1.0	Hz,	1H),	6.85	(app.	d,	J	=	9.0	Hz,	2H),	5.44	(s,	1H),	3.76	(s,	
3H),	3.57	(ABqq,	ΔνAB	=	18.4	Hz,	J	=	9.0,	7.0	Hz,	2H)	1.27	(t,	J	=	7.0	Hz,	3H)	ppm;	13C{1H}	NMR	(125	
MHz,	 CDCl3):	 δ	162.3,	 159.0,	 149.0,	 136.7,	 133.5,	 128.2,	 122.1,	 120.4,	 113.8,	 84.2,	 64.6,	 55.2,	
15.3	ppm;	IR	(thin	film):	2973,	1610,	1588,	1510,	1468,	1433,	1302,	1247,	1171,	1098,	1034,	791,	
752	cm-1;	HRMS	calculated	for	C15H18NO2,	244.1338,	found	244.1336	[M+H]+.	
	
4-(Ethoxy(pyridin-2-yl)methyl)-N,N-dimethylaniline	 (4.4ad).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 D	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
27.4	 mg,	 28	 uL,	 0.2	 mmol)	 and	 4-bromo-N,N-dimethylaniline	 (48.0	 mg,	 0.24	
mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 chromatography	 on	 silica	 gel	 (eluted	 with	
EtOAc:hexanes	=	20:80)	to	afford	the	product	(50.6	mg,	99%	yield)	as	a	yellow	solid.	m.p.	=	55	–	
57	°C;	1H	NMR	(500	MHz,	CDCl3):	δ	8.51	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	7.64	(ddd,	J	=	8.0,	7.5,	1.5	
Hz,	1H),	7.53	(ddd,	J	=	8.0,	1.5,	1.0	Hz,	1H),	7.32	–	7.22	(m,	2H),	7.10	(ddd,	 J	=	7.5,	5.0,	1.0	Hz,	
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1H),	6.69	 (app.	 d,	 J	 =	 8.5	 Hz,	 2H),	 5.41	(s,	 1H),	3.55	 (ABqq,	 ΔνAB	 =	 26.2	 Hz,	 J	 =	 9.5,	 7.0	 Hz,	
2H),	2.90	(s,	 6H),	1.27	 (t,	 J	 =	 7.0	 Hz,	 3H)	 ppm;	 13C{1H}	 NMR	 (125	MHz,	 CDCl3):	 δ	162.6,	 150.1,	
148.9,	136.6,	129.1,	127.9,	121.9,	120.4,	112.4,	84.5,	64.4,	40.5,	15.4	ppm;	IR	(thin	film):	1613,	
1588,	 1433,	 1346,	 1162,	 1098,	 806	 cm-1;	 HRMS	 calculated	 for	 C16H21N2O,	 257.1654,	 found	
257.1655	[M+H]+.	
	
2-(Ethoxy(4-fluorophenyl)methyl)pyridine	 (4.4ae).	 The	 reaction	 was	 performed	
following	General	Procedure	D	with	2-(ethoxymethyl)pyridine	 (4.1a,	27.4	mg,	28	
uL,	 0.2	 mmol)	 and	 1-bromo-4-fluorobenzene	 (31.2	uL,	 0.24	 mmol).	 The	 crude	
product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	10:90)	
to	afford	the	product	(37.8	mg,	82%	yield)	as	a	yellow	oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.50	(ddd,	
J	=	5.0,	1.5,	1.0	Hz,	1H),	7.66	(td,	J	=	8.0,	1.5	Hz,	1H),	7.49	(d,	J	=	8.0	Hz,	1H),	7.37	(dd,	J	=	8.5,	5.0	
Hz,	2H),	7.12	(ddd,	J	=	8.0,	5.0,	1.0	Hz,	1H),	6.97	(app.	t,	J	=	8.5	Hz,	2H),	5.44	(s,	1H),	3.54	(m,	2H),	
1.25	 (t,	 J	 =	 7.0	Hz,	 3H)	 ppm;	 13C{1H}	NMR	 (125	MHz,	 CDCl3):	δ	162.1	 	(d,	 J	 =	 250.0	Hz),	 161.8,	
148.9,	 137.1	 (d,	 J	 =	 3.2	 Hz),	136.7,	 128.5		(d,	 J	 =	 12.5	 Hz),	122.2,	 120.3,	 115.1	 	(d,	 J	 =	 25.0	
Hz),	83.8,	64.7,	15.2	ppm;	 IR	 (thin	 film):	2974,	1609,	1588,	1433,	1337,	1104,	699	cm-1;	HRMS	
calculated	for	C14H15FNO,	232.1138,	found	232.1141	[M+H]+.	
	
2-(Ethoxy(o-tolyl)methyl)pyridine	 (4.4af).	 The	 reaction	 was	 performed	
following	General	Procedure	D	with	2-(ethoxymethyl)pyridine	(4.1a,	27.4	mg,	28	
uL,	 0.2	mmol)	 and	 1-bromo-2-methylbenzene	 (28.8	uL,	 0.24	mmol).	 The	 crude	
product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	10:90)	
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to	 afford	 the	 product	 (34.0	mg,	 75%	 yield)	 as	 a	 yellow	oil.	 	 1H	NMR	 (500	MHz,	 CDCl3):	δ	8.50	
(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	7.64	(ddd,	J	=	8.0,	7.5,	1.5	Hz,	1H),	7.43	(app.	d,	J	=	9.0	Hz,	1H),	7.41	
(dd,	J	=	7.5,	1.5	Hz,	1H),	7.20	–	7.12	(m,	4H),	5.68	(s,	1H),	3.58	(ABqq,	ΔνAB	=	30.6	Hz,	J	=	9.0,	7.0	
Hz,	2H),	2.35	(s,	3H),	1.27	(t,	J	=	7.0	Hz,	3H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	161.5,	148.9,	
139.3,	136.6,	136.3,	130.5,	127.5,	126.6,	126.0,	122.2,	121.4,	82.0,	64.9,	19.6,	15.4	ppm;	IR	(thin	
film):	2973,	1589,	1571,	1467,	1433,	1113,	1083,	993,	750,	723,	661cm-1;	HRMS	calculated	 for	
C15H18NO,	228.1388,	found	228.1390	[M+H]+.	
	
5-(Ethoxy(pyridin-2-yl)methyl)-1-methyl-1H-indole	 (4.4ag).	 The	 reaction	 was	
performed	following	General	Procedure	D	with	2-(ethoxymethyl)pyridine	(4.1a,	28	
uL,	0.2	mmol)	and	5-bromo-1-methyl-1H-indole	(50.4	mg,	0.24	mmol).	The	crude	
product	 was	 purified	 by	 flash	 chromatography	 on	 silica	 gel	 (eluted	 with	
EtOAc:hexanes	=	25:75)	to	afford	the	product	(43.6	mg,	82%	yield)	as	a	white	solid.	m.p.	=	163	–	
165	°C;	1H	NMR	(500	MHz,	CDCl3):	δ	8.53	(d,	J	=	4.5	Hz,	1H),	7.72	(s,	1H),	7.65	(d,	J	=	7.5	Hz,	1H),	
7.60	(d,	J	=	7.5	Hz,	1H),	7.31	(d,	J	=	8.5	Hz,	1H),	7.27	(d,	J	=	8.5	Hz,	1H),	7.11	(dd,	J	=	7.5,	4.5	Hz,	
1H),	7.02	(d,	J	=	3.0	Hz,	1H),	6.46	(d,	J	=	3.0	Hz,	1H),	5.62	(s,	1H),	3.73	(s,	3H),	3.61	(m,	2H),	1.31	
(t,	J	=	7.2	Hz,	3H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	162.9,	148.9,	136.6,	136.3,	132.2,	129.1,	
128.4,	121.9,	120.8,	120.5,	119.6,	109.2,	101.1,	85.3,	64.5,	32.8,	15.4	ppm;	IR	(thin	film):	2972,	
2927,	2872,	1589,	1570,	1433,	1326,	1100,	721	cm-1;	HRMS	calculated	for	C17H19N2O,	267.1497	
found	267.1499	[M+H]+.	
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2-(Benzofuran-5-yl(ethoxy)methyl)pyridine	 (4.4ah).	The	reaction	was	performed	
following	General	Procedure	D	with	2-(ethoxymethyl)pyridine	 (4.1a,	27.4	mg,	28	
uL,	0.2	mmol)	and	5-bromobenzofuran	(30.1	uL,	47.3	mg,	0.24	mmol).	The	crude	
product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	25:75)	
to	afford	the	product	(42.0	mg,	82%	yield)	as	a	white	solid.	m.p.	=	158	–	160	°C;	1H	NMR	(500	
MHz,	 CDCl3):	 δ	8.53	 (d,	 J	 =	 5.0	 Hz,	 1H),	 7.68	 (s,	 1H),	 7.67	 (d,	 J	 =	 8.0	 Hz,	 1H),	 7.59	 –	 7.57	(m,	
2H),	7.44	(d,	J	=	8.5	Hz,	1H),	7.37	(d,	J	=	8.5	Hz,	1H),	7.12	(dd,	J	=	8.0,	4.5	Hz,	1H),	6.73	(s,	1H),	
5.59	(s,	1H),		3.65	–	3.59	(m,	2H),	1.29	(t,	J	=	7.2	Hz,	3H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	
162.2,	154.5,	149.0,	145.3,	136.8,	136.0,	127.5,	123.4,	122.2,	120.5,	119.7,	111.3,	106.7,	84.7,	
64.7,	15.3	ppm;	 IR	 (thin	 film):	2974,	2871,	1588,	1467,	1434,	1263,	1107,	1031,	884,	754,	676	
cm-1;	HRMS	calculated	for	C16H16NO2,	254.1181	found	254.1186	[M+H]+.	
	
4-(Methoxy(pyridin-2-yl)methyl)-N,N-dimethylaniline	 (4.4bd).	The	reaction	was	
performed	following	General	Procedure	D	with	2-(methoxymethyl)pyridine	(4.1b,	
24.6	mg,	0.2	mmol)	and	4-bromo-N,N-dimethylaniline	(48.0	mg,	0.24	mmol).	The	
crude	product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	
10:90)	 to	 afford	 the	 product	 (44.7	mg,	 92%	 yield)	 as	 a	 yellow	 oil.	 1H	NMR	 (500	MHz,	 CDCl3):	
δ	8.50	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	7.63	(ddd,	J	=	8.0,	7.5,	1.5	Hz,	1H),	7.47	(ddd,	J	=	8.0,	1.5,	1.0	
Hz,	1H),	7.25	(d,	J	=	9.0	Hz,	2H),	7.09	(ddd	J	=	7.5,	5.0,	1.0	Hz,	1H),	6.76	(d,	J	=	9.0	Hz,	2H),	5.27	(s,	
1H),		3.38	(s,	3H),	2.89	(s,	6H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	162.1,	150.1,	148.9,	136.5,	
128.4,	127.9,	121.9,	120.3,	112.3,	86.2,	56.8,	40.4	ppm;	 IR	 (thin	 film):	2928,	2819,	1613,	1521,	
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1470,	 1432,	 1347,	 1163,	 1097,	 946,	 809,	 615	 cm-1;	 HRMS	 calculated	 for	 C15H19N2O,	 243.1497	
found	243.1499	[M+H]+.	
	
4-((Cyclohexyloxy)(pyridin-2-yl)methyl)-N,N-dimethylaniline	 (4.4cd).	 The	
reaction	 was	 performed	 following	 General	 Procedure	 D	 with	 2-
((cyclohexyloxy)methyl)pyridine	(4.1c,	38.2	mg,	0.2	mmol)	and	4-bromo-N,N-
dimethylaniline	(48.0	mg,	0.24	mmol).	The	crude	product	was	purified	by	flash	chromatography	
on	silica	gel	(eluted	with	EtOAc:hexanes	=	15:85)	to	afford	the	product	(51.5	mg,	83%	yield)	as	a	
yellow	solid.	m.p.	=	81	–	83	°C.	1H	NMR	(500	MHz,	CDCl3):	δ	8.50	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	
7.64	(ddd,	J	=	8.0,	7.5,	1.5	Hz,	1H),	7.59	(ddd,	J	=	8.0,	1.5,	1.0	Hz,	1H),	7.28	(d,	J	=	8.5	Hz,	2H),	
7.10	(ddd,	J	=	7.5,	5.0,	1.0	Hz,	1H),	6.68	(d,	J	=	8.5	Hz,	2H),	5.60	(s,	1H),	3.42-3.37	(m,	1H),	2.90	(s,	
6H),	 1.94	 –	 1.92	 (m,	 2H),	 1.76	 –	 1.72	 (m,	 2H),	 1.45	 –	 1.40	 (m,	 3H),	 1.18	 –	 1.12	 (m,	 3H)	 ppm;	
13C{1H}	NMR	(125	MHz,	CDCl3):	δ	163.5,	149.9,	148.7,	136.6,	129.9,	127.9,	121.8,	120.6,	112.4,	
81.1,	75.0,	40.6,	32.6,	25.9,	24.2	ppm;	IR	(thin	film):	2930,	2855,	1613,	1520,	1433,	1343,	1162,	
1074,	947,	809	cm-1;	HRMS	calculated	for	C20H27N2O,	311.2123	found	311.2128	[M+H]+.	
	
4-(tert-Butoxy(pyridin-2-yl)methyl)-N,N-dimethylaniline	 (4.4dd).	 The	 reaction	
was	 performed	 following	 General	 Procedure	 D	 with	 2-(tert-
butoxymethyl)pyridine	 (4.1d,	 33.4	 mg,	 0.2	 mmol)	 and	 4-bromo-N,N-
dimethylaniline	(48.0	mg,	0.24	mmol).	The	crude	product	was	purified	by	flash	chromatography	
on	silica	gel	(eluted	with	EtOAc:hexanes	=	15:85)	to	afford	the	product	(50.0	mg,	88%	yield)	as	a	
yellow	solid.	m.p.	=	65	–	66	°C.	1H	NMR	(500	MHz,	CDCl3):	δ	8.45	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	
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7.59	(br.	s,	2H),	7.27	(app.	d,	J	=	8.5	Hz,	2H),	7.05	(ddd,	J	=	6.6,	4.7,	2.0	Hz,	1H),	6.65	(d,	J	=	8.5	Hz,	
2H),	5.65	(s,	1H),		2.87	(s,	6H),	1.21	(s,	9H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	165.2,	149.5,	
148.3,	136.3,	131.8,	127.4,	121.4,	120.9,	112.3,	76.9,	74.8,	40.5,	28.6	ppm;	IR	(thin	film):	2973,	
1613,	1589,	1520,	1470,	1346,	1162,	1063,	1022,	947,	808,	749,	616	cm-1;	HRMS	calculated	for	
C18H25N2O,	285.1967	found	285.1970	[M+H]+.	
	
N,N-Dimethyl-4-(phenoxy(pyridin-2-yl)methyl)aniline	 (4.4ed).	 The	 reaction	
was	 performed	 following	 General	 Procedure	 D	 with	 2-
(phenoxymethyl)pyridine	 (4.1e,	 37.0	 mg,	 0.2	 mmol)	 and	 4-bromo-N,N-
dimethylaniline	(48.0	mg,	0.24	mmol).	The	crude	product	was	purified	by	flash	chromatography	
on	silica	gel	(eluted	with	EtOAc:hexanes	=	15:85)	to	afford	the	product	(49.8	mg,	82%	yield)	as	a	
white	solid.	m.p.	=	84	–	86	°C;	1H	NMR	(500	MHz,	CDCl3):	δ	8.55	(d,	J	=	4.5	Hz,	1H),	7.62	(d,	J	=	8.0	
Hz,	1H),	7.57	(d,	J	=	8.0	Hz,	1H),	7.35	(d,	J	=	8.5	Hz,	2H),	7.20	(d,	J	=	8.5	Hz,	2H),	7.12	(dd,	J	=	8.0,	
4.5	Hz,	 1H),	 6.98	 (d,	 J	 =	 8.5	Hz,	 2H),	 6.88	 (t,	 J	 =	 8.5	Hz,	 1H),	 6.68	 (d,	 J	 =	 8.5	Hz,	 2H),	 6.27	(s,	
1H),		2.90	(s,	6H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	161.3,	157.9,	150.1,	149.1,	136.8,	129.2,	
127.9,	127.7,	122.2,	120.7,	120.5,	115.9,	112.4,	82.4,	40.4	ppm;	IR	(thin	film):	3402,	2974,	2886,	
1613,	 1599,	 1521,	 1445,	 1410,	 1351,	 1163,	 1095,	 796	 cm-1;	 HRMS	 calculated	 for	 C20H21N2O,	
305.1654	found	305.1658	[M+H]+.	
	
2-((4-Fluorophenyl)(methoxy)methyl)pyridine	 (4.4be).	 The	 reaction	 was	
performed	 following	General	Procedure	D	with	2-pyridinylmethyl	methyl	ether	
(4.1b,	 24.6	mg,	0.2	mmol)	and	1-bromo-4-fluorobenzene	 (31.2	uL,	42	mg,	0.24	
N
O
NMe2
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mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 chromatography	 on	 silica	 gel	 (eluted	 with	
EtOAc:hexanes	=	10:90)	to	afford	the	product	(36.8	mg,	85%	yield)	as	a	yellow	oil.	1H	NMR	(500	
MHz,	CDCl3):	δ	8.53	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	7.66	(td,	J	=	8.0,	7.5,	1.5	Hz,	1H),	7.47	(ddd,	J	=	
8.0,	1.5,	1.0	Hz,	1H),	7.38	(dd,	J	=	9.0,	5.5	Hz,	2H),	7.14	(ddd,	J	=	7.5,	5.0,	1.0	Hz,	1H),	6.99	(app.	t,	
J	 =	 9.0	Hz,	 2H),	 5.34	(s,	 1H),	3.40	 (s,	 3H)	 ppm;	 13C{1H}	NMR	 (125	MHz,	 CDCl3):	δ	162.2	 	(d,	 J	 =	
250.0	Hz),	161.3,	149.1,	136.8,	136.7	(d,	J	=	2.5	Hz),		128.6		(d,	J	=	12.5	Hz),	122.4,	120.4,	115.3	
	(d,	J	=	25.0	Hz),	83.7,	57.1	ppm;	IR	(thin	film):	2934,	2825,	1604,	1589,	1507,	1471,	1434,	1221,	
1194,	1156,	1105,	1091,	804,	cm-1;	HRMS	calculated	 for	C13H11FNO,	216.0825,	 found	216.0822	
[M-H]+.		
	
2-((Cyclohexyloxy)(4-fluorophenyl)methyl)pyridine	(4.4ce).	The	reaction	was	
performed	 following	 General	 Procedure	 D	 with	 2-
((cyclohexyloxy)methyl)pyridine	 (4.1c,	 38.2	 mg,	 0.2	 mmol)	 and	 1-bromo-4-
fluorobenzene	 (31.2	uL,	 42	 mg,	 0.24	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	
chromatography	on	 silica	gel	 (eluted	with	EtOAc:hexanes	=	15:85)	 to	afford	 the	product	 (50.1	
mg,	88%	yield)	as	a	yellow	solid.	m.p.	=	82	–	84	°C;	1H	NMR	(500	MHz,	CDCl3):	δ	8.50	(ddd,	J	=	
5.0,	 1.5,	 1.0	 Hz,	 1H),	 7.66	 (td,	 J	 =	 8.0,	 7.5,	 1.5	 Hz,	 1H),	 7.56	 (ddd,	 J	 =	 7.5,	 1.5,	 1.0	 Hz,	 1H),	
7.38	(app.	d,	J	=	8.5,	5.0	Hz,	2H),	7.14	–	7.11	(m,	1H),	6.97	(app.	t,	J	=	8.5	Hz,	2H),	5.62	(s,	1H),	
3.38	 (m,	1H),	1.94	–	1.87	(m,	2H),	1.74	–	1.72	(m,	2H),	1.49	–	1.41	(m,	3H),	1.24	–	1.21	 (m,	3H)	
ppm;	 13C{1H}	NMR	 (125	MHz,	CDCl3):	δ	162.7,	 162.2	 	(d,	 J	 =	 250.0	Hz),	 148.8,	 137.9	 (d,	 J	 =	 2.5	
Hz),	136.8,	128.5		(d,	J	=	12.5	Hz),	122.2,	120.6,	115.1		(d,	J	=	25.0	Hz),	80.7,	75.6,	32.4,	25.7,	24.0	
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ppm;	IR	(thin	film):	3009,	2932,	2857,	1604,	1589,	1507,	1434,	1220,	1155,	1077,	959,	724	cm-1;	
HRMS	calculated	for	C18H21FNO,	286.1607,	found	286.1611	[M+H]+.	
	
2-(tert-Butoxy(4-fluorophenyl)methyl)pyridine	 (4.4de).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 D	 with	 2-(tert-butoxymethyl)pyridine		
(4.7d,	33.0	mg,	0.2	mmol)	and	1-bromo-4-fluorobenzene	(31.2	uL,	0.24	mmol).	
The	 crude	 product	 was	 purified	 by	 flash	 chromatography	 on	 silica	 gel	 (eluted	 with	
EtOAc:hexanes	=	15:85)	to	afford	the	product	(41.4	mg,	80%	yield)	as	a	yellow	oil.	1H	NMR	(500	
MHz,	CDCl3):	δ	8.47	(ddd,	J	=	5.0,	2.0,	1.0	Hz,	1H),	7.64	(td,	J	=	8.0,	2.0	Hz,	1H),	7.57	(d,	J	=	8.0,	
2.0,	1.0	Hz,	1H),	7.40	(app.	dd,	 J	=	8.5,	5.0	Hz,	2H),	7.11	–	7.09	(m,	1H),	6.95	(app.	t,	J	=	8.5	Hz,	
2H),	5.69	(s,	1H),	1.22	 (s,	9H)	ppm;	 13C{1H}	NMR	 (125	MHz,	CDCl3):	δ	164.4,	161.9	(d,	 J	 =	250.0	
Hz),	 148.5,	 139.6	 (d,	 J	 =	 2.5	Hz),	136.6,	 128.2	 (d,	 J	 =	 12.5	Hz),	121.9,	120.9,	115.3	 	(d,	 J	 =	 25.0	
Hz),	76.4,	75.4,	28.5	ppm;	IR	(thin	film):	3054,	2975,	1932,	1604,	1589,	1507,	1469,	1434,	1390,	
1367,	 1220,	 1155,	 1102,	 1072,	 819,	 804,	 750,	 650	 cm-1;	 HRMS	 calculated	 for	 C16H19FNO,	
260.1451,	found	260.1451	[M-H]+.	
	
2-((4-Fluorophenoxy)(4-fluorophenyl)methyl)pyridine	 (4fe).	 The	 reaction	
was	 performed	 following	 General	 Procedure	 D	 with	 2-((4-
fluorophenoxy)methyl)pyridine	 (4.1f,	 40.6	mg,	0.2	mmol)	 and	1-bromo-4-
fluorobenzene	 (31.2	uL,	 42	 mg,	 0.24	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	
chromatography	on	 silica	gel	 (eluted	with	EtOAc:hexanes	=	15:85)	 to	afford	 the	product	 (48.7	
mg,	82%	yield)	as	a	yellow	oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.58	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	
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7.68	(td,	J	=	8.0,	1.5	Hz,	1H),	7.54	(d,	J	=	8.0	Hz,	1H),	7.49-7.41	(m,	2H),	7.20	–	7.17	(m,	1H),	7.02	
(t,	J	=	8.5	Hz,	2H),	6.92	–	6.90	(m,	4H),	6.25	(s,	1H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ		162.4	
	(d,	J	=	250.0	Hz),	161.4,	157.5		(d,	J	=	250.0	Hz),	153.6	(d,	J	=	2.5	Hz),	149.2,	137.2,	135.8	(d,	J	=	
2.5	Hz),	128.5		(d,	J	=	12.5	Hz),	122.8,	120.6,	117.1	(d,	J	=	7.5	Hz),	115.9	(d,	J	=	25.0Hz),	115.5	(d,	J	
=	25.0	Hz),	82.6	ppm;	IR	(thin	film):	3055,	2918,	1604,	1589,	1504,	1471,	1435,	1220,	1205,	1157,	
1097,	 1048,	 827,	 774,	 614	 cm-1;	 HRMS	 calculated	 for	 C18H14F2NO,	 298.1043,	 found	 298.1039	
[M+H]+.	
	
2-((4-(tert-Butyl)phenoxy)(4-fluorophenyl)methyl)pyridine	 (4.4ge).	 The	
reaction	was	performed	 following	General	Procedure	D	with	2-((4-(tert-
butyl)phenoxy)methyl)pyridine	 (4.1g,	 48.2	mg,	0.2	mmol)	and	1-bromo-
4-fluorobenzene	 (31.2	uL,	 42	 mg,	 0.24	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	
chromatography	on	 silica	gel	 (eluted	with	EtOAc:hexanes	=	15:85)	 to	afford	 the	product	 (53.6	
mg,	80%	yield)	as	a	yellow	oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.59	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	
7.68	(dt,	J	=	7.5,	1.5	Hz,	1H),	7.60	(d,	J	=	8.0	Hz,	1H),	7.51	(dd,	J	=	8.5,	5.5	Hz,	2H),	7.27	(d,	J	=	9.0	
Hz,	2H),	7.18	(ddd,	J	=	7.5,	5.0,	1.0	Hz,	1H),	7.03	(app.	t,	J	=	8.5	Hz,	2H),	6.91	(d,	J	=	9.0	Hz,	2H),	
6.32	(s,	1H),	1.28	(s,	9H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ		162.3		(d,	J	=	250.0	Hz),	160.8,	
155.3,	149.1,	143.9,	137.2,	136.2	(d,	J	=	2.5	Hz),	128.5		(d,	J	=	12.5	Hz),	126.2,	122.7,	120.7,	115.5	
(d,	J	=	25.0	Hz),	115.3,	81.8,	34.0,	31.5	ppm;	IR	(thin	film):	2961,	1606,	1509,	1471,	1435,	1363,	
1295,	1232,	1182,	1157,	1100,	1046,	828,	754	cm-1;	HRMS	calculated	for	C22H23FNO,	336.1764,	
found	336.1762	[M+H]+.	
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Procedure	and	characterization	of	Pd-catalyzed	chemoselective	tandem	arylation/[1,2]-Wittig	
rearrangement	reaction	of	2-pyridylmethyl	ethers	(Table	4.4	and	4.5).	
	
General	 Procedure	 E	 for	 the	 Pd-catalyzed	 chemoselective	 tandem	 arylation/[1,2]-Wittig	
rearrangement	reaction	of	2-pyridylmethyl	ethers:	
An	oven-dried	 10	mL	 reaction	 vial	 equipped	with	 a	 stir	 bar	was	 charged	with	 pyridinylmethyl	
ether	(4.1,	0.20	mmol,	1.0	equiv)	and	aryl	bromide	(0.24	mmol,	1.2	equiv)	and	CPME	(1	mL)	in	a	
glove	box	under	a	nitrogen	atmosphere	at	room	temperature.	LiN(SiMe3)2	 (100	mg,	0.6	mmol,	
3.0	 equiv)	was	 added	 to	 the	 reaction	mixture.	 A	 solution	 (from	 a	 stock	 solution)	 of	 Pd(OAc)2	
(1.12	mg,	0.05	mmol,	2.5	mol	%)	and	NIXANTPHOS	(4.14	mg,	0.075	mmol,	3.75	mol	%)	in	1.0	mL	
of	 dry	 CPME	 was	 taken	 up	 by	 syringe,	 and	 added	 to	 the	 reaction	 vial.	 The	 vial	 was	 capped,	
removed	 from	 the	 glove	 box,	 and	 stirred	 for	 24	 h	 at	 45	 °C	 until	 TLC	 showed	 complete	
consumption	of	pyridylmethyl	ether	starting	material	and	arylation	 intermediate.	The	reaction	
mixture	was	quenched	with	four	drops	of	H2O,	diluted	with	3	mL	of	ethyl	acetate,	and	filtered	
over	 a	 pad	 of	 MgSO4	 and	 silica.	 The	 pad	 was	 rinsed	 with	 additional	 ethyl	 acetate,	 and	 the	
solution	was	concentrated	in	vacuo.	The	crude	material	was	loaded	onto	a	silica	gel	column	and	
purified	by	flash	chromatography.	
	
1-Phenyl-1-(pyridin-2-yl)propan-1-ol	 (4.5aa).	 The	 reaction	 was	 performed	
following	General	 Procedure	E	with	2-(ethoxymethyl)pyridine	 (4.1a,	 27.4	mg,	 28	
mL,	0.2	mmol)	and	bromobenzene	 (25.2	uL,	0.24	mmol).	The	crude	product	was	
purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	30:70)	to	afford	the	
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product	(36.2	mg,	85%	yield)	as	a	white	solid.	m.p.	=	72	–	74	°C;	The	1H	and	13C{1H}	NMR	data	for	
this	compound	match	the	literature	data.9	
	
	1-(4-(tert-Butyl)phenyl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ab).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
27.4	mg,	28	uL,	0.2	mmol)	and	1-bromo-4-tert-butylbenzene	(42.0	uL,	0.24	mmol).	
The	 crude	 product	 was	 purified	 by	 flash	 chromatography	 on	 silica	 gel	 (eluted	 with	
EtOAc:hexanes	=	20:80)	to	afford	the	product	(41.9	mg,	78%	yield)	as	a	white	solid.	m.p.	=	45	–	
47	°C;	1H	NMR	(500	MHz,	CDCl3):	δ	8.50	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	7.64	(td,	J	=	8.0,	7.5,	1.5	
Hz,	1H),	7.44	(d,	J	=	8.5	Hz,	2H),	7.35	–	7.31	(m,	3H),	7.15	(ddd,	J	=	7.5,	5.0,	1.0	Hz,	1H),	5.89	(s,	
1H),	2.30		(ABqq,	ΔνAB	=	37.8	Hz,	J	=	14.5,	7.5	Hz,	2H),	1.28	(s,	9H),	0.85	(t,	J	=	7.5	Hz,	3H)	ppm;	
13C{1H}	NMR	(125	MHz,	CDCl3):	δ	163.7,	149.5,	147.1,	143.4,	136.8,	125.6,	125.0,	121.8,	120.6,	
77.2,	34.3,	33.9,	31.3,	8.0	ppm;	IR	(thin	film):	3367,	2964,	1592,	1509,	1467,	1433,	1363,	1269,	
1113,	985,	829,	751,	597	cm-1;	HRMS	calculated	for	C18H24NO,	270.1858,	found	270.1845	[M+H]	
+.	
	
1-(4-Methoxyphenyl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ac).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
27.4	mg,	 28	uL,	 0.2	mmol)	 and	4-bromoanisole	 (30.0	uL,	 0.24	mmol).	 The	 crude	
product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	20:80)	
to	 afford	 the	product	 (36.4	mg,	 75%	yield)	 as	 a	 yellow	 solid.	m.p.	 =	77	–	78	 °C;	 1H	NMR	 (500	
MHz,	CDCl3):	δ	8.50	(ddd,	J	=	4.9,	1.5,	0.9	Hz,	1H),	7.63	(td,	J	=	7.8,	1.5	Hz,	1H),	7.43	(app.	d,	J	=	
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9.0	Hz,	2H),	7.28	(dt,	J	=	7.8,	0.9	Hz,	1H),	7.15	(ddd,	J	=	7.8,	4.9,	0.9	Hz,	1H),	6.84	(d,	J	=	9.0	Hz,	
2H),	5.88	(s,	1H),	3.77	(s,	3H),	2.28		(ABqq,	ΔνAB	=	44.7	Hz,	J	=	14.5,	7.5	Hz,	2H),	0.85	(t,	J	=	7.5	Hz,	
3H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	163.9,	158.4,	147.1,	138.6,	136.9,	127.2,	121.8,	120.4,	
113.5,	77.0,	55.2,	33.9,	8.0	ppm;	IR	(thin	film):	3446,	2964,	2962,	1594,	1569,	1468,	1434,	1304,	
1248,	 1030,	 985,	 841,	 591	 cm-1;	 HRMS	 calculated	 for	 C15H18NO2,	 244.1338,	 found	 244.1330	
[M+H]	+.	
	
	1-(4-(Dimethylamino)phenyl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ad).	 The	 reaction	
was	 performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	
(4.1a,	27.4	mg,	28	uL,	0.2	mmol)	and	4-bromo-N,N-dimethylaniline	(48.0	mg,	0.24	
mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 chromatography	 on	 silica	 gel	 (eluted	 with	
EtOAc:hexanes	=	25:75)	to	afford	the	product	(36.8	mg,	72%	yield)	as	a	yellow	solid.	m.p.	=	108	–	
110	°C;	1H	NMR	(500	MHz,	CDCl3):	δ	8.48	(ddd,	J	=	4.5,	1.7,	1.0	Hz,	1H),	7.59	(ddd,	J	=	8.0,	7.7,	1.7	
Hz,	1H),	7.35	(app.	d,	J	=	8.8	Hz,	2H),	7.29	(app.	d,	J	=	8.0,	1.5,	1.0	Hz,	1H),	7.11	(ddd,	J	=	7.7,	5.0,	
1.0	Hz,	1H),	6.66	(app.	d,	J	=	9.0	Hz,	2H),	5.78	(s,	1H),	2.89	(s,	6H),	2.26	(ABqq,	ΔνAB	=	49.2	Hz,	J	=	
14.3,	 7.3	Hz,	 2H),	0.84	 (t,	 J	 =	 7.3	Hz,	 3H)	 ppm;	 13C{1H}	NMR	 (125	MHz,	 CDCl3):	δ	164.2,	 149.3,	
146.9,	136.6,	134.3,	126.7,	121.5,	120.4,	112.1,	76.7,	40.4,	33.7,	7.9	ppm;	 IR	 (thin	 film):	2924,	
1611,	 1519,	 1432,	 1351,	 1162,	 816	 cm-1;	 HRMS	 calculated	 for	 C16H19N2,	 239.1548,	 found	
239.1545	[M-OH]	+.	
	
1-(4-Fluorophenyl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ae).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
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27.4	 mg,	 28	 uL,	 0.2	 mmol)	 and	 1-bromo-4-fluorobenzene	 31.2	uL,	 0.24	 mmol).	 The	 crude	
product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	20:80)	
to	afford	the	product	(40.6	mg,	88%	yield)	as	a	yellow	oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.48	(ddd,	
J	=	4.7,	1.7,	1.0	Hz,	1H),	7.63	(ddd,	J	=	8.0,	7.5,	1.7	Hz,	1H),	7.47	(app.	d,	J	=	8.5,	5.0	Hz,	2H)	,	7.26	
(ddd,	 J	=	8.0,	1.7,	1.0	Hz,	1H),	7.15	(ddd,	 J	=	7.5,	4.7,	1.0	Hz,	1H),	6.96	(app.	t,	 J	=	8.5	Hz,	2H),		
5.88	(s,	1H),	2.28	 (ABqq,	2H,	ΔνAB	=	38.9	Hz,	 J	=	13.5,	7.5	Hz,	2H),	0.83	 (t,	 J	=	7.5	Hz,	3H)	ppm;	
13C{1H}	NMR	(125	MHz,	CDCl3):	δ	163.3,	162.6	(d,	J	=	250.0	Hz),	147.1,	142.1,	136.9,	127.7		(d,	J	=	
12.5	 Hz),	121.9,	120.2,	114.8	(d,	 J	 =	 25.0	 Hz),	76.9,	33.8,	7.8	 ppm;	 IR	 (thin	 film):	 3364,	 2935,	
1593,	 1506,	 1467,	 1433,	 1392,	 1223,	 1159,	 1087,	 986,	 832,	 750	 cm-1;	 HRMS	 calculated	 for	
C14H13FN,	214.1032,	found	214.1037	[M-OH]	+.	
	
5	mmol	Scale:	An	oven-dried	100	mL	round	bottom	flask	equipped	with	a	stir	bar	was	charged	
with	 Pd(OAc)2	 (28.1	mg,	 0.125	mmol)	 and	NIXANTPHOS	 (103.7	mg,	 0.188	mmol)	 in	 CPME	 (50	
mL).	The	Pd/NIXANTPHOS	solution	was	stirred	for	5	min	and	LiN(SiMe3)2	(2.51	g,	15	mmol)	was	
added.	After	stirring	for	5	min	at	24	°C,	2-(ethoxymethyl)pyridine	(4.1a,	686	mg,	5.0	mmol)	and	
1-bromo-4-fluorobenzene	 (0.66	mL,	 6.0	 mmol)	 were	 added	 to	 the	 solution.	 The	 flask	 was	
capped	with	a	rubber	septum,	removed	from	the	glove	box,	and	stirred	for	9	h	at	45	°C	until	TLC	
showed	complete	consumption	of	4.1a.	The	reaction	mixture	was	then	cooled	to	rt,	quenched	
with	30	mL	of	H2O,	and	diluted	with	30	mL	of	ethyl	acetate.	The	organic	layer	was	separated	and	
the	aqueous	 solution	was	extracted	with	20	mL	of	EtOAc.	The	combined	organic	 solution	was	
washed	with	 saturated	aqueous	NaHCO3	 (30	mL)	and	brine	 (30	mL).	 The	organic	 solution	was	
dried	 over	MgSO4,	 filtered,	 and	 the	 solvent	was	 removed	 under	 reduced	 pressure.	 The	 crude	
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material	was	loaded	onto	a	silica	gel	column	and	purified	by	flash	chromatography	(eluted	with	
EtOAc:hexanes	=	5:95)	to	afford	the	product	(856	mg,	74%)	yield	as	a	yellow	oil.	
	
	1-(4-Chlorophenyl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ai).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
27.4	mg,	28	uL,	0.2	mmol)	and	1-bromo-4-chlorobenzene	 (45.8	mg,	0.24	mmol).	
The	 crude	 product	 was	 purified	 by	 flash	 chromatography	 on	 silica	 gel	 (eluted	 with	
EtOAc:hexanes	=	20:80)	to	afford	the	product	(41.0	mg,	83%	yield)	as	a	yellow	oil.	1H	NMR	(500	
MHz,	CDCl3):	δ	8.48	(ddd,	J	=	5.0,	1.7,	1.0	Hz,	1H),	7.63	(ddd,	J	=	7.9,	7.5,	1.7	Hz,	1H),	7.45	(app.	d,	
J	=	9.0	Hz,	2H),	7.27	(ddd,	J	=	7.9,	1.7,	1.0	Hz,	1H),	7.25	(app.	d,	J	=	9.0	Hz,	2H),	7.15	(ddd,	J	=	7.5,	
5.0,	1.0	Hz,	1H),	5.88	(s,	1H),	2.25	(ABqq,	2H,	ΔνAB	=	37.5	Hz,	J	=	14.0,	7.3	Hz,	2H),	0.83	(t,	J	=	7.3	
Hz,	3H)	ppm;	 13C{1H}	NMR	(125	MHz,	CDCl3):	δ	163.0,	147.2,	144.9,	136.9,	132.6,	128.2,	127.5,	
122.0,	 120.0,	 77.0,	 33.7,	 7.8	 ppm;	 The	 1H	 NMR	 data	 for	 this	 compound	match	 the	 literature	
data.10	
	
1-(Pyridin-2-yl)-1-(3-(trifluoromethyl)phenyl)propan-1-ol	 (4.5aj).	 The	 reaction	
was	 performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	
(4.1a,	 27.4	 mg,	 28	 uL,	 0.2	 mmol)	 and	 1-bromo-2-(trifluoromethyl)benzene	
(32.6	uL,	 0.24	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 chromatography	 on	 silica	 gel	
(eluted	with	EtOAc:hexanes	=	20:80)	to	afford	the	product	(43.8	mg,	78%	yield)	as	a	yellow	oil.	
1H	NMR	(500	MHz,	CDCl3):	δ	8.50	(ddd,	J	=	4.9,	1.7,	1.0	Hz,	1H),	7.81	(br.	s,	1H),	7.69	(app.	d,	J	=	
8.0	Hz,	1H),	7.65	(ddd,	J	=	7.9,	7.4,	1.7	Hz,	1H),	7.45	(app.	d,	J	=	8.0	Hz,	1H),	7.40	(app.	t,	J	=	8.0	
216	
	
Hz,	 1H),	 7.30	 (ddd,	 J	 =	 8.0,	 1.7,	 1.0	 Hz,	 1H),	 7.18	 (ddd,	 J	 =	 7.4,	 4.9,	 1.0	 Hz,	 1H),	 5.98	(s,	
1H),	2.29	(ABqq,	2H,	ΔνAB	=	28.2	Hz,	 J	 =	14.0,	7.3	Hz,	2H),	0.85	 (t,	 J	 =	7.2	Hz,	3H)	ppm;	 13C{1H}	
NMR	(125	MHz,	CDCl3):	δ	162.5,	147.5,	147.3,	137.1,	130.4	(q,	J	=	32.5	Hz),	129.4,	128.5,	124.4	
(q,	J	=	280.5	Hz),	123.6	(q,	J	=	2.5	Hz),	122.8	(q,	J	=	2.5	Hz),	122.1,	120.2,	77.1,	33.8,	7.7	ppm;	IR	
(thin	film):	3367,	2973,	2939,	1592,	1572,	1468,	1434,	1392,	1328,	1165,	1124,	1074,	988,	805,	
703	cm-1;	HRMS	calculated	for	C15H15F3NO,	282.1106,	found	282.1104	[M+H]	+.	
	
1-(1-Methyl-1H-indol-5-yl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ag).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
27.4	mg,	28	uL,	0.2	mmol)	and	5-bromo-1-methyl-1H-indole	(50.4	mg,	0.24	mmol).	
The	crude	product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	
EtOAc:hexanes	=	30:70)	to	afford	the	product	(38.4	mg,	72%	yield)	as	a	white	solid.	m.p.	=	105	–	
106	°C;	1H	NMR	(500	MHz,	CDCl3):	δ	8.48	(ddd,	J	=	4.5,	1.5,	1.0	Hz,	1H),	7.81	–	7.78	(m,	1H),	7.57	
(td,	J	=	8.0,	7.5,	1.5	Hz,	1H),	7.35	(app.	d,	J	=	10.0	Hz,	1H),	7.32	(app.	d,	J	=	8.0	Hz,	1H),	7.23	(app.	
d,	J	=	10.0	Hz,	1H),	7.10	(ddd,	J	=	7.5,	4.5,	1.0	Hz,	1H),	7.00	(d,	J	=	3.0	Hz,	1H),	6.44	(app.	d,	J	=	3.0	
Hz,	1H),	5.92	(s,	1H),	3.72	(s,	3H),	2.38		(ABqq,	2H,	ΔνAB	=	60.2	Hz,	J	=	13.8,	7.2	Hz,	2H),	0.88	(t,	J	=	
7.2	 Hz,	 3H)	 ppm;	 13C{1H}	 NMR	 (125	 MHz,	 CDCl3):	 δ	164.5,	 146.9,	 137.3,	 136.6,	 135.6,	 128.9,	
128.1,	121.5,	120.6,	120.3,	118.0,	108.8,	101.1,	77.5,	34.0,	32.7,	8.0	ppm;	 IR	 (thin	 film):	3366,	
3055,	2966,	2933,	1592,	1568,	1512,	1489,	1467,	1432,	1335,	1295,	1247,	1153,	1081,	984,	885,	
721	cm-1;	HRMS	calculated	for	C17H17N2,	249.1392	found	249.1394	[M-OH]	+.	
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1-(Benzofuran-5-yl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ah).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
27.4	 mg,	 28	 uL,	 0.2	 mmol)	 and	 5-bromobenzofuran	 (30.1	 uL,	 0.24	 mmol).	 The	
crude	product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	
25:75)	to	afford	the	product	(35.5	mg,	70%	yield)	as	a	white	solid.	m.p.	=	170	–	172	°C;	1H	NMR	
(500	MHz,	CDCl3):	δ	8.49	(ddd,	J	=	4.5,	1.5,	1.0	Hz,	1H),	7.81	–	7.77	(m,	1H),	7.61	(dd,	J	=	8.0,	1.5	
Hz,	1H),	7.56	(d,	J	=	2.0	Hz,	1H),	7.45	–	7.38	(m,	2H),	7.31	(app.	d,	J	=	8.0	Hz,	1H),	7.13	(app.	dd,	J	
=	7.5,	5.0	Hz,	1H),	6.73	–	6.69	(m,	1H),	5.95	(s,	1H),		2.35		(ABqq,	2H,	ΔνAB	=	48.5	Hz,	J	=	14.0,	7.3	
Hz,	2H),	0.87	(t,	J	=	7.3	Hz,	3H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	163.9,	153.8,	147.1,	145.1,	
141.1,	136.8,	127.1,	122.8,	121.7,	120.4,	118.6,	110.8,	106.7,	77.4,	34.0,	7.9	ppm;	IR	(thin	film):	
3366,	2969,	2935,	2877,	1592,	1570,	1465,	1433,	1392,	1327,	1261,	1132,	1109,	1030,	986,	892,	
813,	771,	738	cm-1;	HRMS	calculated	for	C16H16NO3,	254.1181	found	254.1183	[M+H]+.	
	
1-(4-(Dimethylamino)phenyl)-1-(pyridin-2-yl)ethanol	 (4.5bd).	 The	 reaction	 was	
performed	 following	General	 Procedure	 E	with	 2-(methoxymethyl)pyridine	 (4.1b,	
24.6	mg,	0.2	mmol)	and	4-bromo-N,N-dimethylaniline	 (48.0	mg,	0.24	mmol).	 The	
crude	product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	
20:80)	 to	 afford	 the	 product	 (34.8	mg,	 72%	 yield)	 as	 a	 yellow	 oil.	 1H	NMR	 (500	MHz,	 CDCl3):	
δ	8.51	(d,	J	=	4.9,	1.7,	1.0	Hz,	1H),	7.62	(ddd,	J	=	8.0,	7.5,	1.7	Hz,	1H),	7.32	(app.	d,	J	=	9.0	Hz,	2H),	
7.27	(ddd,	J	=	8.0,	1,7,	1.0	Hz,	1H),	7.15	(ddd,	 J	=	7.5,	4.9,	1.0	Hz,	1H),	6.68	(d,	J	=	9.0	Hz,	2H),	
5.72	(s,	1H),		2.91	(s,	6H),	1.89	(s,	3H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	165.5,	149.5,	147.2,	
136.8,	135.1,	126.7,	121.7,	120.3,	112.2,	74.7,	40.6,	29.3	ppm;	IR	(thin	film):	3393,	2976,	2928,	
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2800,	1613,1591,	1567,	1520,	1470,	1431,	1351,	1224,	1195,	1164,	1064,	947,	816,	785,	750,595	
cm-1;	HRMS	calculated	for	C15H17N2,	225.1392	found	225.1398	[M-OH]	+.	
	
1-(4-Fluorophenyl)-1-(pyridin-2-yl)ethanol	 (4.5be).	 The	 reaction	 was	 performed	
following	General	Procedure	E	with	2-(methoxymethyl)pyridine	(4.1b,	24.6	mg,	0.2	
mmol)	and	1-bromo-4-fluorobenzene	(31.2	uL,	0.24	mmol).	The	crude	product	was	
purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	20:80)	to	afford	the	
product	(32.5	mg,	75%	yield)	as	a	yellow	oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.52	(ddd,	J	=	5.0,	1.5,	
1.0	Hz,	1H),	7.65	(ddd,	J	=	7.9,	7.5,	1.5	Hz,	1H),	7.44	(app.	dd,	J	=	8.5,	5.0	Hz,	2H),	7.25	(ddd,	J	=	
8.0,	1.5,	1.0	Hz,	1H),	7.19	(ddd,	J	=	7.5,	5.0,	1.0	Hz,	1H),	6.98	(app.	dd,	J	=	9.0,	8.5	Hz,	2H),	5.83	(s,	
1H),	1.90	 (s,	 3H)	ppm;	 13C{1H}	NMR	 (125	MHz,	 CDCl3):	δ	164.5,	 161.8	 	(d,	 J	 =	 250.0	Hz),	 147.4,	
142.9	(d,	J	=	2.5	Hz),		137.0,	127.6		(d,	J	=	12.5	Hz),	122.1,	120.1,	115.3		(d,	J	=	25.0	Hz),	74.7,	29.3	
ppm;	 IR	 (thin	 film):	3391,	3060,	2980,	2932,	1733,	1599,	1507,	1432,	1368,	1225,	1160,	1073,	
925,	836,	750,	597	cm-1;	HRMS	calculated	for	C13H11FN,	200.0876,	found	200.0872	[M-OH]+.	
	
Cyclohexyl(4-(dimethylamino)phenyl)(pyridin-2-yl)methanol	 (4.5cd).	 The	
reaction	 was	 performed	 following	 General	 Procedure	 E	 with	 2-
((cyclohexyloxy)methyl)pyridine	 (4.1c,	 38.2	mg,	 0.2	mmol)	 and	 4-bromo-N,N-
dimethylaniline	(48.0	mg,	0.24	mmol).	The	crude	product	was	purified	by	flash	chromatography	
on	silica	gel	(eluted	with	EtOAc:hexanes	=	20:80)	to	afford	the	product	(50.8	mg,	82%	yield)	as	a	
yellow	oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.43	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	7.61	(ddd,	J	=	7.9,	7.5,	
1.5	Hz,	1H),	7.47	(app.	d,	J	=	8.5	Hz,	2H),	7.42	(ddd,	J	=	7.9,	1.5,	1.0	Hz,	1H),	7.08	(ddd,	J	=	7.4,	5.0,	
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1.0	Hz,	1H),	6.69	 (app.	d,	 J	 =	8.5	Hz,	2H),	6.02	(s,	1H),		2.90	(s,	6H),	2.37	–	2.32	 (m,	1H),	1.78	–	
1.72	 (m,	1H),	1.71	–	1.60	 (m,	3H),	1.35	–	1.10	 (m,	5H),	1.06	–	0.98	 (m,	1H)	ppm;	 13C{1H}	NMR	
(125	MHz,	 CDCl3):	 δ	164.0,	 149.1,	 146.6,	 136.8,	 133.7,	 126.7,	 121.4,	 120.3,	 112.3,	 79.0,	 46.2,	
40.5,	26.9,	26.8,	26.6,	26.4	ppm;	IR	(thin	film):	3352,	2930,	2850,	1733,	1611,	1592,	1392,	1349,	
1161,	 1090,	 998,	 947,	 823,	 750,	 647	 cm-1;	 HRMS	 calculated	 for	 C20H25N2,	 293.2018	 found	
293.2016	[M+H]+.	
	
Cyclohexyl(4-fluorophenyl)(pyridin-2-yl)methanol	 (4.5ce).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 E	 with	 2-
((cyclohexyloxy)methyl)pyridine	 (4.1c,	 38.2	 mg,	 0.2	 mmol)	 and	 1-bromo-4-
fluorobenzene	 (31.2	uL,	0.24	mmol).	 The	crude	product	was	purified	by	 flash	 chromatography	
on	 silica	 gel	 (eluted	with	 EtOAc:hexanes	 =	 20:80)	 to	 afford	 the	product	 (48.4,	 85%	yield)	 as	 a	
yellow	oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.45	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	7.65	(ddd,	J	=	7.9,	7.5,	
1.5	Hz,	1H),	7.58	(app.	dd,	J	=	8.5,	5.5	Hz,	2H),	7.41	(ddd,	J	=	8.0,	1.5,	1.0	Hz,	1H),	7.14	(ddd,	J	=	
7.5,	5.0,	1.0	Hz,	1H),	6.98	(app.	dd,	J	=	9.0,	8.5	Hz,	2H),	6.08	(s,	1H),	2.36	–	2.32	(m,	1H),	1.75	–	
1.54	(m,	 4H),	1.31	 –	 0.98	(m,	 6H)	 ppm;	 13C{1H}	 NMR	 (125	MHz,	 CDCl3):	 δ	163.1,	 162.6	 (d,	 J	 =	
250.0	Hz),	146.9,	141.6	 (d,	 J	=	2.5	Hz),	137.1,	127.6	 (d,	 J	=	12.5	Hz),	121.8,	120.3,	114.9	 (d,	 J	=	
25.0	 Hz),	 79.1,	 46.3,	 26.8,	 26.7,	 26.6,	 26.5,	 26.3	 ppm;	 IR	 (thin	 film):	 3339,	 2932,	 2852,	 1593,	
1505,	 1433,	 1394,	 1224,	 1158,	 1086,	 999,	 835,	 751	 cm-1;	 HRMS	 calculated	 for	 C18H19FN,	
268.1502,	found	268.1499	[M-OH]+.	
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1-(4-(Dimethylamino)phenyl)-2,2-dimethyl-1-(pyridin-2-yl)propan-1-ol	 (4.5dd).	
The	 reaction	 was	 performed	 following	 General	 Procedure	 E	 with	 2-(tert-
butoxymethyl)pyridine	 (4.1d,	 33.0	 mg,	 0.2	 mmol)	 and	 4-bromo-N,N-
dimethylaniline	(48.0	mg,	0.24	mmol).		The	crude	product	was	purified	by	flash	chromatography	
on	silica	gel	(eluted	with	EtOAc:hexanes	=	20:80)	to	afford	the	product	(37.0	mg,	65%	yield)	as	a	
yellow	solid.	m.p.	=	103	–	105	°C,	1H	NMR	(500	MHz,	CDCl3):	δ	8.49	(d,	J	=	5.0	Hz,	1H),	7.75	(d,	J	=	
8.1	Hz,	1H),	7.66	(td,	J	=	7.8,	1.0	Hz,	1H),	7.59	(d,	J	=	9.0	Hz,	2H),	 	7.16	(dd,	J	=	6.9,	5.4	Hz,	1H),	
6.65	(d,	J	=	9.0	Hz,	2H),	6.31	(s,	1H),	2.90	(s,	6H),	1.06	(s,	9H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	
δ	163.2,	 149.2,	 146.8,	 136.0,	 132.5,	 129.1,	 123.0,	 122.0,	 111.6,	 81.2,	 40.7,	 40.1,	 27.2;	 HRMS	
calculated	for	C18H25N2O,	285.1967,	found	285.1965	[M+	H]+.	
	 	
1-(4-Chlorophenyl)-2,2-dimethyl-1-(pyridin-2-yl)propan-1-ol	 (4.5di).	 The	
reaction	 was	 performed	 following	 General	 Procedure	 E	 with	 2-(tert-
butoxymethyl)pyridine	(4.1d,	33.0	mg,	0.2	mmol)	and	1-bromo-4-chlorobenzene	
(45.8	mg,	 0.24	mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 chromatography	 on	 silica	 gel	
(eluted	with	EtOAc:hexanes	=	20:80)	to	afford	the	product	(33.0	mg,	60%	yield)	as	a	yellow	oil.	
1H	NMR	(500	MHz,	CDCl3):	δ	8.51	(ddd,	J	=	4.5,	1.5,	1.0	Hz,	1H),	7.77	(d,	J	=	8.5	Hz,	1H),	7.76	–	
7.69	(m,	1H),	7.70	(d,	J	=	9.0	Hz,	 2H)	7.26	–	7.20	(m,	3H),	6.40	(s,	 1H),	1.05	 (s,	 9H)	ppm;	 13C{1H}	
NMR	 (125	MHz,	 CDCl3):	 δ	161.9,	 146.8,	 142.7,	 136.2,	 132.4,	 129.6,	 127.2,	 122.6,	 122.2,	 81.0,	
39.7,	 26.8	 ppm;	 IR	 (thin	 film):	 3277,	 2958,	 1591,	 1571,	 1488,	 1464,	 1434,	 1399,	 1362,	 1095,	
1064,	1012,	831,	768	cm-1;	HRMS	calculated	for	C16H17NCl,	258.1050,	found	258.1053	[M-OH]+.	
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	3-(Dimethylamino)-1-phenyl-1-(pyridin-2-yl)propan-1-ol	 (4.5ha).	 The	
reaction	was	performed	following	General	Procedure	E	at	60	°C	for	24	h	with	
N,N-dimethyl-2-(pyridin-2-ylmethoxy)ethan-1-amine	(4.1h,	36.1	mg,	0.2	mmol)	
and	 bromobenzene	 (25.2	uL,	 0.24	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	
chromatography	 on	 silica	 gel	 (dichloromethane:methanol	 =	 10:1)	 to	 afford	 the	 product	 (37.9	
mg,	74%	yield)	as	a	white	solid.	m.p.	=	98	–	100	°C;	1H	NMR	(500	MHz,	CDCl3):	δ	8.52	(ddd,	J	=	
4.9,	1.8,	1.0	Hz,	1H),	7.70	–	7.59	(m,	4H),	7.32	–	7.26	(m,	2H),	7.21	–	7.15	(m,	1H),	7.11	(ddd,	=	
7.2,	4.9,	1.0	Hz,	1H),	2.74	–	2.66	(m,	1H),	2.62	–	2.48	(m,	3H),	2.32	(s,	6H)	ppm;	13C{1H}	NMR	(125	
MHz,	 CDCl3):	 δ	165.4,	 147.9,	 146.6,	 136.9,	 128.2,	 126.8,	 125.7,	 121.8,	 121.1,	 79.1,	 56.1,	 44.8,	
35.9	 ppm;	 IR	 (thin	 film):	 3309,	 3054,	 2976,	 2950,	 2860,	 2825,	 2780,	 1586,	 1568,	 1463,	 1447,	
1427,	 1380,	 1307,	 1212,	 1195,	 1178,	 1164,	 1120,	 1066,	 1047	 cm-1;	 HRMS	 calculated	 for	
C16H21N2O,	257.1654,	found	257.1653	[M+H]+.	
	
1-(4-Chlorophenyl)-3-(dimethylamino)-1-(pyridin-2-yl)propan-1-ol	 (4.5hi).	
The	 reaction	was	performed	 following	General	Procedure	E	at	60	 °C	 for	24	h	
with	 N,N-dimethyl-2-(pyridin-2-ylmethoxy)ethan-1-amine	 (4.1h,	 36.1	 mg,	 0.2	
mmol)	and	1-bromo-4-chlorobenzene	(45.8	mg,	0.24	mmol).	The	crude	product	was	purified	by	
flash	 chromatography	 on	 silica	 gel	 (dichloromethane:methanol	 =	 10:1)	 to	 afford	 the	 product	
(41.9	mg,	72%	yield)	as	a	white	solid.	m.p.	=	87	–	90	°C;	1H	NMR	(500	MHz,	CDCl3):	δ	8.52	(ddd,	J	
=	4.9,	1.8,	1.0	Hz,	1H),	7.70		(ddd,	J	=	8.0,	7.5,	1.8	Hz,	1H),	7.61	(ddd,	J	=	8.0,	1.5,	1.0	Hz,	1H),	7.55	
(app.	d,	J	=	9.0	Hz,	2H),	7.28	(app.	d,	J	=	9.0	Hz,	2H),	7.19	(ddd	=	J	=	7.5,	4.9,	1.0	Hz,	1H),	3.05	–	
2.75	 (m,	 4H),	 2.61	 (s,	 6H)	 ppm;	 13C{1H}	 NMR	 (125	 MHz,	 CDCl3):	
N
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δ	162.9,	147.9,	143.9,	137.7,	133.2,	128.7,	127.3,	122.6,	120.9,	77.2,	55.4,	43.9,	35.6	 ppm;	 IR	
(thin	 film):	 3307,	 3056,	 3011,	 2953,	 2826,	 2679,	 2468,	 1588,	 1569,	 1489,	 1467,	 1400,	 1292,	
1250,	 1091,	 1056,	 1013	 cm-1;	 HRMS	 calculated	 for	 C16H20N2OCl,	 291.1264,	 found	 291.1265	
[M+H]+.	
	
		
1-Phenyl-1-(pyridin-2-yl)-3-(pyrrolidin-1-yl)propan-1-ol	 (4.5ia).	 The	
reaction	 was	 performed	 following	 General	 Procedure	 E	 at	 60	 °C	 for	 24	 h	
with	2-((2-(pyrrolidin-1-yl)ethoxy)methyl)pyridine	(4.1i,	41.3	mg,	0.2	mmol)	and	bromobenzene	
(25.2	uL,	 0.24	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 chromatography	 on	 silica	 gel	
(dichloromethane:methanol	=	10:1)	to	afford	the	product	(36.1	mg,	64%	yield)	as	a	white	solid.	
m.p.	=	90	–	93	°C;	1H	NMR	(500	MHz,	CDCl3):	δ		8.52	(dt,	J	=	4.9,	1.3	Hz,	1H),	7.71	–	7.64	(m,	2H),	
7.63	–	7.58	(m,	2H),	7.34	–	7.28	(m,	2H),	7.23	–	7.18	(m,	2H),	7.14	(ddd,	J	=	5.9,	4.9.	2.7	Hz,	1H),	
2.92	 –	 2.64	 (m,	 8H),	 1.97	 –	 1.84	 (m,	 4H)	 ppm;	 13C{1H}	 NMR	 (125	 MHz,	 CDCl3):	
δ	165.2,	147.9,	146.6,	137.0,	128.3,	126.8,	125.7,	121.9,	121.1,	78.9,	53.9,	52.5,	36.9,	23.5	 ppm;	
IR	 (thin	 film):	3254,	3056,	2963,	2931,	2811,	1588,	1569,	1490,	1464,	1447,	1430,	1203,	1137,	
1068	cm-1;	HRMS	calculated	for	C18H23N2O,	283.1810,	found	283.1806	[M+H]+.	
	
	
	1-(Pyridin-2-yl)-3-(pyrrolidin-1-yl)-1-(p-tolyl)propan-1	 (4.5ik).	 The	 reaction	
was	performed	following	General	Procedure	E	at	60	°C	for	24	h	with	2-((2-
(pyrrolidin-1-yl)ethoxy)methyl)pyridine	 (4.1i,	 41.3	 mg,	 0.2	 mmol)	 and	 4-
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bromotoluene	 (29.5	uL,	 0.24	mmol).	 The	 crude	product	was	purified	by	 flash	 chromatography	
on	silica	gel	(dichloromethane:methanol	=	10:1)	to	afford	the	product	(42.1	mg,	71%	yield)	as	a	
white	solid.	m.p.	=	116	–	118	°C;	1H	NMR	(500	MHz,	CDCl3):	δ	8.52	(ddd,	J	=	4.9,	1.8.	1.0	Hz,	1H),	
7.66	(ddd,	J	=	8.0,	1.0.	1.0	Hz,	1H),	7.61	(ddd,	J	=	8.0,	7.5.	1.8	Hz,	1H),	7.49	(app.	d,	J	=	8.0	Hz,	2H),	
7.10	(app.	d,	J	=	8	.0	Hz,	2H),	7.08	(ddd,	J	=	7.5,	4.9,	1.0	Hz,	1H),	2.75	–	2.50	(m,	4H),	2.28	(s,	3H),	
1.84	 –	 1.74	 (m,	 4H)	 ppm;	 13C{1H}	NMR	 (125	MHz,	 CDCl3):	δ	166.1,	 147.9,	 144.1,	 136.8,	 136.1,	
128.8,	 125.6,	 121.6,	 121.0,	 79.4,	 53.9,	 52.7,	 37.0,	 23.6,	 21.1	 ppm;	 IR	 (thin	 film):	 3154,	 3055,	
2964,	 2926,	 2876,	 2810,	 1588,	 1568,	 1510,	 1463,	 1430,	 1293,	 1177,	 1138,	 1110,	 1082	 cm-1;	
HRMS	calculated	for	C19H25N2O,	297.1967,	found	297.1969	[M+H]+.	
	
Procedure	and	characterization	of	Pd-catalyzed	selective	C(sp3)–H	arylation	of	4-pyridylmethyl	
ethers	(Table	4.6).	
	
4-(Ethoxy(pyridin-4-yl)methyl)-N,N-dimethylaniline	 (4.4jd).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 D	 with	 4-(ethoxymethyl)pyridine	 (4.1j,	
27.4	mg,	0.2	mmol)	and	4-bromo-N,N-dimethylaniline	(48.0	mg,	0.24	mmol)	with	
Pd(OAc)2	 (1	mol	%)	and	NIXANTPHOS	 (1.5	mol	%)	 in	1	mL	of	dry	DME	 for	12	h	at	23	 °C.	 	 The	
crude	product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	
10:90)	 to	 afford	 the	 product	 (43.6	mg,	 85%	 yield)	 as	 a	 yellow	 oil.	 1H	NMR	 (500	MHz,	 CDCl3):	
δ	8.49	(dd,	J	=	5.5,	1.5	Hz,	2H),	7.26	(m,	2H),	7.13	(d,	J	=	9.0	Hz,	2H),	6.66	(d,	J	=	9.0	Hz,	2H),	5.21	
(s,	1H),		3.47	(ABqq,	2H,	ΔνAB	=	26.3	Hz,	J	=	9.2,	7.0	Hz,	2H),		2.90	(s,	6H),	1.23	(t,	J	=	7.0	Hz,	3H)	
ppm;	 13C{1H}	 NMR	 (125	MHz,	 CDCl3):	 δ	152.1,	 150.2,	 149.6,	 128.3,	 128.2,	 121.4,	 112.2,	 81.8,	
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64.2,	40.3,	15.2	ppm;	IR	(thin	film):	2889,	1614,	1586,	1522,	1492,	1433,	1350,	1228,	1186,	1164,	
1032,	 992,	 946,	 885,	 804,	 751,	 690	 cm-1;	 HRMS	 calculated	 for	 C16H21N2O,	 257.1654,	 found	
257.1650	[M+H]+.	
	
	4-(tert-Butoxy(4-(tert-butyl)phenyl)methyl)	 (4.4kb).	 The	 reaction	 was	
performed	following	General	Procedure	D	with	4-(butoxymethyl)pyridine	(4.1k,	
33.0	mg,	0.2	mmol)	and	1-bromo-4-tert-butylbenzene	(42.0	uL,	0.24	mmol)	with	
Pd(OAc)2	 (1	mol	%)	and	NIXANTPHOS	 (1.5	mol	%)	 in	1	mL	of	dry	DME	 for	12	h	at	23	 °C.	 	 The	
crude	product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	
20:80)	to	afford	the	product	(51.2	mg,	86%	yield)	as	a	yellow	oil.		The	same	reaction	in	1	mL	of	
dry	CPME	 for	6	h	at	60	°C	following	General	Procedure	E	resulted	in	the	product	(50.0	mg,	
84%	yield).	1H	NMR	(500	MHz,	CDCl3):	δ	8.50	–	8.48		(m,	2H),	7.31	–	7.26	(m,	4H),	7.19	(d,	J	=	8.5	
Hz,	 2H),	 5.50	 (s,	 1H),	 1.27	 (s,	 9H),	 1.20	 (s,	 9H)	 ppm;	 13C{1H}	 NMR	 (125	MHz,	 CDCl3):	 δ	 154.3,	
150.4,	149.8,	140.6,	126.7,	125.5,	122.0,	75.5,	74.7,	34.6,	31.5,	28.8	ppm;	 IR	 (thin	 film):	3026,	
2967,	 2094,	 2869,	 1596,	 1562,	 1511,	 1463,	 1413,	 1391,	 1366,	 1269,	 1109,	 1065,	 1018	 cm-1;	
HRMS	calculated	for	C20H27NO,	298.2171,	found	298.2176	[M+H]+.	
	
	4-(tert-Butoxy(4-methoxyphenyl)methyl)pyridine	 (4.4kc).	 The	 reaction	 was	
performed	following	General	Procedure	D	with	4-(butoxymethyl)pyridine	(4.1k,	
33.0	mg,	0.2	mmol)	and	4-bromoanisole	(30.0	uL,	0.24	mmol)	with	Pd(OAc)2	(1	
mol	%)	and	NIXANTPHOS	(1.5	mol	%)	in	1	mL	of	dry	DME	for	12	h	at	23	°C.	The	crude	product	
was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	20:80)	to	afford	
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the	product	(47.8	mg,	88%	yield)	as	a	yellow	oil.		1H	NMR	(500	MHz,	CDCl3):	δ	8.48	(dd,	J	=	4.5,	
1.5	Hz,	2H),	7.25	(m,	2H),	7.19	(d,	J	=	9.0	Hz,	2H),	6.81	(d,	J	=	9.0	Hz,	2H),	5.47	(s,	1H),	3.75	(s,	3H),	
1.20	 (s,	 9H)	 ppm;	 13C{1H}	 NMR	 (125	MHz,	 CDCl3):	 δ	159.0,	 154.3,	 149.8,	 136.0,	 128.3,	 121.8,	
114.0,	75.5,	74.4,	5.4,	28.8	ppm;	IR	(thin	film):	3074,	3027,	2974,	2934,	2906,	2836,	1610,	1597,	
1561,	 1511,	 1464,	 1477,	 1391,	 1367,	 1303,	 1248,	 1172,	 1110,	 1089,	 1064,	 1035	 cm-1;	 HRMS	
calculated	for	C17H22NO2,	272.1652,	found	272.1636	(-5.5	ppm,	only	choice)	[M+H]+.	
	
	4-(Ethoxy(4-fluorophenyl)methyl)pyridine	 (4.4je).	The	reaction	was	performed	
following	General	Procedure	E	with	4-(ethoxymethyl)pyridine	(4.1j,	27.4	mg,	0.2	
mmol)	and	1-bromo-4-fluorobenzene	(31.2	uL,	0.24	mmol)	with	Pd(OAc)2	(1	mol	
%)	and	NIXANTPHOS	(1.5	mol	%)	in	1	mL	of	dry	CPME	for	12	h	at	60	°C.	The	crude	product	was	
purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	10:90)	to	afford	the	
product	(40.2	mg,	87%	yield)	as	a	yellow	oil.	 	1H	NMR	(500	MHz,	CDCl3):	δ	8.52	(dd,	J	=	4.5,	1.5	
Hz,	1H),	7.29	–	7.25	(m,	2H),	7.25	–	7.22	(m,	2H),	7.00	(t,	J	=	8.5	Hz,	2H),	5.27	(s,	1H),	3.52	–	3.44	
(m,	2H),	1.25	(t,	J	=	7.0	Hz,	3H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	162.6,	(d,	J	=	245.0	Hz),	
151.4,	150.1,	137.0	(d,	J	=	3.5	Hz),	129.0	(d,	J	=	8.1	Hz),	121.7,	115.7	(d,	J	=	21.2	Hz),	81.8,	65.0,	
15.4	 ppm;	 IR	 (thin	 film):	 3030,	 2976,	 2872,	 1600,	 1561,	 1508,	 1443,	 1411,	 1305,	 1223,	 1187,	
1157,	 1104,	 1091,	 1015,	 993	 cm-1;	HRMS	calculated	 for	C14H15NOF,	 232.1138,	 found	232.1134	
[M+H]+.	
	
	4-(Ethoxy(4-methoxyphenyl)methyl)pyridine	 (4.4jc).	 The	 reaction	 was	
performed	 following	General	 Procedure	 E	with	 4-(ethoxymethyl)pyridine	 (4.1j,	
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27.4	 mg	 0.2	 mmol)	 and	 4-bromoanisole	 (30.0	uL,	 0.24	 mmol)	 with	 Pd(OAc)2	 (1	 mol	 %)	 and	
NIXANTPHOS	(1.5	mol	%)	in	1	mL	of	dry	CPME	for	12	h	at	60	°C.	The	crude	product	was	purified	
by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	20:80)	to	afford	the	product	
(42.8	mg,	88%	yield)	as	a	yellow	oil.		1H	NMR	(500	MHz,	CDCl3):	δ	8.51	(m,	2H),	7.26	–	7.	23	(m,	
2H),	7.20	(d,	J	=	8.5	Hz,	2H),	6.84	(d,	J	=	8.5	Hz,	2H),	5.24	(s,	1H),	3.76	(s,	3H),	3.53	–	3.41	(m,	2H),	
1.24	(t,	J	=	7.0	Hz,	3H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	159.6,	151.9,	150.0,	133.2,	128.6,	
121.7,	 114.2,	 81.9,	 64.7,	 55.4,	 15.4	 ppm;	 IR	 (thin	 film):	 3029,	 2974,	 2932,	 2896,	 2871,	 2837,	
1610,	1599,	1561,	1511,	1463,	1442,	1412,	1342,	1304,	1249,	1173,	1111,	1096,	1081,	1034,	992	
cm-1;	HRMS	calculated	for	C15H18NO2,	244.1338,	found	244.1314	9	(only	choice)	[M+H]+.	
	
	4-(tert-Butoxy(4-fluorophenyl)methyl)	 pyridine	 (4.4ke).	 The	 reaction	 was	
performed	following	General	Procedure	E	with	4-(ethoxymethyl)pyridine	(4.1k,	
33.0	mg,	 0.2	mmol)	 and	 1-bromo-4-fluorobenzene	 (31.2	uL,	 0.24	mmol)	 with	
Pd(OAc)2	 (1	mol	%)	and	NIXANTPHOS	 (1.5	mol	%)	 in	1	mL	of	dry	CPME	 for	12	h	at	60	 °C.	The	
crude	product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	
20:80)	 to	 afford	 the	product	 (41.5	mg,	 80%	yield)	 as	 a	 yellow	oil.	 	 1H	NMR	 (500	MHz,	 CDCl3):	
δ	8.49	 (dd,	 J	 =	 4.5,	 2.0	 Hz,	 2H),	 7.29	 –	 7.21	(m,	 4H),		 6.96	 (t,	 J	 =	 8.7	 Hz,	 2H),	 5.49	(s,	
1H),	1.19	(s,	9H)	 ppm;	 13C{1H}	 NMR	 (125	MHz,	 CDCl3):	 δ	162.2	 (d,	 J	 =	 244.2	 Hz),	 153.8,	 149.9,	
139.7	(d,	J	=	2.9	Hz),	128.7	(d,	J	=	8.0	Hz),	121.8,	115.5	(d,	J	=	21.1	Hz),	75.8,	74.2,	28.8	ppm;	IR	
(thin	 film):	 3029,	 2975,	 2934,	 1597,	 1561,	 1508,	 1471,	 1412,	 1391,	 1368,	 1295,	 1223,	 1183,	
1156,	1099,	1087,	1065,	1025,	1015,	993	cm-1;	HRMS	calculated	for	C16H19NOF,	260.1451,	found	
260.1457		[M+H]+.	
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	4-(Ethoxy(o-tolyl)methyl)pyridine	 (4.4jf).	 The	 reaction	 was	 performed	
following	General	Procedure	D	with	4-(ethoxymethyl)pyridine	(4.1j,	27.4	mg,	0.2	
mmol),	1-bromo-2-methylbenzene	(28.8	uL,	0.24	mmol)	with	Pd(OAc)2	(1	mol	%)	
and	NIXANTPHOS	 (1.5	mol	%)	 in	 1	mL	of	 dry	CPME	 for	 12	h	 at	 60	 °C.	 The	 crude	product	was	
purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	20:80)	to	afford	the	
product	(40.0	mg,	88%	yield)	as	a	yellow	oil.	 	1H	NMR	(500	MHz,	CDCl3):	δ	8.51	(dd,	J	=	5.0,	1.5	
Hz,	2H),	7.32	–	7.10	(m,	6H),		5.49	(s,	1H),	3.57	–	3.44	(m,	2H),	2.26	(s,	3H),	1.25	(t,	J	=	7.0	Hz,	3H)	
ppm;	 13C{1H}	NMR	 (125	MHz,	 CDCl3):	δ	150.8,	 150.0,	 138.7,	 136.4,	 131.0,	 128.2,	 127.9,	 126.4,	
122.2,	80.0,	65.0,	19.6,	15.5	ppm;	IR	(thin	film):	3025,	2975,	2871,	1597,	1560,	1491,	1460,	1411,	
1308,	 1180,	 1112,	 1081,	 993	 cm-1;	 HRMS	 calculated	 for	 C15H18NO,	 228.1388,	 found	 228.1398	
[M+H]+.		
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Confirmation	of	the	order	of	tandem	arylation/[1,2]-Wittig	rearrangement(Scheme	4).
	
	
Scheme	4.1A:		
The	 reaction	 was	 performed	 following	 General	 Procedure	 D	 with	 2-((allyloxy)methyl)pyridine	
(4.1l,	 32.6	 mg,	 0.2	 mmol)	 or	 2-((benzyloxy)methyl)pyridine	 (4.1m,	 39.9	 mg,	 0.2	 mmol)	 and	
bromobenzene	(25.2	uL,	0.24	mmol).	The	crude	products	were	purified	by	flash	chromatography	
on	silica	gel	to	afford	the	Wittig	rearrangement	products:	1-(Pyridin-2-yl)but-3-en-1-ol	(4.3l,	26.0	
mg,	80%	yield)	or	2-phenyl-1-(pyridin-2-yl)ethan-1-ol	(4.3m,	32.0	mg,	80%	yield).	
	
Scheme	4.1B:		
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In	 a	 10	 mL	 dry	 one-necked	 flask	 under	 a	 nitrogen	 atmosphere	 was	 added	 2-
(ethoxymethyl)pyridine	 (4.1a,	 109.6	 mg,	 112	 uL,	 0.8	 mmol)	 and	 THF	 (5	 mL)	 at	 room	
temperature.	The	reaction	vessel	was	cooled	to	–	40	°C	in	a	dry	ice	bath	and	stirred	for	5	min.	
nBuLi	 (0.5	 mL,	 2.5	 M	 in	 hexanes,	 1.5	 equiv)	 was	 added	 dropwise.	 The	 reaction	 mixture	 was	
stirred	 for	 2	 h	 at	 –	 40	 °C	 and	warmed	 to	 room	 temperature.	 Next,	 the	 reaction	mixture	was	
quenched	by	addition	of	1	mL	of	water,	and	the	solvent	was	removed	in	vacuo	to	yield	the	crude	
product.	The	crude	product	was	dissolved	in	EtOAc	(20	mL)	and	washed	with	brine	(3	x	5	mL).	
The	organic	layer	was	dried	over	MgSO4,	and	filtered.	The	was	filtrate	collected,	and	the	volatile	
materials	 was	 removed	 in	 vacuo	 to	 yield	 a	 yellow	 oil.	 	 This	 oil	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	 (hexanes:EtOAc	=	10:1)	 to	afford	1-(pyridin-2-yl)propan-1-ol	4.3a	
as	a	yellow	oil	 (49.3	mg,	45%	yield).11	1-(Pyridin-2-yl)propan-1-ol	 (4.3a,	28	mg,	0.2	mmol)	was	
subjected	to	General	Procedure	C	with	4-bromo-N,N-dimethylaniline	(48.0	mg,	0.24	mmol),	but	
no	arylation	product	was	observed.	This	result	 indicates	that	the	arylation	proceeds	the	Wittig	
rearrangement.	
	
Scheme	4.1C:	
An	oven-dried	10	mL	reaction	vial	equipped	with	a	stir	bar	was	charged	with	LiN(SiMe3)2	(66.9	
mg,	 0.4	 mmol,	 2	 equiv)	 and	 by	 2	 mL	 of	 dry	 CPME	 under	 a	 nitrogen	 atmosphere	 at	 room	
temperature.	 	 The	 reaction	 mixture	 was	 stirred	 for	 5	 min	 at	 room	 temperature.	 Next,	 4-
(ethoxy(pyridin-2-yl)methyl)-N,N-dimethylaniline	(4.4ad,	51.2	mg,	0.2	mmol,	1	equiv)	was	added	
to	the	reaction	mixture	under	a	purge	of	nitrogen.	The	vial	was	capped,	removed	from	the	glove	
box,	and	stirred	for	12	h	at	45	°C	until	TLC	showed	complete	consumption	of	4.4ad.	The	reaction	
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mixture	was	cooled	to	room	temperature,	quenched	with	four	drops	of	H2O,	diluted	with	3	mL	
of	ethyl	acetate,	and	filtered	over	a	pad	of	MgSO4	and	silica.	The	pad	was	rinsed	with	additional	
ethyl	 acetate	 (3	 mL),	 and	 the	 solution	 was	 concentrated	 in	 vacuo.	 	 The	 crude	 product	 was	
purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	10:90)	to	afford	1-
(4-(dimethylamino)phenyl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ad,	 40.9	mg,	 80%	 yield)	 as	 a	 yellow	
oil.	
	
Effect	 of	 Alkali	 Metals,	 Solvents	 and	 Additives	 in	 [1,2]-Wittig	 Rearrangement	 of	 Arylation	
product	4.4ab.	
Experiments	were	set	up	inside	a	glove	box	under	a	nitrogen	atmosphere.		
Stock	 solution	 of	 starting	materials:	4.4ab	 in	 CPME	 (0.4	M)	 and	4.4ab	 in	 DME	 (0.4	M)	were	
prepared.	
Stock	Solution	of	bases:	LiN(SiMe3)2	in	CPME	(0.6	M),	NaN(SiMe3)2	in	CPME	(0.6	M),	LiN(SiMe3)2	
in	DME	(0.6	M),	and	NaN(SiMe3)2	in	DME	(0.6	M)	were	prepared	
	
General	Procedure	F	for	[1,2]-Wittig	Rearrangement	of	4.4ab	
In	 a	 4	mL	 reaction	 vial	 equipped	with	 a	 stir	 bar	was	 added	0.6	M	LiN(SiMe3)2	 in	CPME	 (0.075	
mmol,	125	μL)	and	12-Crown-4	(0.075	mmol,	12.1	μL).		After	the	vial	was	stirred	for	3	min,	0.4	M	
4.4ab	 in	 CPME	 (0.05	 mmol,	 125	 μL)	 was	 added	 to	 the	 reaction	 vial.	 	 The	 vial	 was	 capped,	
removed	from	the	glove	box,	and	stirred	for	1	h	at	45	°C,	then	cooled	to	room	temperature.		The	
reaction	mixture	was	 quenched	with	 one	drop	of	H2O,	 diluted	with	 ethyl	 acetate	 (3	mL),	 and	
filtered	over	a	pad	of	Celite.	 	The	pad	was	rinsed	with	additional	ethyl	acetate	(3	mL),	and	the	
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solution	was	concentrated	in	vacuo.		The	sample	was	analyzed	by	1H	NMR	of	the	crude	reaction	
mixture	in	1	mL	of	0.05	M	CH2Br2	in	CDCl3.	
The	results	were	summarized	below.	
	
entry	 solvent	 M	 additive	 4.4ab	(%)[b]	 4.5ab	(%)[b]	
1	 CPME	 Li	 –	 37	 64	
2	 CPME	 Na	 –	 24	 75	
3	 DME	 Li	 –	 72	 27	
4	 DME	 Na	 –	 85	 9	
5	 CPME	 Li	 12-Crown-4	 53	 47	
6	 CPME	 Na	 12-Crown-4	 90	 7	
7	 CPME	 Na	 15-Crown-5	 86	 13	
	[a]	Reaction	conditions:	4.4ab	(0.05	mmol),	MN(SiMe3)2	(0.075	mmol),	Additive	(0.075	mmol)	in	
solvent	(0.25	mL)	at	45	°C.	[b]	Yield	determined	by	1H	NMR	spectroscopy	of	the	crude	reaction	
mixture.	
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Appendix	A:	Chapter	1	Raw	Data	from	Computational	Studies		
Conformations:	
2-unsubstituted,	closed	conformation	
File:	PhHEtAllylPd_PPh3_2_closed_thf.out	
Solution	phase	energy:	DFT(b3lyp-d3)	-2626.22685903356	au	
	
		Pd1										-1.6040910221						1.8916436118					-0.0476526730		
		P2											-0.7342942743						0.6718064781					-1.9161890484		
		P3											-0.6546857447						0.6584036515						1.8162833748		
		C4											-2.5326673803						3.9579073916						0.1263943049		
		C5											-2.9890546401						3.3026693605						1.2814574370		
		C6											-2.7835447266						3.4618333609					-1.1727219691		
		H7											-3.8245538956						2.6099767162						1.1649490915		
		H8											-3.6803765545						2.8550272460					-1.3244535371		
		C10										-3.8549397339					-0.2312724800						5.0712178708		
		C11										-2.5752705044						0.1671060374						5.4671300969		
		C12										-1.5999601285						0.4703816496						4.5136381398		
		C13										-1.8973337778						0.3865738531						3.1462059990		
		C14										-3.1927472504						0.0058456919						2.7549995052		
		C15										-4.1617456155					-0.3109098498						3.7090485764		
		H16										-4.6091341934					-0.4711490346						5.8171901045		
		H17										-2.3314101141						0.2457133711						6.5245420097		
		H18										-0.6148233423						0.7822697529						4.8457003304		
		H19										-3.4524801408					-0.0367464080						1.6987177729		
		H20										-5.1571999367					-0.6098245708						3.3873732225		
		C21											2.9244413109						2.9861208858						3.6371085865		
		C22											2.6810191050						1.6675979425						4.0352280079		
		C23											1.6092797819						0.9583670287						3.4932703709		
		C24											0.7593979156						1.5657216920						2.5516532504		
		C25											1.0178745150						2.8846924182						2.1537785291		
		C26											2.0935339433						3.5927283093						2.6926592884		
		H27											3.7649165437						3.5346644880						4.0570934202		
		H28											3.3313305716						1.1868844251						4.7629412029		
		H29											1.4459906440					-0.0737135956						3.7920414018		
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		H30											0.3795126067						3.3551677112						1.4114879409		
		H31											2.2842357302						4.6145810407						2.3714257323		
		C32											1.1366368912					-3.5784626478						1.1098393306		
		C33										-0.1091635160					-3.4502374732						1.7268820407		
		C34										-0.6514959392					-2.1855770091						1.9611414609		
		C35											0.0479794850					-1.0301337153						1.5790745302		
		C36											1.3061978634					-1.1670015147						0.9698229023		
		C37											1.8428832813					-2.4325627564						0.7357487904		
		H38											1.5577218501					-4.5647577472						0.9264521892		
		H39										-0.6628723366					-4.3359482742						2.0309562765		
		H40										-1.6188199798					-2.1082318605						2.4475632060		
		H41											1.8755820553					-0.2886652937						0.6833705391		
		H42											2.8167897974					-2.5194170842						0.2600564478		
		C43										-2.2290231320					-3.7176452279					-2.2683348734		
		C44										-1.5022769103					-3.1394869351					-3.3153070125		
		C45										-1.0587638876					-1.8207499745					-3.2189335332		
		C46										-1.3235530665					-1.0625248793					-2.0621577943		
		C47										-2.0681751791					-1.6450083428					-1.0284456819		
		C48										-2.5160708885					-2.9644207852					-1.1287600978		
		H49										-2.5763199524					-4.7453816849					-2.3473146441		
		H50										-1.2870185773					-3.7138159247					-4.2138443825		
		H51										-0.5221309231					-1.3777267862					-4.0540879407		
		H52										-2.3001200097					-1.0666836293					-0.1408891727		
		H53										-3.0888244494					-3.4017522244					-0.3143377263		
		C54											3.9041112141						0.6977810022					-1.5576091495		
		C55											3.2735204598					-0.4055451261					-2.1411877564		
		C56											1.8833193039					-0.4403807649					-2.2699578151		
		C57											1.1031671153						0.6333780879					-1.8142700115		
		C58											1.7450642075						1.7440164041					-1.2401280437		
		C59											3.1350303353						1.7764936055					-1.1115790339		
		H60											4.9861159813						0.7147534770					-1.4484722434		
		H61											3.8645364185					-1.2498861721					-2.4896469363		
		H62											1.4160627440					-1.3202892099					-2.6994517278		
		H63											1.1560880103						2.5801803858					-0.8711235308		
		H64											3.6133307039						2.6382353165					-0.6521316986	
		C65										-1.7486111818						2.4567805333					-6.0870770701		
		C66										-0.4810830045						2.6653047093					-5.5383587469		
		C67										-0.1456597382						2.1062348100					-4.3012134308		
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		C68										-1.0802191700						1.3315062100					-3.5998845993		
		C69										-2.3540317466						1.1220815303					-4.1578769841		
		C70										-2.6834730712						1.6791570300					-5.3934706328		
		H71										-2.0077558585						2.8941706308					-7.0485025863		
		H72											0.2537676150						3.2641728318					-6.0722343855		
		H73											0.8449499410						2.2781160753					-3.8894306112		
		H74										-3.0915034346						0.5218461187					-3.6296752217		
		H75										-3.6721858895						1.5077423817					-5.8138011410		
		C76										-2.3774007598						4.5701462304						5.3287068793		
		C77										-3.3947438789						3.6705434844						5.0040504448		
		C78										-3.5705956183						3.2624387933						3.6832966797		
		C79										-2.7364255095						3.7458850796						2.6583030758		
		C80										-1.7217622654						4.6630228042						2.9993370365		
		C81										-1.5437237895						5.0658212348						4.3193087453		
		H82										-2.2315560801						4.8838284130						6.3601109073		
		H83										-4.0476851810						3.2787150364						5.7799335548		
		H84										-4.3557852105						2.5520712865						3.4401158625		
		H85										-1.0616464867						5.0639038867						2.2354063162		
		H86										-0.7500579625						5.7675762618						4.5651456211		
		H87										-1.8361600622						4.7912810857						0.2260120075		
		C88										-2.2950982535						4.2404958939					-2.3696262864		
		H89										-2.2714005070						3.6001645285					-3.2510098189		
		H90										-1.2690225060						4.5896859552					-2.1952719439		
		C91										-3.2131023446						5.4476943199					-2.6464619223		
		H92										-3.2258956659						6.1391934112					-1.7951663488		
		H93										-2.8654758998						5.9971789473					-3.5289932091		
		H94										-4.2441671042						5.1226789234					-2.8322613929		
	
2-unsubstituted,	open	conformation	
File:	PhHEtAllylPd_PPh3_2_thf.out	
Solution	phase	energy:	DFT(b3lyp-d3)	-2626.22475144541	au	
		Pd1										-1.6231432005						1.9116258053					-0.0499103079		
		P2											-0.7448599131						0.6996557582					-1.9170706750		
		P3											-0.6236172236						0.6907653490						1.8017253615		
		C4											-2.6162174916						3.9470450996						0.1453899296		
		C5											-3.0553548750						3.2422941532						1.2788667159		
		C6											-2.8483017472						3.4697137650					-1.1626129085		
		H7											-3.8681904051						2.5269174433						1.1389060967		
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		H8											-3.7186243250						2.8263931344					-1.3130444171		
		C10										-3.7084141726					-0.2686845325						5.1373577624		
		C11										-2.4359703076						0.1794380305						5.4995654266		
		C12										-1.4989027926						0.5151698750						4.5198726627		
		C13										-1.8301746683						0.4141164396						3.1619807931		
		C14										-3.1229646988					-0.0066221245						2.8053696018		
		C15										-4.0526097920					-0.3576051446						3.7853080853		
		H16										-4.4324293583					-0.5363010697						5.9039570069		
		H17										-2.1679346811						0.2696084101						6.5501998218		
		H18										-0.5167004909						0.8622540666						4.8239308982		
		H19										-3.4102851368					-0.0578967301						1.7567446950		
		H20										-5.0464266588					-0.6902921821						3.4927579197		
		C21											2.9609176745						3.0620184070						3.5575413008		
		C22											2.7417171416						1.7399499930						3.9576724414		
		C23											1.6694761802						1.0175418572						3.4340424080		
		C24											0.7946160444						1.6146558119						2.5090001809		
		C25											1.0294834275						2.9373545139						2.1082798500		
		C26											2.1050410011						3.6591709981						2.6290565770		
		H27											3.8015715436						3.6208641529						3.9634726426		
		H28											3.4106716198						1.2666774543						4.6733002024		
		H29											1.5238400934					-0.0162439132						3.7357923623		
		H30											0.3715967794						3.4000188073						1.3779587780		
		H31											2.2768046523						4.6841394910						2.3071726225		
		C32											1.1687561139					-3.5603470519						1.1395616045		
		C33										-0.0909074929					-3.4230693575						1.7255492557		
		C34										-0.6311689209					-2.1547041058						1.9429122369		
		C35											0.0815103327					-1.0023608664						1.5732788775		
		C36											1.3525644099					-1.1498281980						0.9937649317		
		C37											1.8885083638					-2.4192226444						0.7785083864		
		H38											1.5896242686					-4.5494777730						0.9715449122		
		H39										-0.6565738968					-4.3043473762						2.0206715030		
		H40										-1.6079354936					-2.0723086876						2.4083055965		
		H41											1.9355180113					-0.2771888984						0.7195575087		
		H42											2.8736182876					-2.5122437567						0.3279493819		
		C43										-2.3408539235					-3.6515352809					-2.2206143241		
		C44										-1.6174256987					-3.0996403028					-3.2833256115		
		C45										-1.1445117650					-1.7902706331					-3.2041954745		
		C46										-1.3779695210					-1.0182920654					-2.0502184855		
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		C47										-2.1186128215					-1.5761020468					-1.0000891368		
		C48										-2.5954227006					-2.8856384642					-1.0823340477		
		H49										-2.7109046211					-4.6726086083					-2.2857766072		
		H50										-1.4272847242					-3.6870755920					-4.1790409487		
		H51										-0.6087481538					-1.3657581309					-4.0492123658		
		H52										-2.3232934416					-0.9857742011					-0.1139330104		
		H53										-3.1646645371					-3.3060138695					-0.2564887842		
		C54											3.8849806051						0.5726067562					-1.5557272398		
		C55											3.2197741523					-0.5033152076					-2.1510383518		
		C56											1.8297431071					-0.4905948802					-2.2778344002		
		C57											1.0872725372						0.6027084372					-1.8073380211		
		C58											1.7638624253						1.6826578066					-1.2172397013		
		C59											3.1538903021						1.6695077880					-1.0919100153		
		H60											4.9672813346						0.5525395402					-1.4479681608		
		H61											3.7833514622					-1.3622812658					-2.5092755450		
		H62											1.3325781393					-1.3490237131					-2.7174773192		
		H63											1.2011177681						2.5268535372					-0.8290160773		
		H64											3.6614203181						2.5070617891					-0.6195343914		
		C65										-1.6256807684						2.4701331284					-6.1262340270		
		C66										-0.3831827916						2.6924059277					-5.5275959173		
		C67										-0.0921317339						2.1383792208					-4.2775852018		
		C68										-1.0463543571						1.3569481594					-3.6106788659		
		C69										-2.2950474346						1.1341445878					-4.2187333108		
		C70										-2.5794902207						1.6842920075					-5.4690031819		
		H71										-1.8492174052						2.9017746621					-7.0991029938		
		H72											0.3676075178						3.2954468638					-6.0336867648		
		H73											0.8812952700						2.3175186727					-3.8299639914		
		H74										-3.0471873967						0.5272022404					-3.7199314816		
		H75										-3.5479805144						1.5000289371					-5.9290292613		
		C76										-2.5446627453						4.4635569169						5.3541677736		
		C77										-3.5698610653						3.5878705432						4.9899599838		
		C78										-3.7116942480						3.1933437494						3.6610360384		
		C79										-2.8354486826						3.6670409346						2.6676832468		
		C80										-1.8129436283						4.5587853097						3.0478573626		
		C81										-1.6683238772						4.9484234940						4.3763106452		
		H82										-2.4252749686						4.7659169322						6.3923612155		
		H83										-4.2553426422						3.2045640882						5.7416974503		
		H84										-4.5052460581						2.5039732482						3.3861957822		
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		H85										-1.1177173151						4.9460794644						2.3090182216		
		H86										-0.8671421752						5.6299223867						4.6532533438		
		H87										-1.9580987420						4.8021344895						0.2839962767		
		C88										-2.3827265507						4.2232439964					-2.3863599654		
		H89										-3.1402610661						4.9941964043					-2.6028362390		
		H90										-2.4005529751						3.5477305104					-3.2436695344		
		C91										-1.0013080812						4.8767385933					-2.2763001067		
		H92										-0.2387103391						4.1262283503					-2.0368815736		
		H93										-0.7251696539						5.3428637938					-3.2278026204		
		H94										-0.9673812991						5.6554556195					-1.5050724305		
	
2-Me,	closed	conformation	
File:	PhMeEtAllylPd_PPh3_2_thf.out	
Solution	phase	energy:	DFT(b3lyp-d3)	-2665.53443513825	au	
		Pd											-1.4997062694						1.9600324884					-0.0418714055		
		P4											-0.6923925964						0.6638434564					-1.9000521490		
		P7											-0.5730207476						0.7425144099						1.8400379157		
		C10										-2.4016126254						4.0986385198						0.1511302348		
		C11										-2.9236267765						3.3072257914						1.2015145023		
		C12										-2.5612821322						3.5773831707					-1.1679815004		
		H15										-3.7346811496						2.6320292770						0.9174863725		
		H16										-3.4502835160						2.9688125023					-1.3562781281		
		C18										-3.8055103134					-0.1557954714						5.0590639717		
		C19										-2.5477376146						0.2921155411						5.4707822574		
		C20										-1.5620096462						0.6043242290						4.5308979215		
		C21										-1.8281652590						0.4820759690						3.1606514140		
		C22										-3.1065828997						0.0623987223						2.7530864868		
		C23										-4.0833519183					-0.2673082953						3.6935448066		
		H24										-4.5661280360					-0.4053698358						5.7954310045		
		H25										-2.3274207349						0.4007154245						6.5307000988		
		H26										-0.5944489292						0.9533884486						4.8764933161		
		H27										-3.3485624593						0.0007032601						1.6940237245		
		H28										-5.0638728953					-0.5983399651						3.	3576503900		
		C28											3.0615679948						3.0936219128						3.5407886102		
		C29											2.7467770861						1.8315802322						4.0567611036		
		C30											1.6545990573						1.1198955838						3.5578625564		
		C31											0.8491095540						1.6694994737						2.5447454255		
		C32											1.1853021767						2.9269529631						2.0205457753		
243	
	
		C33											2.2818409421						3.6368174133						2.5158353556		
		H34											3.9174722880						3.6431265165						3.9264165150		
		H35											3.3589840064						1.3939745275						4.8424750663		
		H36											1.4437219132						0.1264743060						3.9454591495		
		H37											0.5927864509						3.3453304382						1.2116555886		
		H38											2.5300681200						4.6097980829						2.0968914881		
		C38											1.2513347013					-3.4875504420						1.1704329594		
		C39											0.0288449848					-3.3625086429						1.8331000374		
		C40										-0.5206699043					-2.0999737878						2.0643734048		
		C41											0.1470378738					-0.9439025700						1.6316998831		
		C42											1.3841921606					-1.0772701878						0.9798465024		
		C43											1.9288063302					-2.3402449832						0.7497024879		
		H44											1.6764799279					-4.4721555077						0.9866166204		
		H45										-0.5020461186					-4.2490193134						2.1736578195		
		H46										-1.4712922980					-2.0248758033						2.5827672383		
		H47											1.9296638555					-0.1976652790						0.6532283429		
		H48											2.8843267609					-2.4245981804						0.2377642419		
		C48										-2.3790508500					-3.6690569388					-2.0600681126		
		C49										-1.6911979253					-3.1425831912					-3.1593799059		
		C50										-1.1866426080					-1.8429581508					-3.1157404070		
		C51										-1.3493312152					-1.0530450984					-1.9614592249		
		C52										-2.0548715557					-1.5833637819					-0.8741208600		
		C53										-2.5641161082					-2.8835624438					-0.9211652192		
		H54										-2.7762808594					-4.6810446091					-2.0981418817		
		H55										-1.5553734119					-3.7414538546					-4.0573889635		
		H56										-0.6817991741					-1.4385661502					-3.9893346614		
		H57										-2.2102545935					-0.9798812099						0.0102632437		
		H58										-3.1060438794					-3.2806170733					-0.0660032678		
		C58											3.9537411449						0.5280613701					-1.8284442193		
		C59											3.2492079869					-0.5737056196					-2.3216046959		
		C60											1.8533775398					-0.5604479220					-2.3606336653		
		C61											1.1427858648						0.5598103920					-1.9047481067		
		C62											1.8572654091						1.6671274087					-1.4195557729		
		C63											3.2530690949						1.6526202901					-1.3820134127		
		H64											5.0406175748						0.5097019112					-1.7907476647		
		H65											3.7865693567					-1.4528566721					-2.6707390039		
		H66											1.3280416251					-1.4375282625					-2.7233765494		
		H67											1.3201406112						2.5382465331					-1.0526318107		
244	
	
		H68											3.7916606085						2.5143216918					-0.9951182792		
		C68										-1.9100574968						2.3290031867					-6.0660418950		
		C69										-0.5733113551						2.3959474614					-5.6664037349		
		C70										-0.1754384099						1.8660304004					-4.4335162127		
		C71										-1.1170992343						1.2633771017					-3.5874863240		
		C72										-2.4598888842						1.1882940442					-4.0007016484		
		C73										-2.8520104205						1.7159798865					-5.2304475434		
		H74										-2.2174714447						2.7470622289					-7.0219920286		
		H75											0.1670444628						2.8631009157					-6.3126273948		
		H76											0.8673803175						1.9311030368					-4.1361464647		
		H77										-3.2032114757						0.7200495371					-3.3585911042		
		H78										-3.8943841887						1.6529180370					-5.5355362353		
		C78										-2.9852359346						4.0897309581						5.4218103812		
		C79										-4.0832864375						3.5223977662						4.7705316490		
		C80										-4.0294413209						3.2669037393						3.4021922390		
		C81										-2.8836920373						3.5853748240						2.6479777347		
		C82										-1.7813468081						4.1428687387						3.3222218885		
		C83										-1.8326818079						4.3925545328						4.6919107870		
		H84										-3.0217628878						4.2808642076						6.4921962686		
		H85										-4.9793310400						3.2667037077						5.3314023390		
		H86										-4.8854547796						2.8143704846						2.9063854982		
		H87										-0.8634596730						4.3489925270						2.7879362409		
		H88										-0.9638690871						4.8143748839						5.1924727817		
		C88										-1.5932092279						5.3579058366						0.3911821928		
		H89										-1.8117250825						6.1041331077					-0.3780051278		
		H90										-1.8353938822						5.7938416765						1.3622169191		
		H91										-0.5129545392						5.1743269316						0.3628914682		
		C91										-2.0172382690						4.2969932254					-2.3777461959		
		H92										-1.8094449709						3.5765839029					-3.1676694631		
		H94										-1.0645477295						4.7839769105					-2.1405183363		
		C94										-3.0240554314						5.3303678763					-2.9195882504		
		H95										-3.2699617960						6.0919350977					-2.1701760173		
		H96										-2.6121732209						5.8377407820					-3.7994467611		
		H97										-3.9582339586						4.8389104193					-3.2178736445		
	
2-Me,	open	conformation	
File:	PhMeEtAllylPd_PPh3_2_open_thf.out	
Solution	phase	energy:	DFT(b3lyp-d3)	-2665.53015714998	au	
245	
	
		Pd											-1.5035577969						1.9887941957					-0.0318753647		
		P4											-0.6811512516						0.7099171865					-1.8911191712		
		P7											-0.5610573592						0.7443763819						1.8260611991		
		C10										-2.4961922750						4.1044607263						0.1835700488		
		C11										-2.9561592062						3.2790617924						1.2381073560		
		C12										-2.6458757827						3.5742302274					-1.1330886952		
		H15										-3.7346373248						2.5601411113						0.9704393836		
		H16										-3.5062265215						2.9162944411					-1.2834061564		
		C18										-3.7253005790					-0.1632410565						5.0987467015		
		C19										-2.4643968820						0.2939323367						5.4873636378		
		C20										-1.5014193711						0.6149382769						4.5280940281		
		C21										-1.7966717895						0.4924784385						3.1639991865		
		C22										-3.0812945045						0.0696075707						2.7805248048		
		C23										-4.0346103989					-0.2700771604						3.7402406100		
		H24										-4.4684854552					-0.4208923579						5.8501334521		
		H25										-2.2241716427						0.4015167981						6.5430026564		
		H26										-0.5280622518						0.9679902452						4.8525777937		
		H27										-3.3442801519						0.0092770304						1.7263441358		
		H28										-5.0208031625					-0.6053497611						3.4262470284		
		C28											3.1180110372						2.9895463786						3.5558020852		
		C29											2.8061128632						1.7069066069						4.0180471627		
		C30											1.6997541453						1.0272654790						3.5079298219		
		C31											0.8807436824						1.6299615858						2.5368066499		
		C32											1.2117842354						2.9105258521						2.0705062584		
		C33											2.3214718052						3.5894822573						2.5775364720		
		H34											3.9859505560						3.5139228650						3.9499459697		
		H35											3.4305706115						1.2295234083						4.7701826645		
		H36											1.4859732350						0.0193815609						3.8538886408		
		H37											0.6035302626						3.3731732996						1.2970987051		
		H38											2.5672938645						4.5814819947						2.2046622331		
		C38											1.1580474663					-3.5317108290						1.1403844874		
		C39										-0.0692381231					-3.3770052807						1.7868841443		
		C40										-0.5869983817					-2.1014876102						2.0176173983		
		C41											0.1166664869					-0.9602567384						1.6013619343		
		C42											1.3590467141					-1.1244690449						0.9666237264		
		C43											1.8718557441					-2.4007483066						0.7363906955		
		H44											1.5591840874					-4.5264019029						0.9574595373		
		H45										-0.6286536508					-4.2501417140						2.1159257188		
246	
	
		H46										-1.5414094371					-2.0042787854						2.5242896298		
		H47											1.9358714583					-0.2590508457						0.6579372918		
		H48											2.8327416830					-2.5077574732						0.2390834892		
		C48										-2.4341271462					-3.5928932242					-2.0918044226		
		C49										-1.6973587403					-3.0861037854					-3.1676262112		
		C50										-1.1705059625					-1.7967019300					-3.1109286376		
		C51										-1.3577934044					-0.9996101477					-1.9652359071		
		C52										-2.1127736890					-1.5118023387					-0.9032350328		
		C53										-2.6458498779					-2.8008981002					-0.9630441690		
		H54										-2.8492999658					-4.5973146295					-2.1406041835		
		H55										-1.5421794980					-3.6918140118					-4.0578976136		
		H56										-0.6315156807					-1.4051745000					-3.9695697686		
		H57										-2.2892360332					-0.9012443770					-0.0258719380		
		H58										-3.2267259092					-3.1833305947					-0.1269485772		
		C58											3.9639026670						0.5013761908					-1.7129335829		
		C59											3.2546365634					-0.5641023565					-2.2762354166		
		C60											1.8606082292					-0.5259137068					-2.3494012233		
		C61											1.1544001049						0.5829339988					-1.8574511245		
		C62											1.8749729778						1.6521216949					-1.2998999142		
		C63											3.2690613331						1.6133975733					-1.2285887300		
		H64											5.0489590261						0.4626650369					-1.6484453323		
		H65											3.7868961468					-1.4348772436					-2.6533389611		
		H66											1.3330595194					-1.3770230240					-2.7669265810		
		H67											1.3440426814						2.5086836119					-0.8941771329		
		H68											3.8094571843						2.4449686306					-0.7826090550		
		C68										-1.7604639114						2.1765174736					-6.1657031926		
		C69										-0.4364057440						2.2591243569					-5.7309242746		
		C70										-0.0854368587						1.8163107689					-4.4518937709		
		C71										-1.0621321360						1.2900583963					-3.5971232381		
		C72										-2.3939513884						1.2076089543					-4.0405903559		
		C73										-2.7398004995						1.6458383793					-5.3177942293		
		H74										-2.0305034428						2.5207146610					-7.1616303391		
		H75											0.3301072282						2.6655764604					-6.3872233490		
		H76											0.9495970599						1.8811162200					-4.1286056264		
		H77										-3.1621319324						0.7921115312					-3.3912710848		
		H78										-3.7729256174						1.5744389564					-5.6513602812		
		C78										-2.9615494744						4.1199458409						5.4468607681		
		C79										-4.0564597919						3.5122293270						4.8271798285		
247	
	
		C80										-4.0228196542						3.2350324657						3.4621713889		
		C81										-2.9013140455						3.5723821704						2.6812524356		
		C82										-1.8026290258						4.1728771263						3.3232667333		
		C83										-1.8324287531						4.4427780183						4.6895198633		
		H84										-2.9825178100						4.3286593220						6.5143109305		
		H85										-4.9342608533						3.2430749663						5.4100597465		
		H86										-4.8756849065						2.7522265046						2.9901120188		
		H87										-0.9053920416						4.4017409744						2.7632280866		
		H88										-0.9669744645						4.8982957299						5.1657934685		
		C88										-1.8058824177						5.4285710733						0.4338268134		
		H89										-2.0326921013						6.1292942387					-0.3754501259		
		H90										-2.1538687616						5.8672275999						1.3724471232		
		H91										-0.7162756743						5.3366041607						0.4946309623		
		C91										-2.1897355668						4.2930906604					-2.3876442201		
		H92										-2.7796221342						5.2209852916					-2.4738357074		
		H94										-2.4754473924						3.6816052275					-3.2465549625		
		C94										-0.6956978916						4.6318956110					-2.5056096789		
		H95										-0.0847098211						3.7345703312					-2.3738869068		
		H96										-0.4832200499						5.0317874086					-3.5031807971		
		H97										-0.3673363206						5.3736630460					-1.7731663561		
	
2-BPin,	closed	conformation	
File:	PhBPinEtAllylPd_PPh3_2_thf.out	
Solution	phase	energy:	DFT(b3lyp-d3)	-3036.90454032419	au	
		Pd											-1.7943875210						1.8869742809						0.0351496713		
		P4											-0.8645824671						0.9198457393					-1.9509848298		
		P7											-0.6951036224						0.6123859179						1.7927884480		
		C10										-2.7768856805						3.9047624723						0.3611256824		
		C11										-3.1508170664						3.1560877138						1.4976339511		
		C12										-3.1663532668						3.3898487717					-0.9105363460		
		H15										-3.9921529465						2.4688442848						1.3802904277		
		H16										-4.0515211596						2.7460052864					-0.9369583610		
		C18										-3.7236051048					-0.2321109253						5.2190280514		
		C19										-2.4533511725						0.2484724647						5.5434355471		
		C20										-1.5227031492						0.5301959246						4.5398304263		
		C21										-1.8563649806						0.3377427828						3.1927689823		
		C22										-3.1461616874					-0.1221015241						2.8712266398		
		C23										-4.0693867471					-0.4138631914						3.8760133471		
248	
	
		H24										-4.4435456615					-0.4515611554						6.0040607921		
		H25										-2.1813762455						0.4136940657						6.5837005593		
		H26										-0.5474073440						0.9162710978						4.8166833713		
		H27										-3.4330030021					-0.2521730114						1.8286797482		
		H28										-5.0601503536					-0.7754096771						3.6083531364		
		C28											3.1667921369						2.6325496625						3.3881451228		
		C29											2.7789507077						1.3802641549						3.8764020889		
		C30											1.6129412649						0.7782692727						3.4062766390		
		C31											0.8066236635						1.4322553860						2.4567676572		
		C32											1.2090082724						2.6802634653						1.9629592311		
		C33											2.3840611142						3.2759049023						2.4282701883		
		H34											4.0828905631						3.0971840982						3.7472101383		
		H35											3.3916721015						0.8660424409						4.6138146387		
		H36											1.3391824334					-0.2098736030						3.7671930711		
		H37											0.6187663567						3.1872388518						1.2066842318		
		H38											2.6923483013						4.2394443192						2.0308820437		
		C38											1.0095680350					-3.6034155528						0.7843822660		
		C39										-0.1057860741					-3.5015861914						1.6180034172		
		C40										-0.6300130459					-2.2488492676						1.9516810955		
		C41										-0.0380125559					-1.0795203515						1.4540870808		
		C42											1.0964833073					-1.1887783308						0.6328968926		
		C43											1.6122251587					-2.4391997066						0.2972069753		
		H44											1.4108252000					-4.5795287303						0.5217946012		
		H45										-0.5755771542					-4.3997289172						2.0139529304		
		H46										-1.4991035119					-2.1946319992						2.6000697767		
		H47											1.5837669425					-0.2946067758						0.2572571259		
		H48											2.4883321040					-2.5039787323					-0.3441944389		
		C48										-1.5729745904					-3.6417255591					-2.4749324765		
		C49										-0.8611048486					-2.9296819585					-3.4470155098		
		C50										-0.6439489666					-1.5603071889					-3.2963546323		
		C51										-1.1161930026					-0.8869783320					-2.1540775252		
		C52										-1.8496308759					-1.6035596878					-1.1997376139		
		C53										-2.0745941644					-2.9730357395					-1.3569598740		
		H54										-1.7432280711					-4.7092268221					-2.5956750016		
		H55										-0.4838838111					-3.4393310424					-4.3310970970		
		H56										-0.1205994460					-1.0140803348					-4.0772110015		
		H57										-2.2434247088					-1.0913753342					-0.3280546424		
		H58										-2.6380290970					-3.5149280367					-0.6014216236		
249	
	
		C58											3.6643809263						1.9969716958					-1.9199026997		
		C59											3.2789151749						0.7121195767					-2.3129412308		
		C60											1.9287022829						0.3529448054					-2.3354949293		
		C61											0.9433194795						1.2768787834					-1.9543551772		
		C62											1.3377966939						2.5656721120					-1.5510036257		
		C63											2.6876593116						2.9221967599					-1.5410679200		
		H64											4.7167602506						2.2712827021					-1.9023315346		
		H65											4.0313186765					-0.0184953762					-2.6024969739		
		H66											1.6561695866					-0.6557141643					-2.6281353500		
		H67											0.5936884826						3.2918248252					-1.2310585051		
		H68											2.9781733072						3.9221715013					-1.2260078947		
		C68										-2.4907220228						2.5260416943					-6.0058104353		
		C69										-1.2448999692						2.9605649414					-5.5486141589		
		C70										-0.7201082195						2.4693790399					-4.3487601754		
		C71										-1.4407885331						1.5350257872					-3.5925123396		
		C72										-2.6914131581						1.0945121942					-4.0618169100		
		C73										-3.2110104316						1.5861728503					-5.2589644691		
		H74										-2.8978727762						2.9118254878					-6.9376314434		
		H75										-0.6734658597						3.6842798626					-6.1261139552		
		H76											0.2501240724						2.8204718018					-4.0103002767		
		H77										-3.2628791884						0.3645919221					-3.4925594047		
		H78										-4.1798018089						1.2357571052					-5.6088382794		
		C78										-2.3992555198						4.2096576673						5.5825971075		
		C79										-3.5962142752						3.5955031750						5.2065053334		
		C80										-3.8115821686						3.2334027223						3.8776729844		
		C81										-2.8413633453						3.4964200912						2.8944719767		
		C82										-1.6366534051						4.1043204615						3.2900533569		
		C83										-1.4167943948						4.4564586093						4.6186444359		
		H84										-2.2266030807						4.4823733324						6.6214418793		
		H85										-4.3607521637						3.3883308605						5.9515974878		
		H86										-4.7416732382						2.7459579891						3.5942278387		
		H87										-0.8520193699						4.2687111653						2.5622243186		
		H88										-0.4718117865						4.9128947307						4.9051179429		
		C91										-2.8935534440						4.1417401614					-2.1908381548		
		H92										-3.0050510953						3.4676497359					-3.0397547281		
		H94										-1.8571190182						4.4973084003					-2.2070396692		
		C94										-3.8603168698						5.3297125744					-2.3664329675		
		H95										-3.7461511061						6.0568442082					-1.5557699017		
250	
	
		H96										-3.6643203133						5.8388009698					-3.3176848113		
		H97										-4.9027383890						4.9885482541					-2.3736500855		
		C96										-1.1344862671						7.3308851306						0.6857559409		
		C97											0.0109346650						6.4756823393						0.0103993077		
		C107										0.1525052363						6.7107721565					-1.4966240834		
		H108										0.8267893642						5.9555182014					-1.9143542322		
		H109									-0.8109693272						6.6273128671					-2.0087445409		
		H110										0.5711757796						7.7004534351					-1.7050971634		
		C110										1.3724845568						6.5779076510						0.6916525898		
		H111										2.0944357579						5.9386059145						0.1715462517		
		H112										1.7441661839						7.6081285437						0.6533471850		
		H113										1.3279598063						6.2635115752						1.7371429806		
		C113									-1.4802094994						8.6250870629					-0.0459042388		
		H114									-0.6127369934						9.2950351770					-0.0620024201		
		H115									-1.7974497222						8.4404606841					-1.0749868642		
		H116									-2.2958036152						9.1362906799						0.4763752814		
		C116									-0.9021063723						7.6123720730						2.1730767215		
		H117									-0.0670006783						8.3058882876						2.3154757692		
		H118									-1.8050542240						8.0646726691						2.5955821589		
		H119									-0.6967052404						6.6943219060						2.7300918811		
		B112									-1.8284729690						5.1690216620						0.4059807679		
		O116									-2.2953304344						6.4321726286						0.6055408624		
		O114									-0.4810594901						5.0999026974						0.1677487841		
	
2-BPin,	open	conformation	
File:	PhBPinEtAllylPd_PPh3_2_open_thf.out	
Solution	phase	energy:	DFT(b3lyp-d3)	-3036.89704120554	au	
		Pd											-1.7190739392						1.9504235434					-0.0117907903		
		P4											-0.9196167430						0.8347346340					-1.9933738617		
		P7											-0.5758416348						0.7111396983						1.7381075310		
		C10										-2.7327482912						3.9573634019						0.2699441333		
		C11										-2.9968190163						3.1963340063						1.4431479203		
		C12										-3.2388414382						3.3902236699					-0.9289062293		
		H15										-3.8305370020						2.4944848348						1.3646130430		
		H16										-4.0644820436						2.6817468571					-0.8105813954		
		C18										-3.6036651965					-0.2489918925						5.1282713525		
		C19										-2.3403045763						0.2359241354						5.4707896801		
		C20										-1.4125639924						0.5598980208						4.4776655332		
251	
	
		C21										-1.7439893987						0.4055041076						3.1251600066		
		C22										-3.0286786356					-0.0561440617						2.7877658468		
		C23										-3.9487592001					-0.3902711792						3.7810370697		
		H24										-4.3207720629					-0.5037348740						5.9055193975		
		H25										-2.0716171123						0.3695166683						6.5165041416		
		H26										-0.4412776167						0.9467542727						4.7673313702		
		H27										-3.3156310482					-0.1538813608						1.7423774776		
		H28										-4.9355412761					-0.7537974643						3.5021658781		
		C28											3.2708029101						2.6643643323						3.4498855956		
		C29											2.8675083744						1.3997655144						3.8892965268		
		C30											1.7069450409						0.8227679633						3.3778743221		
		C31											0.9206684303						1.5129894458						2.4358794789		
		C32											1.3383988897						2.7739406767						1.9905482877		
		C33											2.5089765262						3.3437204429						2.4983977138		
		H34											4.1816926818						3.1118532542						3.8420390475		
		H35											3.4620478170						0.8567097837						4.6208758624		
		H36											1.4202031820					-0.1748833604						3.7005617864		
		H37											0.7584444053						3.3142598287						1.2494337636		
		H38											2.8307969044						4.3195627020						2.1456470416		
		C38											1.2001428968					-3.4754458993						0.7621907953		
		C39											0.0572799350					-3.3915795804						1.5589588253		
		C40										-0.4931453664					-2.1472637653						1.8751820243		
		C41											0.0997191213					-0.9707844281						1.3958409705		
		C42											1.2635048320					-1.0618940635						0.6153371173		
		C43											1.8044954854					-2.3049485535						0.2948158485		
		H44											1.6230713881					-4.4460707806						0.5124434338		
		H45										-0.4121721764					-4.2966788884						1.9387427939		
		H46										-1.3823909959					-2.1041908323						2.4957130261		
		H47											1.7562041680					-0.1605234384						0.2657399727		
		H48											2.7019344356					-2.3571452816					-0.3174094799		
		C48										-1.9930379109					-3.6816723590					-2.2792078604		
		C49										-1.3252164256					-3.0545070825					-3.3372767886		
		C50										-1.0042238101					-1.6996014455					-3.2609919007		
		C51										-1.3294311939					-0.9531728084					-2.1124078916		
		C52										-2.0180116307					-1.5855398189					-1.0699461520		
		C53										-2.3460422897					-2.9411001105					-1.1504759779		
		H54										-2.2444483454					-4.7381430473					-2.3419798515		
		H55										-1.0616531352					-3.6193888332					-4.2290218290		
252	
	
		H56										-0.5193860322					-1.2198825011					-4.1071548147		
		H57										-2.3003975072					-1.0175942966					-0.1903691351		
		H58										-2.8739456744					-3.4161787500					-0.3271640796		
		C58											3.6935239767						1.4227606919					-1.9680242171		
		C59											3.1670297085						0.2327341741					-2.4793945562		
		C60											1.7864261603						0.0281241765					-2.5120423466		
		C61											0.9131349311						1.0134193828					-2.0272818876		
		C62											1.4496177193						2.2098241181					-1.5213100068		
		C63											2.8305883227						2.4137384017					-1.4933916602		
		H64											4.7705241377						1.5735466576					-1.9345717752		
		H65											3.8335303458					-0.5442710862					-2.8479873674		
		H66											1.4036336295					-0.9146012447					-2.8871631550		
		H67											0.7888800966						2.9821147425					-1.1333528260		
		H68											3.2325717623						3.3393487243					-1.0877968876		
		C68										-2.3504822539						2.3631058117					-6.1546755313		
		C69										-1.1062255807						2.7633982567					-5.6617558474		
		C70										-0.6527370359						2.2988979671					-4.4231668843		
		C71										-1.4398664822						1.4228115690					-3.6623111953		
		C72										-2.6911440601						1.0214676357					-4.1652165002		
		C73										-3.1405737265						1.4862975430					-5.4019437506		
		H74										-2.7011774472						2.7269886233					-7.1177786916		
		H75										-0.4812503763						3.4399137696					-6.2411624314		
		H76											0.3184639985						2.6213807094					-4.0595888827		
		H77										-3.3154336748						0.3364229411					-3.5956637595		
		H78										-4.1095884794						1.1634858976					-5.7771366563		
		C78										-2.2903325707						4.2029010762						5.5572591355		
		C79										-3.4813965755						3.5971884642						5.1493883968		
		C80										-3.6736723269						3.2643736560						3.8095498227		
		C81										-2.6890761853						3.5473198187						2.8437442039		
		C82										-1.4925230023						4.1502889475						3.2703678171		
		C83										-1.2954045628						4.4713267353						4.6122275590		
		H84										-2.1328681370						4.4510936003						6.6047252360		
		H85										-4.2569104217						3.3700754399						5.8773186980		
		H86										-4.5973340588						2.7783905168						3.5032687324		
		H87										-0.7033030081						4.3425328128						2.5576309025		
		H88										-0.3550768030						4.9216225666						4.9231116565		
		C91										-3.1982601889						4.0031660754					-2.3043417488		
		H92										-4.1320941035						4.5786834721					-2.4202576975		
253	
	
		H94										-3.2714910796						3.1939002439					-3.0340088217		
		C94										-2.0064294162						4.8972603291					-2.6436930564		
		H95										-1.0590677719						4.4112381614					-2.3879233571		
		H96										-1.9910053800						5.1148736301					-3.7160461464		
		H97										-2.0621869743						5.8517774363					-2.1136984177		
		C96										-1.3402742503						7.4574977833						0.7429277623		
		C97										-0.0118771116						6.6483040702						0.4337870392		
		C107										0.6012931478						6.9331882119					-0.9407721484		
		H108										1.4069929116						6.2141654922					-1.1242251981		
		H109									-0.1293382030						6.8336129441					-1.7460556090		
		H110										1.0258058002						7.9418547779					-0.9774510499		
		C110										1.0664847066						6.7771644872						1.5086334478		
		H111										1.9523943395						6.2076208685						1.2115192099		
		H112										1.3654313047						7.8251263911						1.6232400368		
		H113										0.7280665836						6.4050069784						2.4784530972		
		C113									-1.5240248947						8.7218850729					-0.0926249493		
		H114									-0.7198094428						9.4365362296						0.1171151193		
		H115									-1.5267568635						8.5064756825					-1.1641310639		
		H116									-2.4772824695						9.1967881257						0.1630870658		
		C116									-1.5472342992						7.7704103232						2.2288501283		
		H117									-0.8137217776						8.4999820894						2.5869460794		
		H118									-2.5486501959						8.1916219384						2.3661557144		
		H119									-1.4764738849						6.8672985492						2.8418410737		
		B112									-1.8425786114						5.2637558603						0.3321152001		
		O116									-2.3987587210						6.5064096541						0.3796768268		
		O114									-0.4770946269						5.2542528604						0.4103702767		
254	
	
Transition	structures,	attack	at	either	1-	or	3-position,	reacting	position	in	either	syn-	
or	anti-configuration.	
	
Attack	at	1-syn	
File:	PhBPinMeAllyl_1NH3_Pd_PPh3_2_thfd.out;	structure	57		
Solution	phase	energy:	DFT(b3lyp-d3)	-3054.13003134393	au	
		Pd1										-1.6668674134						1.9425685649					-0.0614707163		
		P2											-0.9427600096						0.8041123667					-2.0356044706		
		P3											-0.5065414577						0.8049098696						1.7747014331		
		C4											-2.6993822694						3.9207708302						0.4621406167		
		C5											-3.5340749335						3.5668421230						1.5622218898		
		C6											-3.0541601777						3.4031222778					-0.8395409011		
		H7											-4.3436894252						2.8742298583						1.3412740720		
		H8											-3.9976239665						2.8482297366					-0.8815222031		
		C9											-3.7822985533					-0.3748408895						4.8582155657		
		C10										-2.5692147569						0.1270173775						5.3321334472		
		C11										-1.5680631238						0.5200802531						4.4411546853		
		C12										-1.7733837965						0.4233638085						3.0594086046		
		C13										-3.0092345922					-0.0581673582						2.5911798977		
		C14										-4.0034435460					-0.4622427496						3.4812907668		
		H15										-4.5562654143					-0.6850753856						5.5567389943		
		H16										-2.3978679375						0.2165565064						6.4021545226		
		H17										-0.6355327880						0.9121517826						4.8323952263		
		H18										-3.1940950718					-0.1161947418						1.5205408914		
		H19										-4.9497827675					-0.8405249469						3.0997519400		
		C20											2.9734181823						3.1005316734						3.8470664318		
		C21											2.6695297527						1.7927367515						4.2393441059		
		C22											1.6298714063						1.0999434814						3.6183849491		
		C23											0.8618212095						1.7106128746						2.6107180402		
		C24											1.1880799836						3.0133269969						2.2049797884		
		C25											2.2373646807						3.7012658004						2.8229501748		
		H26											3.7883860570						3.6396869697						4.3248515447		
		H27											3.2487395859						1.3068534636						5.0219864687		
		H28											1.4238434937						0.0731046136						3.9103970314		
		H29											0.6359892491						3.4860638853						1.3965671686		
		H30											2.4912931440						4.7072369285						2.4982949992		
		C31											1.5201235818					-3.3161802761						0.9494847434		
		C32											0.4170882311					-3.2583483456						1.8037081659		
255	
	
		C33										-0.1938151312					-2.0335079995						2.0899584628		
		C34											0.2914367363					-0.8466510459						1.5210824300		
		C35											1.4132876751					-0.9116534832						0.6780578903		
		C36											2.0194769573					-2.1344392675						0.3932219334		
		H37											1.9883815576					-4.2710608836						0.7213337514		
		H38											0.0249521200					-4.1693044133						2.2518061264		
		H39										-1.0526009329					-2.0127710118						2.7538716231		
		H40											1.8150878692					-0.0046598264						0.2380929739		
		H41											2.8802222218					-2.1622470423					-0.2709341221		
		C42										-1.7305862065					-3.7743425829					-2.3693794010		
		C43										-1.3083505755					-3.0574077142					-3.4945551689		
		C44										-1.0812558590					-1.6832465962					-3.4084989560		
		C45										-1.2665212915					-1.0035271943					-2.1905134109		
		C46										-1.7065282590					-1.7279813065					-1.0754283337		
		C47										-1.9311653074					-3.1041335052					-1.1611913321		
		H48										-1.9075007989					-4.8455471401					-2.4385412606		
		H49										-1.1585078856					-3.5683577173					-4.4433598343		
		H50										-0.7686363495					-1.1380296501					-4.2952800554		
		H51										-1.8667752659					-1.2178727082					-0.1333300885		
		H52										-2.2613958242					-3.6498272174					-0.2805952767		
		C53											3.6784994390						1.4055905671					-2.0966197504		
		C54											3.1386364916						0.2272741378					-2.6206992478		
		C55											1.7555832612						0.0279509180					-2.6332685400		
		C56											0.8918447880						1.0058936419					-2.1170405410		
		C57											1.4403343830						2.1943603894					-1.6018749948		
		C58											2.8231716310						2.3909346039					-1.5937287469		
		H59											4.7562048695						1.5526571987					-2.0780885969		
		H60											3.7959206007					-0.5451398942					-3.0152702732		
		H61											1.3597645915					-0.9048025285					-3.0227697913		
		H62											0.7882465428						2.9632224793					-1.1909300203		
		H63											3.2333562779						3.3100255782					-1.1813675271		
		C64										-2.5172430471						2.3865848765					-6.1249549072		
		C65										-1.2094565460						2.6789157080					-5.7335514940		
		C66										-0.7082385547						2.1927220844					-4.5213781529		
		C67										-1.5134154106						1.4091932970					-3.6841245199		
		C68										-2.8298187211						1.1188230286					-4.0837541854		
		C69										-3.3256844229						1.6001495297					-5.2952021025		
		H70										-2.9045095739						2.7633880254					-7.0690788481		
256	
	
		H71										-0.5702976967						3.2833901493					-6.3739631118		
		H72											0.3138124254						2.4243404011					-4.2366642516		
		H73										-3.4704120344						0.5099524496					-3.4488383705		
		H74										-4.3445341742						1.3614899307					-5.5927535507		
		C75										-2.6803319087						3.8212568259						5.7620627445		
		C76										-3.9317058957						3.3932522323						5.3056702122		
		C77										-4.1863593969						3.3066425439						3.9395205493		
		C78										-3.2021089922						3.6575548635						2.9964284731		
		C79										-1.9456820061						4.0637646519						3.4705254267		
		C80										-1.6859971194						4.1480145275						4.8360658130		
		H81										-2.4777965022						3.8820615847						6.8288063598		
		H82										-4.7067599555						3.1163674183						6.0164240377		
		H83										-5.1606313558						2.9683065348						3.5918233271		
		H84										-1.1493279277						4.2763588448						2.7721332213		
		H85										-0.6984684646						4.4513745983						5.1751519493		
		C86										-2.7416666710						4.1455375367					-2.1198901853		
		H87										-2.9376401553						3.5205004118					-2.9916860568		
		H88										-1.7030014878						4.4775599828					-2.1598370554		
		C89										-0.8033322546						7.1541346661						1.0820171649		
		C90										-0.0251247549						6.5315618099					-0.1364604708		
		C91										-0.4646413629						7.1019017436					-1.4901774876		
		H92										-0.0310882167						6.4938375721					-2.2907747576		
		H93										-1.5538505856						7.0808999137					-1.5982632253		
		H94										-0.1209956345						8.1340079037					-1.6155033866		
		C95											1.4951227540						6.5615576552					-0.0230905253		
		H96											1.9386544173						6.0832756872					-0.9029021038		
		H97											1.8572101494						7.5950531197						0.0223265627		
		H98											1.8468381861						6.0320978498						0.8641309107		
		C99										-1.2554026239						8.5979406078						0.8893509364		
		H100									-0.3894691716						9.2512798118						0.7307518899		
		H101									-1.9304800235						8.6982271170						0.0357614463		
		H102									-1.7826014055						8.9425880581						1.7856439243		
		C103									-0.0639584933						7.0024635430						2.4161004366		
		H104										0.7872420920						7.6892221899						2.4721412046		
		H105									-0.7524509928						7.2315755498						3.2357554472		
		H106										0.3071424526						5.9836361454						2.5609485677		
		B107									-1.6921188381						5.1160162457						0.5275500826		
		O108									-1.9940025797						6.3011947802						1.1502597695		
257	
	
		O109									-0.4694491178						5.1356366176					-0.1021052183		
		H111									-3.3842692994						5.0366748317					-2.2032248689		
		N112									-4.9731346838						5.2307118925						1.5368363580		
		H113									-4.3470172490						6.0367551903						1.5534298931		
		H114									-5.6123617441						5.3062882204						2.3295649747		
		H115									-5.5262117191						5.2719118472						0.6792585306		
	
Attack	at	1-anti	
	
File:	antiPhBPinMeAllyl_1NH3_Pd_PPh3_2_thfd.out;	structure	56		
Solution	phase	energy:	DFT(b3lyp-d3)	-3054.13528376566	au	
		Pd1										-1.5418942482						2.0304725205					-0.1849394863		
		P2											-1.0370037992						0.6434752617					-2.0518588220		
		P3											-0.4535476220						1.1209180942						1.7989667191		
		C4											-2.6918485118						4.0209444020						0.0772363581		
		C5											-3.7758627344						3.4805694604						0.8505464312		
		C6											-2.5167733917						3.6419367398					-1.2987094208		
		H7											-3.6106730246						3.4348210242						1.9220151628		
		H8											-3.3404849908						3.1338756683					-1.7891884595		
		C9											-3.2525363019						1.1354696956						5.5204618303		
		C10										-2.1878357043						2.0376352315						5.4600763372		
		C11										-1.3111127860						2.0291954428						4.3703984646		
		C12										-1.4920650852						1.1215667597						3.3165775649		
		C13										-2.5768815317						0.2268129478						3.3793192262		
		C14										-3.4419126573						0.2258246688						4.4743159635		
		H15										-3.9270038047						1.1377303290						6.3735117087		
		H16										-2.0285037348						2.7479049183						6.2689989290		
		H17										-0.4833348037						2.7300533596						4.3505583689		
		H18										-2.7425447476					-0.4826065281						2.5710515688		
		H19										-4.2629459351					-0.4873106378						4.5112902309		
		C20											3.5862834462						3.2555094567						2.6178655630		
		C21											3.0811645649						2.3463519829						3.5556968071		
		C22											1.8444322567						1.7394835021						3.3434825497		
		C23											1.0800975803						2.0582590543						2.2059905783		
		C24											1.5847760941						2.9828705879						1.2806908550		
		C25											2.8400527679						3.5669541234						1.4801077009		
		H26											4.5614767701						3.7128245246						2.7732023475		
		H27											3.6612938163						2.0966319578						4.4421426957		
258	
	
		H28											1.4789268140						1.0030246621						4.0559640573		
		H29											1.0003711049						3.2457891374						0.4032203322		
		H30											3.2329811186						4.2653250976						0.7444007304		
		C31											1.5700852527					-3.0661952942						1.5099991054		
		C32											0.6746078378					-2.8338536389						2.5546489691		
		C33											0.0405809256					-1.5931450723						2.6820441884		
		C34											0.2902616925					-0.5743385891						1.7535612201		
		C35											1.2042564998					-0.8127286211						0.7136612044		
		C36											1.8387467710					-2.0460433030						0.5918636798		
		H37											2.0605059125					-4.0326910825						1.4142752663		
		H38											0.4694234585					-3.6170070218						3.2821850873		
		H39										-0.6381784178					-1.4306032920						3.5132193336		
		H40											1.4250702841					-0.0282306725					-0.0038018942		
		H41											2.5394151333					-2.2101445851					-0.2236798994		
		C42										-2.0781485389					-3.8780170354					-1.6660785264		
		C43										-1.7675698218					-3.3375919018					-2.9191881439		
		C44										-1.4782681798					-1.9781719586					-3.0458775883		
		C45										-1.4846188006					-1.1388570096					-1.9163782422		
		C46										-1.8233114002					-1.6849076580					-0.6712319834		
		C47										-2.1121692685					-3.0459013638					-0.5448952343		
		H48										-2.2975936443					-4.9391333915					-1.5683865541		
		H49										-1.7506637351					-3.9759000280					-3.8003296421		
		H50										-1.2451675591					-1.5696928350					-4.0262595330		
		H51										-1.8508915094					-1.0453322029						0.2031013720		
		H52										-2.3566886746					-3.4547138396						0.4327388086		
		C53											3.5273899958						0.8834311655					-2.9701459855		
		C54											2.8897312426					-0.3585983423					-3.0318089076		
		C55											1.5175166544					-0.4644667584					-2.7841353396		
		C56											0.7635807415						0.6757022651					-2.4621910180		
		C57											1.4152889481						1.9205640249					-2.3956209752		
		C58											2.7828992114						2.0251140258					-2.6552028887		
		H59											4.5956124691						0.9610287853					-3.1607813615		
		H60											3.4610958598					-1.2530869477					-3.2723397879		
		H61											1.0464253234					-1.4417698203					-2.8254004229		
		H62											0.8492260664						2.8111343985					-2.1325042975		
		H63											3.2696404242						2.9968891117					-2.6029326351		
		C64										-3.2718690880						1.8041907768					-5.9665028820		
		C65										-1.8760798832						1.7608027401					-5.9719129195		
259	
	
		C66										-1.1747798574						1.4104831835					-4.8127065062		
		C67										-1.8676234486						1.1033795091					-3.6337144465		
		C68										-3.2728008429						1.1520650754					-3.6333913139		
		C69										-3.9684056575						1.4955079647					-4.7918428435		
		H70										-3.8146978654						2.0751206517					-6.8692552592		
		H71										-1.3254183116						1.9949335473					-6.8808124507		
		H72										-0.0890394756						1.3740016038					-4.8343795582		
		H73										-3.8247151766						0.9190582053					-2.7245207725		
		H74										-5.0558237618						1.5239790773					-4.7789203961		
		C75										-6.7036623874						0.6967227329					-0.5930220742		
		C76										-5.9847595902						0.4389434244						0.5766953048		
		C77										-5.0623957669						1.3732071479						1.0488010201		
		C78										-4.8194859502						2.5618057452						0.3422685061		
		C79										-5.5692159607						2.8251730563					-0.8172896695		
		C80										-6.5036541280						1.9000307499					-1.2789760219		
		H81										-7.4273158980					-0.0274170469					-0.9608243531		
		H82										-6.1493492115					-0.4855019101						1.1258258822		
		H83										-4.5077409481						1.1758356320						1.9606467858		
		H84										-5.4388488040						3.7656172603					-1.3448728277		
		H85										-7.0830214451						2.1199546850					-2.1727675898		
		C86										-1.6299406000						4.3979880618					-2.2611454491		
		H87										-1.3956142305						3.7757083975					-3.1299752911		
		H88										-0.7045653571						4.7383974523					-1.7943630246		
		C89										-1.0613480847						6.3965360764						2.5314438299		
		C90										-0.2946153476						6.7319888719						1.2007483397		
		C91										-0.8702267010						7.9438843096						0.4568711099		
		H92										-0.4267349988						7.9893823113					-0.5431865439		
		H93										-1.9571947599						7.8624371413						0.3445906067		
		H94										-0.6429360188						8.8786521124						0.9804422600		
		C95											1.2166857809						6.8692600877						1.3461435837		
		H96											1.6642693929						7.0738670320						0.3673692567		
		H97											1.4596711696						7.7043048987						2.0138863373		
		H98											1.6676578259						5.9597740812						1.7447035516		
		C99										-1.6532894235						7.6015618361						3.2558160135		
		H100									-0.8586477063						8.2942986509						3.5567276754		
		H101									-2.3655890425						8.1414934857						2.6266620645		
		H102									-2.1765052846						7.2697093592						4.1590852020		
		C103									-0.2418147000						5.5388608893						3.5009094260		
260	
	
		H104										0.5673525580						6.1193818947						3.9568077104		
		H105									-0.8999613160						5.1761193838						4.2967627034		
		H106										0.1947780426						4.6744498047						2.9933099874		
		B107									-1.7739519785						5.0345819633						0.8308449407		
		O108									-2.1613299352						5.5627060326						2.0447175120		
		O109									-0.5913316132						5.5612701628						0.3735957023		
		H111									-2.1585402711						5.2904097580					-2.6318528054		
		N112									-5.0670655834						5.1998262144						1.3163268700		
		H113									-4.4367657109						5.8318534775						1.8092225979		
		H114									-5.8453761895						4.9624140824						1.9340291014		
		H115									-5.4456948638						5.6796206006						0.4988459586		
	
Attack	at	3-syn	
	
File:	PhBPinMeAllyl_3NH3_Pd_PPh3_2_thfd.out;	structure	51	
Solution	phase	energy:	DFT(b3lyp-d3)	-3054.13167066818	au	
		Pd1										-1.7823624660						1.8379318573						0.1670100233		
		P2											-0.7716451838						1.0126067948					-1.8999505642		
		P3											-0.6838017563						0.5720554550						1.8847611366		
		C4											-2.9996578807						3.7855027543						0.1618002749		
		C5											-3.1094370523						3.0455940899						1.4017018195		
		C6											-4.0111063591						3.5628653376					-0.8136044768		
		H7											-3.9765558115						2.3786873485						1.4286925355		
		H8											-4.6998386122						2.7397929781					-0.6315032655		
		C9											-3.5181045449					-0.4971005463						5.4054108992		
		C10										-2.2298625821					-0.0420685026						5.6912395949		
		C11										-1.3589460494						0.3122342160						4.6587120709		
		C12										-1.7734549625						0.2237024467						3.3245467913		
		C13										-3.0806739646					-0.2092036576						3.0462988820		
		C14										-3.9439078545					-0.5789120305						4.0772628867		
		H15										-4.1900283158					-0.7785084737						6.2128267163		
		H16										-1.8969605404						0.0375985788						6.7231299098		
		H17										-0.3624461856						0.6645870904						4.9023594912		
		H18										-3.4253747166					-0.2529991593						2.0153952190		
		H19										-4.9492605241					-0.9217620809						3.8436838693		
		C20											3.0837776464						2.6969048659						3.6058673982		
		C21											2.8686812082						1.3393953288						3.8672572981		
		C22											1.7451155170						0.6939897229						3.3486613409		
261	
	
		C23											0.8166677573						1.3984081911						2.5607055259		
		C24											1.0478005436						2.7541584241						2.2919498886		
		C25											2.1709653920						3.3993563101						2.8160087857		
		H26											3.9609680069						3.1982343764						4.0093078563		
		H27											3.5779422847						0.7796611484						4.4736135228		
		H28											1.5959426719					-0.3635227310						3.5509116425		
		H29											0.3607707347						3.3037254213						1.6590621521		
		H30											2.3341383066						4.4527250343						2.5999576795		
		C31											0.9645126658					-3.6239573259						0.7057958013		
		C32										-0.1801591725					-3.5371411492						1.4990736443		
		C33										-0.6775699082					-2.2905942756						1.8869698168		
		C34										-0.0330576825					-1.1109073246						1.4846427146		
		C35											1.1260581587					-1.2091339929						0.6975160917		
		C36											1.6180090006					-2.4541296175						0.3100641465		
		H37											1.3482149585					-4.5957610599						0.4028190806		
		H38										-0.6901629450					-4.4419016978						1.8240601004		
		H39										-1.5656863268					-2.2478947161						2.5090670952		
		H40											1.6532688556					-0.3120399684						0.3928785988		
		H41											2.5147020023					-2.5073317946					-0.3027328487		
		C42										-1.6812391731					-3.4419850116					-2.8974464938		
		C43										-1.0637867442					-2.6345709993					-3.8594929472		
		C44										-0.7962211330					-1.2926722226					-3.5841768752		
		C45										-1.1372336168					-0.7364533000					-2.3370024200		
		C46										-1.7718047558					-1.5510239877					-1.3880816410		
		C47										-2.0380888891					-2.8946344839					-1.6632493357		
		H48										-1.8879391915					-4.4880879669					-3.1129975169		
		H49										-0.7922592198					-3.0490649958					-4.8281856413		
		H50										-0.3332511523					-0.6739392776					-4.3487378400		
		H51										-2.0486763349					-1.1348655644					-0.4251000720		
		H52										-2.5205670404					-3.5117627765					-0.9091872069		
		C53											3.8499566298						1.4244618798					-1.4349805358		
		C54											3.3373353636						0.3506373889					-2.1710072517		
		C55											1.9592148621						0.2094306219					-2.3525562961		
		C56											1.0700397789						1.1419619235					-1.7946232273		
		C57											1.5931669909						2.2215843697					-1.0613589352		
		C58											2.9719355711						2.3631082088					-0.8855346199		
		H59											4.9229985026						1.5226314702					-1.2856896107		
		H60											4.0122015879					-0.3884047152					-2.5988244462		
262	
	
		H61											1.5852887648					-0.6486409458					-2.9026525191		
		H62											0.9174820160						2.9419241678					-0.6079524248		
		H63											3.3563759667						3.1933518728					-0.2971396640		
		C64										-1.8902250116						3.4054454711					-5.7502330798		
		C65										-0.7914355675						3.7906248460					-4.9754934720		
		C66										-0.4272233071						3.0501671498					-3.8483591020		
		C67										-1.1600279271						1.9128134272					-3.4704184212		
		C68										-2.2654368720						1.5345548690					-4.2531948575		
		C69										-2.6216682094						2.2708473102					-5.3864782023		
		H70										-2.1693920868						3.9802639124					-6.6303698918		
		H71										-0.2067731546						4.6653381891					-5.2544466885		
		H72											0.4393110321						3.3555922144					-3.2702591536		
		H73										-2.8502437310						0.6579482676					-3.9847751559		
		H74										-3.4760954599						1.9556322413					-5.9821973034		
		C75										-2.3031342585						4.3039954145						5.4475248913		
		C76										-3.3393989881						3.4178760852						5.1469836330		
		C77										-3.5697946996						3.0305312790						3.8281529278		
		C78										-2.7726879925						3.5086058710						2.7691369815		
		C79										-1.7381918524						4.4062202276						3.0920337480		
		C80										-1.5059178305						4.7956611022						4.4095105379		
		H81										-2.1145973814						4.6040222413						6.4761816233		
		H82										-3.9664364938						3.0182344978						5.9408750652		
		H83										-4.3716582157						2.3293856482						3.6131265665		
		H84										-1.0904280287						4.7821835115						2.3138938613		
		H85										-0.6886463650						5.4799255269						4.6276979244		
		C86										-3.9226819571						4.0279492595					-2.2386388972		
		H87										-4.9070355763						4.0278448288					-2.7142149322		
		H88										-3.2815376884						3.3388400136					-2.7978186646		
		C89										-1.3073109627						7.1603262325					-0.2436471410		
		C90										-0.0716950483						6.1823147039					-0.3189201628		
		C91											0.4465130188						5.9587005406					-1.7427123399		
		H92											1.1882487465						5.1541441790					-1.7290300565		
		H93										-0.3620097419						5.6596002617					-2.4168725821		
		H94											0.9234557440						6.8600941861					-2.1402802225		
		C95											1.0840839776						6.5247680954						0.6184672317		
		H96											1.8779695216						5.7777768915						0.5089006565		
		H97											1.5052454628						7.5065396944						0.3713219257		
		H98											0.7705701069						6.5361829795						1.6658600998		
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		C99										-1.3714500130						8.1991341731					-1.3588242678		
		H100									-0.4942868289						8.8552011379					-1.3201501590		
		H101									-1.4135713783						7.7305002430					-2.3449730661		
		H102									-2.2662341303						8.8187263655					-1.2356966290		
		C103									-1.4724979531						7.8351152929						1.1228704259		
		H104									-0.6764015952						8.5643192398						1.3051518433		
		H105									-2.4336417161						8.3587939367						1.1470611261		
		H106									-1.4685803929						7.1011161897						1.9349601958		
		B107									-2.0152292046						4.9901160154					-0.0425372377		
		O108									-2.4432211709						6.2449545917					-0.3929377525		
		O109									-0.6515424833						4.9095384849						0.1139401636		
		H111									-3.4886390659						5.0279217068					-2.3139582472		
		N112									-5.5667529174						5.0000022816					-0.2181204805		
		H113									-5.0685339671						5.8885507610					-0.1835511344		
		H114									-5.9082071691						4.7969158344						0.7215125852		
		H115									-6.3784893545						5.1109734565					-0.8275491556		
	
Attack	at	3-anti	
	
File:	PhBPin_antiMeAllyl_3NH3_Pd_PPh3_2_thfd.out;	structure	61		
Solution	phase	energy:	DFT(b3lyp-d3)	-3054.13375710818	au	
		Pd1										-1.7394289045						1.8631914230						0.3374056714		
		P2											-0.7025605205						1.2151496128					-1.7680716260		
		P3											-0.7070326722						0.4225440212						1.9412434520		
		C4											-3.0886333688						3.7146019517						0.4094761358		
		C5											-2.9585800071						3.0920382663						1.7088671554		
		C6											-4.1917159276						3.3734209709					-0.4261445211		
		H7											-3.7465101818						2.3801430101						1.9495873972		
		H8											-4.1211481146						3.7125778513					-1.4543571208		
		C9											-3.8183496365					-0.8326866865						5.1606474210		
		C10										-2.5112479801					-0.5400229755						5.5577612474		
		C11										-1.5550607288					-0.1591379813						4.6131854711		
		C12										-1.8997375788					-0.0589434252						3.2581071490		
		C13										-3.2178788038					-0.3486146307						2.8675260361		
		C14										-4.1698765719					-0.7408964726						3.8099008974		
		H15										-4.5605206273					-1.1273433320						5.8993705604		
		H16										-2.2330303591					-0.6034925072						6.6078344232		
		H17										-0.5481470429						0.0757337171						4.9432222328		
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		H18										-3.5028031771					-0.2580003117						1.8208345493		
		H19										-5.1855783174					-0.9668648281						3.4920193239		
		C20											2.8515694476						2.4084468997						4.1641922866		
		C21											2.6908200750						1.0203487380						4.2211733460		
		C22											1.6329106908						0.4098173348						3.5479148529		
		C23											0.7219670170						1.1830503853						2.8071378584		
		C24											0.9003631176						2.5713916089						2.7428410735		
		C25											1.9546199657						3.1806580324						3.4242914292		
		H26											3.6762164053						2.8830353451						4.6918518310		
		H27											3.3899764832						0.4110503101						4.7900669886		
		H28											1.5230120950					-0.6704637577						3.5933112186		
		H29											0.2163684547						3.1792178468						2.1619533323		
		H30											2.0737207336						4.2604943209						3.3741400159		
		C31											1.0070507226					-3.6589352678						0.4709404022		
		C32										-0.2133676536					-3.6258211673						1.1501917999		
		C33										-0.7294165024					-2.4151324094						1.6198893415		
		C34										-0.0299092439					-1.2148531464						1.4153412906		
		C35											1.2033559401					-1.2592992917						0.7437590919		
		C36											1.7145108158					-2.4694632489						0.2749822421		
		H37											1.4066350109					-4.6023276129						0.1053201318		
		H38										-0.7678841972					-4.5461415205						1.3227539016		
		H39										-1.6772756287					-2.4167400971						2.1498558807		
		H40											1.7748400433					-0.3498902308						0.5954121688		
		H41											2.6702821644					-2.4788002068					-0.2440102181		
		C42										-1.7048043489					-3.0339076271					-3.3651593156		
		C43										-1.1176565403					-2.0999238856					-4.2251464747		
		C44										-0.8239139008					-0.8141140945					-3.7685469439		
		C45										-1.1088758497					-0.4501787820					-2.4407515224		
		C46										-1.7153631499					-1.3875671630					-1.5929395053		
		C47										-2.0056087255					-2.6744927658					-2.0496454207		
		H48										-1.9310787456					-4.0364190215					-3.7228427940		
		H49										-0.8896189779					-2.3722712238					-5.2538105071		
		H50										-0.3758602341					-0.0939588609					-4.4484539518		
		H51										-1.9500990993					-1.1126018132					-0.5703640465		
		H52										-2.4636136787					-3.3946726951					-1.3757419124		
		C53											3.8901723953						1.2946918095					-1.0079464208		
		C54											3.3643577417						0.3303224229					-1.8732345457		
		C55											1.9928077715						0.2933763862					-2.1416767390		
265	
	
		C56											1.1287498612						1.2258728761					-1.5482489863		
		C57											1.6664783272						2.2012726062					-0.6900960847		
		C58											3.0359205384						2.2335737041					-0.4207499682		
		H59											4.9556160317						1.3106452777					-0.7885536293		
		H60											4.0213996680					-0.4049466606					-2.3334726878		
		H61											1.6001517249					-0.4815249472					-2.7932780722		
		H62											1.0079142035						2.9227981883					-0.2131929726		
		H63											3.4320392239						2.9796553211						0.2641220423		
		C64										-1.4457152268						3.9820324639					-5.4462142726		
		C65										-0.1485656699						3.5387892446					-5.1742028985		
		C66											0.0980524051						2.7019023738					-4.0818425405		
		C67										-0.9525676943						2.3004956940					-3.2438218458		
		C68										-2.2554687415						2.7346012014					-3.5357526360		
		C69										-2.5027419264						3.5676117337					-4.6279396961		
		H70										-1.6342966722						4.6395501254					-6.2917735526		
		H71											0.6790276784						3.8494709262					-5.8084303293		
		H72											1.1140362630						2.3767847797					-3.8769143763		
		H73										-3.0808116653						2.4126864705					-2.9056457987		
		H74										-3.5183078783						3.8964686123					-4.8397870301		
		C75										-1.4641486652						4.6673872789						5.4436729427		
		C76										-2.2532081087						3.5153409545						5.3905241816		
		C77										-2.7203201534						3.0380851327						4.1673831976		
		C78										-2.4015133580						3.6789531491						2.9522180542		
		C79										-1.6169656066						4.8479644076						3.0274223441		
		C80										-1.1585309151						5.3312583509						4.2521005608		
		H81										-1.0985231374						5.0446473842						6.3959419312		
		H82										-2.5114982789						2.9851196506						6.3043598913		
		H83										-3.3394128062						2.1458364040						4.1494712821		
		H84										-1.3272158282						5.3671322176						2.1266776239		
		H85										-0.5511079934						6.2342353276						4.2746952122		
		C86										-5.1836186502						2.2630556904					-0.1922617553		
		H87										-6.0395840126						2.3669592916					-0.8642110666		
		H88										-5.5506673239						2.2425000745						0.8379037694		
		C89										-1.7027877416						6.9319870941					-1.0218693834		
		C90										-0.3727489694						6.1168232837					-0.7886123766		
		C91											0.2025654383						5.5260388805					-2.0760892515		
		H92											0.9993840739						4.8188653317					-1.8267793926		
		H93										-0.5614170373						4.9836439799					-2.6361904861		
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		H94											0.6214356444						6.3075360965					-2.7183051058		
		C95											0.7117558314						6.8536624076					-0.0065795950		
		H96											1.5794339619						6.1973090900						0.1201679837		
		H97											1.0379610477						7.7480043005					-0.5500110119		
		H98											0.3669959298						7.1561900742						0.9856908095		
		C99										-1.8390690097						7.5622396667					-2.4050665709		
		H100									-1.0321626912						8.2834551078					-2.5791343756		
		H101									-1.8108639632						6.8056912611					-3.1937872981		
		H102									-2.7941832501						8.0953656406					-2.4742402395		
		C103									-1.9801018956						7.9700485539						0.0727605955		
		H104									-1.2714665348						8.8029635965						0.0195924426		
		H105									-2.9922806246						8.3692116845					-0.0571271915		
		H106									-1.9177933103						7.5233909093						1.0716902962		
		B107									-2.1911745722						4.8722136881					-0.1451541963		
		O108									-2.7332101280						5.9003546015					-0.8800929797		
		O109									-0.8340240762						4.9885282618						0.0224430615		
		H111									-4.7061975721						1.2967755288					-0.3994512982		
		N112									-5.6006144253						5.0395228639					-0.1448804010		
		H113									-4.9969818630						5.8403915928					-0.3286008457		
		H114									-5.9374014054						5.0980849435						0.8170680520		
		H115									-6.4088679973						5.0900745697					-0.7678788126	
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Appendix	B:	Chapter	1	1H	and	13C{1H}	NMR	Spectra	
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Figure	A-	1.	500	MHz	1H	and	125	MHz	13C{1H}	of	1.1e	in	CDCl3.	
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Me
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Figure	A-	2.	300	MHz	1H	and	75	MHz	13C{1H}	of	1.1i	in	CDCl3.	
Ph
n-Bu
n-Bu
OAc
1.1i
270	
	
	
	
Figure	A-	3.	500	MHz	1H	and	125	MHz	13C{1H}	of	1.1j-ol	in	CDCl3.	
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Figure	A-	4.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	1.1j	in	CDCl3.	
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Figure	A-	5.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	1.1k	in	CDCl3.	
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Figure	A-	6.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	1.1l	in	CDCl3.	
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Figure	A-	7.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	1.1m	in	CDCl3.	
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Figure	A-	8.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	1.2e	in	CDCl3.	(Residual	ethyl	acetate	
solvent	(~5%)	peak	is	seen.)	
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Figure	A-	9.	500	MHz	1H	and	125	MHz	13C{1H}	of	1.2f	(minor)	and	1.3f	(major)	in	CDCl3.	
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Figure	A-	10.	500	MHz	1H	and	125	MHz	13C{1H}	of	1.2h	(major)	and	1.3h		in	CDCl3.	
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Figure	A-	11.	500	MHz	1H	and	125	MHz	13C{1H}	of	1.2i	(major)	and	1.3i	in	CDCl3.		
+
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Figure	A-	12.	500	MHz	1H	and	125	MHz	13C{1H}	of	(1Z,3E)-1.4i	(minor)	and	(1E,3E)-1.4i	(major)	in	
CDCl3.		
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Figure	A-	13.	500	MHz	1H	and	125	MHz	13C{1H}	of	1.2j	(major)		and	1.3j	(minor)	in	CDCl3	(Residual	
“grease”	peak	is	seen.)	
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Figure	A-	14.	500	MHz	1H	and	125	MHz	13C{1H}	of	(1Z,3E)-1.4j	(major)	and	(1E,3E)-1.4j	
(minor)	in	CDCl3.		
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Figure	A-	15.	500	MHz	1H	and	125	MHz	13C{1H}	1.2m	(major)	and	1.3m	(minor).	  
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Appendix	C:	Chapter	2	1H	and	13C{1H}	NMR	Spectra
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Figure	A-	16.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.1b	in	C6D6.	
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Figure	A-	17.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of		2.1e	in	CDCl3.	
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Figure	A-	18.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of		2.1i	in	CDCl3.	
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Figure	A-	19.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.1k	in	CDCl3.	
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Figure	A-	20.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of		2.1l	in	CDCl3	
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Figure	A-	21.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.5d	in	CDCl3.	
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Figure	A-	22.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.5e	in	CDCl3.	
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Figure	A-	23.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.5f	in	CDCl3.	
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Figure	A-	24.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.5g		in	CDCl3.	
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Figure	A-	25.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.5h	in	CDCl3.		
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Figure	A-	26.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6a	in	CDCl3.	
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Figure	A-	27.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6b		in	CDCl3.	
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Figure	A-	28.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6c	in	CDCl3.	
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Figure	A-	29.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6d	in	CDCl3.	
n-Bui-Pr
OAc
2.6d
298	
	
 
 
	
Figure	A-	30.	300	MHz	1H	and	75	MHz	13C{1H}	NMR	of	2.	6e	in	CDCl3.	
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Figure	A-	31.	300	MHz	1H	and	75	MHz	13C{1H}	NMR	of	2.6f		in	CDCl3.	
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Figure	A-	32.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6g	in	CDCl3.	
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Figure	A-	33.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.	6h	in	CDCl3.	
n-BuPh
OAc
2.6h
NO2
302	
	
 
 
	
Figure	A-	34. 300	MHz	1H	and	75	MHz	13C{1H}	NMR	of	2.6i	in	CDCl3.		
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Figure	A-	35.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6j		in	CDCl3.	
n-Bun-Bu
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Figure	A-	36.	300	MHz	1H	and	75	MHz	13C{1H}	NMR	of	2.6k	in	CDCl3.	
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Figure	A-	37. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6l	in	CDCl3.		
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Figure	A-	38. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6m	in	CDCl3.	
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Figure	A-	39.500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.7a	in	CDCl3.	
B(pin)
n-Bun-Bu
OBz
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Figure	A-	40.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.7b	in	CDCl3.	
B(pin)
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Figure	A-	41.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.7c-ol	in	CDCl3.	
B(pin)
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Figure	A-	42.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.7c		in	CDCl3.	
B(pin)
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Figure	A-	43.500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.8a	in	CDCl3.		
B(pin)
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Figure	A-	44.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.8b	in	CDCl3.		
B(pin)
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Figure	A-	45. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.8c	in	CDCl3.		
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Figure	A-	46.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	82.8d	in	CDCl3.		
B(pin)
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Figure	A-	47.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.9a	in	CDCl3.	
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Figure	A-	48. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.9b	in	CDCl3.		
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Figure	A-	49.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.9c	in	CDCl3.		
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Figure	A-	50.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.9d	in	CDCl3.		
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Figure	A-	51.	300	MHz	1H	and	75	MHz	13C{1H}	NMR	of	2.9e	in	CDCl3.	
n-Bun-Bu
OCO2t-Bu
2.9e
CF3
320	
	
 
 
Figure	A-	52.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.9f	in	CDCl3.	
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Figure	A-	53.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10a	in	CDCl3.	
2.10a
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Figure	A-	54. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10b	in	CDCl3.	
n-Bu•
Cl
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Figure	A-	55.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10c	in	CDCl3.	
n-Bu•
F3C
2.10c
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Figure	A-	56.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10d	in	CDCl3.		
n-Bu•
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Figure	A-	57.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10e	in	CDCl3.		
2.10e
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Figure	A-	58.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10f	in	CDCl3.		
2.10f
n-Bu•
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Figure	A-	59.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10g	in	CDCl3.	
2.10g
n-Bu•
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Racemic	10a	
	
	
Enantioenriched	10a,	(Table	10,	entry	2,	after	10	min)	
	
	
Racemized	10a,	(Table	10,	entry	6,	after	60	min)	
 
 
Figure	A-	60.	HPLC	spectra	of	racemic	10a	and	representative	(S)-10a	in	10	min	and	racemized	
10a	in	60	min.	
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Figure	A-	61. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1a	in	CDCl3.		
3.1a
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Figure	A-	62. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1b	in	CDCl3.		
 
3.1b
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Figure	A-	63.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1c	in	CDCl3.			
3.1c
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Figure	A-	64.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1d	in	CDCl3.	
3.1d
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Figure	A-	65.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1e	in	CDCl3.	
3.1e
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Figure	A-	66.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1f	in	CDCl3.	
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Figure	A-	67.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1g	in	CDCl3.	
3.1g
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Figure	A-	68.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1h	in	CDCl3.	
3.1h
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Figure	A-	69.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1i	in	CDCl3.		
3.1i
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Figure	A-	70.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1j	in	CDCl3.	
3.1j
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Figure	A-	71.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1k	in	CDCl3.	
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Figure	A-	72.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3a	in	CDCl3.	 
3.3a
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Figure	A-	73.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3b	in	CDCl3.	
3.3b
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Figure	A-	74.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3c	in	CDCl3.	
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Figure	A-	75.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3d	in	CDCl3.	
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Figure	A-	76.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3e	in	CDCl3.	
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Figure	A-	77.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3f	in	CDCl3.	
3.3f
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Figure	A-	78.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3g	in	CDCl3.	
3.3g
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Figure	A-	79.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3h	in	CDCl3.	
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Figure	A-	80.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3i	in	CDCl3.	
3.3i
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igure	A-	81.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3j	in	CDCl3.	
3.3j
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Figure	A-	82.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3k	in	CDCl3.	
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Figure	A-	83.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3l	in	CDCl3.	 
3.3l
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Figure	A-	84.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3m	in	CDCl3.  
3.3m
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Figure	A-	85.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4a	in	CDCl3.	
3.4a
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Figure	A-	86.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4b	in	CDCl3.	
3.4b
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Figure	A-	87.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4c	in	CDCl3.	
3.4c
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Figure	A-	88.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4d	in	CDCl3.	
3.4d
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Figure	A-	89.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4e	in	CDCl3.	 
3.4e
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Figure	A-	90.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4f	in	CDCl3.	
3.4f
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Figure	A-	91.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4g	in	CDCl3.	 
3.4g
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Figure	A-	92.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4h	in	CDCl3.	
3.4h
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Figure	A-	93.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4i	in	CDCl3.	 
3.4i
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Figure	A-	94.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4j	in	CDCl3.	
3.4j
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Figure	A-	95.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4k	in	CDCl3.	
3.4k
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Figure	A-	96.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4l	in	CDCl3.	
3.4l
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Figure	A-	97.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4m	in	CDCl3.	
3.4m
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Figure	A-	98.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4n	in	CDCl3.	
3.4n
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Figure	A-	99.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4o	in	CDCl3.	
3.4o
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Figure	A-	100.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5a	in	CDCl3.	
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Figure	A-	101.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5b	in	CDCl3.	
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Figure	A-	102.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5c	in	CDCl3.	
3.5c
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Figure	A-	103.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5d	in	CDCl3.	
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Figure	A-	104.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5e	in	CDCl3.	
3.5e
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Figure	A-	105.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5f	in	CDCl3.	
3.5f
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Figure	A-	106.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5g	in	CDCl3.		
3.5g
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Figure	A-	107.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5h	in	CDCl3.	
3.5h
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Figure	A-	108.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5i	in	CDCl3.	
 
3.5i
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Figure	A-	109.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1c	in	CDCl3.	
4.1c
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Figure	A-	110.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1d	in	CDCl3.	
4.1d
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Figure	A-	111.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1f	in	CDCl3.	
4.1f
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Figure	A-	112.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1h	in	CDCl3.	
4.1h
N O N
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Figure	A-	113.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1i	in	CDCl3.	
N O N
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Figure	A-	114.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1j	in	CDCl3.	
4.1j
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Figure	A-	115.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1k	in	CDCl3.	
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Figure	A-	116.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4aa	in	CDCl3.	
4.4aa
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Figure	A-	117.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ab	in	CDCl3.	
4.4ab
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Figure	A-	118.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ac	in	CDCl3.	
4.4ac
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Figure	A-	119.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ad	in	CDCl3.	
4.4ad
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Figure	A-	120.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ae	in	CDCl3.	
4.4ae
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Figure	A-	121.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4af	in	CDCl3.	
4.4af
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Figure	A-	122.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ag	in	CDCl3.	
4.4ag
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Figure	A-	123.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ah	in	CDCl3.	
4.4ah
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Figure	A-	124.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4bd	in	CDCl3.	
4.4bd
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Figure	A-	125.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4cd	in	CDCl3.	
4.4af
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Figure	A-	126.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4dd	in	CDCl3.	
4.4dd
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Figure	A-	127.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ed	in	CDCl3.	
398	
	
	
	
Figure	A-	128.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4be	in	CDCl3.	
4.4be
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Figure	S21.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4ce	in	CDCl3.	
4.4ce
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Figure	A-	129.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4de	in	CDCl3.	
4.4de
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Figure	A-	130.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4fe	in	CDCl3.	
4.4fe
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Figure	A-	131.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ge	in	CDCl3.	
4.4ge
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Figure	A-	132.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5aa	in	CDCl3.	
4.5aa
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Figure	A-	133.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ab	in	CDCl3.	
4.5ab
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Figure	A-	134.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ac	in	CDCl3.	
4.5ac
406	
	
	
Figure	A-	135.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ad	in	CDCl3.	
4.5ad
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Figure	A-	136.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ae	in	CDCl3.	
4.5ae
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Figure	A-	137.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ai	in	CDCl3.	
4.5ai
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Figure	A-	138.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5aj	in	CDCl3.	
4.5aj
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Figure	A-	139.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ag	in	CDCl3.	
4.5ag
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Figure	A-	140.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ah	in	CDCl3.	
4.5ah
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Figure	A-	141.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5bd	in	CDCl3.	
4.5bd
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Figure	A-	142.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5be	in	CDCl3.	
4.5be
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Figure	A-	143.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5cd	in	CDCl3.		
4.5cd
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Figure	A-	144.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ce	in	CDCl3.	
4.5ce
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Figure	A-	145.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5dd	in	CDCl3.	
4.5dd
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Figure	A-	146.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5di	in	CDCl3.	
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Figure	A-	147.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ha	in	CDCl3.	
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Figure	A-	148.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5hi	in	CDCl3.	
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Figure	A-	149.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ia	in	CDCl3.	
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Figure	A-	150.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ik	in	CDCl3.	
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Figure	A-	151.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4jd	in	CDCl3.	
4.4jd
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Figure	A-	152.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4kb	in	CDCl3.	
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Figure	A-	153.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4kc	in	CDCl3.	
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Figure	A-	154.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4je	in	CDCl3.	
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Figure	A-	155.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4jc	in	CDCl3.	
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Figure	A-	156.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ke	in	CDCl3.	
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Figure	A-	157.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4jf	in	CDCl3.	 
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